page	event	quadrant	sample_name	position	oscillating_cn_2&3_states	cn_segments	event_region	full_text
1	1	Upper_Left	BTCA_donor_A096	12:1297595−132243589	6, 14	47	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	BTCA_donor_A096 Biliary−AdenoCA Cancer type 12:1297595−132243589 Position With other complex events Type 26 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 8; DUP: 7; h2hINV: 6; SV types t2tINV: 5; TRA: 0 292 SVs in sample 6, 14 Oscillating CN (2 and 3 states) 47 CN segments 0.9179372 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
1	2	Upper_Right	BTCA_donor_A096	18:18873445−62863653	4, 4	16	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	BTCA_donor_A096 Biliary−AdenoCA Cancer type 18:18873445−62863653 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 0 292 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 16 CN segments 0.7735152 FDR fragment joints 0.62 FDR chr. breakp. enrich. Linked to chrs
1	3	Lower_Left	BTCA_donor_A153	6:36165437−108436463	5, 10	28	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 251.87200927734375, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB BTCA_donor_A153 Biliary−AdenoCA Cancer type 6:36165437−108436463 Position With other complex events Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 4; TRA: 1 116 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 28 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
1	4	Lower_Right	BTCA_donor_B070	1:152201706−162468614	4, 5	74	{'min_x': 349.67999267578125, 'min_y': 693.2749633789062, 'max_x': 517.0438842773438, 'max_y': 839.013916015625}	170 MB 190 MB 210 MB BTCA_donor_B070 Biliary−AdenoCA Cancer type 1:152201706−162468614 Position With other complex events Type 47 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 9; DUP: 14; h2hINV: 15; SV types t2tINV: 9; TRA: 1 166 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 74 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
2	1	Upper_Left	BTCA_donor_B083	1:175210783−246161909	5, 6	16	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	BTCA_donor_B083 Biliary−AdenoCA Cancer type 1:175210783−246161909 Position With other complex events Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 7; SV types t2tINV: 2; TRA: 0 112 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 16 CN segments 0.615458 FDR fragment joints 0.04 FDR chr. breakp. enrich. Linked to chrs
2	2	Upper_Right	BTCA_donor_B083	14:35121332−87977558	4, 9	37	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	BTCA_donor_B083 Biliary−AdenoCA Cancer type 14:35121332−87977558 Position With other complex events Type 23 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 6; DUP: 1; h2hINV: 8; SV types t2tINV: 8; TRA: 0 112 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 37 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
2	3	Lower_Left	BTCA_donor_B083	18:22541678−77433482	5, 5	16	{'min_x': 49.330101013183594, 'min_y': 693.2749633789062, 'max_x': 237.71009826660156, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB 70 MB BTCA_donor_B083 Biliary−AdenoCA Cancer type 18:22541678−77433482 Position With other complex events Type 13 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 3; SV types t2tINV: 2; TRA: 1 112 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 16 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
2	4	Lower_Right	BTCA_donor_B083	22:32803334−45752862	4, 6	14	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	30 MB 40 MB BTCA_donor_B083 Biliary−AdenoCA Cancer type 22:32803334−45752862 Position With other complex events Type 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 3 112 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 14 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
3	1	Upper_Left	BTCA_donor_C080	14:22429630−73744179	4, 7	40	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	BTCA_donor_C080 Biliary−AdenoCA Cancer type 14:22429630−73744179 Position With other complex events Type 17 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 3; DUP: 7; h2hINV: 3; SV types t2tINV: 4; TRA: 9 142 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 40 CN segments 0.8172348 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
3	2	Upper_Right	BTCA_donor_R149	14:22402704−54099947	4, 5	47	{'min_x': 351.3500061035156, 'min_y': 280.6499938964844, 'max_x': 515.3779296875, 'max_y': 410.3340148925781}	BTCA_donor_R149 Biliary−AdenoCA Cancer type 14:22402704−54099947 Position With other complex events Type 29 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 10; SV types t2tINV: 9; TRA: 0 108 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 47 CN segments 0.6482122 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
3	3	Lower_Left	BTCA_donor_Y008	22:21053371−41089205	4, 11	12	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 264.7300720214844, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB BTCA_donor_Y008 Biliary−AdenoCA Cancer type 22:21053371−41089205 Position With other complex events Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 0 48 SVs in sample 4, 11 Oscillating CN (2 and 3 states) 12 CN segments 0.854603 FDR fragment joints 0 FDR chr. breakp. enrich.
3	4	Lower_Right	BTCA_donor_Y140	19:29068313−56261033	6, 7	45	{'min_x': 315.3900146484375, 'min_y': 693.2749633789062, 'max_x': 547.7603759765625, 'max_y': 839.013916015625}	30 MB 35 MB 40 MB 45 MB 50 MB 55 MB BTCA_donor_Y140 Biliary−AdenoCA Cancer type 19:29068313−56261033 Position With other complex events Type 19 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 10; SV types t2tINV: 4; TRA: 2 96 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 45 CN segments 0.5774122 FDR fragment joints 0 FDR chr. breakp. enrich.
4	1	Upper_Left	RK137	17:2039238−18611038	5, 5	5	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.3340148925781}	RK137 Biliary−AdenoCA Cancer type 17:2039238−18611038 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 1 43 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
4	2	Upper_Right	RK208	3:54159227−158898997	4, 7	23	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	RK208 Biliary−AdenoCA Cancer type 3:54159227−158898997 Position With other complex events Type 9 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 12 294 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 23 CN segments 0.6610257 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
4	3	Lower_Left	RK279	1:30955993−118910093	5, 5	15	{'min_x': 41.539798736572266, 'min_y': 693.2749633789062, 'max_x': 249.30203247070312, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB RK279 Biliary−AdenoCA Cancer type 1:30955993−118910093 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 35 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 15 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
4	4	Lower_Right	RK298	9:1239088−24282207	4, 6	24	{'min_x': 307.2099914550781, 'min_y': 693.2749633789062, 'max_x': 550.8219604492188, 'max_y': 839.013916015625}	0 MB 25 MB 50 MB 75 MB 100 MB 125 MB RK298 Biliary−AdenoCA Cancer type 9:1239088−24282207 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 3; TRA: 0 74 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 24 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
5	1	Upper_Left	RK307	6:144819172−162778287	5, 9	9	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	RK307 Biliary−AdenoCA Cancer type 6:144819172−162778287 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 5; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 0 89 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
5	2	Upper_Right	24f21425-b001-4986-aedf-5b4dd851c6ad	5:5481718−45983726	6, 9	42	{'min_x': 329.239990234375, 'min_y': 280.6499938964844, 'max_x': 537.491943359375, 'max_y': 410.3340148925781}	24f21425−b001−4986−aedf−5b4dd851c6ad Bladder−TCC Cancer type 5:5481718−45983726 Position With other complex events Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 2 271 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 42 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
5	3	Lower_Left	24f21425-b001-4986-aedf-5b4dd851c6ad	9:5086998−21286063	6, 6	26	{'min_x': 39.73979949951172, 'min_y': 693.2749633789062, 'max_x': 250.64004516601562, 'max_y': 839.013916015625}	10 MB 15 MB 20 MB 24f21425−b001−4986−aedf−5b4dd851c6ad Bladder−TCC Cancer type 9:5086998−21286063 Position With other complex events Type 6 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 5 271 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 26 CN segments 0.7425546 FDR fragment joints 0.29 FDR chr. breakp. enrich.
5	4	Lower_Right	3ed614e7-f356-4d87-985b-d3bbbae3bb40	7:12512048−21119497	4, 7	22	{'min_x': 328.04998779296875, 'min_y': 693.2749633789062, 'max_x': 554.72216796875, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 3ed614e7−f356−4d87−985b−d3bbbae3bb40 Bladder−TCC Cancer type 7:12512048−21119497 Position With other complex events Type 6 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 0; TRA: 8 449 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 22 CN segments 0.5435077 FDR fragment joints 0.22 FDR chr. breakp. enrich.
6	1	Upper_Left	3ed614e7-f356-4d87-985b-d3bbbae3bb40	8:60780756−109595289	6, 6	40	{'min_x': 38.54999923706055, 'min_y': 280.6499938964844, 'max_x': 249.17996215820312, 'max_y': 410.42401123046875}	3ed614e7−f356−4d87−985b−d3bbbae3bb40 Bladder−TCC Cancer type 8:60780756−109595289 Position With other complex events Type 23 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 9; DUP: 2; h2hINV: 7; SV types t2tINV: 5; TRA: 3 449 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 40 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich. 2:14647349−206284284; Linked to chrs
6	2	Upper_Right	3ed614e7-f356-4d87-985b-d3bbbae3bb40	12:13507658−119049122	6, 9	79	{'min_x': 328.04998779296875, 'min_y': 280.6499938964844, 'max_x': 538.6798706054688, 'max_y': 410.3340148925781}	3ed614e7−f356−4d87−985b−d3bbbae3bb40 Bladder−TCC Cancer type 12:13507658−119049122 Position With other complex events Type 32 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 11; DUP: 10; h2hINV: 5; SV types t2tINV: 6; TRA: 6 449 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 79 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
6	3	Lower_Left	3ed614e7-f356-4d87-985b-d3bbbae3bb40	17:28237017−34001517	5, 5	31	{'min_x': 38.360198974609375, 'min_y': 693.2749633789062, 'max_x': 249.17996215820312, 'max_y': 834.6940307617188}	20 MB 30 MB 40 MB 3ed614e7−f356−4d87−985b−d3bbbae3bb40 Bladder−TCC Cancer type 17:28237017−34001517 Position With other complex events Type 9 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 5; SV types t2tINV: 2; TRA: 19 449 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 31 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
6	4	Lower_Right	3ed614e7-f356-4d87-985b-d3bbbae3bb40	22:19474849−40455649	4, 6	32	{'min_x': 313.260009765625, 'min_y': 693.2749633789062, 'max_x': 553.4498291015625, 'max_y': 834.6940307617188}	20 MB 25 MB 30 MB 35 MB 40 MB 3ed614e7−f356−4d87−985b−d3bbbae3bb40 Bladder−TCC Cancer type 22:19474849−40455649 Position With other complex events Type 10 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 8 449 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 32 CN segments 0.641841 FDR fragment joints 0 FDR chr. breakp. enrich.
7	1	Upper_Left	5d54c742-5a8e-4c40-8d62-95e75e210ab8	1:39492660−116722898	4, 5	39	{'min_x': 38.86989974975586, 'min_y': 280.6499938964844, 'max_x': 248.8579559326172, 'max_y': 410.42401123046875}	5d54c742−5a8e−4c40−8d62−95e75e210ab8 Bladder−TCC Cancer type 1:39492660−116722898 Position With other complex events Type 18 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 6; SV types t2tINV: 6; TRA: 6 175 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 39 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 4:72403638−190385401; Linked to chrs
7	2	Upper_Right	8c1dd7f7-b74a-4fa2-b6a7-86f0348d2567	7:5163068−112416677	5, 5	35	{'min_x': 330.07000732421875, 'min_y': 280.6499938964844, 'max_x': 536.6539306640625, 'max_y': 410.3340148925781}	8c1dd7f7−b74a−4fa2−b6a7−86f0348d2567 Bladder−TCC Cancer type 7:5163068−112416677 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 2; TRA: 0 80 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 35 CN segments 0.9625775 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
7	3	Lower_Left	904a8757-e0c5-41ef-b583-c8f170caaac1	17:34199415−58666962	4, 4	17	{'min_x': 40.539798736572266, 'min_y': 693.2749633789062, 'max_x': 247.19195556640625, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB 904a8757−e0c5−41ef−b583−c8f170caaac1 Bladder−TCC Cancer type 17:34199415−58666962 Position With other complex events Type 29 Interleaved intrachr. SVs 74 Total SVs (intrachr. + transl.) DEL: 5; DUP: 9; h2hINV: 7; SV types t2tINV: 8; TRA: 45 274 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 17 CN segments 0.9807783 FDR fragment joints 0 FDR chr. breakp. enrich.
7	4	Lower_Right	9c274536-3ca1-4f0e-93a8-1688074d862f	8:40629167−102330843	6, 8	39	{'min_x': 309.9200134277344, 'min_y': 693.2749633789062, 'max_x': 556.8921508789062, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB 120 MB 140 MB 9c274536−3ca1−4f0e−93a8−1688074d862f Bladder−TCC Cancer type 8:40629167−102330843 Position With other complex events Type 20 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 6; DUP: 2; h2hINV: 6; SV types t2tINV: 6; TRA: 14 270 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 39 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
8	1	Upper_Left	9c274536-3ca1-4f0e-93a8-1688074d862f	17:11629450−33500976	6, 7	34	{'min_x': 40.539798736572266, 'min_y': 280.6499938964844, 'max_x': 247.19195556640625, 'max_y': 410.3340148925781}	9c274536−3ca1−4f0e−93a8−1688074d862f Bladder−TCC Cancer type 17:11629450−33500976 Position With other complex events Type 37 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 10; DUP: 9; h2hINV: 8; SV types t2tINV: 10; TRA: 8 270 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 34 CN segments 0.9849105 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
8	2	Upper_Right	ca554128-da9d-4f37-9560-ca083509e01d	1:168849602−235165090	6, 8	72	{'min_x': 329.0400085449219, 'min_y': 280.6499938964844, 'max_x': 537.68994140625, 'max_y': 410.42401123046875}	ca554128−da9d−4f37−9560−ca083509e01d Bladder−TCC Cancer type 1:168849602−235165090 Position With other complex events Type 30 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 11; DUP: 7; h2hINV: 6; SV types t2tINV: 6; TRA: 8 231 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 72 CN segments 0.7282798 FDR fragment joints 0 FDR chr. breakp. enrich. 3:330518−149204905; Linked to chrs
8	3	Lower_Left	ca554128-da9d-4f37-9560-ca083509e01d	7:7489162−138751893	6, 8	66	{'min_x': 39.539798736572266, 'min_y': 693.2749633789062, 'max_x': 248.18995666503906, 'max_y': 839.013916015625}	50 MB 100 MB ca554128−da9d−4f37−9560−ca083509e01d Bladder−TCC Cancer type 7:7489162−138751893 Position With other complex events Type 28 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 6; DUP: 6; h2hINV: 7; SV types t2tINV: 9; TRA: 3 231 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 66 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
8	4	Lower_Right	ca554128-da9d-4f37-9560-ca083509e01d	14:34967294−99710526	4, 4	13	{'min_x': 325.4200134277344, 'min_y': 693.2749633789062, 'max_x': 561.4420776367188, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB ca554128−da9d−4f37−9560−ca083509e01d Bladder−TCC Cancer type 14:34967294−99710526 Position With other complex events Type 16 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 4 231 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 13 CN segments 0.9625775 FDR fragment joints 0 FDR chr. breakp. enrich.
9	1	Upper_Left	CGP_donor_1437423	3:99097210−115323895	5, 8	19	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	CGP_donor_1437423 Bone−Benign Cancer type 3:99097210−115323895 Position With other complex events Type 20 Interleaved intrachr. SVs 62 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 5; SV types t2tINV: 3; TRA: 42 145 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 19 CN segments 0.7091283 FDR fragment joints 0 FDR chr. breakp. enrich. 6:41870611−56460500; Linked to chrs
9	2	Upper_Right	CGP_donor_1437423	6:41870611−56460501	5, 6	40	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1437423 Bone−Benign Cancer type 6:41870611−56460501 Position With other complex events Type 20 Interleaved intrachr. SVs 70 Total SVs (intrachr. + transl.) DEL: 8; DUP: 3; h2hINV: 5; SV types t2tINV: 4; TRA: 50 145 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 40 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
9	3	Lower_Left	CGP_donor_1397077	5:759551−44322947	5, 8	88	{'min_x': 33.68980026245117, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 834.6940307617188}	50 MB 100 MB CGP_donor_1397077 Bone−Osteosarc Cancer type 5:759551−44322947 Position With other complex events Type 25 Interleaved intrachr. SVs 90 Total SVs (intrachr. + transl.) DEL: 8; DUP: 6; h2hINV: 6; SV types t2tINV: 5; TRA: 65 379 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 88 CN segments 0.935101 FDR fragment joints 0 FDR chr. breakp. enrich.
9	4	Lower_Right	CGP_donor_1397077	18:26924845−64011244	4, 7	21	{'min_x': 337.3999938964844, 'min_y': 693.2749633789062, 'max_x': 540.1602172851562, 'max_y': 839.013916015625}	20 MB 30 MB 40 MB 50 MB 60 MB CGP_donor_1397077 Bone−Osteosarc Cancer type 18:26924845−64011244 Position With other complex events Type 6 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 0; TRA: 16 379 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 21 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
10	1	Upper_Left	CGP_donor_1397077	21:30627381−40515319	4, 6	21	{'min_x': 38.70000076293945, 'min_y': 276.3299865722656, 'max_x': 249.0299530029297, 'max_y': 410.3340148925781}	CGP_donor_1397077 Bone−Osteosarc Cancer type 21:30627381−40515319 Position With other complex events Type 9 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 4; SV types t2tINV: 1; TRA: 38 379 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 21 CN segments 0.8864524 FDR fragment joints 0 FDR chr. breakp. enrich. 5:759551−44322946;6:88458092−155828130 Linked to chrs
10	2	Upper_Right	CGP_donor_1397083	8:95509557−130921648	4, 5	28	{'min_x': 352.4700012207031, 'min_y': 280.6499938964844, 'max_x': 514.260009765625, 'max_y': 410.42401123046875}	CGP_donor_1397083 Bone−Osteosarc Cancer type 8:95509557−130921648 Position With other complex events Type 9 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 2; SV types t2tINV: 0; TRA: 20 142 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 28 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 13:101502303−104764633; Linked to chrs
10	3	Lower_Left	CGP_donor_1437403	1:149900456−232658583	6, 11	36	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 227.28216552734375, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB CGP_donor_1437403 Bone−Osteosarc Cancer type 1:149900456−232658583 Position With other complex events Type 28 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 8; DUP: 6; h2hINV: 8; SV types t2tINV: 6; TRA: 1 445 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 36 CN segments 0.8824283 FDR fragment joints 0 FDR chr. breakp. enrich.
10	4	Lower_Right	CGP_donor_1475256	4:1628586−119770886	6, 8	11	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 556.5823974609375, 'max_y': 839.013916015625}	30 MB 60 MB 90 MB 120 MB CGP_donor_1475256 Bone−Osteosarc Cancer type 4:1628586−119770886 Position With other complex events Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 1 217 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 11 CN segments 0.6776251 FDR fragment joints 0.81 FDR chr. breakp. enrich.
11	1	Upper_Left	CGP_donor_1490914	5:343444−40967400	6, 15	23	{'min_x': 61.849998474121094, 'min_y': 280.6499938964844, 'max_x': 225.87779235839844, 'max_y': 410.42401123046875}	CGP_donor_1490914 Bone−Osteosarc Cancer type 5:343444−40967400 Position With other complex events Type 28 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 10; DUP: 8; h2hINV: 4; SV types t2tINV: 6; TRA: 4 462 SVs in sample 6, 15 Oscillating CN (2 and 3 states) 23 CN segments 0.8505431 FDR fragment joints 0.49 FDR chr. breakp. enrich. 10:50348934−97731678; Linked to chrs
11	2	Upper_Right	CGP_donor_1490914	11:101720341−105872169	6, 7	43	{'min_x': 349.67999267578125, 'min_y': 280.6499938964844, 'max_x': 517.0442504882812, 'max_y': 410.42401123046875}	CGP_donor_1490914 Bone−Osteosarc Cancer type 11:101720341−105872169 Position With other complex events Type 35 Interleaved intrachr. SVs 64 Total SVs (intrachr. + transl.) DEL: 11; DUP: 11; h2hINV: 5; SV types t2tINV: 8; TRA: 29 462 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 43 CN segments 0.9840364 FDR fragment joints 0 FDR chr. breakp. enrich. 6:76106264−166727719; Linked to chrs
11	3	Lower_Left	CGP_donor_1490914	12:75035974−120211927	4, 8	8	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	50 MB 100 MB CGP_donor_1490914 Bone−Osteosarc Cancer type 12:75035974−120211927 Position With other complex events Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 1 462 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.9599662 FDR fragment joints 0.51 FDR chr. breakp. enrich.
11	4	Lower_Right	CGP_donor_1490914	13:104316198−106010540	5, 7	7	{'min_x': 344.2300109863281, 'min_y': 693.2749633789062, 'max_x': 543.5220947265625, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB CGP_donor_1490914 Bone−Osteosarc Cancer type 13:104316198−106010540 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 2; SV types t2tINV: 1; TRA: 4 462 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.7995907 FDR fragment joints 0.82 FDR chr. breakp. enrich.
12	1	Upper_Left	CGP_donor_1490914	16:53455552−89780377	6, 11	26	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1490914 Bone−Osteosarc Cancer type 16:53455552−89780377 Position With other complex events Type 15 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 5; SV types t2tINV: 6; TRA: 15 462 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 26 CN segments 0.662962 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
12	2	Upper_Right	CGP_donor_1528364	1:2249362−182869104	6, 8	64	{'min_x': 323.19000244140625, 'min_y': 276.3299865722656, 'max_x': 543.5379638671875, 'max_y': 410.3340148925781}	CGP_donor_1528364 Bone−Osteosarc Cancer type 1:2249362−182869104 Position With other complex events Type 29 Interleaved intrachr. SVs 86 Total SVs (intrachr. + transl.) DEL: 10; DUP: 5; h2hINV: 7; SV types t2tINV: 7; TRA: 57 927 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 64 CN segments 0.615458 FDR fragment joints 0.04 FDR chr. breakp. enrich. 2:98265301−240710955;3:39705096−116872806 Linked to chrs
12	3	Lower_Left	CGP_donor_1528371	X:137305293−154877002	6, 14	34	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB CGP_donor_1528371 Bone−Osteosarc Cancer type X:137305293−154877002 Position With other complex events Type 23 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 6; SV types t2tINV: 9; TRA: 7 349 SVs in sample 6, 14 Oscillating CN (2 and 3 states) 34 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
12	4	Lower_Right	CGP_donor_1528374	2:171676936−222890322	5, 6	11	{'min_x': 339.1199951171875, 'min_y': 693.2749633789062, 'max_x': 514.3021240234375, 'max_y': 839.013916015625}	125 MB 150 MB 175 MB 200 MB CGP_donor_1528374 Bone−Osteosarc Cancer type 2:171676936−222890322 Position With other complex events Type 7 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 3; TRA: 4 113 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 11 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
13	1	Upper_Left	CGP_donor_1691133	X:56780045−99873812	6, 7	38	{'min_x': 35.360198974609375, 'min_y': 276.3299865722656, 'max_x': 252.3719482421875, 'max_y': 410.3340148925781}	CGP_donor_1691133 Bone−Osteosarc Cancer type X:56780045−99873812 Position With other complex events Type 14 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 6; DUP: 1; h2hINV: 3; SV types t2tINV: 4; TRA: 34 325 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 38 CN segments 0.7908979 FDR fragment joints 0 FDR chr. breakp. enrich. 19:1003699−31085706;6:32255732−170226667 Linked to chrs
13	2	Upper_Right	CGP_donor_1691207	1:146556486−247517843	6, 10	26	{'min_x': 326.5299987792969, 'min_y': 276.3299865722656, 'max_x': 540.1959838867188, 'max_y': 410.3340148925781}	CGP_donor_1691207 Bone−Osteosarc Cancer type 1:146556486−247517843 Position With other complex events Type 10 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 5 415 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 26 CN segments 0.6471662 FDR fragment joints 0.57 FDR chr. breakp. enrich. 2:5332159−125723075;7:3613250−157967148 Linked to chrs
13	3	Lower_Left	CGP_donor_1691207	16:117927−85638502	4, 11	21	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 253.74996948242188, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB CGP_donor_1691207 Bone−Osteosarc Cancer type 16:117927−85638502 Position With other complex events Type 16 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 2; SV types t2tINV: 5; TRA: 2 415 SVs in sample 4, 11 Oscillating CN (2 and 3 states) 21 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
13	4	Lower_Right	CGP_donor_1691210	19:7542257−27863221	5, 9	32	{'min_x': 314.6300048828125, 'min_y': 693.2749633789062, 'max_x': 560.0101318359375, 'max_y': 839.013916015625}	8 MB 12 MB 16 MB 20 MB 24 MB 28 MB CGP_donor_1691210 Bone−Osteosarc Cancer type 19:7542257−27863221 Position With other complex events Type 11 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 3; SV types t2tINV: 3; TRA: 9 183 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 32 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich.
14	1	Upper_Left	CGP_donor_1691211	4:39643156−81985932	4, 5	43	{'min_x': 35.360198974609375, 'min_y': 272.0099792480469, 'max_x': 252.3719482421875, 'max_y': 410.4242248535156}	CGP_donor_1691211 Bone−Osteosarc Cancer type 4:39643156−81985932 Position With other complex events Type 8 Interleaved intrachr. SVs 51 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 1; SV types t2tINV: 2; TRA: 43 606 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 43 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 16:6326850−23636185;20:14482537−55742990 5:27518365−44838184;9:72321762−137935608 Linked to chrs
14	2	Upper_Right	CGP_donor_1691211	5:27518365−44838185	5, 10	43	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	CGP_donor_1691211 Bone−Osteosarc Cancer type 5:27518365−44838185 Position With other complex events Type 15 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 4; SV types t2tINV: 2; TRA: 15 606 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 43 CN segments 0.8572806 FDR fragment joints 0.01 FDR chr. breakp. enrich. 9:72321762−137935608; Linked to chrs
14	3	Lower_Left	CGP_donor_1691211	11:1368421−44085211	4, 11	43	{'min_x': 35.360198974609375, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 830.3740844726562}	50 MB 100 MB CGP_donor_1691211 Bone−Osteosarc Cancer type 11:1368421−44085211 Position With other complex events Type 15 Interleaved intrachr. SVs 65 Total SVs (intrachr. + transl.) DEL: 6; DUP: 1; h2hINV: 3; SV types t2tINV: 5; TRA: 50 606 SVs in sample 4, 11 Oscillating CN (2 and 3 states) 43 CN segments 0.9794281 FDR fragment joints 0 FDR chr. breakp. enrich.
14	4	Lower_Right	CGP_donor_1691211	19:7281972−41134872	4, 8	77	{'min_x': 326.5199890136719, 'min_y': 693.2749633789062, 'max_x': 542.6403198242188, 'max_y': 830.3740844726562}	10 MB 20 MB 30 MB 40 MB CGP_donor_1691211 Bone−Osteosarc Cancer type 19:7281972−41134872 Position With other complex events Type 23 Interleaved intrachr. SVs 86 Total SVs (intrachr. + transl.) DEL: 7; DUP: 7; h2hINV: 3; SV types t2tINV: 6; TRA: 63 606 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 77 CN segments 0.7829107 FDR fragment joints 0 FDR chr. breakp. enrich.
15	1	Upper_Left	CGP_donor_1691212	1:240384329−248714171	6, 17	23	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1691212 Bone−Osteosarc Cancer type 1:240384329−248714171 Position With other complex events Type 19 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 1; DUP: 7; h2hINV: 7; SV types t2tINV: 4; TRA: 0 135 SVs in sample 6, 17 Oscillating CN (2 and 3 states) 23 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
15	2	Upper_Right	CGP_donor_1691213	8:98131760−131862131	6, 6	53	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	CGP_donor_1691213 Bone−Osteosarc Cancer type 8:98131760−131862131 Position With other complex events Type 10 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 3; SV types t2tINV: 4; TRA: 44 596 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 53 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich. 12:38831735−119704558; Linked to chrs
15	3	Lower_Left	CGP_donor_1691213	17:11128144−68285285	4, 10	98	{'min_x': 32.019901275634766, 'min_y': 693.2749633789062, 'max_x': 225.87779235839844, 'max_y': 834.6940307617188}	20 MB 40 MB 60 MB CGP_donor_1691213 Bone−Osteosarc Cancer type 17:11128144−68285285 Position With other complex events Type 31 Interleaved intrachr. SVs 108 Total SVs (intrachr. + transl.) DEL: 11; DUP: 8; h2hINV: 5; SV types t2tINV: 7; TRA: 77 596 SVs in sample 4, 10 Oscillating CN (2 and 3 states) 98 CN segments 0.9685443 FDR fragment joints 0 FDR chr. breakp. enrich.
15	4	Lower_Right	CGP_donor_1691214	1:155935299−166050473	6, 6	19	{'min_x': 352.8399963378906, 'min_y': 693.2749633789062, 'max_x': 518.9521484375, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB CGP_donor_1691214 Bone−Osteosarc Cancer type 1:155935299−166050473 Position With other complex events Type 14 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 7; DUP: 0; h2hINV: 2; SV types t2tINV: 5; TRA: 1 652 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 19 CN segments 0.5435077 FDR fragment joints 0.16 FDR chr. breakp. enrich.
16	1	Upper_Left	CGP_donor_1691214	2:11400−232123609	6, 9	70	{'min_x': 32.019901275634766, 'min_y': 272.0099792480469, 'max_x': 255.70394897460938, 'max_y': 410.4242248535156}	CGP_donor_1691214 Bone−Osteosarc Cancer type 2:11400−232123609 Position With other complex events Type 20 Interleaved intrachr. SVs 60 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 4; SV types t2tINV: 6; TRA: 40 652 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 70 CN segments 0.6776251 FDR fragment joints 0.04 FDR chr. breakp. enrich. 1:155935299−166050472;14:41964680−78837997 3:29117586−189128944;X:48348455−150018346 Linked to chrs
16	2	Upper_Right	CGP_donor_1691217	6:109694663−128848927	5, 8	26	{'min_x': 322.8599853515625, 'min_y': 276.3299865722656, 'max_x': 543.8639526367188, 'max_y': 410.3340148925781}	CGP_donor_1691217 Bone−Osteosarc Cancer type 6:109694663−128848927 Position With other complex events Type 6 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 2; SV types t2tINV: 2; TRA: 9 380 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 26 CN segments 0.615458 FDR fragment joints 0.02 FDR chr. breakp. enrich. 14:27063592−79165065;X:88486379−153095440 Linked to chrs
16	3	Lower_Left	CGP_donor_1232859	11:68987281−88452236	4, 8	82	{'min_x': 33.68980026245117, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 834.6940307617188}	30 MB 50 MB 70 MB CGP_donor_1232859 Breast−AdenoCA Cancer type 11:68987281−88452236 Position With other complex events Type 24 Interleaved intrachr. SVs 73 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 7; SV types t2tINV: 5; TRA: 49 316 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 82 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
16	4	Lower_Right	CGP_donor_1232859	12:50134439−83407108	5, 9	18	{'min_x': 320.489990234375, 'min_y': 693.2749633789062, 'max_x': 536.2501831054688, 'max_y': 839.013916015625}	50 MB 60 MB 70 MB 80 MB CGP_donor_1232859 Breast−AdenoCA Cancer type 12:50134439−83407108 Position With other complex events Type 14 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 3; SV types t2tINV: 4; TRA: 2 316 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 18 CN segments 0.9501265 FDR fragment joints 0.09 FDR chr. breakp. enrich.
17	1	Upper_Left	CGP_donor_1232859	20:33258582−62543745	5, 10	145	{'min_x': 33.68980026245117, 'min_y': 276.3299865722656, 'max_x': 254.03794860839844, 'max_y': 410.3340148925781}	CGP_donor_1232859 Breast−AdenoCA Cancer type 20:33258582−62543745 Position With other complex events Type 71 Interleaved intrachr. SVs 130 Total SVs (intrachr. + transl.) DEL: 21; DUP: 14; h2hINV: 18; SV types t2tINV: 18; TRA: 59 316 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 145 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 6:56201574−162603779;12:50134439−83407107 Linked to chrs
17	2	Upper_Right	CGP_donor_1234121	7:37201530−147378535	4, 7	44	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1234121 Breast−AdenoCA Cancer type 7:37201530−147378535 Position With other complex events Type 25 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 4; DUP: 9; h2hINV: 5; SV types t2tINV: 7; TRA: 2 149 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 44 CN segments 0.8393975 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
17	3	Lower_Left	CGP_donor_1234121	11:63368164−108986358	5, 7	37	{'min_x': 51.53010177612305, 'min_y': 693.2749633789062, 'max_x': 225.45208740234375, 'max_y': 839.013916015625}	70 MB 80 MB 90 MB 100 MB CGP_donor_1234121 Breast−AdenoCA Cancer type 11:63368164−108986358 Position With other complex events Type 20 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 7; SV types t2tINV: 5; TRA: 13 149 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 37 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
17	4	Lower_Right	CGP_donor_1234124	17:36804652−65070726	5, 8	49	{'min_x': 324.45001220703125, 'min_y': 693.2749633789062, 'max_x': 530.4601440429688, 'max_y': 839.013916015625}	20 MB 30 MB 40 MB 50 MB 60 MB CGP_donor_1234124 Breast−AdenoCA Cancer type 17:36804652−65070726 Position With other complex events Type 26 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 7; SV types t2tINV: 9; TRA: 6 95 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 49 CN segments 0.9501265 FDR fragment joints 0 FDR chr. breakp. enrich.
18	1	Upper_Left	CGP_donor_1337214	11:68314464−85167264	4, 9	36	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1337214 Breast−AdenoCA Cancer type 11:68314464−85167264 Position With other complex events Type 12 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 5; SV types t2tINV: 1; TRA: 7 161 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 36 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
18	2	Upper_Right	CGP_donor_1337217	11:712704−77789504	5, 7	16	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1337217 Breast−AdenoCA Cancer type 11:712704−77789504 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 0 143 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 16 CN segments 0.7735152 FDR fragment joints 0.02 FDR chr. breakp. enrich. Linked to chrs
18	3	Lower_Left	CGP_donor_1337217	17:29313383−46309227	4, 6	29	{'min_x': 35.960201263427734, 'min_y': 693.2749633789062, 'max_x': 267.119873046875, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB 70 MB 80 MB CGP_donor_1337217 Breast−AdenoCA Cancer type 17:29313383−46309227 Position With other complex events Type 14 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 3; SV types t2tINV: 3; TRA: 9 143 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 29 CN segments 0.9990251 FDR fragment joints 0 FDR chr. breakp. enrich.
18	4	Lower_Right	CGP_donor_1337220	11:60734477−70720476	4, 6	19	{'min_x': 345.3599853515625, 'min_y': 693.2749633789062, 'max_x': 541.81005859375, 'max_y': 839.013916015625}	62.5 MB 65 MB 67.5 MB 70 MB CGP_donor_1337220 Breast−AdenoCA Cancer type 11:60734477−70720476 Position With other complex events Type 13 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 3; SV types t2tINV: 2; TRA: 16 46 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 19 CN segments 0.7359483 FDR fragment joints 0 FDR chr. breakp. enrich.
19	1	Upper_Left	CGP_donor_1337223	10:76016429−95343437	4, 6	107	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1337223 Breast−AdenoCA Cancer type 10:76016429−95343437 Position With other complex events Type 27 Interleaved intrachr. SVs 89 Total SVs (intrachr. + transl.) DEL: 8; DUP: 4; h2hINV: 9; SV types t2tINV: 6; TRA: 62 318 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 107 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
19	2	Upper_Right	CGP_donor_1337223	17:48154795−54905796	6, 6	14	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1337223 Breast−AdenoCA Cancer type 17:48154795−54905796 Position With other complex events Type 8 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 4; TRA: 5 318 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 14 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
19	3	Lower_Left	CGP_donor_1337225	19:5673576−21753985	4, 9	22	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 231.45999145507812, 'max_y': 839.013916015625}	10 MB 15 MB 20 MB CGP_donor_1337225 Breast−AdenoCA Cancer type 19:5673576−21753985 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 1; SV types t2tINV: 2; TRA: 0 53 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 22 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
19	4	Lower_Right	CGP_donor_1337226	11:364948−79470446	5, 6	69	{'min_x': 308.3599853515625, 'min_y': 693.2749633789062, 'max_x': 560.010009765625, 'max_y': 839.013916015625}	0 MB 20 MB 40 MB 60 MB 80 MB CGP_donor_1337226 Breast−AdenoCA Cancer type 11:364948−79470446 Position With other complex events Type 21 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 5; SV types t2tINV: 7; TRA: 27 473 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 69 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
20	1	Upper_Left	CGP_donor_1347742	14:28909864−42732595	4, 9	16	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1347742 Breast−AdenoCA Cancer type 14:28909864−42732595 Position With other complex events Type 13 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 4; TRA: 2 230 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 16 CN segments 0.925252 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
20	2	Upper_Right	CGP_donor_1347742	17:29361754−67397898	4, 8	68	{'min_x': 321.5199890136719, 'min_y': 276.3299865722656, 'max_x': 545.2039794921875, 'max_y': 410.3340148925781}	CGP_donor_1347742 Breast−AdenoCA Cancer type 17:29361754−67397898 Position With other complex events Type 35 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 11; DUP: 9; h2hINV: 6; SV types t2tINV: 9; TRA: 14 230 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 68 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. 3:25050231−162503836;15:66537420−102369379 Linked to chrs
20	3	Lower_Left	CGP_donor_1353427	10:9142443−92352593	5, 18	30	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 225.29014587402344, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB CGP_donor_1353427 Breast−AdenoCA Cancer type 10:9142443−92352593 Position With other complex events Type 30 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 6; DUP: 9; h2hINV: 7; SV types t2tINV: 8; TRA: 4 267 SVs in sample 5, 18 Oscillating CN (2 and 3 states) 30 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
20	4	Lower_Right	CGP_donor_1353427	17:30795695−44125802	4, 9	16	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB CGP_donor_1353427 Breast−AdenoCA Cancer type 17:30795695−44125802 Position With other complex events Type 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 6 267 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 16 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
21	1	Upper_Left	CGP_donor_1353434	15:28941386−52345122	5, 14	14	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1353434 Breast−AdenoCA Cancer type 15:28941386−52345122 Position With other complex events Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 5; DUP: 1; h2hINV: 4; SV types t2tINV: 6; TRA: 0 291 SVs in sample 5, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
21	2	Upper_Right	CGP_donor_1364028	6:2192497−33282947	4, 6	33	{'min_x': 323.19000244140625, 'min_y': 276.3299865722656, 'max_x': 543.5379638671875, 'max_y': 410.3340148925781}	CGP_donor_1364028 Breast−AdenoCA Cancer type 6:2192497−33282947 Position With other complex events Type 14 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 4; SV types t2tINV: 3; TRA: 28 203 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 33 CN segments 0.8536199 FDR fragment joints 0 FDR chr. breakp. enrich. 14:84761805−88311295;20:13487327−62399710 Linked to chrs
21	3	Lower_Left	CGP_donor_1364033	7:94323289−158670701	5, 9	50	{'min_x': 33.68980026245117, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 834.6940307617188}	80 MB 120 MB CGP_donor_1364033 Breast−AdenoCA Cancer type 7:94323289−158670701 Position With other complex events Type 25 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 6; SV types t2tINV: 6; TRA: 4 529 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 50 CN segments 1 FDR fragment joints 0.01 FDR chr. breakp. enrich.
21	4	Lower_Right	CGP_donor_1364033	10:74137063−96621191	5, 5	56	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	30 MB 60 MB 90 MB CGP_donor_1364033 Breast−AdenoCA Cancer type 10:74137063−96621191 Position With other complex events Type 16 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 6; SV types t2tINV: 3; TRA: 25 529 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 56 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
22	1	Upper_Left	CGP_donor_1364033	11:32528936−85324051	6, 14	25	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	CGP_donor_1364033 Breast−AdenoCA Cancer type 11:32528936−85324051 Position With other complex events Type 26 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 8; SV types t2tINV: 9; TRA: 2 529 SVs in sample 6, 14 Oscillating CN (2 and 3 states) 25 CN segments 0.615458 FDR fragment joints 0.03 FDR chr. breakp. enrich. 3:132552596−181241473; Linked to chrs
22	2	Upper_Right	CGP_donor_1364033	12:38404016−75256147	4, 5	86	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	CGP_donor_1364033 Breast−AdenoCA Cancer type 12:38404016−75256147 Position With other complex events Type 32 Interleaved intrachr. SVs 58 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 7; SV types t2tINV: 12; TRA: 26 529 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 86 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 10:74137063−96621190; Linked to chrs
22	3	Lower_Left	CGP_donor_1364033	15:31008365−57097215	5, 14	23	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 263.119873046875, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB CGP_donor_1364033 Breast−AdenoCA Cancer type 15:31008365−57097215 Position With other complex events Type 18 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 7; DUP: 4; h2hINV: 4; SV types t2tINV: 3; TRA: 1 529 SVs in sample 5, 14 Oscillating CN (2 and 3 states) 23 CN segments 0.615458 FDR fragment joints 0.03 FDR chr. breakp. enrich.
22	4	Lower_Right	CGP_donor_1364033	16:54538858−83487717	5, 11	20	{'min_x': 339.4100036621094, 'min_y': 693.2749633789062, 'max_x': 547.5401611328125, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB CGP_donor_1364033 Breast−AdenoCA Cancer type 16:54538858−83487717 Position With other complex events Type 21 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 7; SV types t2tINV: 7; TRA: 2 529 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 20 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
23	1	Upper_Left	CGP_donor_1364033	20:23008810−61019046	5, 8	44	{'min_x': 32.019901275634766, 'min_y': 276.3299865722656, 'max_x': 255.70394897460938, 'max_y': 410.3340148925781}	CGP_donor_1364033 Breast−AdenoCA Cancer type 20:23008810−61019046 Position With other complex events Type 19 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 3; SV types t2tINV: 7; TRA: 10 529 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 44 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 17:15573740−80067669;5:154600947−177590688 Linked to chrs
23	2	Upper_Right	CGP_donor_1374616	19:34372322−59071044	5, 8	31	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	CGP_donor_1374616 Breast−AdenoCA Cancer type 19:34372322−59071044 Position With other complex events Type 13 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 2; SV types t2tINV: 4; TRA: 4 144 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 31 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. X:3867520−67168966; Linked to chrs
23	3	Lower_Left	CGP_donor_1397086	5:66307170−180674011	6, 17	32	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 269.55206298828125, 'max_y': 839.013916015625}	90 MB 120 MB 150 MB 180 MB CGP_donor_1397086 Breast−AdenoCA Cancer type 5:66307170−180674011 Position With other complex events Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 5; DUP: 7; h2hINV: 3; SV types t2tINV: 2; TRA: 0 82 SVs in sample 6, 17 Oscillating CN (2 and 3 states) 32 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
23	4	Lower_Right	CGP_donor_1397086	16:51856069−69324699	5, 10	19	{'min_x': 351.3500061035156, 'min_y': 693.2749633789062, 'max_x': 515.3779296875, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB CGP_donor_1397086 Breast−AdenoCA Cancer type 16:51856069−69324699 Position With other complex events Type 39 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 8; DUP: 7; h2hINV: 14; SV types t2tINV: 10; TRA: 0 82 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 19 CN segments 0.6278017 FDR fragment joints 0 FDR chr. breakp. enrich.
24	1	Upper_Left	CGP_donor_1397260	6:38510448−42541219	5, 12	12	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1397260 Breast−AdenoCA Cancer type 6:38510448−42541219 Position With other complex events Type 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 0; SV types t2tINV: 2; TRA: 3 160 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
24	2	Upper_Right	CGP_donor_1397262	9:1026203−36225240	4, 4	32	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1397262 Breast−AdenoCA Cancer type 9:1026203−36225240 Position With other complex events Type 9 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 4; SV types t2tINV: 4; TRA: 14 235 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 32 CN segments 0.2592493 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
24	3	Lower_Left	CGP_donor_1397262	16:937916−47287050	4, 9	14	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 251.66004943847656, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB CGP_donor_1397262 Breast−AdenoCA Cancer type 16:937916−47287050 Position With other complex events Type 13 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 11 235 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 14 CN segments 0.7568568 FDR fragment joints 0 FDR chr. breakp. enrich.
24	4	Lower_Right	CGP_donor_1397262	20:43024445−61292598	4, 6	64	{'min_x': 313.8800048828125, 'min_y': 693.2749633789062, 'max_x': 552.8101196289062, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB 60 MB CGP_donor_1397262 Breast−AdenoCA Cancer type 20:43024445−61292598 Position With other complex events Type 25 Interleaved intrachr. SVs 68 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 8; SV types t2tINV: 8; TRA: 43 235 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 64 CN segments 0.7345058 FDR fragment joints 0 FDR chr. breakp. enrich.
25	1	Upper_Left	CGP_donor_1397278	8:36028735−142305374	6, 12	72	{'min_x': 60.18009948730469, 'min_y': 280.6499938964844, 'max_x': 227.54379272460938, 'max_y': 410.3340148925781}	CGP_donor_1397278 Breast−AdenoCA Cancer type 8:36028735−142305374 Position With other complex events Type 40 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 9; DUP: 12; h2hINV: 10; SV types t2tINV: 9; TRA: 3 340 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 72 CN segments 0.9599662 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
25	2	Upper_Right	CGP_donor_1425260	11:67115970−94692580	6, 6	72	{'min_x': 349.67999267578125, 'min_y': 280.6499938964844, 'max_x': 517.0438842773438, 'max_y': 410.42401123046875}	CGP_donor_1425260 Breast−AdenoCA Cancer type 11:67115970−94692580 Position With other complex events Type 52 Interleaved intrachr. SVs 65 Total SVs (intrachr. + transl.) DEL: 9; DUP: 18; h2hINV: 11; SV types t2tINV: 14; TRA: 13 91 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 72 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 6:34298680−40481487; Linked to chrs
25	3	Lower_Left	CGP_donor_1475200	6:16058789−41282014	5, 7	17	{'min_x': 54.18009948730469, 'min_y': 693.2749633789062, 'max_x': 257.7918701171875, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 160 MB CGP_donor_1475200 Breast−AdenoCA Cancer type 6:16058789−41282014 Position With other complex events Type 7 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 7 331 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 17 CN segments 0.8066159 FDR fragment joints 0 FDR chr. breakp. enrich.
25	4	Lower_Right	CGP_donor_1475201	13:81313916−114454357	5, 5	26	{'min_x': 327.2200012207031, 'min_y': 693.2749633789062, 'max_x': 519.4420166015625, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB CGP_donor_1475201 Breast−AdenoCA Cancer type 13:81313916−114454357 Position With other complex events Type 6 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 11 45 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 26 CN segments 0.930656 FDR fragment joints 0 FDR chr. breakp. enrich.
26	1	Upper_Left	CGP_donor_1475202	4:44897680−94849273	4, 5	5	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	CGP_donor_1475202 Breast−AdenoCA Cancer type 4:44897680−94849273 Position After polyploidization Type 12 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 3; TRA: 16 217 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.8988396 FDR fragment joints 0 FDR chr. breakp. enrich. 1:80341830−241765598; Linked to chrs
26	2	Upper_Right	CGP_donor_1475202	12:89302895−108838113	5, 6	29	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1475202 Breast−AdenoCA Cancer type 12:89302895−108838113 Position With other complex events Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 6; SV types t2tINV: 3; TRA: 0 217 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 29 CN segments 0.7735152 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
26	3	Lower_Left	CGP_donor_1475202	19:4796337−21735946	6, 9	16	{'min_x': 47.29999923706055, 'min_y': 693.2749633789062, 'max_x': 258.81988525390625, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB CGP_donor_1475202 Breast−AdenoCA Cancer type 19:4796337−21735946 Position With other complex events Type 7 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 3; DUP: 6; h2hINV: 3; SV types t2tINV: 2; TRA: 18 217 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 16 CN segments 0.9224215 FDR fragment joints 0 FDR chr. breakp. enrich.
26	4	Lower_Right	CGP_donor_1503014	8:36316585−58193474	5, 5	24	{'min_x': 351.3399963378906, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	50 MB 70 MB 90 MB CGP_donor_1503014 Breast−AdenoCA Cancer type 8:36316585−58193474 Position With other complex events Type 9 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 19 161 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 24 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
27	1	Upper_Left	CGP_donor_1503014	11:57620337−81529411	5, 7	53	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	CGP_donor_1503014 Breast−AdenoCA Cancer type 11:57620337−81529411 Position With other complex events Type 20 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 4; SV types t2tINV: 3; TRA: 20 161 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 53 CN segments 0.8135044 FDR fragment joints 0 FDR chr. breakp. enrich. 8:36316585−58193473; Linked to chrs
27	2	Upper_Right	CGP_donor_1503016	11:67121530−83614852	5, 12	14	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1503016 Breast−AdenoCA Cancer type 11:67121530−83614852 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 0 72 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 14 CN segments 0.7735152 FDR fragment joints 0.08 FDR chr. breakp. enrich. Linked to chrs
27	3	Lower_Left	CGP_donor_1503021	16:46993430−84786026	6, 7	9	{'min_x': 36.33980178833008, 'min_y': 693.2749633789062, 'max_x': 239.74012756347656, 'max_y': 839.013916015625}	50 MB 60 MB 70 MB 80 MB CGP_donor_1503021 Breast−AdenoCA Cancer type 16:46993430−84786026 Position Before polyploidization Type 8 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 4; TRA: 3 25 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 9 CN segments 0.7425546 FDR fragment joints 0 FDR chr. breakp. enrich.
27	4	Lower_Right	CGP_donor_1503150	6:3658692−44465119	6, 9	18	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 559.5821533203125, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 160 MB CGP_donor_1503150 Breast−AdenoCA Cancer type 6:3658692−44465119 Position With other complex events Type 21 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 6; SV types t2tINV: 6; TRA: 5 180 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 18 CN segments 0.8172348 FDR fragment joints 0 FDR chr. breakp. enrich.
28	1	Upper_Left	CGP_donor_1503150	8:36031131−90557044	4, 7	19	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1503150 Breast−AdenoCA Cancer type 8:36031131−90557044 Position With other complex events Type 8 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 1; SV types t2tINV: 1; TRA: 3 180 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 19 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
28	2	Upper_Right	CGP_donor_1114881	8:31373451−72632912	4, 13	60	{'min_x': 351.3500061035156, 'min_y': 280.6499938964844, 'max_x': 515.3779296875, 'max_y': 410.42401123046875}	CGP_donor_1114881 Breast−AdenoCA Cancer type 8:31373451−72632912 Position With other complex events Type 39 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 9; DUP: 7; h2hINV: 11; SV types t2tINV: 12; TRA: 8 249 SVs in sample 4, 13 Oscillating CN (2 and 3 states) 60 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 6:65175120−68525091; Linked to chrs
28	3	Lower_Left	CGP_donor_1114881	10:17464930−97184502	6, 10	12	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB CGP_donor_1114881 Breast−AdenoCA Cancer type 10:17464930−97184502 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 249 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 12 CN segments 0.9284301 FDR fragment joints 0.77 FDR chr. breakp. enrich.
28	4	Lower_Right	CGP_donor_1187030	20:24116036−55592291	4, 6	26	{'min_x': 350.6199951171875, 'min_y': 693.2749633789062, 'max_x': 517.460205078125, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB CGP_donor_1187030 Breast−AdenoCA Cancer type 20:24116036−55592291 Position With other complex events Type 11 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 4 98 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 26 CN segments 0.9905774 FDR fragment joints 0 FDR chr. breakp. enrich.
29	1	Upper_Left	CGP_donor_1187033	12:14425084−25928588	6, 8	8	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.3340148925781}	CGP_donor_1187033 Breast−AdenoCA Cancer type 12:14425084−25928588 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 2 228 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.8572806 FDR fragment joints 0.1 FDR chr. breakp. enrich. Linked to chrs
29	2	Upper_Right	CGP_donor_1187033	17:38442067−79276431	5, 5	116	{'min_x': 348.010009765625, 'min_y': 280.6499938964844, 'max_x': 518.72021484375, 'max_y': 410.3340148925781}	CGP_donor_1187033 Breast−AdenoCA Cancer type 17:38442067−79276431 Position With other complex events Type 84 Interleaved intrachr. SVs 114 Total SVs (intrachr. + transl.) DEL: 20; DUP: 22; h2hINV: 23; SV types t2tINV: 19; TRA: 30 228 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 116 CN segments 0.8784945 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
29	3	Lower_Left	CGP_donor_1199104	2:122442175−191880486	6, 8	26	{'min_x': 33.68980026245117, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 834.6940307617188}	150 MB 180 MB 210 MB CGP_donor_1199104 Breast−AdenoCA Cancer type 2:122442175−191880486 Position With other complex events Type 10 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 7 803 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 26 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
29	4	Lower_Right	CGP_donor_1199104	4:53118926−163564696	6, 11	115	{'min_x': 307.54998779296875, 'min_y': 693.2749633789062, 'max_x': 531.5020751953125, 'max_y': 834.6940307617188}	0 MB 50 MB 100 MB 150 MB CGP_donor_1199104 Breast−AdenoCA Cancer type 4:53118926−163564696 Position With other complex events Type 52 Interleaved intrachr. SVs 106 Total SVs (intrachr. + transl.) DEL: 14; DUP: 11; h2hINV: 15; SV types t2tINV: 12; TRA: 54 803 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 115 CN segments 0.9922157 FDR fragment joints 0 FDR chr. breakp. enrich.
30	1	Upper_Left	CGP_donor_1199104	5:77648424−175567950	6, 9	9	{'min_x': 32.019901275634766, 'min_y': 276.3299865722656, 'max_x': 255.70394897460938, 'max_y': 410.3340148925781}	CGP_donor_1199104 Breast−AdenoCA Cancer type 5:77648424−175567950 Position After polyploidization Type 7 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 5 803 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.6776251 FDR fragment joints 0.23 FDR chr. breakp. enrich. 12:24474408−110217684;4:53118926−163564695 Linked to chrs
30	2	Upper_Right	CGP_donor_1199104	8:13736456−132773372	6, 6	155	{'min_x': 321.5199890136719, 'min_y': 267.6899719238281, 'max_x': 545.2039794921875, 'max_y': 410.3340148925781}	CGP_donor_1199104 Breast−AdenoCA Cancer type 8:13736456−132773372 Position With other complex events Type 50 Interleaved intrachr. SVs 164 Total SVs (intrachr. + transl.) DEL: 12; DUP: 14; h2hINV: 11; SV types t2tINV: 13; TRA: 114 803 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 155 CN segments 0.9339031 FDR fragment joints 0 FDR chr. breakp. enrich. 11:66056632−80789771;12:24474408−110217684 2:122442175−191880485;4:53118926−163564695 Linked to chrs
30	3	Lower_Left	CGP_donor_1199104	10:800474−27783066	4, 6	50	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB CGP_donor_1199104 Breast−AdenoCA Cancer type 10:800474−27783066 Position With other complex events Type 20 Interleaved intrachr. SVs 65 Total SVs (intrachr. + transl.) DEL: 8; DUP: 1; h2hINV: 7; SV types t2tINV: 4; TRA: 45 803 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 50 CN segments 0.9147564 FDR fragment joints 0 FDR chr. breakp. enrich.
30	4	Lower_Right	CGP_donor_1199104	11:66056632−80789772	5, 5	75	{'min_x': 321.5199890136719, 'min_y': 693.2749633789062, 'max_x': 536.1001586914062, 'max_y': 834.6940307617188}	40 MB 60 MB 80 MB CGP_donor_1199104 Breast−AdenoCA Cancer type 11:66056632−80789772 Position With other complex events Type 21 Interleaved intrachr. SVs 96 Total SVs (intrachr. + transl.) DEL: 9; DUP: 3; h2hINV: 3; SV types t2tINV: 6; TRA: 75 803 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 75 CN segments 0.9343093 FDR fragment joints 0 FDR chr. breakp. enrich.
31	1	Upper_Left	CGP_donor_1199129	12:1812499−12002882	5, 17	17	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1199129 Breast−AdenoCA Cancer type 12:1812499−12002882 Position With other complex events Type 13 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 1; SV types t2tINV: 4; TRA: 18 416 SVs in sample 5, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.8168871 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
31	2	Upper_Right	CGP_donor_1199131	8:41127422−122943006	4, 6	33	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1199131 Breast−AdenoCA Cancer type 8:41127422−122943006 Position With other complex events Type 14 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 4; SV types t2tINV: 4; TRA: 7 240 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 33 CN segments 0.9462199 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
31	3	Lower_Left	CGP_donor_1199131	19:831618−58208210	5, 5	34	{'min_x': 54.849998474121094, 'min_y': 693.2749633789062, 'max_x': 235.94985961914062, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB CGP_donor_1199131 Breast−AdenoCA Cancer type 19:831618−58208210 Position With other complex events Type 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 4; SV types t2tINV: 4; TRA: 2 240 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 34 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
31	4	Lower_Right	CGP_donor_1199138	2:16077672−242757221	5, 7	30	{'min_x': 347.5400085449219, 'min_y': 693.2749633789062, 'max_x': 518.112060546875, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB CGP_donor_1199138 Breast−AdenoCA Cancer type 2:16077672−242757221 Position With other complex events Type 16 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 4; SV types t2tINV: 6; TRA: 15 426 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 30 CN segments 0.930656 FDR fragment joints 0.23 FDR chr. breakp. enrich.
32	1	Upper_Left	CGP_donor_1199138	8:106917395−143420924	4, 7	24	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1199138 Breast−AdenoCA Cancer type 8:106917395−143420924 Position With other complex events Type 15 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 4; SV types t2tINV: 4; TRA: 2 426 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 24 CN segments 0.9934091 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
32	2	Upper_Right	CGP_donor_1199138	11:64326051−80060406	5, 5	56	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1199138 Breast−AdenoCA Cancer type 11:64326051−80060406 Position With other complex events Type 23 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 3; SV types t2tINV: 7; TRA: 12 426 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 56 CN segments 0.9757835 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
32	3	Lower_Left	CGP_donor_1230722	3:3536437−158590135	5, 6	34	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 273.0021667480469, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 160 MB CGP_donor_1230722 Breast−AdenoCA Cancer type 3:3536437−158590135 Position With other complex events Type 10 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 4; SV types t2tINV: 2; TRA: 3 192 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 34 CN segments 0.6776251 FDR fragment joints 0.15 FDR chr. breakp. enrich.
32	4	Lower_Right	CGP_donor_1230722	4:53307836−100323926	5, 5	46	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	75 MB 100 MB 125 MB CGP_donor_1230722 Breast−AdenoCA Cancer type 4:53307836−100323926 Position With other complex events Type 27 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 7; SV types t2tINV: 7; TRA: 1 192 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 46 CN segments 0.9794281 FDR fragment joints 0 FDR chr. breakp. enrich.
33	1	Upper_Left	CGP_donor_1230722	14:31249224−43197371	4, 5	8	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1230722 Breast−AdenoCA Cancer type 14:31249224−43197371 Position With other complex events Type 9 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 4; TRA: 1 192 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 8 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
33	2	Upper_Right	CGP_donor_1230728	5:51047194−59523791	4, 4	41	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1230728 Breast−AdenoCA Cancer type 5:51047194−59523791 Position With other complex events Type 7 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 0; SV types t2tINV: 3; TRA: 29 329 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 41 CN segments 0.641841 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
33	3	Lower_Left	CGP_donor_1230728	12:39789055−71175213	4, 6	29	{'min_x': 44.53010177612305, 'min_y': 693.2749633789062, 'max_x': 263.12994384765625, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB 70 MB CGP_donor_1230728 Breast−AdenoCA Cancer type 12:39789055−71175213 Position With other complex events Type 9 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 1; TRA: 13 329 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 29 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
33	4	Lower_Right	CGP_donor_1230728	13:33627141−81483301	4, 9	13	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	50 MB 70 MB 90 MB CGP_donor_1230728 Breast−AdenoCA Cancer type 13:33627141−81483301 Position With other complex events Type 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 6 329 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 13 CN segments 0.9284301 FDR fragment joints 0.04 FDR chr. breakp. enrich.
34	1	Upper_Left	CGP_donor_1230729	1:52686225−58856084	4, 7	10	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1230729 Breast−AdenoCA Cancer type 1:52686225−58856084 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 0 107 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 10 CN segments 0.9625775 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
34	2	Upper_Right	CGP_donor_1230778	1:30154115−107830373	5, 10	44	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1230778 Breast−AdenoCA Cancer type 1:30154115−107830373 Position With other complex events Type 26 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 8; DUP: 9; h2hINV: 4; SV types t2tINV: 5; TRA: 5 182 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 44 CN segments 0.7013708 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
34	3	Lower_Left	CGP_donor_1230785	2:2703128−76418672	6, 8	25	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 238.47195434570312, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB CGP_donor_1230785 Breast−AdenoCA Cancer type 2:2703128−76418672 Position With other complex events Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 2; SV types t2tINV: 1; TRA: 2 502 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 25 CN segments 0.8653243 FDR fragment joints 0.63 FDR chr. breakp. enrich.
34	4	Lower_Right	CGP_donor_1230785	X:108712192−124865542	5, 6	23	{'min_x': 308.7799987792969, 'min_y': 693.2749633789062, 'max_x': 559.26220703125, 'max_y': 839.013916015625}	0 MB 50 MB 100 MB 150 MB CGP_donor_1230785 Breast−AdenoCA Cancer type X:108712192−124865542 Position With other complex events Type 12 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 7 502 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 23 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
35	1	Upper_Left	CGP_donor_1310131	8:37059484−62040279	5, 9	35	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1310131 Breast−AdenoCA Cancer type 8:37059484−62040279 Position With other complex events Type 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 4; SV types t2tINV: 1; TRA: 3 256 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 35 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
35	2	Upper_Right	CGP_donor_1347720	2:146257863−227776482	6, 6	9	{'min_x': 344.2300109863281, 'min_y': 280.6499938964844, 'max_x': 522.4959716796875, 'max_y': 410.3340148925781}	CGP_donor_1347720 Breast−AdenoCA Cancer type 2:146257863−227776482 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 3 173 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 9 CN segments 0.6776251 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
35	3	Lower_Left	CGP_donor_1347737	13:25444057−108478748	4, 6	41	{'min_x': 58.43009948730469, 'min_y': 693.2749633789062, 'max_x': 247.34190368652344, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB CGP_donor_1347737 Breast−AdenoCA Cancer type 13:25444057−108478748 Position With other complex events Type 22 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 4; SV types t2tINV: 5; TRA: 4 245 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 41 CN segments 0.9179372 FDR fragment joints 0 FDR chr. breakp. enrich.
35	4	Lower_Right	CGP_donor_1347737	19:712477−38656509	5, 7	36	{'min_x': 348.010009765625, 'min_y': 693.2749633789062, 'max_x': 518.72021484375, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB CGP_donor_1347737 Breast−AdenoCA Cancer type 19:712477−38656509 Position With other complex events Type 102 Interleaved intrachr. SVs 102 Total SVs (intrachr. + transl.) DEL: 31; DUP: 27; h2hINV: 21; SV types t2tINV: 23; TRA: 0 245 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 36 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
36	1	Upper_Left	CGP_donor_1353431	9:77800927−139754035	5, 8	130	{'min_x': 32.019901275634766, 'min_y': 276.3299865722656, 'max_x': 255.70394897460938, 'max_y': 410.3340148925781}	CGP_donor_1353431 Breast−AdenoCA Cancer type 9:77800927−139754035 Position With other complex events Type 103 Interleaved intrachr. SVs 113 Total SVs (intrachr. + transl.) DEL: 33; DUP: 28; h2hINV: 21; SV types t2tINV: 21; TRA: 10 276 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 130 CN segments 0.6661212 FDR fragment joints 0 FDR chr. breakp. enrich. 11:65669076−121347314;17:27282661−72008911 Linked to chrs
36	2	Upper_Right	CGP_donor_1353431	10:6930033−52299947	6, 10	40	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1353431 Breast−AdenoCA Cancer type 10:6930033−52299947 Position With other complex events Type 23 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 6; SV types t2tINV: 9; TRA: 0 276 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 40 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
36	3	Lower_Left	CGP_donor_1353431	17:27282661−72008912	5, 8	34	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 235.5299072265625, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 70 MB CGP_donor_1353431 Breast−AdenoCA Cancer type 17:27282661−72008912 Position With other complex events Type 8 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 17 276 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 34 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
36	4	Lower_Right	CGP_donor_1353432	11:57883853−105414478	4, 6	45	{'min_x': 349.6700134277344, 'min_y': 693.2749633789062, 'max_x': 547.7124633789062, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB CGP_donor_1353432 Breast−AdenoCA Cancer type 11:57883853−105414478 Position With other complex events Type 15 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 3; SV types t2tINV: 5; TRA: 15 185 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 45 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
37	1	Upper_Left	CGP_donor_1363963	3:157158956−178255600	5, 7	16	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1363963 Breast−AdenoCA Cancer type 3:157158956−178255600 Position With other complex events Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 2 324 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 16 CN segments 0.615458 FDR fragment joints 0.05 FDR chr. breakp. enrich. Linked to chrs
37	2	Upper_Right	CGP_donor_1456607	12:5519258−24071782	4, 5	39	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1456607 Breast−AdenoCA Cancer type 12:5519258−24071782 Position With other complex events Type 15 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 6; TRA: 12 172 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 39 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
37	3	Lower_Left	CGP_donor_1456607	X:144433858−145805852	6, 8	8	{'min_x': 54.730098724365234, 'min_y': 693.2749633789062, 'max_x': 232.99598693847656, 'max_y': 839.013916015625}	50 MB 100 MB CGP_donor_1456607 Breast−AdenoCA Cancer type X:144433858−145805852 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 172 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.9723381 FDR fragment joints 0 FDR chr. breakp. enrich.
37	4	Lower_Right	CGP_donor_1472394	12:47550216−98458711	5, 5	5	{'min_x': 307.3999938964844, 'min_y': 693.2749633789062, 'max_x': 555.9720458984375, 'max_y': 839.013916015625}	0 MB 25 MB 50 MB 75 MB 100 MB 125 MB CGP_donor_1472394 Breast−AdenoCA Cancer type 12:47550216−98458711 Position Canonical without polyploidization Type 13 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 4; SV types t2tINV: 3; TRA: 8 366 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.8882853 FDR fragment joints 0 FDR chr. breakp. enrich.
38	1	Upper_Left	CGP_donor_1472395	15:28701023−57607104	5, 10	20	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1472395 Breast−AdenoCA Cancer type 15:28701023−57607104 Position With other complex events Type 20 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 3; SV types t2tINV: 7; TRA: 1 132 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 20 CN segments 0.8882853 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
38	2	Upper_Right	CGP_donor_1606179	9:4256540−29177994	4, 7	22	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1606179 Breast−AdenoCA Cancer type 9:4256540−29177994 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 0 372 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 22 CN segments 1 FDR fragment joints 0.28 FDR chr. breakp. enrich. Linked to chrs
38	3	Lower_Left	CGP_donor_1606179	12:17064462−27430583	4, 4	24	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	15 MB 20 MB 25 MB CGP_donor_1606179 Breast−AdenoCA Cancer type 12:17064462−27430583 Position With other complex events Type 25 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 8; DUP: 7; h2hINV: 7; SV types t2tINV: 3; TRA: 17 372 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 24 CN segments 0.8988396 FDR fragment joints 0 FDR chr. breakp. enrich.
38	4	Lower_Right	CGP_donor_1654385	1:154387036−165898515	4, 7	63	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 562.432373046875, 'max_y': 839.013916015625}	175 MB 200 MB 225 MB 250 MB CGP_donor_1654385 Breast−AdenoCA Cancer type 1:154387036−165898515 Position With other complex events Type 26 Interleaved intrachr. SVs 111 Total SVs (intrachr. + transl.) DEL: 6; DUP: 6; h2hINV: 7; SV types t2tINV: 7; TRA: 85 372 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 63 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
39	1	Upper_Left	CGP_donor_1701345	1:35101528−48512693	5, 11	11	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1701345 Breast−AdenoCA Cancer type 1:35101528−48512693 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 0; SV types t2tINV: 0; TRA: 0 368 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.5435077 FDR fragment joints 0.69 FDR chr. breakp. enrich. Linked to chrs
39	2	Upper_Right	CGP_donor_1701345	2:102310161−225180735	6, 12	78	{'min_x': 328.20001220703125, 'min_y': 276.3299865722656, 'max_x': 538.5299682617188, 'max_y': 410.3340148925781}	CGP_donor_1701345 Breast−AdenoCA Cancer type 2:102310161−225180735 Position With other complex events Type 37 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 11; DUP: 6; h2hINV: 9; SV types t2tINV: 11; TRA: 18 368 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 78 CN segments 0.9723381 FDR fragment joints 0 FDR chr. breakp. enrich. 1:35101528−48512692;10:290666−86528974 Linked to chrs
39	3	Lower_Left	CGP_donor_1701345	5:28386068−38607621	6, 6	17	{'min_x': 57.21989822387695, 'min_y': 693.2749633789062, 'max_x': 254.84193420410156, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 160 MB CGP_donor_1701345 Breast−AdenoCA Cancer type 5:28386068−38607621 Position With other complex events Type 11 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 4; SV types t2tINV: 3; TRA: 5 368 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 17 CN segments 0.9501265 FDR fragment joints 0.42 FDR chr. breakp. enrich.
39	4	Lower_Right	CGP_donor_1701345	10:290666−86528975	5, 7	52	{'min_x': 308.8800048828125, 'min_y': 693.2749633789062, 'max_x': 516.7020874023438, 'max_y': 839.013916015625}	0 MB 25 MB 50 MB 75 MB 100 MB CGP_donor_1701345 Breast−AdenoCA Cancer type 10:290666−86528975 Position With other complex events Type 18 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 3; SV types t2tINV: 5; TRA: 16 368 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 52 CN segments 0.9717738 FDR fragment joints 0 FDR chr. breakp. enrich.
40	1	Upper_Left	CGP_donor_1701345	X:47359209−62646302	4, 8	33	{'min_x': 35.360198974609375, 'min_y': 276.3299865722656, 'max_x': 252.3719482421875, 'max_y': 410.3340148925781}	CGP_donor_1701345 Breast−AdenoCA Cancer type X:47359209−62646302 Position With other complex events Type 14 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 2; SV types t2tINV: 0; TRA: 5 368 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 33 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 10:290666−86528974;2:102310161−225180734 Linked to chrs
40	2	Upper_Right	084c6aec-94f7-4090-8f3f-59fa9e89721a	17:25508004−62998961	4, 5	41	{'min_x': 331.5400085449219, 'min_y': 280.6499938964844, 'max_x': 535.1859130859375, 'max_y': 410.3340148925781}	084c6aec−94f7−4090−8f3f−59fa9e89721a Breast−AdenoCA Cancer type 17:25508004−62998961 Position With other complex events Type 40 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 9; DUP: 8; h2hINV: 14; SV types t2tINV: 9; TRA: 9 257 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 41 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
40	3	Lower_Left	08da7c4c-3067-4bcf-9d7a-78566df72e69	12:3255392−12445504	6, 9	56	{'min_x': 40.039798736572266, 'min_y': 693.2749633789062, 'max_x': 251.1617889404297, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB 08da7c4c−3067−4bcf−9d7a−78566df72e69 Breast−AdenoCA Cancer type 12:3255392−12445504 Position With other complex events Type 37 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 11; DUP: 9; h2hINV: 8; SV types t2tINV: 9; TRA: 5 151 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 56 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich.
40	4	Lower_Right	0a2a3529-f645-4967-9a58-89ee20b8bb62	8:28068350−48961471	4, 7	21	{'min_x': 311.29998779296875, 'min_y': 693.2749633789062, 'max_x': 537.6900024414062, 'max_y': 839.013916015625}	30 MB 60 MB 90 MB 120 MB 0a2a3529−f645−4967−9a58−89ee20b8bb62 Breast−AdenoCA Cancer type 8:28068350−48961471 Position With other complex events Type 12 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 1; SV types t2tINV: 3; TRA: 1 190 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 21 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
41	1	Upper_Left	0bc5744c-5fa3-45bb-87d0-70a02068b392	1:755344−72678036	5, 7	43	{'min_x': 39.210201263427734, 'min_y': 280.6499938964844, 'max_x': 248.51995849609375, 'max_y': 410.42401123046875}	0bc5744c−5fa3−45bb−87d0−70a02068b392 Breast−AdenoCA Cancer type 1:755344−72678036 Position With other complex events Type 50 Interleaved intrachr. SVs 85 Total SVs (intrachr. + transl.) DEL: 18; DUP: 7; h2hINV: 14; SV types t2tINV: 11; TRA: 35 487 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 43 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 14:39530849−45584133; Linked to chrs
41	2	Upper_Right	0bc5744c-5fa3-45bb-87d0-70a02068b392	8:22116077−140133049	4, 5	21	{'min_x': 328.20001220703125, 'min_y': 276.3299865722656, 'max_x': 538.5299682617188, 'max_y': 410.3340148925781}	0bc5744c−5fa3−45bb−87d0−70a02068b392 Breast−AdenoCA Cancer type 8:22116077−140133049 Position With other complex events Type 22 Interleaved intrachr. SVs 37 Total SVs (intrachr. + transl.) DEL: 7; DUP: 3; h2hINV: 6; SV types t2tINV: 6; TRA: 15 487 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 21 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. 1:755344−72678035;14:39530849−45584133 Linked to chrs
41	3	Lower_Left	0bc5744c-5fa3-45bb-87d0-70a02068b392	11:67403366−89463830	5, 9	47	{'min_x': 39.210201263427734, 'min_y': 693.2749633789062, 'max_x': 248.51995849609375, 'max_y': 839.013916015625}	70 MB 75 MB 80 MB 85 MB 0bc5744c−5fa3−45bb−87d0−70a02068b392 Breast−AdenoCA Cancer type 11:67403366−89463830 Position With other complex events Type 12 Interleaved intrachr. SVs 56 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 3; SV types t2tINV: 4; TRA: 44 487 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 47 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
41	4	Lower_Right	0bc5744c-5fa3-45bb-87d0-70a02068b392	17:31395557−80441361	6, 14	179	{'min_x': 317.7099914550781, 'min_y': 693.2749633789062, 'max_x': 556.5299682617188, 'max_y': 834.6940307617188}	30 MB 40 MB 50 MB 60 MB 70 MB 80 MB 0bc5744c−5fa3−45bb−87d0−70a02068b392 Breast−AdenoCA Cancer type 17:31395557−80441361 Position With other complex events Type 137 Interleaved intrachr. SVs 206 Total SVs (intrachr. + transl.) DEL: 37; DUP: 36; h2hINV: 31; SV types t2tINV: 33; TRA: 69 487 SVs in sample 6, 14 Oscillating CN (2 and 3 states) 179 CN segments 0.7425546 FDR fragment joints 0 FDR chr. breakp. enrich.
42	1	Upper_Left	0bc5744c-5fa3-45bb-87d0-70a02068b392	20:2672158−18490675	5, 6	13	{'min_x': 39.210201263427734, 'min_y': 280.6499938964844, 'max_x': 248.51995849609375, 'max_y': 410.3340148925781}	0bc5744c−5fa3−45bb−87d0−70a02068b392 Breast−AdenoCA Cancer type 20:2672158−18490675 Position With other complex events Type 22 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 6; DUP: 3; h2hINV: 8; SV types t2tINV: 5; TRA: 1 487 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 13 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
42	2	Upper_Right	0dca98b0-f43e-45b6-9a02-00092c78678c	5:24520−120779185	6, 15	97	{'min_x': 321.5199890136719, 'min_y': 276.3299865722656, 'max_x': 545.2039794921875, 'max_y': 410.3340148925781}	0dca98b0−f43e−45b6−9a02−00092c78678c Breast−AdenoCA Cancer type 5:24520−120779185 Position With other complex events Type 70 Interleaved intrachr. SVs 81 Total SVs (intrachr. + transl.) DEL: 17; DUP: 12; h2hINV: 19; SV types t2tINV: 22; TRA: 11 552 SVs in sample 6, 15 Oscillating CN (2 and 3 states) 97 CN segments 0.8086009 FDR fragment joints 0 FDR chr. breakp. enrich. 10:14391438−105152621;6:53464511−167310325 Linked to chrs
42	3	Lower_Left	1174f6e4-ffbe-4e59-a000-8d861c968369	3:95813661−124485880	6, 10	94	{'min_x': 41.039798736572266, 'min_y': 693.2749633789062, 'max_x': 246.6839599609375, 'max_y': 839.013916015625}	100 MB 125 MB 150 MB 175 MB 1174f6e4−ffbe−4e59−a000−8d861c968369 Breast−AdenoCA Cancer type 3:95813661−124485880 Position With other complex events Type 46 Interleaved intrachr. SVs 111 Total SVs (intrachr. + transl.) DEL: 13; DUP: 9; h2hINV: 13; SV types t2tINV: 11; TRA: 65 357 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 94 CN segments 0.7814391 FDR fragment joints 0 FDR chr. breakp. enrich.
42	4	Lower_Right	1174f6e4-ffbe-4e59-a000-8d861c968369	6:71335682−87123000	4, 7	16	{'min_x': 330.5400085449219, 'min_y': 693.2749633789062, 'max_x': 536.1838989257812, 'max_y': 839.013916015625}	60 MB 70 MB 80 MB 90 MB 100 MB 1174f6e4−ffbe−4e59−a000−8d861c968369 Breast−AdenoCA Cancer type 6:71335682−87123000 Position With other complex events Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 4; TRA: 1 357 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 16 CN segments 0.615458 FDR fragment joints 1 FDR chr. breakp. enrich.
43	1	Upper_Left	1174f6e4-ffbe-4e59-a000-8d861c968369	17:35714118−65191896	6, 9	81	{'min_x': 41.039798736572266, 'min_y': 280.6499938964844, 'max_x': 246.6839599609375, 'max_y': 410.42401123046875}	1174f6e4−ffbe−4e59−a000−8d861c968369 Breast−AdenoCA Cancer type 17:35714118−65191896 Position With other complex events Type 21 Interleaved intrachr. SVs 71 Total SVs (intrachr. + transl.) DEL: 5; DUP: 7; h2hINV: 4; SV types t2tINV: 5; TRA: 50 357 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 81 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 3:95813661−124485879; Linked to chrs
43	2	Upper_Right	1557183c-aedd-4df6-b98a-3654667f7b69	4:155589998−190789670	5, 14	14	{'min_x': 329.4100036621094, 'min_y': 280.6499938964844, 'max_x': 537.3218383789062, 'max_y': 410.42401123046875}	1557183c−aedd−4df6−b98a−3654667f7b69 Breast−AdenoCA Cancer type 4:155589998−190789670 Position With other complex events Type 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 2; SV types t2tINV: 0; TRA: 4 435 SVs in sample 5, 14 Oscillating CN (2 and 3 states) 14 CN segments 0.5435077 FDR fragment joints 0.44 FDR chr. breakp. enrich. 17:29145267−69232448; Linked to chrs
43	3	Lower_Left	1557183c-aedd-4df6-b98a-3654667f7b69	11:19167099−105816357	5, 9	103	{'min_x': 39.91019821166992, 'min_y': 693.2749633789062, 'max_x': 247.82186889648438, 'max_y': 839.013916015625}	50 MB 100 MB 1557183c−aedd−4df6−b98a−3654667f7b69 Breast−AdenoCA Cancer type 11:19167099−105816357 Position With other complex events Type 46 Interleaved intrachr. SVs 51 Total SVs (intrachr. + transl.) DEL: 13; DUP: 14; h2hINV: 9; SV types t2tINV: 10; TRA: 5 435 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 103 CN segments 0.9681319 FDR fragment joints 0 FDR chr. breakp. enrich.
43	4	Lower_Right	1557183c-aedd-4df6-b98a-3654667f7b69	13:49252644−68873475	6, 9	9	{'min_x': 316.20001220703125, 'min_y': 693.2749633789062, 'max_x': 537.3218383789062, 'max_y': 839.013916015625}	50 MB 55 MB 60 MB 65 MB 1557183c−aedd−4df6−b98a−3654667f7b69 Breast−AdenoCA Cancer type 13:49252644−68873475 Position After polyploidization Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 1 435 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.7735152 FDR fragment joints 0.61 FDR chr. breakp. enrich.
44	1	Upper_Left	1557183c-aedd-4df6-b98a-3654667f7b69	17:29145267−69232449	5, 7	324	{'min_x': 39.91019821166992, 'min_y': 280.6499938964844, 'max_x': 247.82186889648438, 'max_y': 410.3340148925781}	1557183c−aedd−4df6−b98a−3654667f7b69 Breast−AdenoCA Cancer type 17:29145267−69232449 Position With other complex events Type 255 Interleaved intrachr. SVs 265 Total SVs (intrachr. + transl.) DEL: 71; DUP: 67; h2hINV: 59; SV types t2tINV: 58; TRA: 10 435 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 324 CN segments 0.7933887 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
44	2	Upper_Right	233b02f3-c4f0-4a67-9db5-e68d5cdaccb6	7:52434693−145134157	4, 5	31	{'min_x': 324.5299987792969, 'min_y': 276.3299865722656, 'max_x': 542.197998046875, 'max_y': 410.3340148925781}	233b02f3−c4f0−4a67−9db5−e68d5cdaccb6 Breast−AdenoCA Cancer type 7:52434693−145134157 Position With other complex events Type 7 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 3; TRA: 28 618 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 31 CN segments 0.7526697 FDR fragment joints 0 FDR chr. breakp. enrich. 8:63956033−143798716;X:3683303−142419843 Linked to chrs
44	3	Lower_Left	233b02f3-c4f0-4a67-9db5-e68d5cdaccb6	8:63956033−143798717	5, 13	150	{'min_x': 35.03010177612305, 'min_y': 693.2749633789062, 'max_x': 248.02195739746094, 'max_y': 834.6940307617188}	50 MB 100 MB 233b02f3−c4f0−4a67−9db5−e68d5cdaccb6 Breast−AdenoCA Cancer type 8:63956033−143798717 Position With other complex events Type 63 Interleaved intrachr. SVs 108 Total SVs (intrachr. + transl.) DEL: 15; DUP: 20; h2hINV: 12; SV types t2tINV: 16; TRA: 45 618 SVs in sample 5, 13 Oscillating CN (2 and 3 states) 150 CN segments 0.7137217 FDR fragment joints 0 FDR chr. breakp. enrich.
44	4	Lower_Right	233b02f3-c4f0-4a67-9db5-e68d5cdaccb6	9:30724383−136978634	4, 8	34	{'min_x': 329.2099914550781, 'min_y': 693.2749633789062, 'max_x': 537.5219116210938, 'max_y': 839.013916015625}	50 MB 100 MB 233b02f3−c4f0−4a67−9db5−e68d5cdaccb6 Breast−AdenoCA Cancer type 9:30724383−136978634 Position With other complex events Type 16 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 4; SV types t2tINV: 4; TRA: 5 618 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 34 CN segments 0.9462199 FDR fragment joints 0.09 FDR chr. breakp. enrich.
45	1	Upper_Left	233b02f3-c4f0-4a67-9db5-e68d5cdaccb6	X:3683303−142419844	5, 7	77	{'min_x': 35.360198974609375, 'min_y': 276.3299865722656, 'max_x': 252.3719482421875, 'max_y': 410.3340148925781}	233b02f3−c4f0−4a67−9db5−e68d5cdaccb6 Breast−AdenoCA Cancer type X:3683303−142419844 Position With other complex events Type 53 Interleaved intrachr. SVs 94 Total SVs (intrachr. + transl.) DEL: 10; DUP: 13; h2hINV: 14; SV types t2tINV: 16; TRA: 41 618 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 77 CN segments 0.6714613 FDR fragment joints 0 FDR chr. breakp. enrich. 17:29900854−72983270;18:1797061−70607437 Linked to chrs
45	2	Upper_Right	2779fa01-ac93-4e80-a997-3385f72172c3	17:11610139−39394274	5, 9	128	{'min_x': 330.20001220703125, 'min_y': 280.6499938964844, 'max_x': 536.5319213867188, 'max_y': 410.3340148925781}	2779fa01−ac93−4e80−a997−3385f72172c3 Breast−AdenoCA Cancer type 17:11610139−39394274 Position With other complex events Type 103 Interleaved intrachr. SVs 127 Total SVs (intrachr. + transl.) DEL: 35; DUP: 20; h2hINV: 27; SV types t2tINV: 21; TRA: 24 190 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 128 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
45	3	Lower_Left	38a8b734-9acc-42f9-b5b7-e51b0dfc6504	19:28234779−29767781	6, 7	7	{'min_x': 39.88010025024414, 'min_y': 693.2749633789062, 'max_x': 247.85195922851562, 'max_y': 839.013916015625}	20 MB 30 MB 38a8b734−9acc−42f9−b5b7−e51b0dfc6504 Breast−AdenoCA Cancer type 19:28234779−29767781 Position After polyploidization Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 1 54 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
45	4	Lower_Right	441919eb-8c9f-478c-bda3-8de4f8295e8a	1:94026241−145056864	4, 6	51	{'min_x': 324.8599853515625, 'min_y': 693.2749633789062, 'max_x': 537.19189453125, 'max_y': 834.6940307617188}	50 MB 100 MB 150 MB 200 MB 441919eb−8c9f−478c−bda3−8de4f8295e8a Breast−AdenoCA Cancer type 1:94026241−145056864 Position With other complex events Type 18 Interleaved intrachr. SVs 37 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 5; SV types t2tINV: 3; TRA: 19 744 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 51 CN segments 0.818888 FDR fragment joints 0 FDR chr. breakp. enrich.
46	1	Upper_Left	44bec761-b603-49c0-8634-f6bfe0319bb1	17:47241742−74862785	6, 7	71	{'min_x': 33.68980026245117, 'min_y': 276.3299865722656, 'max_x': 254.03794860839844, 'max_y': 410.3340148925781}	44bec761−b603−49c0−8634−f6bfe0319bb1 Breast−AdenoCA Cancer type 17:47241742−74862785 Position With other complex events Type 26 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 9; SV types t2tINV: 11; TRA: 15 320 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 71 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 22:18266499−42732086;3:79667212−191335907 Linked to chrs
46	2	Upper_Right	4da999a0-ef41-4a0b-b1d1-446b39cc855a	2:115111736−198568025	5, 9	63	{'min_x': 324.8599853515625, 'min_y': 276.3299865722656, 'max_x': 541.8719482421875, 'max_y': 410.3340148925781}	4da999a0−ef41−4a0b−b1d1−446b39cc855a Breast−AdenoCA Cancer type 2:115111736−198568025 Position With other complex events Type 25 Interleaved intrachr. SVs 63 Total SVs (intrachr. + transl.) DEL: 6; DUP: 6; h2hINV: 8; SV types t2tINV: 5; TRA: 38 423 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 63 CN segments 0.9936601 FDR fragment joints 0 FDR chr. breakp. enrich. 15:56597551−99238230;17:2048893−25902796 Linked to chrs
46	3	Lower_Left	4da999a0-ef41-4a0b-b1d1-446b39cc855a	18:6714837−10477636	4, 5	11	{'min_x': 35.360198974609375, 'min_y': 693.2749633789062, 'max_x': 248.51995849609375, 'max_y': 834.6940307617188}	10 MB 20 MB 30 MB 4da999a0−ef41−4a0b−b1d1−446b39cc855a Breast−AdenoCA Cancer type 18:6714837−10477636 Position With other complex events Type 12 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 14 423 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 11 CN segments 0.6338796 FDR fragment joints 0 FDR chr. breakp. enrich.
46	4	Lower_Right	53886143-c1c6-40e9-88e6-e4e5e0271fc8	19:27822952−53535690	5, 7	24	{'min_x': 327.0199890136719, 'min_y': 693.2749633789062, 'max_x': 537.199951171875, 'max_y': 839.013916015625}	30 MB 35 MB 40 MB 45 MB 50 MB 53886143−c1c6−40e9−88e6−e4e5e0271fc8 Breast−AdenoCA Cancer type 19:27822952−53535690 Position With other complex events Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 4; SV types t2tINV: 1; TRA: 2 113 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 24 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
47	1	Upper_Left	53886143-c1c6-40e9-88e6-e4e5e0271fc8	X:16428213−98616120	6, 9	9	{'min_x': 40.03010177612305, 'min_y': 280.6499938964844, 'max_x': 247.699951171875, 'max_y': 410.3340148925781}	53886143−c1c6−40e9−88e6−e4e5e0271fc8 Breast−AdenoCA Cancer type X:16428213−98616120 Position After polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 0 113 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.6776251 FDR fragment joints 0.53 FDR chr. breakp. enrich. Linked to chrs
47	2	Upper_Right	5580b21a-2cdb-4777-ad79-6e06654144f5	17:27472457−78723957	5, 8	232	{'min_x': 328.8699951171875, 'min_y': 280.6499938964844, 'max_x': 537.85986328125, 'max_y': 410.3340148925781}	5580b21a−2cdb−4777−ad79−6e06654144f5 Breast−AdenoCA Cancer type 17:27472457−78723957 Position With other complex events Type 141 Interleaved intrachr. SVs 158 Total SVs (intrachr. + transl.) DEL: 29; DUP: 28; h2hINV: 42; SV types t2tINV: 42; TRA: 17 252 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 232 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
47	3	Lower_Left	566792ae-f853-4a47-856d-f02cdcfcb18a	1:35669387−215888510	6, 10	117	{'min_x': 30.360200881958008, 'min_y': 693.2749633789062, 'max_x': 246.8539581298828, 'max_y': 834.6940307617188}	50 MB 100 MB 150 MB 200 MB 566792ae−f853−4a47−856d−f02cdcfcb18a Breast−AdenoCA Cancer type 1:35669387−215888510 Position With other complex events Type 91 Interleaved intrachr. SVs 130 Total SVs (intrachr. + transl.) DEL: 25; DUP: 18; h2hINV: 25; SV types t2tINV: 23; TRA: 39 579 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 117 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
47	4	Lower_Right	566792ae-f853-4a47-856d-f02cdcfcb18a	11:76728327−84744117	5, 8	18	{'min_x': 330.3699951171875, 'min_y': 693.2749633789062, 'max_x': 550.0720825195312, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB 566792ae−f853−4a47−856d−f02cdcfcb18a Breast−AdenoCA Cancer type 11:76728327−84744117 Position With other complex events Type 6 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 1; TRA: 10 579 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 18 CN segments 0.6776251 FDR fragment joints 0.01 FDR chr. breakp. enrich.
48	1	Upper_Left	566792ae-f853-4a47-856d-f02cdcfcb18a	13:20809449−38507871	6, 11	32	{'min_x': 40.86989974975586, 'min_y': 280.6499938964844, 'max_x': 246.8539581298828, 'max_y': 410.42401123046875}	566792ae−f853−4a47−856d−f02cdcfcb18a Breast−AdenoCA Cancer type 13:20809449−38507871 Position With other complex events Type 15 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 6; SV types t2tINV: 4; TRA: 13 579 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 32 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 17:25885913−74155396; Linked to chrs
48	2	Upper_Right	566792ae-f853-4a47-856d-f02cdcfcb18a	17:25885913−74155397	5, 9	84	{'min_x': 319.8599853515625, 'min_y': 276.3299865722656, 'max_x': 546.8699951171875, 'max_y': 410.3340148925781}	566792ae−f853−4a47−856d−f02cdcfcb18a Breast−AdenoCA Cancer type 17:25885913−74155397 Position With other complex events Type 43 Interleaved intrachr. SVs 90 Total SVs (intrachr. + transl.) DEL: 10; DUP: 15; h2hINV: 12; SV types t2tINV: 6; TRA: 47 579 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 84 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 1:35669387−215888509;10:109264246−123915302 Linked to chrs
48	3	Lower_Left	5dd423e8-feaa-4568-a750-500948c41d6c	1:150805216−169752869	4, 6	33	{'min_x': 39.599998474121094, 'min_y': 693.2749633789062, 'max_x': 248.13003540039062, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 5dd423e8−feaa−4568−a750−500948c41d6c Breast−AdenoCA Cancer type 1:150805216−169752869 Position With other complex events Type 16 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 5; SV types t2tINV: 5; TRA: 6 255 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 33 CN segments 0.8874881 FDR fragment joints 0 FDR chr. breakp. enrich.
48	4	Lower_Right	5dd423e8-feaa-4568-a750-500948c41d6c	10:68422126−88297594	4, 11	25	{'min_x': 329.1000061035156, 'min_y': 693.2749633789062, 'max_x': 537.6300048828125, 'max_y': 839.013916015625}	50 MB 60 MB 70 MB 80 MB 5dd423e8−feaa−4568−a750−500948c41d6c Breast−AdenoCA Cancer type 10:68422126−88297594 Position With other complex events Type 27 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 8; DUP: 5; h2hINV: 7; SV types t2tINV: 7; TRA: 1 255 SVs in sample 4, 11 Oscillating CN (2 and 3 states) 25 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
49	1	Upper_Left	5ed024e8-d05e-4c65-9441-eda9930ccc82	13:27374782−90659951	5, 5	14	{'min_x': 38.86989974975586, 'min_y': 280.6499938964844, 'max_x': 248.8579559326172, 'max_y': 410.3340148925781}	5ed024e8−d05e−4c65−9441−eda9930ccc82 Breast−AdenoCA Cancer type 13:27374782−90659951 Position With other complex events Type 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 4; SV types t2tINV: 5; TRA: 0 475 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 14 CN segments 0.925252 FDR fragment joints 0.04 FDR chr. breakp. enrich. Linked to chrs
49	2	Upper_Right	60df7543-6da5-4c75-943b-5800c1e08234	8:38109487−141109862	4, 5	106	{'min_x': 329.0400085449219, 'min_y': 280.6499938964844, 'max_x': 537.6898803710938, 'max_y': 410.3340148925781}	60df7543−6da5−4c75−943b−5800c1e08234 Breast−AdenoCA Cancer type 8:38109487−141109862 Position With other complex events Type 66 Interleaved intrachr. SVs 77 Total SVs (intrachr. + transl.) DEL: 11; DUP: 15; h2hINV: 22; SV types t2tINV: 18; TRA: 11 156 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 106 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
49	3	Lower_Left	60df7543-6da5-4c75-943b-5800c1e08234	9:7101017−102960994	4, 8	10	{'min_x': 39.539798736572266, 'min_y': 693.2749633789062, 'max_x': 248.18995666503906, 'max_y': 839.013916015625}	30 MB 60 MB 90 MB 60df7543−6da5−4c75−943b−5800c1e08234 Breast−AdenoCA Cancer type 9:7101017−102960994 Position With other complex events Type 18 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 3; SV types t2tINV: 5; TRA: 2 156 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 10 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
49	4	Lower_Right	6fa2a667-9c36-4526-8a58-1975e863a806	1:94274301−226426398	4, 6	42	{'min_x': 329.5299987792969, 'min_y': 693.2749633789062, 'max_x': 561.952392578125, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB 250 MB 6fa2a667−9c36−4526−8a58−1975e863a806 Breast−AdenoCA Cancer type 1:94274301−226426398 Position With other complex events Type 10 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 4; SV types t2tINV: 2; TRA: 8 259 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 42 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
50	1	Upper_Left	733a2a0f-b37a-4b81-b49e-3c0f30d1eb37	17:34384789−59566711	5, 7	47	{'min_x': 32.019901275634766, 'min_y': 276.3299865722656, 'max_x': 255.70394897460938, 'max_y': 410.3340148925781}	733a2a0f−b37a−4b81−b49e−3c0f30d1eb37 Breast−AdenoCA Cancer type 17:34384789−59566711 Position With other complex events Type 21 Interleaved intrachr. SVs 70 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 8; SV types t2tINV: 5; TRA: 49 403 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 47 CN segments 0.7592608 FDR fragment joints 0 FDR chr. breakp. enrich. 1:145117775−243098982;8:31896789−139505358 Linked to chrs
50	2	Upper_Right	75113445-d2d6-44a0-866c-c9175e6d214b	3:32984474−82175838	5, 6	23	{'min_x': 328.20001220703125, 'min_y': 280.6499938964844, 'max_x': 538.5279541015625, 'max_y': 410.42401123046875}	75113445−d2d6−44a0−866c−c9175e6d214b Breast−AdenoCA Cancer type 3:32984474−82175838 Position With other complex events Type 11 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 7 212 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 23 CN segments 0.9875525 FDR fragment joints 0 FDR chr. breakp. enrich. 10:54407919−63446306; Linked to chrs
50	3	Lower_Left	75113445-d2d6-44a0-866c-c9175e6d214b	10:54407919−63446307	5, 10	109	{'min_x': 38.70000076293945, 'min_y': 693.2749633789062, 'max_x': 249.0279541015625, 'max_y': 839.013916015625}	56 MB 58 MB 60 MB 62 MB 75113445−d2d6−44a0−866c−c9175e6d214b Breast−AdenoCA Cancer type 10:54407919−63446307 Position With other complex events Type 74 Interleaved intrachr. SVs 102 Total SVs (intrachr. + transl.) DEL: 15; DUP: 15; h2hINV: 19; SV types t2tINV: 25; TRA: 28 212 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 109 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
50	4	Lower_Right	75113445-d2d6-44a0-866c-c9175e6d214b	11:59935523−67621236	5, 8	17	{'min_x': 328.20001220703125, 'min_y': 693.2749633789062, 'max_x': 538.5279541015625, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 75113445−d2d6−44a0−866c−c9175e6d214b Breast−AdenoCA Cancer type 11:59935523−67621236 Position With other complex events Type 10 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 4; SV types t2tINV: 3; TRA: 7 212 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 17 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
51	1	Upper_Left	75113445-d2d6-44a0-866c-c9175e6d214b	14:21299867−63371689	4, 7	22	{'min_x': 38.70000076293945, 'min_y': 280.6499938964844, 'max_x': 249.0279541015625, 'max_y': 410.42401123046875}	75113445−d2d6−44a0−866c−c9175e6d214b Breast−AdenoCA Cancer type 14:21299867−63371689 Position With other complex events Type 8 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 3; TRA: 10 212 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 22 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 11:59935523−67621235; Linked to chrs
51	2	Upper_Right	784de7ac-8424-42eb-83d4-a1bebaa42b97	11:48231454−78887152	4, 6	86	{'min_x': 327.8699951171875, 'min_y': 280.6499938964844, 'max_x': 538.85791015625, 'max_y': 410.3340148925781}	784de7ac−8424−42eb−83d4−a1bebaa42b97 Breast−AdenoCA Cancer type 11:48231454−78887152 Position With other complex events Type 34 Interleaved intrachr. SVs 69 Total SVs (intrachr. + transl.) DEL: 10; DUP: 8; h2hINV: 6; SV types t2tINV: 10; TRA: 35 106 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 86 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
51	3	Lower_Left	8785012f-f73e-4d68-87cf-1d804af32782	21:38958060−45893770	4, 6	8	{'min_x': 41.710201263427734, 'min_y': 693.2749633789062, 'max_x': 257.99029541015625, 'max_y': 839.013916015625}	30 MB 35 MB 40 MB 45 MB 8785012f−f73e−4d68−87cf−1d804af32782 Breast−AdenoCA Cancer type 21:38958060−45893770 Position With other complex events Type 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 0; SV types t2tINV: 2; TRA: 6 530 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 8 CN segments 0.9284301 FDR fragment joints 0.01 FDR chr. breakp. enrich.
51	4	Lower_Right	8cf54607-01ce-42b0-9bd9-8627edd9f3b7	3:4979331−87053735	5, 5	35	{'min_x': 321.5199890136719, 'min_y': 693.2749633789062, 'max_x': 537.4917602539062, 'max_y': 834.6940307617188}	40 MB 80 MB 120 MB 8cf54607−01ce−42b0−9bd9−8627edd9f3b7 Breast−AdenoCA Cancer type 3:4979331−87053735 Position With other complex events Type 8 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 28 500 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 35 CN segments 0.8653243 FDR fragment joints 0.02 FDR chr. breakp. enrich.
52	1	Upper_Left	8cf54607-01ce-42b0-9bd9-8627edd9f3b7	6:66019356−135278033	6, 6	57	{'min_x': 33.68980026245117, 'min_y': 276.3299865722656, 'max_x': 254.03794860839844, 'max_y': 410.3340148925781}	8cf54607−01ce−42b0−9bd9−8627edd9f3b7 Breast−AdenoCA Cancer type 6:66019356−135278033 Position With other complex events Type 6 Interleaved intrachr. SVs 50 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 1; SV types t2tINV: 1; TRA: 38 500 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 57 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 12:2943203−96943877;13:22850041−105164538 Linked to chrs
52	2	Upper_Right	8cf54607-01ce-42b0-9bd9-8627edd9f3b7	8:61853482−136089944	4, 7	65	{'min_x': 321.5199890136719, 'min_y': 272.0099792480469, 'max_x': 545.2039794921875, 'max_y': 410.4242248535156}	8cf54607−01ce−42b0−9bd9−8627edd9f3b7 Breast−AdenoCA Cancer type 8:61853482−136089944 Position With other complex events Type 26 Interleaved intrachr. SVs 63 Total SVs (intrachr. + transl.) DEL: 7; DUP: 7; h2hINV: 7; SV types t2tINV: 5; TRA: 37 500 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 65 CN segments 0.7735152 FDR fragment joints 0 FDR chr. breakp. enrich. 10:37398211−116249332;15:32410181−71959925 3:4979331−87053734;4:39957449−163913724 Linked to chrs
52	3	Lower_Left	8cf54607-01ce-42b0-9bd9-8627edd9f3b7	15:32410181−71959926	5, 10	34	{'min_x': 39.73979949951172, 'min_y': 693.2749633789062, 'max_x': 255.29977416992188, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 70 MB 80 MB 90 MB 8cf54607−01ce−42b0−9bd9−8627edd9f3b7 Breast−AdenoCA Cancer type 15:32410181−71959926 Position With other complex events Type 17 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 5; SV types t2tINV: 9; TRA: 5 500 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 34 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
52	4	Lower_Right	8cf54607-01ce-42b0-9bd9-8627edd9f3b7	21:35999819−47786448	5, 5	54	{'min_x': 307.4800109863281, 'min_y': 693.2749633789062, 'max_x': 537.4917602539062, 'max_y': 839.013916015625}	36 MB 39 MB 42 MB 45 MB 8cf54607−01ce−42b0−9bd9−8627edd9f3b7 Breast−AdenoCA Cancer type 21:35999819−47786448 Position With other complex events Type 29 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 11; DUP: 7; h2hINV: 3; SV types t2tINV: 8; TRA: 14 500 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 54 CN segments 0.8609429 FDR fragment joints 0 FDR chr. breakp. enrich.
53	1	Upper_Left	9435447e-d65f-408b-863b-6576b1d652dd	8:27280903−40031251	5, 9	15	{'min_x': 38.91019821166992, 'min_y': 280.6499938964844, 'max_x': 248.8200225830078, 'max_y': 410.42401123046875}	9435447e−d65f−408b−863b−6576b1d652dd Breast−AdenoCA Cancer type 8:27280903−40031251 Position With other complex events Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 2 137 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 15 CN segments 0.8572806 FDR fragment joints 0.22 FDR chr. breakp. enrich. 6:11657826−66411416; Linked to chrs
53	2	Upper_Right	993103b1-e5a1-4c33-8629-be53ebc41d64	X:29228730−35455689	4, 10	15	{'min_x': 328.20001220703125, 'min_y': 280.6499938964844, 'max_x': 538.5279541015625, 'max_y': 410.3340148925781}	993103b1−e5a1−4c33−8629−be53ebc41d64 Breast−AdenoCA Cancer type X:29228730−35455689 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 3; TRA: 0 202 SVs in sample 4, 10 Oscillating CN (2 and 3 states) 15 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
53	3	Lower_Left	9938ce5c-e74e-446e-a932-f096f85cc3b1	3:8619684−170470349	5, 5	5	{'min_x': 40.539798736572266, 'min_y': 693.2749633789062, 'max_x': 247.19195556640625, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 9938ce5c−e74e−446e−a932−f096f85cc3b1 Breast−AdenoCA Cancer type 3:8619684−170470349 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 2 361 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.615458 FDR fragment joints 0.16 FDR chr. breakp. enrich.
53	4	Lower_Right	9fefbe7c-f66a-4940-843e-285cb7b392c1	6:5413201−164420806	6, 16	129	{'min_x': 321.5199890136719, 'min_y': 693.2749633789062, 'max_x': 553.9921264648438, 'max_y': 834.6940307617188}	40 MB 80 MB 120 MB 160 MB 9fefbe7c−f66a−4940−843e−285cb7b392c1 Breast−AdenoCA Cancer type 6:5413201−164420806 Position With other complex events Type 102 Interleaved intrachr. SVs 163 Total SVs (intrachr. + transl.) DEL: 23; DUP: 27; h2hINV: 23; SV types t2tINV: 29; TRA: 61 740 SVs in sample 6, 16 Oscillating CN (2 and 3 states) 129 CN segments 0.8517294 FDR fragment joints 0 FDR chr. breakp. enrich.
54	1	Upper_Left	9fefbe7c-f66a-4940-843e-285cb7b392c1	18:3037071−12644210	6, 6	6	{'min_x': 40.900001525878906, 'min_y': 280.6499938964844, 'max_x': 246.82379150390625, 'max_y': 410.3340148925781}	9fefbe7c−f66a−4940−843e−285cb7b392c1 Breast−AdenoCA Cancer type 18:3037071−12644210 Position After polyploidization Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 2 740 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9804396 FDR fragment joints 0.33 FDR chr. breakp. enrich. Linked to chrs
54	2	Upper_Right	9fefbe7c-f66a-4940-843e-285cb7b392c1	19:12822132−24591286	4, 6	27	{'min_x': 330.3999938964844, 'min_y': 280.6499938964844, 'max_x': 536.3237915039062, 'max_y': 410.42401123046875}	9fefbe7c−f66a−4940−843e−285cb7b392c1 Breast−AdenoCA Cancer type 19:12822132−24591286 Position With other complex events Type 8 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 0; SV types t2tINV: 2; TRA: 23 740 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 27 CN segments 0.5257473 FDR fragment joints 0 FDR chr. breakp. enrich. 1:31254630−243789936; Linked to chrs
54	3	Lower_Left	9fefbe7c-f66a-4940-843e-285cb7b392c1	X:115424165−135666891	4, 7	29	{'min_x': 40.900001525878906, 'min_y': 693.2749633789062, 'max_x': 271.11181640625, 'max_y': 839.013916015625}	125 MB 135 MB 145 MB 155 MB 9fefbe7c−f66a−4940−843e−285cb7b392c1 Breast−AdenoCA Cancer type X:115424165−135666891 Position With other complex events Type 19 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 7; SV types t2tINV: 6; TRA: 5 740 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 29 CN segments 0.7568568 FDR fragment joints 0.25 FDR chr. breakp. enrich.
54	4	Lower_Right	a824b3bd-34d5-4cc1-a92f-f9d6ac0f1814	1:147408680−212272247	6, 9	62	{'min_x': 330.0400085449219, 'min_y': 693.2749633789062, 'max_x': 536.683837890625, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB a824b3bd−34d5−4cc1−a92f−f9d6ac0f1814 Breast−AdenoCA Cancer type 1:147408680−212272247 Position With other complex events Type 37 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 9; DUP: 9; h2hINV: 10; SV types t2tINV: 9; TRA: 2 463 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 62 CN segments 0.9800011 FDR fragment joints 0 FDR chr. breakp. enrich.
55	1	Upper_Left	a824b3bd-34d5-4cc1-a92f-f9d6ac0f1814	11:10547187−101046437	5, 15	78	{'min_x': 32.019901275634766, 'min_y': 276.3299865722656, 'max_x': 255.70394897460938, 'max_y': 410.3340148925781}	a824b3bd−34d5−4cc1−a92f−f9d6ac0f1814 Breast−AdenoCA Cancer type 11:10547187−101046437 Position With other complex events Type 25 Interleaved intrachr. SVs 70 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 9; SV types t2tINV: 5; TRA: 45 463 SVs in sample 5, 15 Oscillating CN (2 and 3 states) 78 CN segments 0.8066159 FDR fragment joints 0 FDR chr. breakp. enrich. 2:26459899−233537708;5:108659861−118357838 Linked to chrs
55	2	Upper_Right	a9b7d7fe-be31-4f71-afee-c1bfdf511888	8:63227110−131599267	6, 8	173	{'min_x': 331.44000244140625, 'min_y': 280.6499938964844, 'max_x': 535.2877807617188, 'max_y': 410.3340148925781}	a9b7d7fe−be31−4f71−afee−c1bfdf511888 Breast−AdenoCA Cancer type 8:63227110−131599267 Position With other complex events Type 10 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 4 460 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 173 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
55	3	Lower_Left	b43e41af-1d82-4b5f-b8f1-add0510e6b86	11:55581976−79948001	4, 6	37	{'min_x': 40.23979949951172, 'min_y': 693.2749633789062, 'max_x': 269.4498291015625, 'max_y': 839.013916015625}	60 MB 65 MB 70 MB 75 MB 80 MB b43e41af−1d82−4b5f−b8f1−add0510e6b86 Breast−AdenoCA Cancer type 11:55581976−79948001 Position With other complex events Type 15 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 16 296 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 37 CN segments 0.7622832 FDR fragment joints 0 FDR chr. breakp. enrich.
55	4	Lower_Right	b43e41af-1d82-4b5f-b8f1-add0510e6b86	17:26793465−79998471	4, 7	64	{'min_x': 329.739990234375, 'min_y': 693.2749633789062, 'max_x': 558.4697875976562, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB b43e41af−1d82−4b5f−b8f1−add0510e6b86 Breast−AdenoCA Cancer type 17:26793465−79998471 Position With other complex events Type 49 Interleaved intrachr. SVs 66 Total SVs (intrachr. + transl.) DEL: 13; DUP: 12; h2hINV: 13; SV types t2tINV: 11; TRA: 17 296 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 64 CN segments 0.992996 FDR fragment joints 0 FDR chr. breakp. enrich.
56	1	Upper_Left	b43e41af-1d82-4b5f-b8f1-add0510e6b86	20:4186490−34159090	5, 8	19	{'min_x': 40.23979949951172, 'min_y': 280.6499938964844, 'max_x': 247.48394775390625, 'max_y': 410.42401123046875}	b43e41af−1d82−4b5f−b8f1−add0510e6b86 Breast−AdenoCA Cancer type 20:4186490−34159090 Position With other complex events Type 14 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 6; SV types t2tINV: 4; TRA: 14 296 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 19 CN segments 0.9794281 FDR fragment joints 0 FDR chr. breakp. enrich. 22:24093006−30283045; Linked to chrs
56	2	Upper_Right	b97bf89a-7a85-4eef-ae7e-f787aead1f0a	5:8856070−26153658	6, 8	13	{'min_x': 331.0400085449219, 'min_y': 280.6499938964844, 'max_x': 535.6859130859375, 'max_y': 410.3340148925781}	b97bf89a−7a85−4eef−ae7e−f787aead1f0a Breast−AdenoCA Cancer type 5:8856070−26153658 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 0 194 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 13 CN segments 0.6776251 FDR fragment joints 0.78 FDR chr. breakp. enrich. Linked to chrs
56	3	Lower_Left	c0892598-1f7b-4f23-9cd8-731f797753d5	3:166105643−176738060	5, 8	13	{'min_x': 40.86989974975586, 'min_y': 693.2749633789062, 'max_x': 246.8539581298828, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB c0892598−1f7b−4f23−9cd8−731f797753d5 Breast−AdenoCA Cancer type 3:166105643−176738060 Position With other complex events Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 1 358 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 13 CN segments 0.9723381 FDR fragment joints 1 FDR chr. breakp. enrich.
56	4	Lower_Right	c0892598-1f7b-4f23-9cd8-731f797753d5	22:19004440−50133204	5, 16	16	{'min_x': 314.8599853515625, 'min_y': 693.2749633789062, 'max_x': 557.4697265625, 'max_y': 834.6940307617188}	20 MB 30 MB 40 MB 50 MB c0892598−1f7b−4f23−9cd8−731f797753d5 Breast−AdenoCA Cancer type 22:19004440−50133204 Position With other complex events Type 10 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 5; TRA: 6 358 SVs in sample 5, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
57	1	Upper_Left	c364e81c-eb1e-4870-ab37-9c661f5f2e3d	12:56913152−101125708	5, 8	81	{'min_x': 35.360198974609375, 'min_y': 276.3299865722656, 'max_x': 252.3719482421875, 'max_y': 410.3340148925781}	c364e81c−eb1e−4870−ab37−9c661f5f2e3d Breast−AdenoCA Cancer type 12:56913152−101125708 Position With other complex events Type 50 Interleaved intrachr. SVs 124 Total SVs (intrachr. + transl.) DEL: 10; DUP: 13; h2hINV: 13; SV types t2tINV: 14; TRA: 74 397 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 81 CN segments 0.854603 FDR fragment joints 0 FDR chr. breakp. enrich. 16:5415371−33325042;20:24138933−61546428 Linked to chrs
57	2	Upper_Right	c364e81c-eb1e-4870-ab37-9c661f5f2e3d	20:24138933−61546429	5, 7	148	{'min_x': 323.19000244140625, 'min_y': 276.3299865722656, 'max_x': 543.5379638671875, 'max_y': 410.3340148925781}	c364e81c−eb1e−4870−ab37−9c661f5f2e3d Breast−AdenoCA Cancer type 20:24138933−61546429 Position With other complex events Type 87 Interleaved intrachr. SVs 196 Total SVs (intrachr. + transl.) DEL: 25; DUP: 20; h2hINV: 23; SV types t2tINV: 19; TRA: 109 397 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 148 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 12:56913152−101125707;16:5415371−33325042 Linked to chrs
57	3	Lower_Left	d3d545b3-457f-4389-821f-704cb24aff7f	8:67453419−86357134	5, 6	20	{'min_x': 42.04999923706055, 'min_y': 693.2749633789062, 'max_x': 245.67796325683594, 'max_y': 839.013916015625}	60 MB 90 MB 120 MB d3d545b3−457f−4389−821f−704cb24aff7f Breast−AdenoCA Cancer type 8:67453419−86357134 Position With other complex events Type 14 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 3; SV types t2tINV: 3; TRA: 1 709 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 20 CN segments 0.925252 FDR fragment joints 0 FDR chr. breakp. enrich.
57	4	Lower_Right	d3d545b3-457f-4389-821f-704cb24aff7f	11:47447817−102287472	4, 6	18	{'min_x': 331.54998779296875, 'min_y': 693.2749633789062, 'max_x': 557.6324462890625, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB 125 MB d3d545b3−457f−4389−821f−704cb24aff7f Breast−AdenoCA Cancer type 11:47447817−102287472 Position With other complex events Type 6 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 9 709 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 18 CN segments 0.9905774 FDR fragment joints 0.44 FDR chr. breakp. enrich.
58	1	Upper_Left	d67cd793-2931-429a-9084-2f3c4c8be7ad	6:57423175−76896760	6, 12	21	{'min_x': 39.36989974975586, 'min_y': 280.6499938964844, 'max_x': 248.35995483398438, 'max_y': 410.42401123046875}	d67cd793−2931−429a−9084−2f3c4c8be7ad Breast−AdenoCA Cancer type 6:57423175−76896760 Position With other complex events Type 13 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 4; TRA: 22 427 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 21 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 14:20136324−55556439; Linked to chrs
58	2	Upper_Right	d67cd793-2931-429a-9084-2f3c4c8be7ad	9:17497087−129076121	4, 5	32	{'min_x': 328.8699951171875, 'min_y': 280.6499938964844, 'max_x': 537.8599243164062, 'max_y': 410.42401123046875}	d67cd793−2931−429a−9084−2f3c4c8be7ad Breast−AdenoCA Cancer type 9:17497087−129076121 Position With other complex events Type 10 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 4; TRA: 2 427 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 32 CN segments 0.6776251 FDR fragment joints 0.76 FDR chr. breakp. enrich. 12:33908610−132258020; Linked to chrs
58	3	Lower_Left	d67cd793-2931-429a-9084-2f3c4c8be7ad	11:1800449−37610887	5, 5	13	{'min_x': 39.36989974975586, 'min_y': 693.2749633789062, 'max_x': 249.7418975830078, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB d67cd793−2931−429a−9084−2f3c4c8be7ad Breast−AdenoCA Cancer type 11:1800449−37610887 Position With other complex events Type 7 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 7 427 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 13 CN segments 0.9794281 FDR fragment joints 0.79 FDR chr. breakp. enrich.
58	4	Lower_Right	d67cd793-2931-429a-9084-2f3c4c8be7ad	14:20136324−55556440	6, 8	76	{'min_x': 307.0199890136719, 'min_y': 693.2749633789062, 'max_x': 537.8599243164062, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB d67cd793−2931−429a−9084−2f3c4c8be7ad Breast−AdenoCA Cancer type 14:20136324−55556440 Position With other complex events Type 34 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 9; DUP: 7; h2hINV: 9; SV types t2tINV: 9; TRA: 21 427 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 76 CN segments 0.930656 FDR fragment joints 0 FDR chr. breakp. enrich.
59	1	Upper_Left	d6f7afc0-1558-43ad-acb1-2b5311ed2264	6:105302877−111874190	4, 9	35	{'min_x': 39.88010025024414, 'min_y': 280.6499938964844, 'max_x': 247.85195922851562, 'max_y': 410.3340148925781}	d6f7afc0−1558−43ad−acb1−2b5311ed2264 Breast−AdenoCA Cancer type 6:105302877−111874190 Position With other complex events Type 27 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 9; DUP: 8; h2hINV: 6; SV types t2tINV: 4; TRA: 2 304 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 35 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
59	2	Upper_Right	d6f7afc0-1558-43ad-acb1-2b5311ed2264	13:65488647−114881095	5, 8	93	{'min_x': 329.3800048828125, 'min_y': 280.6499938964844, 'max_x': 537.3518676757812, 'max_y': 410.42401123046875}	d6f7afc0−1558−43ad−acb1−2b5311ed2264 Breast−AdenoCA Cancer type 13:65488647−114881095 Position With other complex events Type 52 Interleaved intrachr. SVs 71 Total SVs (intrachr. + transl.) DEL: 13; DUP: 9; h2hINV: 17; SV types t2tINV: 13; TRA: 19 304 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 93 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 12:66502753−130003738; Linked to chrs
59	3	Lower_Left	d8d7a6c2-6427-4f47-968c-6c3affba4617	8:78814327−143134735	4, 7	214	{'min_x': 40.86989974975586, 'min_y': 693.2749633789062, 'max_x': 261.8821105957031, 'max_y': 839.013916015625}	80 MB 100 MB 120 MB 140 MB d8d7a6c2−6427−4f47−968c−6c3affba4617 Breast−AdenoCA Cancer type 8:78814327−143134735 Position With other complex events Type 116 Interleaved intrachr. SVs 220 Total SVs (intrachr. + transl.) DEL: 30; DUP: 32; h2hINV: 29; SV types t2tINV: 25; TRA: 104 453 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 214 CN segments 0.8274637 FDR fragment joints 0 FDR chr. breakp. enrich.
59	4	Lower_Right	d8d7a6c2-6427-4f47-968c-6c3affba4617	12:61134794−98290462	5, 6	48	{'min_x': 311.2900085449219, 'min_y': 693.2749633789062, 'max_x': 536.3538818359375, 'max_y': 839.013916015625}	30 MB 50 MB 70 MB 90 MB d8d7a6c2−6427−4f47−968c−6c3affba4617 Breast−AdenoCA Cancer type 12:61134794−98290462 Position With other complex events Type 8 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 40 453 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 48 CN segments 0.9501265 FDR fragment joints 0 FDR chr. breakp. enrich.
60	1	Upper_Left	d9dc3b59-613d-469e-8b4f-6c5a557eb26a	6:15838701−146459167	4, 9	70	{'min_x': 39.039798736572266, 'min_y': 280.6499938964844, 'max_x': 248.68995666503906, 'max_y': 410.42401123046875}	d9dc3b59−613d−469e−8b4f−6c5a557eb26a Breast−AdenoCA Cancer type 6:15838701−146459167 Position With other complex events Type 8 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 4; SV types t2tINV: 2; TRA: 20 1222 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 70 CN segments 0.8653243 FDR fragment joints 0.01 FDR chr. breakp. enrich. 17:2481365−78698345; Linked to chrs
60	2	Upper_Right	e4fc0909-f284-4471-866d-d8967b6adcbc	13:35528163−62533552	6, 10	48	{'min_x': 329.3800048828125, 'min_y': 280.6499938964844, 'max_x': 537.3519287109375, 'max_y': 410.42401123046875}	e4fc0909−f284−4471−866d−d8967b6adcbc Breast−AdenoCA Cancer type 13:35528163−62533552 Position With other complex events Type 9 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 2; SV types t2tINV: 2; TRA: 18 630 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 48 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 6:93474674−108070112; Linked to chrs
60	3	Lower_Left	e4fc0909-f284-4471-866d-d8967b6adcbc	17:14753198−76302171	6, 7	91	{'min_x': 33.68980026245117, 'min_y': 693.2749633789062, 'max_x': 247.85195922851562, 'max_y': 834.6940307617188}	20 MB 40 MB 60 MB e4fc0909−f284−4471−866d−d8967b6adcbc Breast−AdenoCA Cancer type 17:14753198−76302171 Position With other complex events Type 44 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 11; DUP: 17; h2hINV: 9; SV types t2tINV: 7; TRA: 10 630 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 91 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
60	4	Lower_Right	e4fc0909-f284-4471-866d-d8967b6adcbc	20:34495099−60210989	5, 10	75	{'min_x': 329.3800048828125, 'min_y': 693.2749633789062, 'max_x': 557.60009765625, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB e4fc0909−f284−4471−866d−d8967b6adcbc Breast−AdenoCA Cancer type 20:34495099−60210989 Position With other complex events Type 39 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 10; DUP: 12; h2hINV: 9; SV types t2tINV: 8; TRA: 10 630 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 75 CN segments 0.9410753 FDR fragment joints 0 FDR chr. breakp. enrich.
61	1	Upper_Left	f0787165-6f58-4d67-b510-928eea2c4882	11:64649854−90375457	4, 8	90	{'min_x': 40.36989974975586, 'min_y': 280.6499938964844, 'max_x': 247.36195373535156, 'max_y': 410.3340148925781}	f0787165−6f58−4d67−b510−928eea2c4882 Breast−AdenoCA Cancer type 11:64649854−90375457 Position With other complex events Type 70 Interleaved intrachr. SVs 78 Total SVs (intrachr. + transl.) DEL: 17; DUP: 19; h2hINV: 13; SV types t2tINV: 21; TRA: 8 421 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 90 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
61	2	Upper_Right	f45210d3-9e66-4f5e-bef1-5ee5547cc893	12:15014157−131294963	6, 10	22	{'min_x': 330.5400085449219, 'min_y': 280.6499938964844, 'max_x': 536.1838989257812, 'max_y': 410.3340148925781}	f45210d3−9e66−4f5e−bef1−5ee5547cc893 Breast−AdenoCA Cancer type 12:15014157−131294963 Position With other complex events Type 8 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 11 179 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 22 CN segments 0.8082862 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
61	3	Lower_Left	f45210d3-9e66-4f5e-bef1-5ee5547cc893	X:64048649−139724918	6, 12	19	{'min_x': 41.039798736572266, 'min_y': 693.2749633789062, 'max_x': 265.0919494628906, 'max_y': 839.013916015625}	60 MB 90 MB 120 MB 150 MB f45210d3−9e66−4f5e−bef1−5ee5547cc893 Breast−AdenoCA Cancer type X:64048649−139724918 Position With other complex events Type 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 6 179 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 19 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
61	4	Lower_Right	f51af6db-2655-47fb-9ffc-83a503a728ea	17:49337625−73767807	5, 5	35	{'min_x': 306.42999267578125, 'min_y': 693.2749633789062, 'max_x': 539.6499633789062, 'max_y': 839.013916015625}	20 MB 30 MB 40 MB 50 MB 60 MB 70 MB f51af6db−2655−47fb−9ffc−83a503a728ea Breast−AdenoCA Cancer type 17:49337625−73767807 Position With other complex events Type 23 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 4; SV types t2tINV: 8; TRA: 8 49 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 35 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
62	1	Upper_Left	f6e1ec78-5ad9-4879-9b7e-262d17b166ad	11:59328137−82524424	4, 5	77	{'min_x': 39.210201263427734, 'min_y': 280.6499938964844, 'max_x': 248.51995849609375, 'max_y': 410.42401123046875}	f6e1ec78−5ad9−4879−9b7e−262d17b166ad Breast−AdenoCA Cancer type 11:59328137−82524424 Position With other complex events Type 32 Interleaved intrachr. SVs 108 Total SVs (intrachr. + transl.) DEL: 12; DUP: 6; h2hINV: 8; SV types t2tINV: 6; TRA: 76 320 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 77 CN segments 0.8298498 FDR fragment joints 0 FDR chr. breakp. enrich. 3:20060433−168725244; Linked to chrs
62	2	Upper_Right	f6e1ec78-5ad9-4879-9b7e-262d17b166ad	17:26949478−66253676	4, 5	81	{'min_x': 328.7099914550781, 'min_y': 280.6499938964844, 'max_x': 538.0199584960938, 'max_y': 410.42401123046875}	f6e1ec78−5ad9−4879−9b7e−262d17b166ad Breast−AdenoCA Cancer type 17:26949478−66253676 Position With other complex events Type 77 Interleaved intrachr. SVs 161 Total SVs (intrachr. + transl.) DEL: 19; DUP: 20; h2hINV: 21; SV types t2tINV: 17; TRA: 84 320 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 81 CN segments 0.988335 FDR fragment joints 0 FDR chr. breakp. enrich. 3:20060433−168725244; Linked to chrs
62	3	Lower_Left	CGP_donor_1451426	17:17901920−60667439	6, 11	37	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 263.4402160644531, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB CGP_donor_1451426 Breast−DCIS Cancer type 17:17901920−60667439 Position With other complex events Type 19 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 6; SV types t2tINV: 7; TRA: 0 52 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 37 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
62	4	Lower_Right	CGP_donor_1114930	16:8249679−22198632	4, 6	20	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB CGP_donor_1114930 Breast−DCIS Cancer type 16:8249679−22198632 Position With other complex events Type 7 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 2 33 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 20 CN segments 0.9723381 FDR fragment joints 0 FDR chr. breakp. enrich.
63	1	Upper_Left	CGP_donor_1234120	5:27117220−142566044	4, 7	32	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	CGP_donor_1234120 Breast−LobularCA Cancer type 5:27117220−142566044 Position With other complex events Type 15 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 7; DUP: 4; h2hINV: 2; SV types t2tINV: 2; TRA: 8 344 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 32 CN segments 0.7861024 FDR fragment joints 0 FDR chr. breakp. enrich. 11:62942614−98446661; Linked to chrs
63	2	Upper_Right	CGP_donor_1234120	7:108549083−153423652	5, 7	22	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1234120 Breast−LobularCA Cancer type 7:108549083−153423652 Position With other complex events Type 20 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 3; DUP: 8; h2hINV: 6; SV types t2tINV: 3; TRA: 4 344 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 22 CN segments 0.8298498 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
63	3	Lower_Left	CGP_donor_1234120	15:59922904−101226389	4, 6	18	{'min_x': 51.849998474121094, 'min_y': 693.2749633789062, 'max_x': 265.05206298828125, 'max_y': 839.013916015625}	60 MB 70 MB 80 MB 90 MB 100 MB CGP_donor_1234120 Breast−LobularCA Cancer type 15:59922904−101226389 Position With other complex events Type 18 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 4; DUP: 7; h2hINV: 4; SV types t2tINV: 3; TRA: 2 344 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 18 CN segments 0.662962 FDR fragment joints 0 FDR chr. breakp. enrich.
63	4	Lower_Right	CGP_donor_1353429	8:22728682−56379069	4, 5	45	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 514.7200317382812, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB CGP_donor_1353429 Breast−LobularCA Cancer type 8:22728682−56379069 Position With other complex events Type 16 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 4; SV types t2tINV: 6; TRA: 15 83 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 45 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
64	1	Upper_Left	CGP_donor_1353429	11:39761387−78170654	4, 5	55	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_1353429 Breast−LobularCA Cancer type 11:39761387−78170654 Position With other complex events Type 21 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 7; SV types t2tINV: 6; TRA: 15 83 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 55 CN segments 0.641841 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
64	2	Upper_Right	CGP_donor_1230724	17:6272054−47320751	4, 5	30	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_1230724 Breast−LobularCA Cancer type 17:6272054−47320751 Position With other complex events Type 28 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 6; DUP: 8; h2hINV: 9; SV types t2tINV: 5; TRA: 0 33 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 30 CN segments 0.8066159 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
64	3	Lower_Left	2d29a4ac-98e7-4663-9dd6-5681bc32ac2e	1:202357683−216952427	5, 11	12	{'min_x': 38.730098724365234, 'min_y': 693.2749633789062, 'max_x': 248.99810791015625, 'max_y': 839.013916015625}	140 MB 160 MB 180 MB 200 MB 2d29a4ac−98e7−4663−9dd6−5681bc32ac2e Breast−LobularCA Cancer type 1:202357683−216952427 Position With other complex events Type 8 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 0; SV types t2tINV: 0; TRA: 10 105 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 12 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
64	4	Lower_Right	2d29a4ac-98e7-4663-9dd6-5681bc32ac2e	11:68233404−80019931	5, 10	57	{'min_x': 328.2300109863281, 'min_y': 693.2749633789062, 'max_x': 558.2501831054688, 'max_y': 839.013916015625}	60 MB 65 MB 70 MB 75 MB 80 MB 2d29a4ac−98e7−4663−9dd6−5681bc32ac2e Breast−LobularCA Cancer type 11:68233404−80019931 Position With other complex events Type 48 Interleaved intrachr. SVs 74 Total SVs (intrachr. + transl.) DEL: 17; DUP: 13; h2hINV: 10; SV types t2tINV: 8; TRA: 26 105 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 57 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
65	1	Upper_Left	ef4cbd38-bc79-4d60-a715-647edd2ebe9e	21:32373739−47753333	5, 8	45	{'min_x': 33.68980026245117, 'min_y': 276.3299865722656, 'max_x': 254.03794860839844, 'max_y': 410.3340148925781}	ef4cbd38−bc79−4d60−a715−647edd2ebe9e Breast−LobularCA Cancer type 21:32373739−47753333 Position With other complex events Type 33 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 11; SV types t2tINV: 10; TRA: 11 134 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 45 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 8:42881572−135695929;13:19943737−57122358 Linked to chrs
65	2	Upper_Right	00bca18c-b3d4-45a3-8f19-034cc40449a4	12:47208673−56550744	4, 6	6	{'min_x': 329.0400085449219, 'min_y': 280.6499938964844, 'max_x': 537.6898803710938, 'max_y': 410.3340148925781}	00bca18c−b3d4−45a3−8f19−034cc40449a4 Cervix−SCC Cancer type 12:47208673−56550744 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 0; SV types t2tINV: 3; TRA: 0 168 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.615458 FDR fragment joints 0.07 FDR chr. breakp. enrich. Linked to chrs
65	3	Lower_Left	8a4da4f0-30f2-497e-8a7c-988fd6b813cb	21:18922646−26760076	4, 5	11	{'min_x': 40.710201263427734, 'min_y': 693.2749633789062, 'max_x': 247.0139617919922, 'max_y': 839.013916015625}	25 MB 30 MB 35 MB 40 MB 8a4da4f0−30f2−497e−8a7c−988fd6b813cb Cervix−SCC Cancer type 21:18922646−26760076 Position With other complex events Type 19 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 5; SV types t2tINV: 7; TRA: 1 117 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 11 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich.
65	4	Lower_Right	eb59cf69-1997-41b9-bf69-69ad7da292a1	1:151719688−220597001	5, 5	8	{'min_x': 329.3800048828125, 'min_y': 693.2749633789062, 'max_x': 537.3518676757812, 'max_y': 839.013916015625}	175 MB 200 MB 225 MB eb59cf69−1997−41b9−bf69−69ad7da292a1 Cervix−SCC Cancer type 1:151719688−220597001 Position After polyploidization Type 14 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 2 63 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 8 CN segments 0.9501265 FDR fragment joints 0 FDR chr. breakp. enrich.
66	1	Upper_Left	01a92062-967a-4900-8dc7-a5ecd3b3f8e2	9:115736690−134498722	5, 9	27	{'min_x': 39.539798736572266, 'min_y': 280.6499938964844, 'max_x': 248.18995666503906, 'max_y': 410.3340148925781}	01a92062−967a−4900−8dc7−a5ecd3b3f8e2 CNS−GBM Cancer type 9:115736690−134498722 Position With other complex events Type 27 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 7; DUP: 4; h2hINV: 6; SV types t2tINV: 10; TRA: 17 98 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 27 CN segments 0.8874881 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
66	2	Upper_Right	0798dbe2-1914-427c-a2fe-2a865d0d6eda	9:17843117−36219343	5, 9	19	{'min_x': 324.8599853515625, 'min_y': 276.3299865722656, 'max_x': 541.8719482421875, 'max_y': 410.3340148925781}	0798dbe2−1914−427c−a2fe−2a865d0d6eda CNS−GBM Cancer type 9:17843117−36219343 Position With other complex events Type 12 Interleaved intrachr. SVs 51 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 5; SV types t2tINV: 3; TRA: 39 209 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 19 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich. 1:8762210−205453074;10:5388962−135052040 Linked to chrs
66	3	Lower_Left	2c5fa2d4-8e35-42e4-8bca-9fb3371a19c8	12:2835782−133092445	5, 5	28	{'min_x': 40.210201263427734, 'min_y': 693.2749633789062, 'max_x': 247.52195739746094, 'max_y': 839.013916015625}	50 MB 100 MB 2c5fa2d4−8e35−42e4−8bca−9fb3371a19c8 CNS−GBM Cancer type 12:2835782−133092445 Position With other complex events Type 44 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 10; DUP: 9; h2hINV: 12; SV types t2tINV: 13; TRA: 1 77 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 28 CN segments 0.9161301 FDR fragment joints 0 FDR chr. breakp. enrich.
66	4	Lower_Right	386b629e-fab1-4033-b088-45d6eeb4a13e	3:126688674−182097458	5, 18	18	{'min_x': 328.7099914550781, 'min_y': 693.2749633789062, 'max_x': 538.0198974609375, 'max_y': 839.013916015625}	80 MB 120 MB 160 MB 386b629e−fab1−4033−b088−45d6eeb4a13e CNS−GBM Cancer type 3:126688674−182097458 Position With other complex events Type 54 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 14; DUP: 11; h2hINV: 15; SV types t2tINV: 14; TRA: 1 114 SVs in sample 5, 18 Oscillating CN (2 and 3 states) 18 CN segments 0.8833361 FDR fragment joints 0 FDR chr. breakp. enrich.
67	1	Upper_Left	521ea765-1bd1-423d-a75d-091243df37a9	12:57657463−59700261	4, 6	30	{'min_x': 39.210201263427734, 'min_y': 280.6499938964844, 'max_x': 248.51995849609375, 'max_y': 410.3340148925781}	521ea765−1bd1−423d−a75d−091243df37a9 CNS−GBM Cancer type 12:57657463−59700261 Position With other complex events Type 36 Interleaved intrachr. SVs 52 Total SVs (intrachr. + transl.) DEL: 8; DUP: 10; h2hINV: 7; SV types t2tINV: 11; TRA: 16 90 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 30 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
67	2	Upper_Right	5c984433-33cf-42fc-b3ba-511efcdcab19	4:54735188−55541337	4, 7	25	{'min_x': 330.2099914550781, 'min_y': 280.6499938964844, 'max_x': 536.513916015625, 'max_y': 410.3340148925781}	5c984433−33cf−42fc−b3ba−511efcdcab19 CNS−GBM Cancer type 4:54735188−55541337 Position With other complex events Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 7; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 0 107 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 25 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
67	3	Lower_Left	5c984433-33cf-42fc-b3ba-511efcdcab19	9:20593576−38007522	5, 11	11	{'min_x': 40.710201263427734, 'min_y': 693.2749633789062, 'max_x': 247.0139617919922, 'max_y': 839.013916015625}	50 MB 100 MB 5c984433−33cf−42fc−b3ba−511efcdcab19 CNS−GBM Cancer type 9:20593576−38007522 Position With other complex events Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 1 107 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.7735152 FDR fragment joints 0.21 FDR chr. breakp. enrich.
67	4	Lower_Right	737b35e1-d668-4fce-9b6e-76946c7952b6	12:8669087−9519921	5, 5	5	{'min_x': 314.8900146484375, 'min_y': 693.2749633789062, 'max_x': 554.0364379882812, 'max_y': 839.013916015625}	8.7 MB 8.9 MB 9.1 MB 9.3 MB 9.5 MB 737b35e1−d668−4fce−9b6e−76946c7952b6 CNS−GBM Cancer type 12:8669087−9519921 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 4; SV types t2tINV: 2; TRA: 0 173 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.6776251 FDR fragment joints 0.9 FDR chr. breakp. enrich.
68	1	Upper_Left	74139255-a635-4c87-814d-3dd04ed630a8	9:21130542−26979040	5, 9	21	{'min_x': 38.730098724365234, 'min_y': 280.6499938964844, 'max_x': 248.99777221679688, 'max_y': 410.42401123046875}	74139255−a635−4c87−814d−3dd04ed630a8 CNS−GBM Cancer type 9:21130542−26979040 Position With other complex events Type 17 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 6; SV types t2tINV: 4; TRA: 18 291 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 21 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. 15:34114739−74116043; Linked to chrs
68	2	Upper_Right	93ed7a2b-b0cb-4a84-871f-5c34a0b6a640	6:71789357−170660594	6, 8	27	{'min_x': 328.7099914550781, 'min_y': 280.6499938964844, 'max_x': 538.0198974609375, 'max_y': 410.42401123046875}	93ed7a2b−b0cb−4a84−871f−5c34a0b6a640 CNS−GBM Cancer type 6:71789357−170660594 Position With other complex events Type 63 Interleaved intrachr. SVs 66 Total SVs (intrachr. + transl.) DEL: 13; DUP: 17; h2hINV: 15; SV types t2tINV: 18; TRA: 3 175 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 27 CN segments 0.845361 FDR fragment joints 0 FDR chr. breakp. enrich. 12:44665062−82704890; Linked to chrs
68	3	Lower_Left	93ed7a2b-b0cb-4a84-871f-5c34a0b6a640	12:44665062−82704891	6, 6	12	{'min_x': 39.210201263427734, 'min_y': 693.2749633789062, 'max_x': 253.90199279785156, 'max_y': 839.013916015625}	60 MB 80 MB 100 MB 93ed7a2b−b0cb−4a84−871f−5c34a0b6a640 CNS−GBM Cancer type 12:44665062−82704891 Position With other complex events Type 47 Interleaved intrachr. SVs 52 Total SVs (intrachr. + transl.) DEL: 12; DUP: 12; h2hINV: 13; SV types t2tINV: 10; TRA: 5 175 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 12 CN segments 0.958094 FDR fragment joints 0 FDR chr. breakp. enrich.
68	4	Lower_Right	a2ac9937-f351-4d78-9261-264bf6c21e0c	1:5166554−214663754	4, 5	8	{'min_x': 329.8699951171875, 'min_y': 693.2749633789062, 'max_x': 544.251953125, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB a2ac9937−f351−4d78−9261−264bf6c21e0c CNS−GBM Cancer type 1:5166554−214663754 Position With other complex events Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 3; SV types t2tINV: 2; TRA: 2 102 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 8 CN segments 0.8653243 FDR fragment joints 0.51 FDR chr. breakp. enrich.
69	1	Upper_Left	b37d944c-c65c-46d6-bb8b-3eb37cb85b68	12:57781868−59706359	4, 5	29	{'min_x': 37.88010025024414, 'min_y': 280.6499938964844, 'max_x': 249.84796142578125, 'max_y': 410.3340148925781}	b37d944c−c65c−46d6−bb8b−3eb37cb85b68 CNS−GBM Cancer type 12:57781868−59706359 Position With other complex events Type 81 Interleaved intrachr. SVs 82 Total SVs (intrachr. + transl.) DEL: 22; DUP: 14; h2hINV: 23; SV types t2tINV: 22; TRA: 1 130 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 29 CN segments 0.6444888 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
69	2	Upper_Right	be3a7ef3-34ed-40e1-9d9c-187940596b26	7:25442783−152694109	4, 5	39	{'min_x': 328.8699951171875, 'min_y': 280.6499938964844, 'max_x': 537.8599243164062, 'max_y': 410.3340148925781}	be3a7ef3−34ed−40e1−9d9c−187940596b26 CNS−GBM Cancer type 7:25442783−152694109 Position With other complex events Type 60 Interleaved intrachr. SVs 63 Total SVs (intrachr. + transl.) DEL: 13; DUP: 16; h2hINV: 15; SV types t2tINV: 16; TRA: 3 93 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 39 CN segments 0.9599662 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
69	3	Lower_Left	bf339349-062f-4ea9-a0b2-d87d3a21099e	7:16533917−100901571	6, 6	36	{'min_x': 40.039798736572266, 'min_y': 693.2749633789062, 'max_x': 268.4219970703125, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB bf339349−062f−4ea9−a0b2−d87d3a21099e CNS−GBM Cancer type 7:16533917−100901571 Position With other complex events Type 19 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 3; DUP: 7; h2hINV: 4; SV types t2tINV: 5; TRA: 0 338 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 36 CN segments 0.7158792 FDR fragment joints 0.46 FDR chr. breakp. enrich.
69	4	Lower_Right	c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab	6:43602359−48828217	4, 4	26	{'min_x': 325.0400085449219, 'min_y': 693.2749633789062, 'max_x': 537.8518676757812, 'max_y': 839.013916015625}	44 MB 45 MB 46 MB 47 MB 48 MB c931f3bd−74c5−4ebd−bc0f−c7c6becd25ab CNS−GBM Cancer type 6:43602359−48828217 Position With other complex events Type 16 Interleaved intrachr. SVs 106 Total SVs (intrachr. + transl.) DEL: 5; DUP: 6; h2hINV: 2; SV types t2tINV: 3; TRA: 90 241 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 26 CN segments 0.7498275 FDR fragment joints 0 FDR chr. breakp. enrich.
70	1	Upper_Left	c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab	12:57367262−69519356	4, 5	46	{'min_x': 39.38010025024414, 'min_y': 280.6499938964844, 'max_x': 248.3519744873047, 'max_y': 410.3340148925781}	c931f3bd−74c5−4ebd−bc0f−c7c6becd25ab CNS−GBM Cancer type 12:57367262−69519356 Position With other complex events Type 79 Interleaved intrachr. SVs 181 Total SVs (intrachr. + transl.) DEL: 16; DUP: 20; h2hINV: 24; SV types t2tINV: 19; TRA: 102 241 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 46 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
70	2	Upper_Right	de7b7cac-f094-4d59-8651-e991e34ea093	2:4931914−5944046	6, 6	6	{'min_x': 329.0400085449219, 'min_y': 280.6499938964844, 'max_x': 537.6898803710938, 'max_y': 410.3340148925781}	de7b7cac−f094−4d59−8651−e991e34ea093 CNS−GBM Cancer type 2:4931914−5944046 Position After polyploidization Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 2 105 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 1 FDR fragment joints 0.36 FDR chr. breakp. enrich. Linked to chrs
70	3	Lower_Left	de7b7cac-f094-4d59-8651-e991e34ea093	4:54660832−64870856	4, 7	7	{'min_x': 39.539798736572266, 'min_y': 693.2749633789062, 'max_x': 248.18994140625, 'max_y': 839.013916015625}	57.5 MB 60 MB 62.5 MB de7b7cac−f094−4d59−8651−e991e34ea093 CNS−GBM Cancer type 4:54660832−64870856 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 3; TRA: 0 105 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.8653243 FDR fragment joints 0.89 FDR chr. breakp. enrich.
70	4	Lower_Right	ICGC_MB131	8:22113923−128760777	5, 6	25	{'min_x': 313.7300109863281, 'min_y': 693.2749633789062, 'max_x': 552.2720947265625, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB 125 MB ICGC_MB131 CNS−Medullo Cancer type 8:22113923−128760777 Position With other complex events Type 13 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 4; SV types t2tINV: 2; TRA: 6 39 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 25 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
71	1	Upper_Left	ICGC_MB177	2:15386910−16129075	4, 7	21	{'min_x': 60.18009948730469, 'min_y': 280.6499938964844, 'max_x': 227.54379272460938, 'max_y': 410.3340148925781}	ICGC_MB177 CNS−Medullo Cancer type 2:15386910−16129075 Position With other complex events Type 51 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 14; DUP: 9; h2hINV: 14; SV types t2tINV: 14; TRA: 3 59 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 21 CN segments 0.8481558 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
71	2	Upper_Right	ICGC_MB181	5:63000287−120810285	4, 7	7	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	ICGC_MB181 CNS−Medullo Cancer type 5:63000287−120810285 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 6 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
71	3	Lower_Left	ICGC_MB34	12:461707−31932605	5, 10	32	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB ICGC_MB34 CNS−Medullo Cancer type 12:461707−31932605 Position With other complex events Type 30 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 7; DUP: 9; h2hINV: 6; SV types t2tINV: 8; TRA: 1 242 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 32 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
71	4	Lower_Right	ICGC_MB34	17:27146708−67502119	6, 15	20	{'min_x': 323.7799987792969, 'min_y': 693.2749633789062, 'max_x': 515.4100341796875, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB ICGC_MB34 CNS−Medullo Cancer type 17:27146708−67502119 Position With other complex events Type 12 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 3; SV types t2tINV: 1; TRA: 11 242 SVs in sample 6, 15 Oscillating CN (2 and 3 states) 20 CN segments 0.7861024 FDR fragment joints 0 FDR chr. breakp. enrich.
72	1	Upper_Left	ICGC_MB50	8:126667508−129701837	4, 4	36	{'min_x': 60.18009948730469, 'min_y': 280.6499938964844, 'max_x': 227.54379272460938, 'max_y': 410.3340148925781}	ICGC_MB50 CNS−Medullo Cancer type 8:126667508−129701837 Position With other complex events Type 43 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 8; DUP: 13; h2hINV: 11; SV types t2tINV: 11; TRA: 0 60 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 36 CN segments 0.8609429 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
72	2	Upper_Right	ICGC_MB91	17:19371748−79563637	6, 10	15	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	ICGC_MB91 CNS−Medullo Cancer type 17:19371748−79563637 Position With other complex events Type 27 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 7; DUP: 7; h2hINV: 6; SV types t2tINV: 7; TRA: 0 34 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 15 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
72	3	Lower_Left	6a0bcf0c-fa4c-4119-99d2-f722b781d20f	2:214706062−225494723	6, 6	11	{'min_x': 41.38010025024414, 'min_y': 693.2749633789062, 'max_x': 246.34596252441406, 'max_y': 839.013916015625}	100 MB 150 MB 200 MB 6a0bcf0c−fa4c−4119−99d2−f722b781d20f CNS−Oligo Cancer type 2:214706062−225494723 Position With other complex events Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 5; SV types t2tINV: 3; TRA: 0 45 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 11 CN segments 0.9501265 FDR fragment joints 0 FDR chr. breakp. enrich.
72	4	Lower_Right	70939245-41e0-4845-a473-5fef719b9828	4:483333−4943380	6, 8	14	{'min_x': 330.07000732421875, 'min_y': 693.2749633789062, 'max_x': 536.6620483398438, 'max_y': 839.013916015625}	1 MB 2 MB 3 MB 4 MB 70939245−41e0−4845−a473−5fef719b9828 CNS−Oligo Cancer type 4:483333−4943380 Position With other complex events Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 4; SV types t2tINV: 4; TRA: 0 62 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 14 CN segments 0.8988396 FDR fragment joints 0 FDR chr. breakp. enrich.
73	1	Upper_Left	f86fa219-34e9-4812-8edf-2b66d7219779	1:186471142−228569911	4, 4	22	{'min_x': 40.86989974975586, 'min_y': 280.6499938964844, 'max_x': 246.8539581298828, 'max_y': 410.3340148925781}	f86fa219−34e9−4812−8edf−2b66d7219779 CNS−Oligo Cancer type 1:186471142−228569911 Position With other complex events Type 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 2 22 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 22 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
73	2	Upper_Right	5116e3b4-2bac-40f5-8046-b9c1783faaa5	19:8475496−27976857	5, 7	18	{'min_x': 329.7099914550781, 'min_y': 280.6499938964844, 'max_x': 537.0219116210938, 'max_y': 410.3340148925781}	5116e3b4−2bac−40f5−8046−b9c1783faaa5 ColoRect−AdenoCA Cancer type 19:8475496−27976857 Position With other complex events Type 19 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 6; DUP: 2; h2hINV: 5; SV types t2tINV: 6; TRA: 2 322 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 18 CN segments 0.6610257 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
73	3	Lower_Left	6fa41234-9077-4d05-a295-6820f3bedf5b	17:22158710−65973469	4, 5	32	{'min_x': 40.710201263427734, 'min_y': 693.2749633789062, 'max_x': 247.0139617919922, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB 6fa41234−9077−4d05−a295−6820f3bedf5b ColoRect−AdenoCA Cancer type 17:22158710−65973469 Position With other complex events Type 21 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 3; DUP: 6; h2hINV: 5; SV types t2tINV: 7; TRA: 0 74 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 32 CN segments 0.7568568 FDR fragment joints 0 FDR chr. breakp. enrich.
73	4	Lower_Right	d8e9ea52-ff28-4626-baa3-71350fd53ddf	7:81604311−155367371	5, 9	71	{'min_x': 310.7900085449219, 'min_y': 693.2749633789062, 'max_x': 550.6721801757812, 'max_y': 839.013916015625}	30 MB 60 MB 90 MB 120 MB 150 MB d8e9ea52−ff28−4626−baa3−71350fd53ddf ColoRect−AdenoCA Cancer type 7:81604311−155367371 Position With other complex events Type 53 Interleaved intrachr. SVs 60 Total SVs (intrachr. + transl.) DEL: 21; DUP: 11; h2hINV: 12; SV types t2tINV: 9; TRA: 7 181 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 71 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
74	1	Upper_Left	d8e9ea52-ff28-4626-baa3-71350fd53ddf	13:19541475−97747877	5, 5	22	{'min_x': 41.23979949951172, 'min_y': 280.6499938964844, 'max_x': 246.48614501953125, 'max_y': 410.3340148925781}	d8e9ea52−ff28−4626−baa3−71350fd53ddf ColoRect−AdenoCA Cancer type 13:19541475−97747877 Position With other complex events Type 13 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 2; SV types t2tINV: 3; TRA: 2 181 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 22 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
74	2	Upper_Right	335d0351-3740-4847-9ff4-be2f078c70f7	17:28133401−66354370	4, 7	22	{'min_x': 331.2099914550781, 'min_y': 280.6499938964844, 'max_x': 535.515869140625, 'max_y': 410.3340148925781}	335d0351−3740−4847−9ff4−be2f078c70f7 ColoRect−AdenoCA Cancer type 17:28133401−66354370 Position With other complex events Type 11 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 6 72 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 22 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
74	3	Lower_Left	8e00e7e7-ffaf-44f0-91a7-172671f18e08	17:26926287−80606072	4, 7	7	{'min_x': 42.710201263427734, 'min_y': 693.2749633789062, 'max_x': 266.36004638671875, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 70 MB 80 MB 8e00e7e7−ffaf−44f0−91a7−172671f18e08 ColoRect−AdenoCA Cancer type 17:26926287−80606072 Position With other complex events Type 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 3; SV types t2tINV: 3; TRA: 2 126 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
74	4	Lower_Right	9af35239-ffb9-4d4f-889e-f743da271eef	20:14694871−15096752	4, 4	4	{'min_x': 332.3800048828125, 'min_y': 693.2749633789062, 'max_x': 534.349853515625, 'max_y': 839.013916015625}	10 MB 12 MB 14 MB 9af35239−ffb9−4d4f−889e−f743da271eef ColoRect−AdenoCA Cancer type 20:14694871−15096752 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 89 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 4 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
75	1	Upper_Left	OCCAMS-AH-021	19:4125375−58935360	4, 7	45	{'min_x': 60.18009948730469, 'min_y': 280.6499938964844, 'max_x': 227.54379272460938, 'max_y': 410.3340148925781}	OCCAMS−AH−021 Eso−AdenoCA Cancer type 19:4125375−58935360 Position With other complex events Type 31 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 6; DUP: 10; h2hINV: 10; SV types t2tINV: 5; TRA: 2 262 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 45 CN segments 0.780201 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
75	2	Upper_Right	OCCAMS-AH-036	17:38600780−56393627	4, 5	33	{'min_x': 351.3500061035156, 'min_y': 280.6499938964844, 'max_x': 515.3778686523438, 'max_y': 410.3340148925781}	OCCAMS−AH−036 Eso−AdenoCA Cancer type 17:38600780−56393627 Position With other complex events Type 40 Interleaved intrachr. SVs 46 Total SVs (intrachr. + transl.) DEL: 9; DUP: 11; h2hINV: 9; SV types t2tINV: 11; TRA: 6 149 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 33 CN segments 0.9152324 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
75	3	Lower_Left	OCCAMS-AH-039	11:68863900−132284467	4, 6	54	{'min_x': 61.849998474121094, 'min_y': 693.2749633789062, 'max_x': 249.28213500976562, 'max_y': 839.013916015625}	50 MB 75 MB 100 MB 125 MB OCCAMS−AH−039 Eso−AdenoCA Cancer type 11:68863900−132284467 Position With other complex events Type 32 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 13; DUP: 7; h2hINV: 6; SV types t2tINV: 6; TRA: 0 146 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 54 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
75	4	Lower_Right	OCCAMS-AH-042	18:827310−25488324	6, 18	27	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB OCCAMS−AH−042 Eso−AdenoCA Cancer type 18:827310−25488324 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 0 85 SVs in sample 6, 18 Oscillating CN (2 and 3 states) 27 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
76	1	Upper_Left	OCCAMS-AH-047	22:46434583−50985112	6, 13	13	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	OCCAMS−AH−047 Eso−AdenoCA Cancer type 22:46434583−50985112 Position With other complex events Type 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 2; SV types t2tINV: 2; TRA: 1 211 SVs in sample 6, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
76	2	Upper_Right	OCCAMS-AH-064	7:64763385−155596659	6, 9	48	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	OCCAMS−AH−064 Eso−AdenoCA Cancer type 7:64763385−155596659 Position With other complex events Type 11 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 3; SV types t2tINV: 1; TRA: 38 448 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 48 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. 3:1926043−196423190; Linked to chrs
76	3	Lower_Left	OCCAMS-AH-064	16:8170195−89798592	5, 8	35	{'min_x': 35.360198974609375, 'min_y': 693.2749633789062, 'max_x': 227.12998962402344, 'max_y': 834.6940307617188}	25 MB 50 MB 75 MB OCCAMS−AH−064 Eso−AdenoCA Cancer type 16:8170195−89798592 Position With other complex events Type 7 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 3; TRA: 22 448 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 35 CN segments 0.5680234 FDR fragment joints 0 FDR chr. breakp. enrich.
76	4	Lower_Right	OCCAMS-AH-071	8:26605057−141712244	5, 10	19	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	50 MB 100 MB OCCAMS−AH−071 Eso−AdenoCA Cancer type 8:26605057−141712244 Position With other complex events Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 1 134 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 19 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
77	1	Upper_Left	OCCAMS-AH-077	13:69907738−73751361	4, 5	9	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	OCCAMS−AH−077 Eso−AdenoCA Cancer type 13:69907738−73751361 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 0 68 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 9 CN segments 0.7735152 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
77	2	Upper_Right	OCCAMS-AH-096	11:63032046−128045151	4, 6	39	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	OCCAMS−AH−096 Eso−AdenoCA Cancer type 11:63032046−128045151 Position With other complex events Type 12 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 4; SV types t2tINV: 4; TRA: 12 326 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 39 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
77	3	Lower_Left	OCCAMS-AH-096	19:27855418−58222100	6, 7	98	{'min_x': 58.51020050048828, 'min_y': 693.2749633789062, 'max_x': 229.22010803222656, 'max_y': 839.013916015625}	40 MB 50 MB OCCAMS−AH−096 Eso−AdenoCA Cancer type 19:27855418−58222100 Position With other complex events Type 70 Interleaved intrachr. SVs 75 Total SVs (intrachr. + transl.) DEL: 16; DUP: 18; h2hINV: 18; SV types t2tINV: 18; TRA: 5 326 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 98 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
77	4	Lower_Right	OCCAMS-AH-108	21:19802561−41893624	5, 10	10	{'min_x': 309.5400085449219, 'min_y': 693.2749633789062, 'max_x': 538.6800537109375, 'max_y': 839.013916015625}	20 MB 25 MB 30 MB 35 MB 40 MB OCCAMS−AH−108 Eso−AdenoCA Cancer type 21:19802561−41893624 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 0 162 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
78	1	Upper_Left	OCCAMS-AH-127	8:24116542−40417339	4, 7	11	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	OCCAMS−AH−127 Eso−AdenoCA Cancer type 8:24116542−40417339 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 0 148 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 11 CN segments 0.9284301 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
78	2	Upper_Right	OCCAMS-AH-127	12:21670505−75969433	4, 6	15	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	OCCAMS−AH−127 Eso−AdenoCA Cancer type 12:21670505−75969433 Position With other complex events Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 2 148 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 15 CN segments 0.8572806 FDR fragment joints 0.01 FDR chr. breakp. enrich. 2:5457516−205931055; Linked to chrs
78	3	Lower_Left	OCCAMS-AH-131	14:22399406−106374496	5, 6	39	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 253.39181518554688, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB OCCAMS−AH−131 Eso−AdenoCA Cancer type 14:22399406−106374496 Position With other complex events Type 17 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 5; SV types t2tINV: 6; TRA: 4 266 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 39 CN segments 0.7568568 FDR fragment joints 0 FDR chr. breakp. enrich.
78	4	Lower_Right	OCCAMS-AH-135	5:29118627−180500252	5, 13	37	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 518.8720703125, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB OCCAMS−AH−135 Eso−AdenoCA Cancer type 5:29118627−180500252 Position With other complex events Type 7 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 3; TRA: 9 298 SVs in sample 5, 13 Oscillating CN (2 and 3 states) 37 CN segments 0.7908979 FDR fragment joints 0.01 FDR chr. breakp. enrich.
79	1	Upper_Left	OCCAMS-AH-135	6:39890387−56314680	5, 7	27	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	OCCAMS−AH−135 Eso−AdenoCA Cancer type 6:39890387−56314680 Position With other complex events Type 9 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 5 298 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 27 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 5:29118627−180500251; Linked to chrs
79	2	Upper_Right	OCCAMS-AH-136	6:45096268−148600879	5, 5	14	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	OCCAMS−AH−136 Eso−AdenoCA Cancer type 6:45096268−148600879 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 3; TRA: 0 67 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 14 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
79	3	Lower_Left	OCCAMS-AH-146	4:21026782−98969606	4, 7	40	{'min_x': 60.18009948730469, 'min_y': 693.2749633789062, 'max_x': 227.54379272460938, 'max_y': 839.013916015625}	50 MB 100 MB OCCAMS−AH−146 Eso−AdenoCA Cancer type 4:21026782−98969606 Position With other complex events Type 41 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 9; DUP: 10; h2hINV: 10; SV types t2tINV: 12; TRA: 0 195 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 40 CN segments 0.9577901 FDR fragment joints 0 FDR chr. breakp. enrich.
79	4	Lower_Right	OCCAMS-AH-146	17:25626424−76366954	4, 6	80	{'min_x': 349.67999267578125, 'min_y': 693.2749633789062, 'max_x': 517.0438842773438, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB OCCAMS−AH−146 Eso−AdenoCA Cancer type 17:25626424−76366954 Position With other complex events Type 42 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 8; DUP: 10; h2hINV: 12; SV types t2tINV: 12; TRA: 0 195 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 80 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
80	1	Upper_Left	OCCAMS-AH-167	17:26331304−40471971	5, 6	28	{'min_x': 58.51020050048828, 'min_y': 280.6499938964844, 'max_x': 229.22010803222656, 'max_y': 410.3340148925781}	OCCAMS−AH−167 Eso−AdenoCA Cancer type 17:26331304−40471971 Position With other complex events Type 73 Interleaved intrachr. SVs 82 Total SVs (intrachr. + transl.) DEL: 18; DUP: 17; h2hINV: 19; SV types t2tINV: 19; TRA: 9 307 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 28 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
80	2	Upper_Right	OCCAMS-AH-174	7:50712649−55386047	4, 5	28	{'min_x': 324.8599853515625, 'min_y': 276.3299865722656, 'max_x': 541.8719482421875, 'max_y': 410.3340148925781}	OCCAMS−AH−174 Eso−AdenoCA Cancer type 7:50712649−55386047 Position With other complex events Type 50 Interleaved intrachr. SVs 99 Total SVs (intrachr. + transl.) DEL: 16; DUP: 11; h2hINV: 12; SV types t2tINV: 11; TRA: 49 572 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 28 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 2:32595317−181665721;9:73771445−82788409 Linked to chrs
80	3	Lower_Left	OCCAMS-AH-174	8:1230941−38668853	5, 9	12	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	50 MB 100 MB OCCAMS−AH−174 Eso−AdenoCA Cancer type 8:1230941−38668853 Position With other complex events Type 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 0; SV types t2tINV: 3; TRA: 3 572 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 12 CN segments 0.615458 FDR fragment joints 0.02 FDR chr. breakp. enrich.
80	4	Lower_Right	OCCAMS-AH-174	17:1185559−19439852	4, 5	31	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 557.219970703125, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB OCCAMS−AH−174 Eso−AdenoCA Cancer type 17:1185559−19439852 Position With other complex events Type 22 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 5; DUP: 6; h2hINV: 6; SV types t2tINV: 5; TRA: 0 572 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 31 CN segments 0.992996 FDR fragment joints 0 FDR chr. breakp. enrich.
81	1	Upper_Left	OCCAMS-AH-174	21:16251242−47972973	5, 8	41	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	OCCAMS−AH−174 Eso−AdenoCA Cancer type 21:16251242−47972973 Position With other complex events Type 18 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 3; SV types t2tINV: 5; TRA: 3 572 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 41 CN segments 0.7568568 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
81	2	Upper_Right	OCCAMS-AH-182	1:41909912−244361254	6, 6	28	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	OCCAMS−AH−182 Eso−AdenoCA Cancer type 1:41909912−244361254 Position With other complex events Type 7 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 1; TRA: 2 223 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 28 CN segments 0.615458 FDR fragment joints 0.9 FDR chr. breakp. enrich. Linked to chrs
81	3	Lower_Left	OCCAMS-AH-182	4:74456231−153507115	4, 10	41	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 264.241943359375, 'max_y': 839.013916015625}	60 MB 90 MB 120 MB 150 MB OCCAMS−AH−182 Eso−AdenoCA Cancer type 4:74456231−153507115 Position With other complex events Type 23 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 8; SV types t2tINV: 6; TRA: 12 223 SVs in sample 4, 10 Oscillating CN (2 and 3 states) 41 CN segments 0.9176394 FDR fragment joints 0 FDR chr. breakp. enrich.
81	4	Lower_Right	OCCAMS-GS-002	13:23188644−59775992	5, 13	33	{'min_x': 351.760009765625, 'min_y': 693.2749633789062, 'max_x': 559.8600463867188, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB OCCAMS−GS−002 Eso−AdenoCA Cancer type 13:23188644−59775992 Position With other complex events Type 7 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 2 134 SVs in sample 5, 13 Oscillating CN (2 and 3 states) 33 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
82	1	Upper_Left	OCCAMS-PS-013	1:193309911−196936704	4, 5	8	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	OCCAMS−PS−013 Eso−AdenoCA Cancer type 1:193309911−196936704 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 0 162 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 8 CN segments 0.7735152 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
82	2	Upper_Right	OCCAMS-QE-095	17:25534782−75535929	6, 7	56	{'min_x': 351.3500061035156, 'min_y': 280.6499938964844, 'max_x': 515.3778686523438, 'max_y': 410.42401123046875}	OCCAMS−QE−095 Eso−AdenoCA Cancer type 17:25534782−75535929 Position With other complex events Type 29 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 11; DUP: 3; h2hINV: 7; SV types t2tINV: 8; TRA: 3 247 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 56 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 2:47217884−215282384; Linked to chrs
82	3	Lower_Left	OCCAMS-RS-006	17:50758967−64888510	5, 11	11	{'min_x': 41.5, 'min_y': 693.2749633789062, 'max_x': 269.89007568359375, 'max_y': 839.013916015625}	40 MB 45 MB 50 MB 55 MB 60 MB 65 MB OCCAMS−RS−006 Eso−AdenoCA Cancer type 17:50758967−64888510 Position With other complex events Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 4; SV types t2tINV: 4; TRA: 0 198 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.9501265 FDR fragment joints 0 FDR chr. breakp. enrich.
82	4	Lower_Right	OCCAMS-RS-007	12:25246063−31515072	4, 4	41	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 517.0799560546875, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB OCCAMS−RS−007 Eso−AdenoCA Cancer type 12:25246063−31515072 Position With other complex events Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 6; DUP: 1; h2hINV: 0; SV types t2tINV: 4; TRA: 0 242 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 41 CN segments 0.4888368 FDR fragment joints 0 FDR chr. breakp. enrich.
83	1	Upper_Left	OCCAMS-RS-008	11:38894113−101762285	6, 11	51	{'min_x': 35.360198974609375, 'min_y': 276.3299865722656, 'max_x': 252.3719482421875, 'max_y': 410.3340148925781}	OCCAMS−RS−008 Eso−AdenoCA Cancer type 11:38894113−101762285 Position With other complex events Type 21 Interleaved intrachr. SVs 80 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 6; SV types t2tINV: 6; TRA: 59 303 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 51 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 12:1702270−74329203;2:43419451−218499372 Linked to chrs
83	2	Upper_Right	OCCAMS-RS-008	12:1702270−74329204	5, 5	69	{'min_x': 321.5199890136719, 'min_y': 276.3299865722656, 'max_x': 545.2039794921875, 'max_y': 410.3340148925781}	OCCAMS−RS−008 Eso−AdenoCA Cancer type 12:1702270−74329204 Position With other complex events Type 57 Interleaved intrachr. SVs 131 Total SVs (intrachr. + transl.) DEL: 17; DUP: 12; h2hINV: 12; SV types t2tINV: 16; TRA: 74 303 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 69 CN segments 0.964753 FDR fragment joints 0 FDR chr. breakp. enrich. 11:38894113−101762284;2:43419451−218499372 Linked to chrs
83	3	Lower_Left	OCCAMS-RS-031	14:25421773−106863854	5, 6	19	{'min_x': 59.099998474121094, 'min_y': 693.2749633789062, 'max_x': 250.53213500976562, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB OCCAMS−RS−031 Eso−AdenoCA Cancer type 14:25421773−106863854 Position With other complex events Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 156 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 19 CN segments 0.9723381 FDR fragment joints 0 FDR chr. breakp. enrich.
83	4	Lower_Right	OCCAMS-RS-036	17:38588621−39990043	4, 7	30	{'min_x': 348.010009765625, 'min_y': 693.2749633789062, 'max_x': 558.440185546875, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB OCCAMS−RS−036 Eso−AdenoCA Cancer type 17:38588621−39990043 Position With other complex events Type 78 Interleaved intrachr. SVs 79 Total SVs (intrachr. + transl.) DEL: 18; DUP: 18; h2hINV: 19; SV types t2tINV: 23; TRA: 1 332 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 30 CN segments 0.8497879 FDR fragment joints 0 FDR chr. breakp. enrich.
84	1	Upper_Left	OCCAMS-RS-047	17:37640778−73863270	6, 8	39	{'min_x': 32.019901275634766, 'min_y': 267.6899719238281, 'max_x': 255.70394897460938, 'max_y': 410.3340148925781}	OCCAMS−RS−047 Eso−AdenoCA Cancer type 17:37640778−73863270 Position With other complex events Type 9 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 1; SV types t2tINV: 2; TRA: 39 894 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 39 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 1:23826407−235519805;11:66812374−111289395 12:56993350−123682991;2:43059538−85800998 Linked to chrs
84	2	Upper_Right	OCCAMS-SH-003	11:76719544−87065454	5, 5	21	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	OCCAMS−SH−003 Eso−AdenoCA Cancer type 11:76719544−87065454 Position With other complex events Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 1; SV types t2tINV: 3; TRA: 1 250 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 21 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
84	3	Lower_Left	OCCAMS-SH-003	18:14973143−55776093	5, 9	46	{'min_x': 42.460201263427734, 'min_y': 693.2749633789062, 'max_x': 257.4600830078125, 'max_y': 839.013916015625}	20 MB 30 MB 40 MB 50 MB 60 MB OCCAMS−SH−003 Eso−AdenoCA Cancer type 18:14973143−55776093 Position With other complex events Type 23 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 5; SV types t2tINV: 5; TRA: 6 250 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 46 CN segments 0.930656 FDR fragment joints 0 FDR chr. breakp. enrich.
84	4	Lower_Right	OCCAMS-SH-024	1:32513613−249217731	6, 13	114	{'min_x': 308.3999938964844, 'min_y': 693.2749633789062, 'max_x': 561.1321411132812, 'max_y': 839.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB 250 MB OCCAMS−SH−024 Eso−AdenoCA Cancer type 1:32513613−249217731 Position With other complex events Type 30 Interleaved intrachr. SVs 52 Total SVs (intrachr. + transl.) DEL: 6; DUP: 12; h2hINV: 6; SV types t2tINV: 6; TRA: 22 656 SVs in sample 6, 13 Oscillating CN (2 and 3 states) 114 CN segments 0.9961719 FDR fragment joints 0 FDR chr. breakp. enrich.
85	1	Upper_Left	OCCAMS-SH-024	3:101679749−195089023	6, 6	116	{'min_x': 61.849998474121094, 'min_y': 280.6499938964844, 'max_x': 225.87779235839844, 'max_y': 410.3340148925781}	OCCAMS−SH−024 Eso−AdenoCA Cancer type 3:101679749−195089023 Position With other complex events Type 40 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 9; DUP: 14; h2hINV: 6; SV types t2tINV: 11; TRA: 9 656 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 116 CN segments 0.7124738 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
85	2	Upper_Right	OCCAMS-SH-038	17:26663234−66204181	4, 4	38	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	OCCAMS−SH−038 Eso−AdenoCA Cancer type 17:26663234−66204181 Position With other complex events Type 24 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 7; DUP: 4; h2hINV: 5; SV types t2tINV: 8; TRA: 4 146 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 38 CN segments 0.9794281 FDR fragment joints 0 FDR chr. breakp. enrich. 4:13404057−187928989; Linked to chrs
85	3	Lower_Left	OCCAMS-SH-051	11:83876112−130719233	6, 12	23	{'min_x': 59.98979949951172, 'min_y': 693.2749633789062, 'max_x': 260.69189453125, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB 125 MB OCCAMS−SH−051 Eso−AdenoCA Cancer type 11:83876112−130719233 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 450 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 23 CN segments 0.8572806 FDR fragment joints 0.3 FDR chr. breakp. enrich.
85	4	Lower_Right	OCCAMS-SH-071	15:42066409−91876190	5, 5	35	{'min_x': 344.2300109863281, 'min_y': 693.2749633789062, 'max_x': 549.7698974609375, 'max_y': 839.013916015625}	50 MB 60 MB 70 MB 80 MB 90 MB OCCAMS−SH−071 Eso−AdenoCA Cancer type 15:42066409−91876190 Position With other complex events Type 29 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 4; DUP: 10; h2hINV: 8; SV types t2tINV: 7; TRA: 3 284 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 35 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
86	1	Upper_Left	OCCAMS-ST-020	18:1524644−24959091	6, 6	13	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	OCCAMS−ST−020 Eso−AdenoCA Cancer type 18:1524644−24959091 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 0 165 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 13 CN segments 0.9284301 FDR fragment joints 0.15 FDR chr. breakp. enrich. Linked to chrs
86	2	Upper_Right	OCCAMS-ST-029	17:1828973−80871688	4, 5	29	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	OCCAMS−ST−029 Eso−AdenoCA Cancer type 17:1828973−80871688 Position With other complex events Type 9 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 4; TRA: 6 286 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 29 CN segments 0.8462769 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
86	3	Lower_Left	OCCAMS-ST-037	7:12338056−28936629	4, 5	7	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB OCCAMS−ST−037 Eso−AdenoCA Cancer type 7:12338056−28936629 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 0 438 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 7 CN segments 0.6776251 FDR fragment joints 1 FDR chr. breakp. enrich.
86	4	Lower_Right	OCCAMS-ST-037	8:56764256−133807235	5, 5	40	{'min_x': 350.57000732421875, 'min_y': 693.2749633789062, 'max_x': 519.9620361328125, 'max_y': 839.013916015625}	60 MB 80 MB 100 MB 120 MB OCCAMS−ST−037 Eso−AdenoCA Cancer type 8:56764256−133807235 Position With other complex events Type 17 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 5; SV types t2tINV: 4; TRA: 3 438 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 40 CN segments 0.8572806 FDR fragment joints 0.01 FDR chr. breakp. enrich.
87	1	Upper_Left	OCCAMS-ST-037	17:29160620−67758256	5, 5	36	{'min_x': 58.51020050048828, 'min_y': 280.6499938964844, 'max_x': 229.22010803222656, 'max_y': 410.3340148925781}	OCCAMS−ST−037 Eso−AdenoCA Cancer type 17:29160620−67758256 Position With other complex events Type 186 Interleaved intrachr. SVs 215 Total SVs (intrachr. + transl.) DEL: 39; DUP: 51; h2hINV: 48; SV types t2tINV: 48; TRA: 29 438 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 36 CN segments 0.7170622 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
87	2	Upper_Right	OCCAMS-ST-041	5:15221088−46212518	5, 8	27	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	OCCAMS−ST−041 Eso−AdenoCA Cancer type 5:15221088−46212518 Position With other complex events Type 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 5; SV types t2tINV: 5; TRA: 0 163 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 27 CN segments 0.6471662 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
87	3	Lower_Left	OCCAMS-WG-001	17:20549700−75923156	6, 6	10	{'min_x': 54.730098724365234, 'min_y': 693.2749633789062, 'max_x': 244.28005981445312, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB 70 MB OCCAMS−WG−001 Eso−AdenoCA Cancer type 17:20549700−75923156 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 151 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 10 CN segments 0.9599662 FDR fragment joints 0.02 FDR chr. breakp. enrich.
87	4	Lower_Right	OCCAMS-WG-005	7:64499272−112538689	4, 6	40	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	50 MB 100 MB OCCAMS−WG−005 Eso−AdenoCA Cancer type 7:64499272−112538689 Position With other complex events Type 19 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 5; DUP: 6; h2hINV: 4; SV types t2tINV: 4; TRA: 0 277 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 40 CN segments 0.9348624 FDR fragment joints 0 FDR chr. breakp. enrich.
88	1	Upper_Left	OCCAMS-WG-008	4:10386453−188335991	4, 11	67	{'min_x': 61.849998474121094, 'min_y': 280.6499938964844, 'max_x': 225.87779235839844, 'max_y': 410.3340148925781}	OCCAMS−WG−008 Eso−AdenoCA Cancer type 4:10386453−188335991 Position With other complex events Type 35 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 6; DUP: 11; h2hINV: 8; SV types t2tINV: 10; TRA: 1 357 SVs in sample 4, 11 Oscillating CN (2 and 3 states) 67 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
88	2	Upper_Right	OCCAMS-WG-008	6:24415766−65407598	4, 6	23	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	OCCAMS−WG−008 Eso−AdenoCA Cancer type 6:24415766−65407598 Position With other complex events Type 10 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 2 357 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 23 CN segments 0.9284301 FDR fragment joints 0.21 FDR chr. breakp. enrich. Linked to chrs
88	3	Lower_Left	OCCAMS-ZZ-004	8:8960637−125604409	5, 12	31	{'min_x': 50.56019973754883, 'min_y': 693.2749633789062, 'max_x': 269.7117919921875, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB 125 MB OCCAMS−ZZ−004 Eso−AdenoCA Cancer type 8:8960637−125604409 Position With other complex events Type 7 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 40 323 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 31 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
88	4	Lower_Right	OCCAMS-ZZ-004	14:22899463−27108658	6, 7	7	{'min_x': 351.3500061035156, 'min_y': 693.2749633789062, 'max_x': 543.6519775390625, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB OCCAMS−ZZ−004 Eso−AdenoCA Cancer type 14:22899463−27108658 Position After polyploidization Type 38 Interleaved intrachr. SVs 70 Total SVs (intrachr. + transl.) DEL: 8; DUP: 6; h2hINV: 12; SV types t2tINV: 12; TRA: 32 323 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
89	1	Upper_Left	OCCAMS-ZZ-009	12:15448042−117609293	6, 10	110	{'min_x': 58.51020050048828, 'min_y': 280.6499938964844, 'max_x': 229.22010803222656, 'max_y': 410.42401123046875}	OCCAMS−ZZ−009 Eso−AdenoCA Cancer type 12:15448042−117609293 Position With other complex events Type 82 Interleaved intrachr. SVs 90 Total SVs (intrachr. + transl.) DEL: 13; DUP: 19; h2hINV: 22; SV types t2tINV: 28; TRA: 8 353 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 110 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich. 1:2485334−247277614; Linked to chrs
89	2	Upper_Right	OCCAMS-ZZ-016	7:16983311−102542434	6, 6	38	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	OCCAMS−ZZ−016 Eso−AdenoCA Cancer type 7:16983311−102542434 Position With other complex events Type 6 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 3; TRA: 7 286 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 38 CN segments 0.7995907 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
89	3	Lower_Left	OCCAMS-ZZ-016	17:2088600−25571414	6, 8	13	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 233.49014282226562, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB OCCAMS−ZZ−016 Eso−AdenoCA Cancer type 17:2088600−25571414 Position With other complex events Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 3; SV types t2tINV: 4; TRA: 0 286 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 13 CN segments 0.9794281 FDR fragment joints 0 FDR chr. breakp. enrich.
89	4	Lower_Right	3e5f451a-5882-4914-ae1a-95c898c2bcca	2:164623105−179954501	5, 15	56	{'min_x': 329.3699951171875, 'min_y': 693.2749633789062, 'max_x': 547.2919921875, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB 3e5f451a−5882−4914−ae1a−95c898c2bcca Head−SCC Cancer type 2:164623105−179954501 Position With other complex events Type 30 Interleaved intrachr. SVs 52 Total SVs (intrachr. + transl.) DEL: 6; DUP: 10; h2hINV: 6; SV types t2tINV: 8; TRA: 22 362 SVs in sample 5, 15 Oscillating CN (2 and 3 states) 56 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
90	1	Upper_Left	64bb5550-2735-4401-a0db-58ec1020a32d	17:35502073−70069761	4, 4	26	{'min_x': 38.539798736572266, 'min_y': 280.6499938964844, 'max_x': 249.18795776367188, 'max_y': 410.3340148925781}	64bb5550−2735−4401−a0db−58ec1020a32d Head−SCC Cancer type 17:35502073−70069761 Position With other complex events Type 6 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 0; TRA: 11 179 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 26 CN segments 0.7735152 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
90	2	Upper_Right	7de19081-d5fd-468c-ad0d-f6e3e8b2ad70	6:132384731−147888916	4, 5	36	{'min_x': 329.04998779296875, 'min_y': 280.6499938964844, 'max_x': 537.681884765625, 'max_y': 410.3340148925781}	7de19081−d5fd−468c−ad0d−f6e3e8b2ad70 Head−SCC Cancer type 6:132384731−147888916 Position With other complex events Type 8 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 4; TRA: 10 140 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 36 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
90	3	Lower_Left	7de19081-d5fd-468c-ad0d-f6e3e8b2ad70	14:37204606−75501405	4, 4	27	{'min_x': 39.54999923706055, 'min_y': 693.2749633789062, 'max_x': 248.1819610595703, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 70 MB 7de19081−d5fd−468c−ad0d−f6e3e8b2ad70 Head−SCC Cancer type 14:37204606−75501405 Position With other complex events Type 13 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 2; SV types t2tINV: 1; TRA: 9 140 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 27 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
90	4	Lower_Right	7de19081-d5fd-468c-ad0d-f6e3e8b2ad70	16:56444067−89001559	6, 8	16	{'min_x': 327.75, 'min_y': 693.2749633789062, 'max_x': 537.681884765625, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 70 MB 80 MB 7de19081−d5fd−468c−ad0d−f6e3e8b2ad70 Head−SCC Cancer type 16:56444067−89001559 Position With other complex events Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 1 140 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 16 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
91	1	Upper_Left	8fc1f1be-d2d5-4b3a-9973-f4d964018beb	11:78556791−103094093	5, 6	34	{'min_x': 40.210201263427734, 'min_y': 280.6499938964844, 'max_x': 247.5139617919922, 'max_y': 410.3340148925781}	8fc1f1be−d2d5−4b3a−9973−f4d964018beb Head−SCC Cancer type 11:78556791−103094093 Position With other complex events Type 24 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 5; DUP: 7; h2hINV: 6; SV types t2tINV: 6; TRA: 0 216 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 34 CN segments 0.9723381 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
91	2	Upper_Right	90a8d2cb-1f31-45f9-8575-eed3cb9a7798	11:15147379−100462923	5, 8	26	{'min_x': 329.5400085449219, 'min_y': 280.6499938964844, 'max_x': 537.19189453125, 'max_y': 410.3340148925781}	90a8d2cb−1f31−45f9−8575−eed3cb9a7798 Head−SCC Cancer type 11:15147379−100462923 Position With other complex events Type 24 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 9; DUP: 7; h2hINV: 3; SV types t2tINV: 5; TRA: 0 67 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 26 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
91	3	Lower_Left	ad6c9d09-2c03-4786-a72d-dd2aa5f603d4	22:19715951−51129703	6, 8	61	{'min_x': 39.06990051269531, 'min_y': 693.2749633789062, 'max_x': 260.66009521484375, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB ad6c9d09−2c03−4786−a72d−dd2aa5f603d4 Head−SCC Cancer type 22:19715951−51129703 Position With other complex events Type 68 Interleaved intrachr. SVs 68 Total SVs (intrachr. + transl.) DEL: 18; DUP: 15; h2hINV: 19; SV types t2tINV: 16; TRA: 0 360 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 61 CN segments 0.9332614 FDR fragment joints 0 FDR chr. breakp. enrich.
91	4	Lower_Right	70e306ee-9584-49d6-81a1-a49d837ab6aa	8:48323075−117143870	5, 8	70	{'min_x': 312.3399963378906, 'min_y': 693.2749633789062, 'max_x': 538.3579711914062, 'max_y': 834.6940307617188}	50 MB 70 MB 90 MB 110 MB 70e306ee−9584−49d6−81a1−a49d837ab6aa Kidney−ChRCC Cancer type 8:48323075−117143870 Position With other complex events Type 26 Interleaved intrachr. SVs 74 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 8; SV types t2tINV: 6; TRA: 48 305 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 70 CN segments 0.9807783 FDR fragment joints 0 FDR chr. breakp. enrich.
92	1	Upper_Left	b809c2f2-185c-496a-a1d4-589294443a1d	19:1021778−54719797	5, 9	30	{'min_x': 39.539798736572266, 'min_y': 280.6499938964844, 'max_x': 248.18994140625, 'max_y': 410.3340148925781}	b809c2f2−185c−496a−a1d4−589294443a1d Kidney−RCC Cancer type 19:1021778−54719797 Position With other complex events Type 28 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 7; DUP: 8; h2hINV: 6; SV types t2tINV: 7; TRA: 5 64 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 30 CN segments 0.9067785 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
92	2	Upper_Right	d80f601b-1064-4ff0-9c51-7f6afb22d1f5	4:76505435−82891389	6, 6	6	{'min_x': 332.2200012207031, 'min_y': 280.6499938964844, 'max_x': 534.5098876953125, 'max_y': 410.3340148925781}	d80f601b−1064−4ff0−9c51−7f6afb22d1f5 Kidney−RCC Cancer type 4:76505435−82891389 Position Canonical without polyploidization Type 17 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 3; SV types t2tINV: 4; TRA: 10 61 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
92	3	Lower_Left	C0066	3:65418245−76275813	6, 11	11	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 263.09991455078125, 'max_y': 839.013916015625}	68 MB 70 MB 72 MB 74 MB 76 MB C0066 Kidney−RCC Cancer type 3:65418245−76275813 Position With other complex events Type 14 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 4; SV types t2tINV: 4; TRA: 8 25 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.8874881 FDR fragment joints 0 FDR chr. breakp. enrich.
92	4	Lower_Right	1987b453-f97d-45c7-9c89-b9a33313d645	20:20959449−62129528	6, 8	28	{'min_x': 323.19000244140625, 'min_y': 693.2749633789062, 'max_x': 550.2498779296875, 'max_y': 830.3740844726562}	20 MB 40 MB 60 MB 1987b453−f97d−45c7−9c89−b9a33313d645 Liver−HCC Cancer type 20:20959449−62129528 Position With other complex events Type 8 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 4; TRA: 17 524 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 28 CN segments 0.9599662 FDR fragment joints 0 FDR chr. breakp. enrich.
93	1	Upper_Left	2854ffe8-1f77-497a-bf49-11e0189fee35	2:184611141−197996965	4, 8	17	{'min_x': 42.599998474121094, 'min_y': 280.6499938964844, 'max_x': 245.1280975341797, 'max_y': 410.3340148925781}	2854ffe8−1f77−497a−bf49−11e0189fee35 Liver−HCC Cancer type 2:184611141−197996965 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 0 43 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 17 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
93	2	Upper_Right	3acf7438-fd65-442c-8a30-68b6714537f3	14:34361058−105047156	4, 5	21	{'min_x': 330.5400085449219, 'min_y': 280.6499938964844, 'max_x': 536.1838989257812, 'max_y': 410.42401123046875}	3acf7438−fd65−442c−8a30−68b6714537f3 Liver−HCC Cancer type 14:34361058−105047156 Position With other complex events Type 10 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 2; SV types t2tINV: 4; TRA: 21 222 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 21 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 5:141997−63388892; Linked to chrs
93	3	Lower_Left	52292ffc-0902-4d97-b461-20723987a177	14:20673089−49273351	5, 12	12	{'min_x': 40.36989974975586, 'min_y': 693.2749633789062, 'max_x': 247.36195373535156, 'max_y': 839.013916015625}	30 MB 40 MB 52292ffc−0902−4d97−b461−20723987a177 Liver−HCC Cancer type 14:20673089−49273351 Position With other complex events Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 0; TRA: 2 129 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.6776251 FDR fragment joints 0.01 FDR chr. breakp. enrich.
93	4	Lower_Right	56a82a56-0241-4d3d-9de2-696b0c36df91	20:3053950−60453503	4, 5	25	{'min_x': 328.7099914550781, 'min_y': 693.2749633789062, 'max_x': 552.4298706054688, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 56a82a56−0241−4d3d−9de2−696b0c36df91 Liver−HCC Cancer type 20:3053950−60453503 Position With other complex events Type 7 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 6 109 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 25 CN segments 0.7995907 FDR fragment joints 0 FDR chr. breakp. enrich.
94	1	Upper_Left	614c0ecf-6a84-4c86-8706-79be5bb00991	6:63448509−112361461	4, 4	4	{'min_x': 39.539798736572266, 'min_y': 280.6499938964844, 'max_x': 248.18995666503906, 'max_y': 410.3340148925781}	614c0ecf−6a84−4c86−8706−79be5bb00991 Liver−HCC Cancer type 6:63448509−112361461 Position Canonical without polyploidization Type 16 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 4; SV types t2tINV: 3; TRA: 1 171 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 4 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
94	2	Upper_Right	65e430e1-0c9a-4045-83a9-653b7cff811d	3:99990176−110508418	4, 7	11	{'min_x': 329.8699951171875, 'min_y': 280.6499938964844, 'max_x': 536.8619384765625, 'max_y': 410.3340148925781}	65e430e1−0c9a−4045−83a9−653b7cff811d Liver−HCC Cancer type 3:99990176−110508418 Position With other complex events Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 2; TRA: 1 54 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 11 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
94	3	Lower_Left	6dcfc418-ab28-4365-95ea-c1ae254f2341	9:71361828−139860149	6, 6	36	{'min_x': 35.360198974609375, 'min_y': 693.2749633789062, 'max_x': 271.2118835449219, 'max_y': 834.6940307617188}	60 MB 80 MB 100 MB 120 MB 140 MB 6dcfc418−ab28−4365−95ea−c1ae254f2341 Liver−HCC Cancer type 9:71361828−139860149 Position With other complex events Type 6 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 0; SV types t2tINV: 1; TRA: 14 572 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 36 CN segments 0.8572806 FDR fragment joints 0.11 FDR chr. breakp. enrich.
94	4	Lower_Right	8afa3140-dcbd-44c0-ab13-4ada6a0444d4	19:38719064−58932021	5, 14	27	{'min_x': 319.7300109863281, 'min_y': 693.2749633789062, 'max_x': 538.1898803710938, 'max_y': 839.013916015625}	20 MB 30 MB 40 MB 50 MB 8afa3140−dcbd−44c0−ab13−4ada6a0444d4 Liver−HCC Cancer type 19:38719064−58932021 Position With other complex events Type 14 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 3; SV types t2tINV: 3; TRA: 2 301 SVs in sample 5, 14 Oscillating CN (2 and 3 states) 27 CN segments 0.9501265 FDR fragment joints 0 FDR chr. breakp. enrich.
95	1	Upper_Left	b865dec4-f051-4fbe-9405-f832ff2010d7	8:47804145−122986495	4, 6	25	{'min_x': 42.04999923706055, 'min_y': 280.6499938964844, 'max_x': 245.67796325683594, 'max_y': 410.42401123046875}	b865dec4−f051−4fbe−9405−f832ff2010d7 Liver−HCC Cancer type 8:47804145−122986495 Position With other complex events Type 27 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 10; DUP: 6; h2hINV: 6; SV types t2tINV: 5; TRA: 8 245 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 25 CN segments 0.7526697 FDR fragment joints 0 FDR chr. breakp. enrich. 11:49377920−77893091; Linked to chrs
95	2	Upper_Right	b865dec4-f051-4fbe-9405-f832ff2010d7	11:49377920−77893092	5, 9	42	{'min_x': 331.54998779296875, 'min_y': 280.6499938964844, 'max_x': 535.1778564453125, 'max_y': 410.42401123046875}	b865dec4−f051−4fbe−9405−f832ff2010d7 Liver−HCC Cancer type 11:49377920−77893092 Position With other complex events Type 9 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 18 245 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 42 CN segments 0.9625775 FDR fragment joints 0 FDR chr. breakp. enrich. 1:77623355−98337818; Linked to chrs
95	3	Lower_Left	c0bf9278-9cbb-4361-b4d8-ab172b67e276	11:56563250−70581761	6, 6	23	{'min_x': 38.88010025024414, 'min_y': 693.2749633789062, 'max_x': 248.84996032714844, 'max_y': 839.013916015625}	60 MB 64 MB 68 MB c0bf9278−9cbb−4361−b4d8−ab172b67e276 Liver−HCC Cancer type 11:56563250−70581761 Position With other complex events Type 11 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 8 49 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 23 CN segments 0.8082862 FDR fragment joints 0 FDR chr. breakp. enrich.
95	4	Lower_Right	c95ed407-bcc2-44aa-bc59-bf7549f2d665	6:41892254−58688812	6, 12	18	{'min_x': 329.3800048828125, 'min_y': 693.2749633789062, 'max_x': 562.412109375, 'max_y': 839.013916015625}	60 MB 80 MB 100 MB 120 MB c95ed407−bcc2−44aa−bc59−bf7549f2d665 Liver−HCC Cancer type 6:41892254−58688812 Position With other complex events Type 6 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 1; SV types t2tINV: 3; TRA: 12 81 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 18 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
96	1	Upper_Left	ca8afb2c-be3d-41e8-8dbc-19fe7ab6154b	6:57869537−70524555	4, 6	17	{'min_x': 39.580101013183594, 'min_y': 280.6499938964844, 'max_x': 248.1517791748047, 'max_y': 410.3340148925781}	ca8afb2c−be3d−41e8−8dbc−19fe7ab6154b Liver−HCC Cancer type 6:57869537−70524555 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 3; SV types t2tINV: 2; TRA: 0 125 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 17 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
96	2	Upper_Right	d680df09-368e-42b5-b540-45c41ed31042	13:24796654−56409610	5, 5	5	{'min_x': 328.7099914550781, 'min_y': 280.6499938964844, 'max_x': 538.0198974609375, 'max_y': 410.3340148925781}	d680df09−368e−42b5−b540−45c41ed31042 Liver−HCC Cancer type 13:24796654−56409610 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 17 82 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.7359483 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
96	3	Lower_Left	dfa15fbe-bb14-40ce-afc6-70694112e3e2	8:882836−39730717	5, 7	12	{'min_x': 40.710201263427734, 'min_y': 693.2749633789062, 'max_x': 270.5599670410156, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB dfa15fbe−bb14−40ce−afc6−70694112e3e2 Liver−HCC Cancer type 8:882836−39730717 Position With other complex events Type 8 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 4 27 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 12 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
96	4	Lower_Right	HX12	15:29329993−102165441	5, 9	17	{'min_x': 341.2900085449219, 'min_y': 693.2749633789062, 'max_x': 553.542236328125, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB HX12 Liver−HCC Cancer type 15:29329993−102165441 Position With other complex events Type 14 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 7; SV types t2tINV: 3; TRA: 9 66 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 17 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
97	1	Upper_Left	HX14	8:11152586−52033115	5, 8	25	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	HX14 Liver−HCC Cancer type 8:11152586−52033115 Position With other complex events Type 12 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 4; TRA: 5 70 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 25 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
97	2	Upper_Right	HX21	8:53518261−139231447	5, 12	89	{'min_x': 348.010009765625, 'min_y': 280.6499938964844, 'max_x': 518.72021484375, 'max_y': 410.3340148925781}	HX21 Liver−HCC Cancer type 8:53518261−139231447 Position With other complex events Type 52 Interleaved intrachr. SVs 53 Total SVs (intrachr. + transl.) DEL: 13; DUP: 14; h2hINV: 14; SV types t2tINV: 11; TRA: 1 133 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 89 CN segments 0.9299383 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
97	3	Lower_Left	HX25	5:29249343−44428121	6, 8	18	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 244.7900848388672, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB HX25 Liver−HCC Cancer type 5:29249343−44428121 Position With other complex events Type 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 0 111 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 18 CN segments 0.9905774 FDR fragment joints 0 FDR chr. breakp. enrich.
97	4	Lower_Right	HX28	6:63623695−135334641	4, 5	12	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	50 MB 100 MB HX28 Liver−HCC Cancer type 6:63623695−135334641 Position With other complex events Type 6 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 8 160 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 12 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
98	1	Upper_Left	HX35	4:1056612−57295598	4, 8	36	{'min_x': 61.849998474121094, 'min_y': 280.6499938964844, 'max_x': 225.87783813476562, 'max_y': 410.3340148925781}	HX35 Liver−HCC Cancer type 4:1056612−57295598 Position With other complex events Type 29 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 10; SV types t2tINV: 9; TRA: 0 135 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 36 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
98	2	Upper_Right	HX35	17:8507299−11666681	6, 12	28	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	HX35 Liver−HCC Cancer type 17:8507299−11666681 Position With other complex events Type 17 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 4; SV types t2tINV: 5; TRA: 2 135 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 28 CN segments 0.9958447 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
98	3	Lower_Left	RK003	17:35358262−80803775	5, 5	24	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 265.88006591796875, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB RK003 Liver−HCC Cancer type 17:35358262−80803775 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 0 51 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 24 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich.
98	4	Lower_Right	RK038	6:102965111−108005363	6, 8	8	{'min_x': 307.1099853515625, 'min_y': 693.2749633789062, 'max_x': 560.302001953125, 'max_y': 839.013916015625}	96 MB 99 MB 102 MB 105 MB 108 MB RK038 Liver−HCC Cancer type 6:102965111−108005363 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 2; TRA: 1 99 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.9804396 FDR fragment joints 0 FDR chr. breakp. enrich.
99	1	Upper_Left	RK042	4:26444895−45511514	5, 9	17	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	RK042 Liver−HCC Cancer type 4:26444895−45511514 Position With other complex events Type 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 3 93 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 17 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
99	2	Upper_Right	RK061	7:1738702−57285072	6, 9	28	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	RK061 Liver−HCC Cancer type 7:1738702−57285072 Position With other complex events Type 28 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 6; SV types t2tINV: 10; TRA: 0 229 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 28 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
99	3	Lower_Left	RK061	8:24743909−48399104	5, 9	20	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	50 MB 100 MB RK061 Liver−HCC Cancer type 8:24743909−48399104 Position With other complex events Type 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 3 229 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 20 CN segments 0.9625775 FDR fragment joints 0.02 FDR chr. breakp. enrich.
99	4	Lower_Right	RK072	3:144516195−181561816	4, 10	67	{'min_x': 318.9800109863281, 'min_y': 693.2749633789062, 'max_x': 554.8919067382812, 'max_y': 839.013916015625}	120 MB 140 MB 160 MB 180 MB RK072 Liver−HCC Cancer type 3:144516195−181561816 Position With other complex events Type 52 Interleaved intrachr. SVs 58 Total SVs (intrachr. + transl.) DEL: 13; DUP: 13; h2hINV: 14; SV types t2tINV: 12; TRA: 6 282 SVs in sample 4, 10 Oscillating CN (2 and 3 states) 67 CN segments 0.8644076 FDR fragment joints 0 FDR chr. breakp. enrich.
100	1	Upper_Left	RK079	8:92616813−123287245	4, 9	9	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	RK079 Liver−HCC Cancer type 8:92616813−123287245 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 80 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.9599662 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
100	2	Upper_Right	RK079	9:3532306−27548765	5, 5	11	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	RK079 Liver−HCC Cancer type 9:3532306−27548765 Position With other complex events Type 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 3 80 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 11 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
100	3	Lower_Left	RK085	7:68220087−124871888	5, 7	147	{'min_x': 58.51020050048828, 'min_y': 693.2749633789062, 'max_x': 248.13221740722656, 'max_y': 839.013916015625}	80 MB 90 MB 100 MB 110 MB 120 MB RK085 Liver−HCC Cancer type 7:68220087−124871888 Position With other complex events Type 98 Interleaved intrachr. SVs 106 Total SVs (intrachr. + transl.) DEL: 29; DUP: 32; h2hINV: 16; SV types t2tINV: 21; TRA: 8 208 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 147 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
100	4	Lower_Right	RK085	8:87033701−105868006	4, 5	20	{'min_x': 323.94000244140625, 'min_y': 693.2749633789062, 'max_x': 551.4921875, 'max_y': 839.013916015625}	85 MB 90 MB 95 MB 100 MB 105 MB RK085 Liver−HCC Cancer type 8:87033701−105868006 Position With other complex events Type 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 2 208 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 20 CN segments 0.9000538 FDR fragment joints 0.51 FDR chr. breakp. enrich.
101	1	Upper_Left	RK087	12:24148141−34697150	4, 5	14	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	RK087 Liver−HCC Cancer type 12:24148141−34697150 Position With other complex events Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 62 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 14 CN segments 0.9723381 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
101	2	Upper_Right	RK088	6:18913889−66058087	6, 7	13	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	RK088 Liver−HCC Cancer type 6:18913889−66058087 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 75 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 13 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
101	3	Lower_Left	RK089	9:23213827−137506288	5, 9	17	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 240.87208557128906, 'max_y': 839.013916015625}	50 MB 75 MB 100 MB 125 MB RK089 Liver−HCC Cancer type 9:23213827−137506288 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 3; SV types t2tINV: 4; TRA: 0 57 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 17 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
101	4	Lower_Right	RK091	12:46659315−73611218	5, 6	61	{'min_x': 351.3500061035156, 'min_y': 693.2749633789062, 'max_x': 530.6500854492188, 'max_y': 839.013916015625}	50 MB 60 MB 70 MB RK091 Liver−HCC Cancer type 12:46659315−73611218 Position With other complex events Type 39 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 12; DUP: 9; h2hINV: 9; SV types t2tINV: 9; TRA: 4 427 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 61 CN segments 0.9077541 FDR fragment joints 0 FDR chr. breakp. enrich.
102	1	Upper_Left	RK092	4:26100061−63228862	4, 4	30	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	RK092 Liver−HCC Cancer type 4:26100061−63228862 Position With other complex events Type 23 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 4; DUP: 8; h2hINV: 7; SV types t2tINV: 4; TRA: 3 89 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 30 CN segments 0.8172348 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
102	2	Upper_Right	RK098	11:2705633−93356459	5, 8	21	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	RK098 Liver−HCC Cancer type 11:2705633−93356459 Position With other complex events Type 8 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 14 145 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 21 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
102	3	Lower_Left	RK098	X:63781853−76077025	5, 6	24	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 259.9117431640625, 'max_y': 839.013916015625}	75 MB 100 MB 125 MB 150 MB RK098 Liver−HCC Cancer type X:63781853−76077025 Position With other complex events Type 15 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 4 145 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 24 CN segments 0.8082862 FDR fragment joints 0 FDR chr. breakp. enrich.
102	4	Lower_Right	RK099	8:50144650−144536434	5, 12	12	{'min_x': 307.1300048828125, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	50 MB 75 MB 100 MB 125 MB RK099 Liver−HCC Cancer type 8:50144650−144536434 Position With other complex events Type 7 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 0; SV types t2tINV: 2; TRA: 2 56 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
103	1	Upper_Left	RK100	X:48002589−124488576	5, 7	18	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	RK100 Liver−HCC Cancer type X:48002589−124488576 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 5; TRA: 0 104 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 18 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
103	2	Upper_Right	RK101	11:69040190−120528008	5, 7	92	{'min_x': 348.010009765625, 'min_y': 280.6499938964844, 'max_x': 518.72021484375, 'max_y': 410.42401123046875}	RK101 Liver−HCC Cancer type 11:69040190−120528008 Position With other complex events Type 59 Interleaved intrachr. SVs 73 Total SVs (intrachr. + transl.) DEL: 18; DUP: 15; h2hINV: 14; SV types t2tINV: 12; TRA: 14 218 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 92 CN segments 0.8246614 FDR fragment joints 0 FDR chr. breakp. enrich. 9:4642656−38474065; Linked to chrs
103	3	Lower_Left	RK111	10:73592301−80444902	6, 6	6	{'min_x': 54.730098724365234, 'min_y': 693.2749633789062, 'max_x': 267.6000061035156, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB RK111 Liver−HCC Cancer type 10:73592301−80444902 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 176 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.8572806 FDR fragment joints 0.05 FDR chr. breakp. enrich.
103	4	Lower_Right	RK117	16:12581311−86577989	5, 5	5	{'min_x': 344.2300109863281, 'min_y': 693.2749633789062, 'max_x': 540.7402954101562, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB RK117 Liver−HCC Cancer type 16:12581311−86577989 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 2 130 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.615458 FDR fragment joints 0.01 FDR chr. breakp. enrich.
104	1	Upper_Left	RK119	2:152075233−182020726	6, 7	37	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	RK119 Liver−HCC Cancer type 2:152075233−182020726 Position With other complex events Type 21 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 8; SV types t2tINV: 3; TRA: 1 110 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 37 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
104	2	Upper_Right	RK135	8:124217126−136178634	4, 6	29	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	RK135 Liver−HCC Cancer type 8:124217126−136178634 Position With other complex events Type 27 Interleaved intrachr. SVs 78 Total SVs (intrachr. + transl.) DEL: 7; DUP: 8; h2hINV: 5; SV types t2tINV: 7; TRA: 51 192 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 29 CN segments 0.7510435 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
104	3	Lower_Left	RK135	14:31416617−39741028	4, 6	16	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB RK135 Liver−HCC Cancer type 14:31416617−39741028 Position With other complex events Type 6 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 1; TRA: 39 192 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 16 CN segments 0.793803 FDR fragment joints 0 FDR chr. breakp. enrich.
104	4	Lower_Right	RK141	6:63658682−134453042	5, 7	18	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 514.1521606445312, 'max_y': 839.013916015625}	80 MB 100 MB 120 MB RK141 Liver−HCC Cancer type 6:63658682−134453042 Position With other complex events Type 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 4 30 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 18 CN segments 0.9000538 FDR fragment joints 0 FDR chr. breakp. enrich.
105	1	Upper_Left	RK152	8:43410563−143686658	6, 7	15	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	RK152 Liver−HCC Cancer type 8:43410563−143686658 Position With other complex events Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 0; SV types t2tINV: 2; TRA: 1 53 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 15 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
105	2	Upper_Right	RK166	13:96936658−104475344	5, 7	18	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	RK166 Liver−HCC Cancer type 13:96936658−104475344 Position With other complex events Type 15 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 3; SV types t2tINV: 7; TRA: 2 74 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 18 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
105	3	Lower_Left	RK169	14:73252280−85449372	6, 6	22	{'min_x': 51.04999923706055, 'min_y': 693.2749633789062, 'max_x': 260.4600830078125, 'max_y': 839.013916015625}	75 MB 77.5 MB 80 MB 82.5 MB 85 MB RK169 Liver−HCC Cancer type 14:73252280−85449372 Position With other complex events Type 9 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 2; SV types t2tINV: 2; TRA: 6 75 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 22 CN segments 0.7257048 FDR fragment joints 0 FDR chr. breakp. enrich.
105	4	Lower_Right	RK171	8:33403096−52649600	5, 6	8	{'min_x': 326.6300048828125, 'min_y': 693.2749633789062, 'max_x': 526.6901245117188, 'max_y': 839.013916015625}	35 MB 40 MB 45 MB 50 MB RK171 Liver−HCC Cancer type 8:33403096−52649600 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 11 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 8 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
106	1	Upper_Left	RK176	5:99356960−113044705	5, 5	5	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.3340148925781}	RK176 Liver−HCC Cancer type 5:99356960−113044705 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 1; SV types t2tINV: 3; TRA: 2 94 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.8653243 FDR fragment joints 0.16 FDR chr. breakp. enrich. Linked to chrs
106	2	Upper_Right	RK178	1:191304671−213916961	4, 7	16	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	RK178 Liver−HCC Cancer type 1:191304671−213916961 Position With other complex events Type 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 1 63 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 16 CN segments 0.7425546 FDR fragment joints 0.02 FDR chr. breakp. enrich. Linked to chrs
106	3	Lower_Left	RK191	4:9755982−47376821	5, 13	44	{'min_x': 54.51020050048828, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB RK191 Liver−HCC Cancer type 4:9755982−47376821 Position With other complex events Type 34 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 9; DUP: 7; h2hINV: 9; SV types t2tINV: 9; TRA: 0 64 SVs in sample 5, 13 Oscillating CN (2 and 3 states) 44 CN segments 0.9717738 FDR fragment joints 0 FDR chr. breakp. enrich.
106	4	Lower_Right	RK195	1:5994422−74247978	4, 12	14	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 545.1823120117188, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB RK195 Liver−HCC Cancer type 1:5994422−74247978 Position With other complex events Type 14 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 3 121 SVs in sample 4, 12 Oscillating CN (2 and 3 states) 14 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
107	1	Upper_Left	RK195	6:1017490−56519171	5, 8	63	{'min_x': 60.18009948730469, 'min_y': 280.6499938964844, 'max_x': 227.54379272460938, 'max_y': 410.3340148925781}	RK195 Liver−HCC Cancer type 6:1017490−56519171 Position With other complex events Type 44 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 11; DUP: 9; h2hINV: 10; SV types t2tINV: 14; TRA: 0 121 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 63 CN segments 0.845361 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
107	2	Upper_Right	RK200	1:157162614−246658065	5, 9	21	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	RK200 Liver−HCC Cancer type 1:157162614−246658065 Position With other complex events Type 29 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 6; DUP: 9; h2hINV: 7; SV types t2tINV: 7; TRA: 0 79 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 21 CN segments 0.930656 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
107	3	Lower_Left	RK201	8:40469509−138579299	6, 10	17	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 230.9618377685547, 'max_y': 839.013916015625}	60 MB 90 MB 120 MB RK201 Liver−HCC Cancer type 8:40469509−138579299 Position With other complex events Type 7 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 5 65 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 17 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
107	4	Lower_Right	RK207	11:33703119−70073261	4, 6	40	{'min_x': 329.6499938964844, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB RK207 Liver−HCC Cancer type 11:33703119−70073261 Position With other complex events Type 23 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 9; DUP: 6; h2hINV: 5; SV types t2tINV: 3; TRA: 3 122 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 40 CN segments 0.7510435 FDR fragment joints 0 FDR chr. breakp. enrich.
108	1	Upper_Left	RK214	17:5363418−21101598	6, 6	6	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.3340148925781}	RK214 Liver−HCC Cancer type 17:5363418−21101598 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 3; TRA: 0 43 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9625775 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
108	2	Upper_Right	RK216	11:94543805−123946518	6, 10	10	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	RK216 Liver−HCC Cancer type 11:94543805−123946518 Position Before polyploidization Type 14 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 5; SV types t2tINV: 4; TRA: 9 38 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.7861024 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
108	3	Lower_Left	RK217	6:2765669−66192793	4, 8	9	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 246.4300079345703, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB RK217 Liver−HCC Cancer type 6:2765669−66192793 Position With other complex events Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 1 44 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 9 CN segments 0.6776251 FDR fragment joints 0.01 FDR chr. breakp. enrich.
108	4	Lower_Right	RK232	17:20606173−77059952	6, 9	25	{'min_x': 345.8800048828125, 'min_y': 693.2749633789062, 'max_x': 529.5999145507812, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB 70 MB RK232 Liver−HCC Cancer type 17:20606173−77059952 Position With other complex events Type 18 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 4; SV types t2tINV: 6; TRA: 0 56 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 25 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
109	1	Upper_Left	RK256	17:27669465−62576041	6, 8	18	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	RK256 Liver−HCC Cancer type 17:27669465−62576041 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 2; SV types t2tINV: 2; TRA: 0 91 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 18 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
109	2	Upper_Right	RK256	19:28565715−32327841	5, 5	12	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	RK256 Liver−HCC Cancer type 19:28565715−32327841 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 1; SV types t2tINV: 1; TRA: 0 91 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 12 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
109	3	Lower_Left	RK275	12:86498848−132672926	6, 6	6	{'min_x': 43.21989822387695, 'min_y': 693.2749633789062, 'max_x': 258.0321044921875, 'max_y': 839.013916015625}	90 MB 100 MB 110 MB 120 MB 130 MB RK275 Liver−HCC Cancer type 12:86498848−132672926 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 0 69 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9625775 FDR fragment joints 0 FDR chr. breakp. enrich.
109	4	Lower_Right	RK280	12:69541748−115904220	5, 8	14	{'min_x': 309.760009765625, 'min_y': 693.2749633789062, 'max_x': 531.02197265625, 'max_y': 839.013916015625}	70 MB 80 MB 90 MB 100 MB 110 MB RK280 Liver−HCC Cancer type 12:69541748−115904220 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 111 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 14 CN segments 0.8653243 FDR fragment joints 0.03 FDR chr. breakp. enrich.
110	1	Upper_Left	RK282	12:1853016−122894996	4, 4	4	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.3340148925781}	RK282 Liver−HCC Cancer type 12:1853016−122894996 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 1 40 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 4 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
110	2	Upper_Right	RK297	9:9687693−31438879	6, 9	9	{'min_x': 344.2300109863281, 'min_y': 280.6499938964844, 'max_x': 522.4959716796875, 'max_y': 410.3340148925781}	RK297 Liver−HCC Cancer type 9:9687693−31438879 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 1; SV types t2tINV: 1; TRA: 0 34 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
110	3	Lower_Left	0d66bf6c-eed0-4726-bd5b-3bf6d610b4e0	9:524316−133004751	6, 8	90	{'min_x': 33.68980026245117, 'min_y': 693.2749633789062, 'max_x': 248.511962890625, 'max_y': 830.3740844726562}	50 MB 100 MB 0d66bf6c−eed0−4726−bd5b−3bf6d610b4e0 Lung−AdenoCA Cancer type 9:524316−133004751 Position With other complex events Type 30 Interleaved intrachr. SVs 74 Total SVs (intrachr. + transl.) DEL: 10; DUP: 7; h2hINV: 9; SV types t2tINV: 4; TRA: 44 414 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 90 CN segments 0.7745035 FDR fragment joints 0 FDR chr. breakp. enrich.
110	4	Lower_Right	0d66bf6c-eed0-4726-bd5b-3bf6d610b4e0	19:14859949−58216996	4, 5	64	{'min_x': 324.5299987792969, 'min_y': 693.2749633789062, 'max_x': 538.0118408203125, 'max_y': 834.6940307617188}	20 MB 30 MB 40 MB 50 MB 0d66bf6c−eed0−4726−bd5b−3bf6d610b4e0 Lung−AdenoCA Cancer type 19:14859949−58216996 Position With other complex events Type 41 Interleaved intrachr. SVs 51 Total SVs (intrachr. + transl.) DEL: 7; DUP: 9; h2hINV: 12; SV types t2tINV: 13; TRA: 10 414 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 64 CN segments 0.6434443 FDR fragment joints 0 FDR chr. breakp. enrich.
111	1	Upper_Left	0df573ee-28f0-4244-b434-09e6ca59fbf0	8:56923598−143961644	4, 5	25	{'min_x': 41.539798736572266, 'min_y': 280.6499938964844, 'max_x': 246.1859588623047, 'max_y': 410.42401123046875}	0df573ee−28f0−4244−b434−09e6ca59fbf0 Lung−AdenoCA Cancer type 8:56923598−143961644 Position With other complex events Type 9 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 13 350 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 25 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 20:15841444−61654373; Linked to chrs
111	2	Upper_Right	0df573ee-28f0-4244-b434-09e6ca59fbf0	14:33787461−97407133	5, 10	36	{'min_x': 331.0400085449219, 'min_y': 280.6499938964844, 'max_x': 535.6859130859375, 'max_y': 410.42401123046875}	0df573ee−28f0−4244−b434−09e6ca59fbf0 Lung−AdenoCA Cancer type 14:33787461−97407133 Position With other complex events Type 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 0; TRA: 6 350 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 36 CN segments 0.8298498 FDR fragment joints 0 FDR chr. breakp. enrich. 13:30424355−100177239; Linked to chrs
111	3	Lower_Left	31c96e35-5e2f-429c-b12a-7bc5a497a300	2:141983404−237479460	4, 8	34	{'min_x': 39.70000076293945, 'min_y': 693.2749633789062, 'max_x': 248.0299530029297, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB 31c96e35−5e2f−429c−b12a−7bc5a497a300 Lung−AdenoCA Cancer type 2:141983404−237479460 Position With other complex events Type 11 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 0; DUP: 6; h2hINV: 2; SV types t2tINV: 3; TRA: 20 276 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 34 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
111	4	Lower_Right	31c96e35-5e2f-429c-b12a-7bc5a497a300	18:18573755−77402934	5, 9	15	{'min_x': 329.20001220703125, 'min_y': 693.2749633789062, 'max_x': 537.5299072265625, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 31c96e35−5e2f−429c−b12a−7bc5a497a300 Lung−AdenoCA Cancer type 18:18573755−77402934 Position With other complex events Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 2 276 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 15 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
112	1	Upper_Left	35cb7841-9b09-465a-90c5-e3b8a9faad49	5:78381−54831894	5, 10	109	{'min_x': 39.36989974975586, 'min_y': 280.6499938964844, 'max_x': 248.35995483398438, 'max_y': 410.3340148925781}	35cb7841−9b09−465a−90c5−e3b8a9faad49 Lung−AdenoCA Cancer type 5:78381−54831894 Position With other complex events Type 57 Interleaved intrachr. SVs 71 Total SVs (intrachr. + transl.) DEL: 16; DUP: 18; h2hINV: 13; SV types t2tINV: 10; TRA: 14 208 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 109 CN segments 0.9037055 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
112	2	Upper_Right	61c655ec-52b5-453f-a6cc-b2aba445b027	8:78610917−146172492	5, 7	30	{'min_x': 328.8699951171875, 'min_y': 280.6499938964844, 'max_x': 537.8599243164062, 'max_y': 410.3340148925781}	61c655ec−52b5−453f−a6cc−b2aba445b027 Lung−AdenoCA Cancer type 8:78610917−146172492 Position With other complex events Type 14 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 5; SV types t2tINV: 4; TRA: 7 44 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 30 CN segments 0.8419568 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
112	3	Lower_Left	6dfd47d2-831a-4386-9051-f78199a16bb5	21:15568990−47382700	5, 7	23	{'min_x': 39.88010025024414, 'min_y': 693.2749633789062, 'max_x': 247.85195922851562, 'max_y': 839.013916015625}	20 MB 30 MB 40 MB 6dfd47d2−831a−4386−9051−f78199a16bb5 Lung−AdenoCA Cancer type 21:15568990−47382700 Position With other complex events Type 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 2; SV types t2tINV: 5; TRA: 0 113 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 23 CN segments 0.8462769 FDR fragment joints 0 FDR chr. breakp. enrich.
112	4	Lower_Right	762dea8a-5b41-4058-979a-b7876ed13d7e	15:60153021−74051084	5, 6	14	{'min_x': 314.9200134277344, 'min_y': 693.2749633789062, 'max_x': 538.6879272460938, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB 70 MB 762dea8a−5b41−4058−979a−b7876ed13d7e Lung−AdenoCA Cancer type 15:60153021−74051084 Position With other complex events Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 2 74 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 14 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
113	1	Upper_Left	97831d28-ab41-4c18-bfc2-c4c6bc757d13	8:19746812−144761257	5, 8	79	{'min_x': 39.210201263427734, 'min_y': 280.6499938964844, 'max_x': 248.51995849609375, 'max_y': 410.3340148925781}	97831d28−ab41−4c18−bfc2−c4c6bc757d13 Lung−AdenoCA Cancer type 8:19746812−144761257 Position With other complex events Type 34 Interleaved intrachr. SVs 68 Total SVs (intrachr. + transl.) DEL: 12; DUP: 6; h2hINV: 5; SV types t2tINV: 11; TRA: 34 229 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 79 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
113	2	Upper_Right	97831d28-ab41-4c18-bfc2-c4c6bc757d13	17:18917497−78501499	4, 9	46	{'min_x': 328.7099914550781, 'min_y': 280.6499938964844, 'max_x': 538.0198974609375, 'max_y': 410.42401123046875}	97831d28−ab41−4c18−bfc2−c4c6bc757d13 Lung−AdenoCA Cancer type 17:18917497−78501499 Position With other complex events Type 23 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 6; SV types t2tINV: 7; TRA: 22 229 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 46 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 8:19746812−144761256; Linked to chrs
113	3	Lower_Left	9b132e4f-7e35-4cc5-8711-43ad62b906d0	1:194754133−247990684	5, 9	79	{'min_x': 39.36989974975586, 'min_y': 693.2749633789062, 'max_x': 272.6021423339844, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB 250 MB 9b132e4f−7e35−4cc5−8711−43ad62b906d0 Lung−AdenoCA Cancer type 1:194754133−247990684 Position With other complex events Type 73 Interleaved intrachr. SVs 73 Total SVs (intrachr. + transl.) DEL: 21; DUP: 18; h2hINV: 18; SV types t2tINV: 16; TRA: 0 209 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 79 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
113	4	Lower_Right	9b132e4f-7e35-4cc5-8711-43ad62b906d0	7:27678717−58038295	5, 5	14	{'min_x': 328.8699951171875, 'min_y': 693.2749633789062, 'max_x': 537.8599243164062, 'max_y': 839.013916015625}	50 MB 100 MB 9b132e4f−7e35−4cc5−8711−43ad62b906d0 Lung−AdenoCA Cancer type 7:27678717−58038295 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 0 209 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 14 CN segments 0.9284301 FDR fragment joints 0.37 FDR chr. breakp. enrich.
114	1	Upper_Left	9b132e4f-7e35-4cc5-8711-43ad62b906d0	13:28780200−112141515	6, 7	31	{'min_x': 39.36989974975586, 'min_y': 280.6499938964844, 'max_x': 248.35995483398438, 'max_y': 410.3340148925781}	9b132e4f−7e35−4cc5−8711−43ad62b906d0 Lung−AdenoCA Cancer type 13:28780200−112141515 Position With other complex events Type 21 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 8; SV types t2tINV: 6; TRA: 11 209 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 31 CN segments 0.7379502 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
114	2	Upper_Right	9b132e4f-7e35-4cc5-8711-43ad62b906d0	18:26992235−64244136	4, 6	6	{'min_x': 328.8699951171875, 'min_y': 280.6499938964844, 'max_x': 537.8599243164062, 'max_y': 410.42401123046875}	9b132e4f−7e35−4cc5−8711−43ad62b906d0 Lung−AdenoCA Cancer type 18:26992235−64244136 Position After polyploidization Type 6 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 1; TRA: 4 209 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9625775 FDR fragment joints 0.06 FDR chr. breakp. enrich. 13:28780200−112141514; Linked to chrs
114	3	Lower_Left	9b132e4f-7e35-4cc5-8711-43ad62b906d0	19:13858390−58445196	4, 7	22	{'min_x': 39.36989974975586, 'min_y': 693.2749633789062, 'max_x': 248.35995483398438, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB 9b132e4f−7e35−4cc5−8711−43ad62b906d0 Lung−AdenoCA Cancer type 19:13858390−58445196 Position With other complex events Type 9 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 7 209 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 22 CN segments 0.9501265 FDR fragment joints 0 FDR chr. breakp. enrich.
114	4	Lower_Right	a8d6694c-a213-4544-ac0b-63bce16d8f4e	1:20472132−114994801	5, 5	8	{'min_x': 306.3299865722656, 'min_y': 693.2749633789062, 'max_x': 537.8599243164062, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB 100 MB a8d6694c−a213−4544−ac0b−63bce16d8f4e Lung−AdenoCA Cancer type 1:20472132−114994801 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 3; TRA: 0 21 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 8 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
115	1	Upper_Left	bf15f7ad-9d92-473b-91d1-f24aa373ab97	7:147214684−153396315	5, 7	19	{'min_x': 40.38010025024414, 'min_y': 280.6499938964844, 'max_x': 247.34396362304688, 'max_y': 410.3340148925781}	bf15f7ad−9d92−473b−91d1−f24aa373ab97 Lung−AdenoCA Cancer type 7:147214684−153396315 Position With other complex events Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 0 108 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 19 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
115	2	Upper_Right	bf15f7ad-9d92-473b-91d1-f24aa373ab97	14:23868021−40684899	4, 8	54	{'min_x': 329.8800048828125, 'min_y': 280.6499938964844, 'max_x': 536.8438720703125, 'max_y': 410.3340148925781}	bf15f7ad−9d92−473b−91d1−f24aa373ab97 Lung−AdenoCA Cancer type 14:23868021−40684899 Position With other complex events Type 35 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 8; DUP: 9; h2hINV: 8; SV types t2tINV: 10; TRA: 0 108 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 54 CN segments 0.9757835 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
115	3	Lower_Left	cc4bd56a-25c5-4c48-b583-ac3aeb778ca6	7:83811028−152303288	5, 15	27	{'min_x': 38.70000076293945, 'min_y': 693.2749633789062, 'max_x': 267.1219482421875, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB cc4bd56a−25c5−4c48−b583−ac3aeb778ca6 Lung−AdenoCA Cancer type 7:83811028−152303288 Position With other complex events Type 14 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 5; SV types t2tINV: 4; TRA: 4 237 SVs in sample 5, 15 Oscillating CN (2 and 3 states) 27 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
115	4	Lower_Right	cc4bd56a-25c5-4c48-b583-ac3aeb778ca6	19:28395079−36324916	5, 6	11	{'min_x': 313.82000732421875, 'min_y': 693.2749633789062, 'max_x': 553.6204223632812, 'max_y': 839.013916015625}	20 MB 25 MB 30 MB 35 MB 40 MB cc4bd56a−25c5−4c48−b583−ac3aeb778ca6 Lung−AdenoCA Cancer type 19:28395079−36324916 Position With other complex events Type 10 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 4; SV types t2tINV: 4; TRA: 2 237 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 11 CN segments 0.8298498 FDR fragment joints 0 FDR chr. breakp. enrich.
116	1	Upper_Left	cd0dc947-b708-464e-beb7-954c9d4583e7	8:898539−112976203	4, 8	49	{'min_x': 38.36989974975586, 'min_y': 280.6499938964844, 'max_x': 249.3579559326172, 'max_y': 410.42401123046875}	cd0dc947−b708−464e−beb7−954c9d4583e7 Lung−AdenoCA Cancer type 8:898539−112976203 Position With other complex events Type 14 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 6; DUP: 1; h2hINV: 5; SV types t2tINV: 2; TRA: 14 73 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 49 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 3:111543−188368918; Linked to chrs
116	2	Upper_Right	d5326429-9805-47f9-97b0-fbda658e3f01	6:39244076−50016258	5, 5	14	{'min_x': 330.2099914550781, 'min_y': 280.6499938964844, 'max_x': 536.5138549804688, 'max_y': 410.3340148925781}	d5326429−9805−47f9−97b0−fbda658e3f01 Lung−AdenoCA Cancer type 6:39244076−50016258 Position With other complex events Type 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 1 209 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 14 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
116	3	Lower_Left	d5326429-9805-47f9-97b0-fbda658e3f01	12:49376535−90124478	5, 20	41	{'min_x': 40.710201263427734, 'min_y': 693.2749633789062, 'max_x': 269.2521057128906, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB d5326429−9805−47f9−97b0−fbda658e3f01 Lung−AdenoCA Cancer type 12:49376535−90124478 Position With other complex events Type 7 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 0; TRA: 19 209 SVs in sample 5, 20 Oscillating CN (2 and 3 states) 41 CN segments 0.7510435 FDR fragment joints 0 FDR chr. breakp. enrich.
116	4	Lower_Right	d5326429-9805-47f9-97b0-fbda658e3f01	13:33846175−41641608	4, 5	13	{'min_x': 330.2099914550781, 'min_y': 693.2749633789062, 'max_x': 560.94189453125, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB d5326429−9805−47f9−97b0−fbda658e3f01 Lung−AdenoCA Cancer type 13:33846175−41641608 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 0 209 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 13 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
117	1	Upper_Left	dbd5b0de-94c9-45dd-afb3-6820a7ecaca2	17:9065515−76403933	6, 6	6	{'min_x': 38.73979949951172, 'min_y': 280.6499938964844, 'max_x': 248.98992919921875, 'max_y': 410.42401123046875}	dbd5b0de−94c9−45dd−afb3−6820a7ecaca2 Lung−AdenoCA Cancer type 17:9065515−76403933 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 1; TRA: 4 40 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich. 6:3073059−49773929; Linked to chrs
117	2	Upper_Right	f063ddbb-1668-40df-9ec2-b0a23ca2c389	12:60485092−69941157	4, 14	20	{'min_x': 329.239990234375, 'min_y': 280.6499938964844, 'max_x': 537.491943359375, 'max_y': 410.3340148925781}	f063ddbb−1668−40df−9ec2−b0a23ca2c389 Lung−AdenoCA Cancer type 12:60485092−69941157 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 0; SV types t2tINV: 2; TRA: 0 20 SVs in sample 4, 14 Oscillating CN (2 and 3 states) 20 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
117	3	Lower_Left	037c57d1-b4a5-45dc-bda4-0550461d321b	15:74425114−99150104	5, 5	9	{'min_x': 38.210201263427734, 'min_y': 693.2749633789062, 'max_x': 249.51795959472656, 'max_y': 839.013916015625}	50 MB 60 MB 70 MB 80 MB 90 MB 037c57d1−b4a5−45dc−bda4−0550461d321b Lung−SCC Cancer type 15:74425114−99150104 Position With other complex events Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 2 307 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 9 CN segments 0.8653243 FDR fragment joints 0.08 FDR chr. breakp. enrich.
117	4	Lower_Right	0398eae1-7216-4595-80a5-6b117d96e070	9:15996503−22530833	5, 10	10	{'min_x': 307.6000061035156, 'min_y': 693.2749633789062, 'max_x': 539.719970703125, 'max_y': 839.013916015625}	16 MB 18 MB 20 MB 22 MB 0398eae1−7216−4595−80a5−6b117d96e070 Lung−SCC Cancer type 9:15996503−22530833 Position With other complex events Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 209 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.9723381 FDR fragment joints 0.9 FDR chr. breakp. enrich.
118	1	Upper_Left	0398eae1-7216-4595-80a5-6b117d96e070	18:1190790−67995083	6, 7	46	{'min_x': 39.03010177612305, 'min_y': 280.6499938964844, 'max_x': 248.6979522705078, 'max_y': 410.3340148925781}	0398eae1−7216−4595−80a5−6b117d96e070 Lung−SCC Cancer type 18:1190790−67995083 Position With other complex events Type 25 Interleaved intrachr. SVs 41 Total SVs (intrachr. + transl.) DEL: 8; DUP: 8; h2hINV: 3; SV types t2tINV: 6; TRA: 16 209 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 46 CN segments 0.8053298 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
118	2	Upper_Right	0398eae1-7216-4595-80a5-6b117d96e070	21:14366223−44334417	6, 10	20	{'min_x': 328.5299987792969, 'min_y': 280.6499938964844, 'max_x': 538.1979370117188, 'max_y': 410.3340148925781}	0398eae1−7216−4595−80a5−6b117d96e070 Lung−SCC Cancer type 21:14366223−44334417 Position With other complex events Type 7 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 11 209 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 20 CN segments 0.641841 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
118	3	Lower_Left	1ee543d5-b8c0-4f79-8373-6bb6319f2ee2	8:127118996−135131269	4, 5	23	{'min_x': 40.039798736572266, 'min_y': 693.2749633789062, 'max_x': 247.69195556640625, 'max_y': 839.013916015625}	50 MB 100 MB 1ee543d5−b8c0−4f79−8373−6bb6319f2ee2 Lung−SCC Cancer type 8:127118996−135131269 Position With other complex events Type 6 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 24 287 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 23 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
118	4	Lower_Right	1f11de87-a5fe-49fd-80c1-e279b2bc69de	3:143326907−193269619	5, 5	53	{'min_x': 330.07000732421875, 'min_y': 693.2749633789062, 'max_x': 536.654052734375, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 1f11de87−a5fe−49fd−80c1−e279b2bc69de Lung−SCC Cancer type 3:143326907−193269619 Position With other complex events Type 17 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 5; SV types t2tINV: 3; TRA: 11 165 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 53 CN segments 0.9794281 FDR fragment joints 0 FDR chr. breakp. enrich.
119	1	Upper_Left	1f6b2aca-7357-40d1-ba7a-99227d9900a2	3:77709025−174601176	5, 9	49	{'min_x': 35.360198974609375, 'min_y': 276.3299865722656, 'max_x': 252.3719482421875, 'max_y': 410.3340148925781}	1f6b2aca−7357−40d1−ba7a−99227d9900a2 Lung−SCC Cancer type 3:77709025−174601176 Position With other complex events Type 16 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 5; SV types t2tINV: 4; TRA: 10 602 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 49 CN segments 0.8172348 FDR fragment joints 0.1 FDR chr. breakp. enrich. 21:14740825−17506647;4:2720902−165169008 Linked to chrs
119	2	Upper_Right	1f6b2aca-7357-40d1-ba7a-99227d9900a2	11:46508302−111537992	5, 8	129	{'min_x': 324.8599853515625, 'min_y': 272.0099792480469, 'max_x': 541.8719482421875, 'max_y': 410.4242248535156}	1f6b2aca−7357−40d1−ba7a−99227d9900a2 Lung−SCC Cancer type 11:46508302−111537992 Position With other complex events Type 112 Interleaved intrachr. SVs 195 Total SVs (intrachr. + transl.) DEL: 27; DUP: 31; h2hINV: 26; SV types t2tINV: 28; TRA: 83 602 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 129 CN segments 0.9723381 FDR fragment joints 0 FDR chr. breakp. enrich. 12:4696888−43872964;18:21140095−63388412 4:2720902−165169008;6:47045197−150310816 Linked to chrs
119	3	Lower_Left	1f6b2aca-7357-40d1-ba7a-99227d9900a2	12:4696888−43872965	4, 5	14	{'min_x': 32.019901275634766, 'min_y': 693.2749633789062, 'max_x': 248.35995483398438, 'max_y': 834.6940307617188}	25 MB 50 MB 75 MB 100 MB 1f6b2aca−7357−40d1−ba7a−99227d9900a2 Lung−SCC Cancer type 12:4696888−43872965 Position With other complex events Type 7 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 0; SV types t2tINV: 3; TRA: 13 602 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 14 CN segments 0.8572806 FDR fragment joints 0.35 FDR chr. breakp. enrich.
119	4	Lower_Right	1f6b2aca-7357-40d1-ba7a-99227d9900a2	21:14740825−17506648	5, 6	12	{'min_x': 309.5199890136719, 'min_y': 693.2749633789062, 'max_x': 537.8599243164062, 'max_y': 839.013916015625}	15 MB 20 MB 25 MB 30 MB 35 MB 40 MB 1f6b2aca−7357−40d1−ba7a−99227d9900a2 Lung−SCC Cancer type 21:14740825−17506648 Position With other complex events Type 10 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 4; TRA: 3 602 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 12 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
120	1	Upper_Left	3666bc65-8e40-409e-9a1f-41583dd6d978	3:121469766−183835935	4, 4	28	{'min_x': 39.400001525878906, 'min_y': 280.6499938964844, 'max_x': 248.33001708984375, 'max_y': 410.3340148925781}	3666bc65−8e40−409e−9a1f−41583dd6d978 Lung−SCC Cancer type 3:121469766−183835935 Position With other complex events Type 16 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 4; SV types t2tINV: 4; TRA: 2 154 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 28 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
120	2	Upper_Right	3666bc65-8e40-409e-9a1f-41583dd6d978	7:8021176−96585488	4, 5	38	{'min_x': 328.8999938964844, 'min_y': 280.6499938964844, 'max_x': 537.830078125, 'max_y': 410.42401123046875}	3666bc65−8e40−409e−9a1f−41583dd6d978 Lung−SCC Cancer type 7:8021176−96585488 Position With other complex events Type 6 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 0; TRA: 14 154 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 38 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich. 5:1891003−59309258; Linked to chrs
120	3	Lower_Left	376dfd27-68e8-4a1a-9c4f-5064279b2a9e	3:84207634−196397331	5, 5	76	{'min_x': 40.210201263427734, 'min_y': 693.2749633789062, 'max_x': 247.52195739746094, 'max_y': 839.013916015625}	100 MB 150 MB 376dfd27−68e8−4a1a−9c4f−5064279b2a9e Lung−SCC Cancer type 3:84207634−196397331 Position With other complex events Type 30 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 6; DUP: 10; h2hINV: 8; SV types t2tINV: 6; TRA: 5 234 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 76 CN segments 0.8007013 FDR fragment joints 0 FDR chr. breakp. enrich.
120	4	Lower_Right	376dfd27-68e8-4a1a-9c4f-5064279b2a9e	14:29694281−42596449	4, 5	9	{'min_x': 312.95001220703125, 'min_y': 693.2749633789062, 'max_x': 559.658447265625, 'max_y': 839.013916015625}	30 MB 32.5 MB 35 MB 37.5 MB 40 MB 42.5 MB 376dfd27−68e8−4a1a−9c4f−5064279b2a9e Lung−SCC Cancer type 14:29694281−42596449 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 0 234 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 9 CN segments 0.8653243 FDR fragment joints 0.7 FDR chr. breakp. enrich.
121	1	Upper_Left	376dfd27-68e8-4a1a-9c4f-5064279b2a9e	X:714035−155073186	4, 6	6	{'min_x': 40.210201263427734, 'min_y': 280.6499938964844, 'max_x': 247.52195739746094, 'max_y': 410.3340148925781}	376dfd27−68e8−4a1a−9c4f−5064279b2a9e Lung−SCC Cancer type X:714035−155073186 Position Canonical without polyploidization Type 55 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 13; DUP: 16; h2hINV: 14; SV types t2tINV: 12; TRA: 0 234 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.930656 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
121	2	Upper_Right	395babb3-3f5d-4e71-a675-af4443f23028	1:71829305−246323132	6, 11	38	{'min_x': 330.2099914550781, 'min_y': 280.6499938964844, 'max_x': 536.5138549804688, 'max_y': 410.3340148925781}	395babb3−3f5d−4e71−a675−af4443f23028 Lung−SCC Cancer type 1:71829305−246323132 Position With other complex events Type 19 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 7; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 1 113 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 38 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
121	3	Lower_Left	43abe847-4ba7-466e-8283-5d7b80b999a7	8:30016639−108126673	5, 7	82	{'min_x': 38.539798736572266, 'min_y': 693.2749633789062, 'max_x': 249.18795776367188, 'max_y': 839.013916015625}	50 MB 100 MB 43abe847−4ba7−466e−8283−5d7b80b999a7 Lung−SCC Cancer type 8:30016639−108126673 Position With other complex events Type 13 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 8; DUP: 9; h2hINV: 4; SV types t2tINV: 5; TRA: 5 500 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 82 CN segments 0.7013708 FDR fragment joints 0 FDR chr. breakp. enrich.
121	4	Lower_Right	43abe847-4ba7-466e-8283-5d7b80b999a7	10:44557512−95329436	4, 8	34	{'min_x': 328.0400085449219, 'min_y': 693.2749633789062, 'max_x': 538.6879272460938, 'max_y': 839.013916015625}	60 MB 80 MB 100 MB 43abe847−4ba7−466e−8283−5d7b80b999a7 Lung−SCC Cancer type 10:44557512−95329436 Position With other complex events Type 17 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 3; SV types t2tINV: 4; TRA: 14 500 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 34 CN segments 0.8653243 FDR fragment joints 0.01 FDR chr. breakp. enrich.
122	1	Upper_Left	4ca13c92-84b4-4edf-842a-b20b7e713415	2:54467990−78652935	5, 6	16	{'min_x': 39.36989974975586, 'min_y': 280.6499938964844, 'max_x': 248.35995483398438, 'max_y': 410.3340148925781}	4ca13c92−84b4−4edf−842a−b20b7e713415 Lung−SCC Cancer type 2:54467990−78652935 Position With other complex events Type 17 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 4; SV types t2tINV: 3; TRA: 2 103 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 16 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
122	2	Upper_Right	585e6487-b0a3-4828-8a06-46bee01dff74	X:1585455−33684999	4, 5	41	{'min_x': 329.7099914550781, 'min_y': 280.6499938964844, 'max_x': 537.0219116210938, 'max_y': 410.3340148925781}	585e6487−b0a3−4828−8a06−46bee01dff74 Lung−SCC Cancer type X:1585455−33684999 Position With other complex events Type 45 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 9; DUP: 13; h2hINV: 11; SV types t2tINV: 12; TRA: 0 129 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 41 CN segments 0.9161301 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
122	3	Lower_Left	6fd72426-f6c8-47ca-a500-d5d3600b9b15	3:181546045−189173080	4, 8	18	{'min_x': 39.88010025024414, 'min_y': 693.2749633789062, 'max_x': 272.8118896484375, 'max_y': 839.013916015625}	110 MB 130 MB 150 MB 170 MB 190 MB 6fd72426−f6c8−47ca−a500−d5d3600b9b15 Lung−SCC Cancer type 3:181546045−189173080 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 5; SV types t2tINV: 2; TRA: 0 130 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 18 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
122	4	Lower_Right	6fd72426-f6c8-47ca-a500-d5d3600b9b15	17:18108890−41996624	6, 12	33	{'min_x': 329.3800048828125, 'min_y': 693.2749633789062, 'max_x': 540.8402709960938, 'max_y': 839.013916015625}	20 MB 25 MB 30 MB 35 MB 40 MB 6fd72426−f6c8−47ca−a500−d5d3600b9b15 Lung−SCC Cancer type 17:18108890−41996624 Position With other complex events Type 18 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 6; DUP: 2; h2hINV: 2; SV types t2tINV: 8; TRA: 3 130 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 33 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
123	1	Upper_Left	7d905f8f-3967-4ea8-96c8-17b1b03fbec3	5:1687513−37366455	4, 4	15	{'min_x': 40.710201263427734, 'min_y': 280.6499938964844, 'max_x': 247.0139617919922, 'max_y': 410.3340148925781}	7d905f8f−3967−4ea8−96c8−17b1b03fbec3 Lung−SCC Cancer type 5:1687513−37366455 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 385 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 15 CN segments 0.6776251 FDR fragment joints 0.05 FDR chr. breakp. enrich. Linked to chrs
123	2	Upper_Right	9293e197-e38a-4e19-a7d0-1b45d1ad48bd	4:43364661−73902886	4, 5	18	{'min_x': 327.8699951171875, 'min_y': 280.6499938964844, 'max_x': 538.8579711914062, 'max_y': 410.3340148925781}	9293e197−e38a−4e19−a7d0−1b45d1ad48bd Lung−SCC Cancer type 4:43364661−73902886 Position With other complex events Type 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 6 187 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 18 CN segments 0.6776251 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
123	3	Lower_Left	9293e197-e38a-4e19-a7d0-1b45d1ad48bd	7:67945786−122441992	6, 12	15	{'min_x': 38.36989974975586, 'min_y': 693.2749633789062, 'max_x': 271.0919494628906, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 9293e197−e38a−4e19−a7d0−1b45d1ad48bd Lung−SCC Cancer type 7:67945786−122441992 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 3; SV types t2tINV: 1; TRA: 0 187 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 15 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
123	4	Lower_Right	9af6ed4e-8cdc-4f49-84e9-ba1053b5b3ca	1:76535798−99663065	5, 5	41	{'min_x': 324.8599853515625, 'min_y': 693.2749633789062, 'max_x': 537.3519287109375, 'max_y': 834.6940307617188}	50 MB 100 MB 150 MB 200 MB 9af6ed4e−8cdc−4f49−84e9−ba1053b5b3ca Lung−SCC Cancer type 1:76535798−99663065 Position With other complex events Type 47 Interleaved intrachr. SVs 61 Total SVs (intrachr. + transl.) DEL: 8; DUP: 11; h2hINV: 16; SV types t2tINV: 12; TRA: 14 428 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 41 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
124	1	Upper_Left	9af6ed4e-8cdc-4f49-84e9-ba1053b5b3ca	5:30463771−37215413	4, 8	10	{'min_x': 39.88010025024414, 'min_y': 280.6499938964844, 'max_x': 247.85195922851562, 'max_y': 410.42401123046875}	9af6ed4e−8cdc−4f49−84e9−ba1053b5b3ca Lung−SCC Cancer type 5:30463771−37215413 Position With other complex events Type 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 3 428 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 10 CN segments 0.9723381 FDR fragment joints 0.78 FDR chr. breakp. enrich. 1:76535798−99663064; Linked to chrs
124	2	Upper_Right	aecf85cc-058c-46f3-9cdc-3573ac3b8438	19:9018583−18930769	5, 8	19	{'min_x': 329.8699951171875, 'min_y': 280.6499938964844, 'max_x': 536.8619384765625, 'max_y': 410.42401123046875}	aecf85cc−058c−46f3−9cdc−3573ac3b8438 Lung−SCC Cancer type 19:9018583−18930769 Position With other complex events Type 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 1; SV types t2tINV: 3; TRA: 4 232 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 19 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich. 2:24457554−239354640; Linked to chrs
124	3	Lower_Left	c2598334-f866-4cc3-93ec-2d2e8b85d319	3:141119758−191946026	5, 21	61	{'min_x': 39.539798736572266, 'min_y': 693.2749633789062, 'max_x': 248.18995666503906, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB c2598334−f866−4cc3−93ec−2d2e8b85d319 Lung−SCC Cancer type 3:141119758−191946026 Position With other complex events Type 43 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 3; DUP: 14; h2hINV: 14; SV types t2tINV: 12; TRA: 1 165 SVs in sample 5, 21 Oscillating CN (2 and 3 states) 61 CN segments 0.5076332 FDR fragment joints 0 FDR chr. breakp. enrich.
124	4	Lower_Right	c2598334-f866-4cc3-93ec-2d2e8b85d319	16:81457961−89793192	5, 7	8	{'min_x': 329.0400085449219, 'min_y': 693.2749633789062, 'max_x': 537.68994140625, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB c2598334−f866−4cc3−93ec−2d2e8b85d319 Lung−SCC Cancer type 16:81457961−89793192 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 0; SV types t2tINV: 2; TRA: 4 165 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 8 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
125	1	Upper_Left	ce8612ab-3149-4a6a-b424-29c0c21c9b8b	3:145882159−191906843	5, 14	88	{'min_x': 38.70000076293945, 'min_y': 280.6499938964844, 'max_x': 249.0279541015625, 'max_y': 410.3340148925781}	ce8612ab−3149−4a6a−b424−29c0c21c9b8b Lung−SCC Cancer type 3:145882159−191906843 Position With other complex events Type 65 Interleaved intrachr. SVs 73 Total SVs (intrachr. + transl.) DEL: 16; DUP: 10; h2hINV: 23; SV types t2tINV: 16; TRA: 8 213 SVs in sample 5, 14 Oscillating CN (2 and 3 states) 88 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
125	2	Upper_Right	e6b72c24-1607-43b9-8b8a-7bf83eea5895	6:62569792−169514744	4, 8	78	{'min_x': 328.8699951171875, 'min_y': 280.6499938964844, 'max_x': 537.85986328125, 'max_y': 410.3340148925781}	e6b72c24−1607−43b9−8b8a−7bf83eea5895 Lung−SCC Cancer type 6:62569792−169514744 Position With other complex events Type 48 Interleaved intrachr. SVs 52 Total SVs (intrachr. + transl.) DEL: 12; DUP: 17; h2hINV: 10; SV types t2tINV: 9; TRA: 4 265 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 78 CN segments 0.6338796 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
125	3	Lower_Left	a8e2df1e-4042-42af-9231-3a00e83489f0	1:52105012−170864080	5, 5	5	{'min_x': 41.20000076293945, 'min_y': 693.2749633789062, 'max_x': 246.52395629882812, 'max_y': 839.013916015625}	75 MB 100 MB 125 MB 150 MB a8e2df1e−4042−42af−9231−3a00e83489f0 Lymph−BNHL Cancer type 1:52105012−170864080 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 0 112 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.7735152 FDR fragment joints 1 FDR chr. breakp. enrich.
125	4	Lower_Right	a8e2df1e-4042-42af-9231-3a00e83489f0	2:60753889−124345172	4, 5	34	{'min_x': 330.70001220703125, 'min_y': 693.2749633789062, 'max_x': 554.132080078125, 'max_y': 839.013916015625}	100 MB 150 MB 200 MB a8e2df1e−4042−42af−9231−3a00e83489f0 Lymph−BNHL Cancer type 2:60753889−124345172 Position With other complex events Type 29 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 8; DUP: 5; h2hINV: 7; SV types t2tINV: 9; TRA: 2 112 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 34 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
126	1	Upper_Left	f0a326d2-1f3e-4a5d-bca8-32aaccc52338	9:8189397−96357054	6, 12	49	{'min_x': 40.210201263427734, 'min_y': 280.6499938964844, 'max_x': 247.52195739746094, 'max_y': 410.42401123046875}	f0a326d2−1f3e−4a5d−bca8−32aaccc52338 Lymph−BNHL Cancer type 9:8189397−96357054 Position With other complex events Type 30 Interleaved intrachr. SVs 89 Total SVs (intrachr. + transl.) DEL: 10; DUP: 4; h2hINV: 9; SV types t2tINV: 7; TRA: 59 194 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 49 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 18:24492930−66759171; Linked to chrs
126	2	Upper_Right	4101316	3:81591651−155801731	5, 11	64	{'min_x': 351.3500061035156, 'min_y': 280.6499938964844, 'max_x': 515.3779296875, 'max_y': 410.3340148925781}	4101316 Lymph−BNHL Cancer type 3:81591651−155801731 Position With other complex events Type 32 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 13; SV types t2tINV: 9; TRA: 1 69 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 64 CN segments 0.565038 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
126	3	Lower_Left	4111337	11:114660441−124818719	4, 5	27	{'min_x': 59.51020050048828, 'min_y': 693.2749633789062, 'max_x': 258.11187744140625, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB 125 MB 4111337 Lymph−BNHL Cancer type 11:114660441−124818719 Position With other complex events Type 18 Interleaved intrachr. SVs 69 Total SVs (intrachr. + transl.) DEL: 3; DUP: 6; h2hINV: 3; SV types t2tINV: 6; TRA: 51 226 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 27 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
126	4	Lower_Right	4115001	17:35776511−77685244	4, 8	15	{'min_x': 329.57000732421875, 'min_y': 693.2749633789062, 'max_x': 559.0403442382812, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 70 MB 80 MB 4115001 Lymph−BNHL Cancer type 17:35776511−77685244 Position With other complex events Type 19 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 5; SV types t2tINV: 6; TRA: 2 61 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 15 CN segments 0.7568568 FDR fragment joints 0 FDR chr. breakp. enrich.
127	1	Upper_Left	4120193	9:2435903−130371802	5, 7	64	{'min_x': 60.18009948730469, 'min_y': 280.6499938964844, 'max_x': 227.54379272460938, 'max_y': 410.3340148925781}	4120193 Lymph−BNHL Cancer type 9:2435903−130371802 Position With other complex events Type 40 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 8; DUP: 10; h2hINV: 12; SV types t2tINV: 10; TRA: 0 101 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 64 CN segments 0.9109641 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
127	2	Upper_Right	4120193	19:11710100−28359979	4, 8	8	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	4120193 Lymph−BNHL Cancer type 19:11710100−28359979 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 0 101 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
127	3	Lower_Left	4133511	13:64436002−110393802	5, 10	19	{'min_x': 45.919898986816406, 'min_y': 693.2749633789062, 'max_x': 268.93212890625, 'max_y': 839.013916015625}	70 MB 80 MB 90 MB 100 MB 110 MB 4133511 Lymph−BNHL Cancer type 13:64436002−110393802 Position With other complex events Type 8 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 5 33 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 19 CN segments 0.9000538 FDR fragment joints 0 FDR chr. breakp. enrich.
127	4	Lower_Right	4135099	1:1563247−89014486	5, 13	28	{'min_x': 307.5799865722656, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	0 MB 50 MB 100 MB 150 MB 4135099 Lymph−BNHL Cancer type 1:1563247−89014486 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 3; SV types t2tINV: 2; TRA: 0 297 SVs in sample 5, 13 Oscillating CN (2 and 3 states) 28 CN segments 0.7995907 FDR fragment joints 0.37 FDR chr. breakp. enrich.
128	1	Upper_Left	4139696	4:172175721−178144474	6, 6	6	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.3340148925781}	4139696 Lymph−BNHL Cancer type 4:172175721−178144474 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 1 33 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.6776251 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
128	2	Upper_Right	4147081	6:97247266−142316157	6, 11	11	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	4147081 Lymph−BNHL Cancer type 6:97247266−142316157 Position With other complex events Type 7 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 2 107 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.854603 FDR fragment joints 0.03 FDR chr. breakp. enrich. 5:149829718−164575330; Linked to chrs
128	3	Lower_Left	4157186	2:36073033−243043088	5, 10	10	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	100 MB 150 MB 200 MB 4157186 Lymph−BNHL Cancer type 2:36073033−243043088 Position With other complex events Type 15 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 0; DUP: 3; h2hINV: 6; SV types t2tINV: 6; TRA: 13 46 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
128	4	Lower_Right	4157186	4:69602537−108006799	4, 4	4	{'min_x': 344.2300109863281, 'min_y': 693.2749633789062, 'max_x': 522.4959716796875, 'max_y': 839.013916015625}	50 MB 70 MB 90 MB 4157186 Lymph−BNHL Cancer type 4:69602537−108006799 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 46 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 4 CN segments 1 FDR fragment joints 0.01 FDR chr. breakp. enrich.
129	1	Upper_Left	4158726	9:20938863−81861602	6, 11	11	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	4158726 Lymph−BNHL Cancer type 9:20938863−81861602 Position With other complex events Type 6 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 1; SV types t2tINV: 2; TRA: 5 47 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.7425546 FDR fragment joints 0 FDR chr. breakp. enrich. 18:49801362−72732255; Linked to chrs
129	2	Upper_Right	4160100	19:945638−56277099	4, 5	24	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	4160100 Lymph−BNHL Cancer type 19:945638−56277099 Position With other complex events Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 1; SV types t2tINV: 2; TRA: 0 60 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 24 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
129	3	Lower_Left	AOCS-060	8:34955549−139173410	4, 6	36	{'min_x': 37.03010177612305, 'min_y': 693.2749633789062, 'max_x': 272.7420349121094, 'max_y': 834.6940307617188}	60 MB 80 MB 100 MB 120 MB 140 MB AOCS−060 Ovary−AdenoCA Cancer type 8:34955549−139173410 Position With other complex events Type 9 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 2; SV types t2tINV: 2; TRA: 14 197 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 36 CN segments 0.7861024 FDR fragment joints 0 FDR chr. breakp. enrich.
129	4	Lower_Right	AOCS-061	19:29415891−40712326	4, 5	34	{'min_x': 346.5899963378906, 'min_y': 693.2749633789062, 'max_x': 538.1904907226562, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB AOCS−061 Ovary−AdenoCA Cancer type 19:29415891−40712326 Position With other complex events Type 13 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 6; h2hINV: 2; SV types t2tINV: 2; TRA: 1 177 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 34 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
130	1	Upper_Left	AOCS-080	19:15866356−45529483	4, 8	30	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	AOCS−080 Ovary−AdenoCA Cancer type 19:15866356−45529483 Position With other complex events Type 10 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 3; SV types t2tINV: 4; TRA: 11 207 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 30 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 20:15018409−22766306; Linked to chrs
130	2	Upper_Right	AOCS-083	19:3716326−58806899	4, 6	75	{'min_x': 349.67999267578125, 'min_y': 280.6499938964844, 'max_x': 517.0442504882812, 'max_y': 410.42401123046875}	AOCS−083 Ovary−AdenoCA Cancer type 19:3716326−58806899 Position With other complex events Type 37 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 13; DUP: 11; h2hINV: 5; SV types t2tINV: 8; TRA: 5 242 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 75 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 16:4385507−32390908; Linked to chrs
130	3	Lower_Left	AOCS-084	8:124079382−137843454	5, 7	32	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	50 MB 100 MB AOCS−084 Ovary−AdenoCA Cancer type 8:124079382−137843454 Position With other complex events Type 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 1; SV types t2tINV: 3; TRA: 2 146 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 32 CN segments 0.7995907 FDR fragment joints 0 FDR chr. breakp. enrich.
130	4	Lower_Right	AOCS-090	19:36827818−51385886	5, 9	34	{'min_x': 323.29998779296875, 'min_y': 693.2749633789062, 'max_x': 551.26025390625, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB AOCS−090 Ovary−AdenoCA Cancer type 19:36827818−51385886 Position With other complex events Type 14 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 5; DUP: 6; h2hINV: 1; SV types t2tINV: 2; TRA: 1 334 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 34 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
131	1	Upper_Left	AOCS-096	17:6837884−79840758	6, 9	22	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	AOCS−096 Ovary−AdenoCA Cancer type 17:6837884−79840758 Position With other complex events Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 5; SV types t2tINV: 5; TRA: 0 197 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 22 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
131	2	Upper_Right	AOCS-096	19:12910667−55473944	5, 9	43	{'min_x': 324.8599853515625, 'min_y': 276.3299865722656, 'max_x': 541.8719482421875, 'max_y': 410.3340148925781}	AOCS−096 Ovary−AdenoCA Cancer type 19:12910667−55473944 Position With other complex events Type 10 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 2; SV types t2tINV: 1; TRA: 4 197 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 43 CN segments 0.9794281 FDR fragment joints 0 FDR chr. breakp. enrich. 3:967694−180645312;5:129143431−180006097 Linked to chrs
131	3	Lower_Left	AOCS-097	1:15828920−34169833	6, 6	6	{'min_x': 53.76020050048828, 'min_y': 693.2749633789062, 'max_x': 232.99598693847656, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB AOCS−097 Ovary−AdenoCA Cancer type 1:15828920−34169833 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 0 51 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9284301 FDR fragment joints 0.01 FDR chr. breakp. enrich.
131	4	Lower_Right	AOCS-111	19:28894477−56155202	5, 10	54	{'min_x': 336.6099853515625, 'min_y': 693.2749633789062, 'max_x': 528.3197021484375, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB AOCS−111 Ovary−AdenoCA Cancer type 19:28894477−56155202 Position With other complex events Type 36 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 9; DUP: 13; h2hINV: 6; SV types t2tINV: 8; TRA: 3 106 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 54 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
132	1	Upper_Left	AOCS-120	17:3078252−65644573	5, 11	17	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	AOCS−120 Ovary−AdenoCA Cancer type 17:3078252−65644573 Position With other complex events Type 6 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 8 790 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 17 CN segments 0.7735152 FDR fragment joints 0.07 FDR chr. breakp. enrich. 15:40235127−98220741; Linked to chrs
132	2	Upper_Right	AOCS-120	20:24772924−44101646	4, 7	37	{'min_x': 326.20001220703125, 'min_y': 276.3299865722656, 'max_x': 540.531982421875, 'max_y': 410.3340148925781}	AOCS−120 Ovary−AdenoCA Cancer type 20:24772924−44101646 Position With other complex events Type 18 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 3; SV types t2tINV: 2; TRA: 9 790 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 37 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 9:16411704−136399897;X:6640984−97824094 Linked to chrs
132	3	Lower_Left	AOCS-128	1:3190607−179536707	6, 13	64	{'min_x': 61.849998474121094, 'min_y': 693.2749633789062, 'max_x': 226.76182556152344, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB AOCS−128 Ovary−AdenoCA Cancer type 1:3190607−179536707 Position With other complex events Type 37 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 9; DUP: 9; h2hINV: 10; SV types t2tINV: 9; TRA: 10 496 SVs in sample 6, 13 Oscillating CN (2 and 3 states) 64 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
132	4	Lower_Right	AOCS-142	6:73883485−159307243	4, 6	30	{'min_x': 333.32000732421875, 'min_y': 693.2749633789062, 'max_x': 544.5620727539062, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 160 MB AOCS−142 Ovary−AdenoCA Cancer type 6:73883485−159307243 Position With other complex events Type 13 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 8; TRA: 13 587 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 30 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
133	1	Upper_Left	AOCS-142	8:35024834−35538986	4, 11	17	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	AOCS−142 Ovary−AdenoCA Cancer type 8:35024834−35538986 Position With other complex events Type 10 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 5; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 2 587 SVs in sample 4, 11 Oscillating CN (2 and 3 states) 17 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 1:14110378−72283224; Linked to chrs
133	2	Upper_Right	AOCS-142	10:2950088−32730004	4, 5	96	{'min_x': 326.5299987792969, 'min_y': 276.3299865722656, 'max_x': 540.1959838867188, 'max_y': 410.3340148925781}	AOCS−142 Ovary−AdenoCA Cancer type 10:2950088−32730004 Position With other complex events Type 16 Interleaved intrachr. SVs 70 Total SVs (intrachr. + transl.) DEL: 7; DUP: 2; h2hINV: 3; SV types t2tINV: 4; TRA: 54 587 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 96 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 1:14110378−72283224;5:5590317−141885071 Linked to chrs
133	3	Lower_Left	AOCS-155	15:20012055−76793985	5, 7	14	{'min_x': 58.5699348449707, 'min_y': 693.2749633789062, 'max_x': 241.34994506835938, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB 70 MB AOCS−155 Ovary−AdenoCA Cancer type 15:20012055−76793985 Position With other complex events Type 7 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 6 268 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 14 CN segments 0.9865804 FDR fragment joints 0.01 FDR chr. breakp. enrich.
133	4	Lower_Right	AOCS-159	11:8857856−44579253	6, 11	55	{'min_x': 349.1600036621094, 'min_y': 693.2749633789062, 'max_x': 553.36181640625, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB 125 MB AOCS−159 Ovary−AdenoCA Cancer type 11:8857856−44579253 Position With other complex events Type 17 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 6; SV types t2tINV: 4; TRA: 10 259 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 55 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
134	1	Upper_Left	AOCS-159	18:132344−49228552	5, 14	69	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	AOCS−159 Ovary−AdenoCA Cancer type 18:132344−49228552 Position With other complex events Type 30 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 7; DUP: 5; h2hINV: 8; SV types t2tINV: 10; TRA: 13 259 SVs in sample 5, 14 Oscillating CN (2 and 3 states) 69 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
134	2	Upper_Right	AOCS-162	8:84960470−142202378	4, 6	45	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	AOCS−162 Ovary−AdenoCA Cancer type 8:84960470−142202378 Position With other complex events Type 20 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 5; DUP: 7; h2hINV: 3; SV types t2tINV: 5; TRA: 1 172 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 45 CN segments 0.8882853 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
134	3	Lower_Left	AOCS-163	13:55650980−65277402	4, 9	13	{'min_x': 49.66019821166992, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	60 MB 70 MB 80 MB AOCS−163 Ovary−AdenoCA Cancer type 13:55650980−65277402 Position With other complex events Type 7 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 4 152 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 13 CN segments 0.9804396 FDR fragment joints 0 FDR chr. breakp. enrich.
134	4	Lower_Right	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	13:24753200−112130103	6, 12	36	{'min_x': 331.0400085449219, 'min_y': 693.2749633789062, 'max_x': 535.6858520507812, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB 098acb76−0bf5−44e5−bcae−f919cf5fa5e5 Ovary−AdenoCA Cancer type 13:24753200−112130103 Position With other complex events Type 12 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 1; SV types t2tINV: 2; TRA: 1 718 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 36 CN segments 0.615458 FDR fragment joints 0.2 FDR chr. breakp. enrich.
135	1	Upper_Left	15556b28-c6bd-455a-87b6-4b7b3e33d0e4	12:280423−20208244	4, 4	29	{'min_x': 38.210201263427734, 'min_y': 280.6499938964844, 'max_x': 249.51795959472656, 'max_y': 410.3340148925781}	15556b28−c6bd−455a−87b6−4b7b3e33d0e4 Ovary−AdenoCA Cancer type 12:280423−20208244 Position With other complex events Type 20 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 4; SV types t2tINV: 5; TRA: 0 154 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 29 CN segments 0.9625775 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
135	2	Upper_Right	21f6bf91-dfc6-4a59-8b76-88a0f95c7b47	5:12399998−45103030	6, 6	64	{'min_x': 330.8800048828125, 'min_y': 280.6499938964844, 'max_x': 535.8458862304688, 'max_y': 410.3340148925781}	21f6bf91−dfc6−4a59−8b76−88a0f95c7b47 Ovary−AdenoCA Cancer type 5:12399998−45103030 Position With other complex events Type 18 Interleaved intrachr. SVs 46 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 1; SV types t2tINV: 7; TRA: 28 204 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 64 CN segments 0.7198692 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
135	3	Lower_Left	21f6bf91-dfc6-4a59-8b76-88a0f95c7b47	19:30340862−58891648	5, 6	68	{'min_x': 37.03010177612305, 'min_y': 693.2749633789062, 'max_x': 246.34596252441406, 'max_y': 834.6940307617188}	10 MB 20 MB 30 MB 40 MB 50 MB 21f6bf91−dfc6−4a59−8b76−88a0f95c7b47 Ovary−AdenoCA Cancer type 19:30340862−58891648 Position With other complex events Type 24 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 10; DUP: 4; h2hINV: 5; SV types t2tINV: 5; TRA: 23 204 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 68 CN segments 0.6933701 FDR fragment joints 0 FDR chr. breakp. enrich.
135	4	Lower_Right	58d34254-4f5b-40a4-9e9f-7160062fb2a4	12:17804209−25436246	4, 4	15	{'min_x': 330.3699951171875, 'min_y': 693.2749633789062, 'max_x': 536.3538818359375, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 58d34254−4f5b−40a4−9e9f−7160062fb2a4 Ovary−AdenoCA Cancer type 12:17804209−25436246 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 0; TRA: 0 113 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 15 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
136	1	Upper_Left	5c127332-5ca0-45f1-a5ac-4876ad94e491	1:19995601−44453593	5, 8	44	{'min_x': 39.86989974975586, 'min_y': 280.6499938964844, 'max_x': 247.85995483398438, 'max_y': 410.42401123046875}	5c127332−5ca0−45f1−a5ac−4876ad94e491 Ovary−AdenoCA Cancer type 1:19995601−44453593 Position With other complex events Type 14 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 4; DUP: 7; h2hINV: 1; SV types t2tINV: 2; TRA: 15 318 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 44 CN segments 0.6482122 FDR fragment joints 0 FDR chr. breakp. enrich. 5:37201411−40485616; Linked to chrs
136	2	Upper_Right	5c127332-5ca0-45f1-a5ac-4876ad94e491	12:44542331−85299341	4, 5	44	{'min_x': 324.8599853515625, 'min_y': 272.0099792480469, 'max_x': 541.8719482421875, 'max_y': 410.4242248535156}	5c127332−5ca0−45f1−a5ac−4876ad94e491 Ovary−AdenoCA Cancer type 12:44542331−85299341 Position With other complex events Type 7 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 2; TRA: 29 318 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 44 CN segments 0.641841 FDR fragment joints 0 FDR chr. breakp. enrich. 10:4028896−29263432;2:29255147−191672688 5:37201411−40485616;7:1928595−38075627 Linked to chrs
136	3	Lower_Left	62379be5-13f0-474b-94d3-6f944ec4ee96	3:79636893−115666941	5, 7	57	{'min_x': 40.210201263427734, 'min_y': 693.2749633789062, 'max_x': 261.6020202636719, 'max_y': 839.013916015625}	75 MB 100 MB 125 MB 150 MB 175 MB 62379be5−13f0−474b−94d3−6f944ec4ee96 Ovary−AdenoCA Cancer type 3:79636893−115666941 Position With other complex events Type 36 Interleaved intrachr. SVs 48 Total SVs (intrachr. + transl.) DEL: 9; DUP: 12; h2hINV: 7; SV types t2tINV: 8; TRA: 12 216 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 57 CN segments 0.9031749 FDR fragment joints 0 FDR chr. breakp. enrich.
136	4	Lower_Right	6d10d4ee-6331-4bba-93bc-a7b64cc0b22a	6:1989523−147659776	6, 6	28	{'min_x': 309.0899963378906, 'min_y': 693.2749633789062, 'max_x': 557.2323608398438, 'max_y': 839.013916015625}	0 MB 50 MB 100 MB 150 MB 6d10d4ee−6331−4bba−93bc−a7b64cc0b22a Ovary−AdenoCA Cancer type 6:1989523−147659776 Position With other complex events Type 15 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 4; SV types t2tINV: 5; TRA: 3 239 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 28 CN segments 0.9875525 FDR fragment joints 0 FDR chr. breakp. enrich.
137	1	Upper_Left	90f4b65c-cfd4-4066-a5b9-842885c172e2	19:14465820−33816769	5, 6	18	{'min_x': 40.210201263427734, 'min_y': 280.6499938964844, 'max_x': 247.52195739746094, 'max_y': 410.3340148925781}	90f4b65c−cfd4−4066−a5b9−842885c172e2 Ovary−AdenoCA Cancer type 19:14465820−33816769 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 0 163 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 18 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
137	2	Upper_Right	90f4b65c-cfd4-4066-a5b9-842885c172e2	20:85330−26233761	5, 9	72	{'min_x': 329.7099914550781, 'min_y': 280.6499938964844, 'max_x': 537.0219116210938, 'max_y': 410.3340148925781}	90f4b65c−cfd4−4066−a5b9−842885c172e2 Ovary−AdenoCA Cancer type 20:85330−26233761 Position With other complex events Type 52 Interleaved intrachr. SVs 52 Total SVs (intrachr. + transl.) DEL: 12; DUP: 16; h2hINV: 13; SV types t2tINV: 11; TRA: 0 163 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 72 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
137	3	Lower_Left	ee0a4a13-613e-4c5d-96c3-8083a013702d	11:70316616−123074109	6, 15	15	{'min_x': 39.03010177612305, 'min_y': 693.2749633789062, 'max_x': 248.6979522705078, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB ee0a4a13−613e−4c5d−96c3−8083a013702d Ovary−AdenoCA Cancer type 11:70316616−123074109 Position With other complex events Type 8 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 4 173 SVs in sample 6, 15 Oscillating CN (2 and 3 states) 15 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
137	4	Lower_Right	ff530f28-0ec0-4494-bb54-44bb055bae1c	3:96961383−117251520	4, 6	23	{'min_x': 330.0400085449219, 'min_y': 693.2749633789062, 'max_x': 536.6838989257812, 'max_y': 839.013916015625}	50 MB 100 MB ff530f28−0ec0−4494−bb54−44bb055bae1c Ovary−AdenoCA Cancer type 3:96961383−117251520 Position With other complex events Type 10 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 4 170 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 23 CN segments 0.6776251 FDR fragment joints 0.01 FDR chr. breakp. enrich.
138	1	Upper_Left	ff530f28-0ec0-4494-bb54-44bb055bae1c	8:41830249−134064686	6, 6	36	{'min_x': 40.539798736572266, 'min_y': 280.6499938964844, 'max_x': 247.1839599609375, 'max_y': 410.3340148925781}	ff530f28−0ec0−4494−bb54−44bb055bae1c Ovary−AdenoCA Cancer type 8:41830249−134064686 Position With other complex events Type 15 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 1; SV types t2tINV: 3; TRA: 2 170 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 36 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
138	2	Upper_Right	ICGC_0006	4:119147689−190577193	6, 8	14	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	ICGC_0006 Panc−AdenoCA Cancer type 4:119147689−190577193 Position With other complex events Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 2 258 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 14 CN segments 0.9625775 FDR fragment joints 1 FDR chr. breakp. enrich. 2:7594273−219080787; Linked to chrs
138	3	Lower_Left	ICGC_0006	11:3857736−45323041	4, 5	49	{'min_x': 60.18009948730469, 'min_y': 693.2749633789062, 'max_x': 267.190185546875, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB ICGC_0006 Panc−AdenoCA Cancer type 11:3857736−45323041 Position With other complex events Type 46 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 10; DUP: 17; h2hINV: 9; SV types t2tINV: 10; TRA: 1 258 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 49 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
138	4	Lower_Right	ICGC_0009	10:80347920−132334500	5, 6	31	{'min_x': 305.95001220703125, 'min_y': 693.2749633789062, 'max_x': 548.5419311523438, 'max_y': 839.013916015625}	80 MB 90 MB 100 MB 110 MB 120 MB 130 MB ICGC_0009 Panc−AdenoCA Cancer type 10:80347920−132334500 Position With other complex events Type 31 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 5; DUP: 14; h2hINV: 7; SV types t2tINV: 5; TRA: 0 41 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 31 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
139	1	Upper_Left	ICGC_0021	18:394262−19382550	5, 8	42	{'min_x': 60.18009948730469, 'min_y': 280.6499938964844, 'max_x': 227.54379272460938, 'max_y': 410.3340148925781}	ICGC_0021 Panc−AdenoCA Cancer type 18:394262−19382550 Position With other complex events Type 33 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 11; DUP: 2; h2hINV: 11; SV types t2tINV: 9; TRA: 0 162 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 42 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
139	2	Upper_Right	ICGC_0025	7:93519827−153063819	4, 5	7	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	ICGC_0025 Panc−AdenoCA Cancer type 7:93519827−153063819 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 1; TRA: 0 118 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 7 CN segments 0.615458 FDR fragment joints 0.2 FDR chr. breakp. enrich. Linked to chrs
139	3	Lower_Left	ICGC_0026	X:30577518−57551527	4, 8	22	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	40 MB 50 MB ICGC_0026 Panc−AdenoCA Cancer type X:30577518−57551527 Position With other complex events Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 3; SV types t2tINV: 5; TRA: 0 66 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 22 CN segments 0.8066159 FDR fragment joints 0 FDR chr. breakp. enrich.
139	4	Lower_Right	ICGC_0037	13:22638525−90523945	6, 13	13	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB ICGC_0037 Panc−AdenoCA Cancer type 13:22638525−90523945 Position With other complex events Type 7 Interleaved intrachr. SVs 31 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 4; SV types t2tINV: 1; TRA: 24 165 SVs in sample 6, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
140	1	Upper_Left	ICGC_0059	3:78038205−190530121	5, 5	44	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	ICGC_0059 Panc−AdenoCA Cancer type 3:78038205−190530121 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 4; SV types t2tINV: 3; TRA: 0 68 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 44 CN segments 0.9865804 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
140	2	Upper_Right	ICGC_0066	15:23941952−39581480	4, 7	17	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	ICGC_0066 Panc−AdenoCA Cancer type 15:23941952−39581480 Position With other complex events Type 16 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 4; SV types t2tINV: 3; TRA: 1 66 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 17 CN segments 0.930656 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
140	3	Lower_Left	ICGC_0069	15:62553528−96290031	6, 8	26	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 227.5498809814453, 'max_y': 839.013916015625}	70 MB 80 MB 90 MB ICGC_0069 Panc−AdenoCA Cancer type 15:62553528−96290031 Position With other complex events Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 4; SV types t2tINV: 7; TRA: 0 73 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 26 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
140	4	Lower_Right	ICGC_0087	7:17124522−62387137	5, 12	15	{'min_x': 322.1400146484375, 'min_y': 693.2749633789062, 'max_x': 546.2904663085938, 'max_y': 839.013916015625}	20 MB 30 MB 40 MB 50 MB 60 MB ICGC_0087 Panc−AdenoCA Cancer type 7:17124522−62387137 Position With other complex events Type 11 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 3; SV types t2tINV: 2; TRA: 3 79 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 15 CN segments 0.8988396 FDR fragment joints 0 FDR chr. breakp. enrich.
141	1	Upper_Left	ICGC_0087	18:18629528−22549984	5, 5	12	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	ICGC_0087 Panc−AdenoCA Cancer type 18:18629528−22549984 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 0 79 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 12 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
141	2	Upper_Right	ICGC_0103	13:20741975−20956570	6, 7	8	{'min_x': 344.2300109863281, 'min_y': 280.6499938964844, 'max_x': 522.4959716796875, 'max_y': 410.3340148925781}	ICGC_0103 Panc−AdenoCA Cancer type 13:20741975−20956570 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 1 28 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 8 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
141	3	Lower_Left	ICGC_0108	19:793019−40693235	4, 4	34	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 261.01983642578125, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB ICGC_0108 Panc−AdenoCA Cancer type 19:793019−40693235 Position With other complex events Type 14 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 5; SV types t2tINV: 5; TRA: 7 130 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 34 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
141	4	Lower_Right	ICGC_0114	6:92940256−139746601	6, 14	66	{'min_x': 349.5299987792969, 'min_y': 693.2749633789062, 'max_x': 552.3021240234375, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 160 MB ICGC_0114 Panc−AdenoCA Cancer type 6:92940256−139746601 Position With other complex events Type 33 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 7; DUP: 7; h2hINV: 9; SV types t2tINV: 10; TRA: 3 195 SVs in sample 6, 14 Oscillating CN (2 and 3 states) 66 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
142	1	Upper_Left	ICGC_0115	16:3802028−23118217	4, 5	26	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	ICGC_0115 Panc−AdenoCA Cancer type 16:3802028−23118217 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 5; TRA: 0 104 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 26 CN segments 0.7995907 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
142	2	Upper_Right	ICGC_0149	8:39662139−131797224	6, 7	59	{'min_x': 348.010009765625, 'min_y': 280.6499938964844, 'max_x': 518.72021484375, 'max_y': 410.3340148925781}	ICGC_0149 Panc−AdenoCA Cancer type 8:39662139−131797224 Position With other complex events Type 63 Interleaved intrachr. SVs 63 Total SVs (intrachr. + transl.) DEL: 16; DUP: 18; h2hINV: 11; SV types t2tINV: 18; TRA: 0 238 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 59 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
142	3	Lower_Left	ICGC_0150	19:14991068−24021988	5, 10	17	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 226.86004638671875, 'max_y': 839.013916015625}	20 MB 30 MB 40 MB 50 MB ICGC_0150 Panc−AdenoCA Cancer type 19:14991068−24021988 Position With other complex events Type 8 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 3; SV types t2tINV: 1; TRA: 4 115 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 17 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
142	4	Lower_Right	ICGC_0207	7:121034912−151110416	6, 6	6	{'min_x': 344.2300109863281, 'min_y': 693.2749633789062, 'max_x': 551.89208984375, 'max_y': 839.013916015625}	130 MB 140 MB 150 MB ICGC_0207 Panc−AdenoCA Cancer type 7:121034912−151110416 Position Canonical without polyploidization Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 0 27 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
143	1	Upper_Left	ICGC_0224	14:61112011−65419128	5, 9	9	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	ICGC_0224 Panc−AdenoCA Cancer type 14:61112011−65419128 Position With other complex events Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 3; SV types t2tINV: 1; TRA: 0 76 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
143	2	Upper_Right	ICGC_0296	18:350045−21877313	5, 11	15	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	ICGC_0296 Panc−AdenoCA Cancer type 18:350045−21877313 Position With other complex events Type 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 4 115 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 15 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
143	3	Lower_Left	ICGC_0300	13:27875998−52774140	5, 5	12	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 247.07997131347656, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB ICGC_0300 Panc−AdenoCA Cancer type 13:27875998−52774140 Position With other complex events Type 7 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 3 68 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 12 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
143	4	Lower_Right	ICGC_0301	18:25572442−75675714	4, 4	18	{'min_x': 327.8699951171875, 'min_y': 693.2749633789062, 'max_x': 532.3204345703125, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB 70 MB ICGC_0301 Panc−AdenoCA Cancer type 18:25572442−75675714 Position With other complex events Type 15 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 4; SV types t2tINV: 3; TRA: 1 27 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 18 CN segments 0.9501265 FDR fragment joints 0 FDR chr. breakp. enrich.
144	1	Upper_Left	ICGC_0303	2:10700671−144337304	4, 6	18	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	ICGC_0303 Panc−AdenoCA Cancer type 2:10700671−144337304 Position With other complex events Type 7 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 0; TRA: 7 132 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 18 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 1:109159140−230863765; Linked to chrs
144	2	Upper_Right	ICGC_0304	18:1490133−31586695	5, 5	17	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	ICGC_0304 Panc−AdenoCA Cancer type 18:1490133−31586695 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 0 55 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 17 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
144	3	Lower_Left	ICGC_0393	22:18789020−50349275	5, 7	51	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 266.4100646972656, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB ICGC_0393 Panc−AdenoCA Cancer type 22:18789020−50349275 Position With other complex events Type 22 Interleaved intrachr. SVs 62 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 6; SV types t2tINV: 5; TRA: 40 158 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 51 CN segments 0.8249489 FDR fragment joints 0 FDR chr. breakp. enrich.
144	4	Lower_Right	ICGC_0395	7:86041901−153362571	5, 5	24	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 546.3920288085938, 'max_y': 839.013916015625}	60 MB 90 MB 120 MB 150 MB ICGC_0395 Panc−AdenoCA Cancer type 7:86041901−153362571 Position With other complex events Type 11 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 2; SV types t2tINV: 1; TRA: 5 87 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 24 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
145	1	Upper_Left	ICGC_0502	5:23468779−45905623	5, 5	5	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.3340148925781}	ICGC_0502 Panc−AdenoCA Cancer type 5:23468779−45905623 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 120 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.9625775 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
145	2	Upper_Right	ICGC_0521	4:131685289−183295953	5, 16	16	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	ICGC_0521 Panc−AdenoCA Cancer type 4:131685289−183295953 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 0 107 SVs in sample 5, 16 Oscillating CN (2 and 3 states) 16 CN segments 0.6776251 FDR fragment joints 0.12 FDR chr. breakp. enrich. Linked to chrs
145	3	Lower_Left	ICGC_0522	1:35264067−46448813	4, 6	13	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 269.66192626953125, 'max_y': 839.013916015625}	60 MB 80 MB 100 MB 120 MB ICGC_0522 Panc−AdenoCA Cancer type 1:35264067−46448813 Position With other complex events Type 7 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 5 80 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 13 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
145	4	Lower_Right	ICGC_0526	6:11005830−53074096	4, 6	28	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	50 MB 100 MB ICGC_0526 Panc−AdenoCA Cancer type 6:11005830−53074096 Position With other complex events Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 5; SV types t2tINV: 5; TRA: 0 127 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 28 CN segments 0.8653243 FDR fragment joints 0.01 FDR chr. breakp. enrich.
146	1	Upper_Left	ICGC_0535	10:89522467−110477428	5, 8	8	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.3340148925781}	ICGC_0535 Panc−AdenoCA Cancer type 10:89522467−110477428 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 1 102 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.9599662 FDR fragment joints 0.1 FDR chr. breakp. enrich. Linked to chrs
146	2	Upper_Right	ICGC_0535	18:896558−21110916	4, 7	18	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	ICGC_0535 Panc−AdenoCA Cancer type 18:896558−21110916 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 2; SV types t2tINV: 2; TRA: 0 102 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 18 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
146	3	Lower_Left	ICGC_0535	X:141345603−144825631	5, 7	7	{'min_x': 53.650001525878906, 'min_y': 693.2749633789062, 'max_x': 232.99598693847656, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB ICGC_0535 Panc−AdenoCA Cancer type X:141345603−144825631 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 0 102 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
146	4	Lower_Right	ICGC_0543	9:187480−137300565	6, 10	32	{'min_x': 309.1099853515625, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	0 MB 50 MB 100 MB ICGC_0543 Panc−AdenoCA Cancer type 9:187480−137300565 Position With other complex events Type 14 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 5; SV types t2tINV: 5; TRA: 2 161 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 32 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
147	1	Upper_Left	ICGC_0543	20:15750921−60842706	6, 7	19	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	ICGC_0543 Panc−AdenoCA Cancer type 20:15750921−60842706 Position With other complex events Type 18 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 8; DUP: 2; h2hINV: 5; SV types t2tINV: 3; TRA: 1 161 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 19 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
147	2	Upper_Right	PCSI_0001	18:18631561−76740272	4, 5	32	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	PCSI_0001 Panc−AdenoCA Cancer type 18:18631561−76740272 Position With other complex events Type 22 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 6; SV types t2tINV: 9; TRA: 0 37 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 32 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
147	3	Lower_Left	PCSI_0015	4:10893126−58422207	5, 7	29	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 260.6220397949219, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 160 MB PCSI_0015 Panc−AdenoCA Cancer type 4:10893126−58422207 Position With other complex events Type 26 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 9; DUP: 5; h2hINV: 6; SV types t2tINV: 6; TRA: 9 541 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 29 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
147	4	Lower_Right	PCSI_0044	6:2763282−35849850	5, 8	18	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 530.8800659179688, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB PCSI_0044 Panc−AdenoCA Cancer type 6:2763282−35849850 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 0 98 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 18 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
148	1	Upper_Left	PCSI_0044	12:46852610−65968411	5, 8	22	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	PCSI_0044 Panc−AdenoCA Cancer type 12:46852610−65968411 Position With other complex events Type 9 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 0; TRA: 19 98 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 22 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 18:42542834−54212828; Linked to chrs
148	2	Upper_Right	PCSI_0044	18:42542834−54212829	6, 10	30	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	PCSI_0044 Panc−AdenoCA Cancer type 18:42542834−54212829 Position With other complex events Type 15 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 5; SV types t2tINV: 4; TRA: 13 98 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 30 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 12:46852610−65968410; Linked to chrs
148	3	Lower_Left	PCSI_0077	9:32610603−37173324	5, 6	19	{'min_x': 55.36989974975586, 'min_y': 693.2749633789062, 'max_x': 260.9299621582031, 'max_y': 839.013916015625}	33 MB 34 MB 35 MB 36 MB 37 MB PCSI_0077 Panc−AdenoCA Cancer type 9:32610603−37173324 Position With other complex events Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 2 74 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 19 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
148	4	Lower_Right	PCSI_0077	18:6803844−24203012	5, 6	18	{'min_x': 349.8699951171875, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	10 MB 15 MB 20 MB PCSI_0077 Panc−AdenoCA Cancer type 18:6803844−24203012 Position With other complex events Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 4; SV types t2tINV: 2; TRA: 0 74 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 18 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
149	1	Upper_Left	PCSI_0078	18:49556708−77332270	4, 7	15	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	PCSI_0078 Panc−AdenoCA Cancer type 18:49556708−77332270 Position With other complex events Type 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 4; TRA: 1 101 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 15 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
149	2	Upper_Right	PCSI_0081	5:145519578−179491764	4, 5	8	{'min_x': 349.67999267578125, 'min_y': 280.6499938964844, 'max_x': 517.0442504882812, 'max_y': 410.42401123046875}	PCSI_0081 Panc−AdenoCA Cancer type 5:145519578−179491764 Position With other complex events Type 50 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 14; DUP: 17; h2hINV: 9; SV types t2tINV: 10; TRA: 4 195 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 8 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 19:33279297−57149842; Linked to chrs
149	3	Lower_Left	PCSI_0081	20:5377429−36576271	5, 13	31	{'min_x': 37.68980026245117, 'min_y': 693.2749633789062, 'max_x': 271.0401916503906, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB 60 MB PCSI_0081 Panc−AdenoCA Cancer type 20:5377429−36576271 Position With other complex events Type 20 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 5; SV types t2tINV: 4; TRA: 0 195 SVs in sample 5, 13 Oscillating CN (2 and 3 states) 31 CN segments 0.9625775 FDR fragment joints 0 FDR chr. breakp. enrich.
149	4	Lower_Right	PCSI_0082	12:10809610−87566605	4, 6	19	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 538.2198486328125, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB PCSI_0082 Panc−AdenoCA Cancer type 12:10809610−87566605 Position With other complex events Type 7 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 4 160 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 19 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
150	1	Upper_Left	PCSI_0082	18:1716536−32009794	5, 13	36	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	PCSI_0082 Panc−AdenoCA Cancer type 18:1716536−32009794 Position With other complex events Type 17 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 8; h2hINV: 2; SV types t2tINV: 4; TRA: 1 160 SVs in sample 5, 13 Oscillating CN (2 and 3 states) 36 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
150	2	Upper_Right	PCSI_0086	18:1082109−77329138	5, 7	7	{'min_x': 344.2300109863281, 'min_y': 280.6499938964844, 'max_x': 522.4959716796875, 'max_y': 410.3340148925781}	PCSI_0086 Panc−AdenoCA Cancer type 18:1082109−77329138 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 0 23 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
150	3	Lower_Left	PCSI_0101	22:17987673−43447488	4, 7	30	{'min_x': 36.21989822387695, 'min_y': 693.2749633789062, 'max_x': 237.7197265625, 'max_y': 839.013916015625}	20 MB 25 MB 30 MB 35 MB 40 MB PCSI_0101 Panc−AdenoCA Cancer type 22:17987673−43447488 Position With other complex events Type 22 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 2; DUP: 7; h2hINV: 5; SV types t2tINV: 8; TRA: 0 202 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 30 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
150	4	Lower_Right	PCSI_0105	3:33556195−40791777	4, 16	18	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 554.52001953125, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB PCSI_0105 Panc−AdenoCA Cancer type 3:33556195−40791777 Position With other complex events Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 3; SV types t2tINV: 5; TRA: 1 91 SVs in sample 4, 16 Oscillating CN (2 and 3 states) 18 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
151	1	Upper_Left	PCSI_0105	13:34326449−109417492	5, 5	34	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	PCSI_0105 Panc−AdenoCA Cancer type 13:34326449−109417492 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 4; TRA: 0 91 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 34 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
151	2	Upper_Right	PCSI_0111	6:104571922−165438064	6, 11	37	{'min_x': 348.010009765625, 'min_y': 280.6499938964844, 'max_x': 518.72021484375, 'max_y': 410.42401123046875}	PCSI_0111 Panc−AdenoCA Cancer type 6:104571922−165438064 Position With other complex events Type 42 Interleaved intrachr. SVs 46 Total SVs (intrachr. + transl.) DEL: 10; DUP: 10; h2hINV: 11; SV types t2tINV: 11; TRA: 4 260 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 37 CN segments 0.9599662 FDR fragment joints 0 FDR chr. breakp. enrich. 3:35128015−182834758; Linked to chrs
151	3	Lower_Left	PCSI_0145	3:76628774−82950282	5, 8	23	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB PCSI_0145 Panc−AdenoCA Cancer type 3:76628774−82950282 Position With other complex events Type 11 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 0; SV types t2tINV: 4; TRA: 13 550 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 23 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
151	4	Lower_Right	PCSI_0145	8:19058905−142399781	4, 9	41	{'min_x': 323.19000244140625, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 834.6940307617188}	50 MB 100 MB PCSI_0145 Panc−AdenoCA Cancer type 8:19058905−142399781 Position With other complex events Type 11 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 24 550 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 41 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
152	1	Upper_Left	PCSI_0145	18:3500844−76201208	6, 13	28	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	PCSI_0145 Panc−AdenoCA Cancer type 18:3500844−76201208 Position With other complex events Type 21 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 8; DUP: 6; h2hINV: 3; SV types t2tINV: 4; TRA: 7 550 SVs in sample 6, 13 Oscillating CN (2 and 3 states) 28 CN segments 0.8066159 FDR fragment joints 0 FDR chr. breakp. enrich. 13:62732753−113705989; Linked to chrs
152	2	Upper_Right	PCSI_0145	19:8923906−46548614	4, 6	41	{'min_x': 323.19000244140625, 'min_y': 276.3299865722656, 'max_x': 543.5379638671875, 'max_y': 410.3340148925781}	PCSI_0145 Panc−AdenoCA Cancer type 19:8923906−46548614 Position With other complex events Type 7 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 26 550 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 41 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 14:32259593−106721662;3:76628774−82950281 Linked to chrs
152	3	Lower_Left	PCSI_0162	16:33791525−89932613	4, 7	23	{'min_x': 43.5, 'min_y': 693.2749633789062, 'max_x': 269.2402038574219, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 70 MB 80 MB 90 MB PCSI_0162 Panc−AdenoCA Cancer type 16:33791525−89932613 Position With other complex events Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 1 66 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 23 CN segments 0.9723381 FDR fragment joints 0 FDR chr. breakp. enrich.
152	4	Lower_Right	PCSI_0173	5:9311584−45281354	5, 9	21	{'min_x': 309.3999938964844, 'min_y': 693.2749633789062, 'max_x': 554.0221557617188, 'max_y': 839.013916015625}	0 MB 40 MB 80 MB 120 MB 160 MB PCSI_0173 Panc−AdenoCA Cancer type 5:9311584−45281354 Position With other complex events Type 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 3; TRA: 1 140 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 21 CN segments 0.8653243 FDR fragment joints 0.01 FDR chr. breakp. enrich.
153	1	Upper_Left	PCSI_0173	18:10487843−54651877	6, 7	22	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	PCSI_0173 Panc−AdenoCA Cancer type 18:10487843−54651877 Position With other complex events Type 9 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 1 140 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 22 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
153	2	Upper_Right	PCSI_0208	17:27512548−52837653	6, 6	17	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	PCSI_0208 Panc−AdenoCA Cancer type 17:27512548−52837653 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 0 27 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 17 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
153	3	Lower_Left	PCSI_0210	3:161515687−194895663	4, 8	35	{'min_x': 60.18009948730469, 'min_y': 693.2749633789062, 'max_x': 227.5441131591797, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB PCSI_0210 Panc−AdenoCA Cancer type 3:161515687−194895663 Position With other complex events Type 45 Interleaved intrachr. SVs 47 Total SVs (intrachr. + transl.) DEL: 12; DUP: 12; h2hINV: 9; SV types t2tINV: 12; TRA: 2 194 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 35 CN segments 0.9625775 FDR fragment joints 0 FDR chr. breakp. enrich.
153	4	Lower_Right	PCSI_0210	8:33791127−43503910	4, 6	30	{'min_x': 346.7799987792969, 'min_y': 693.2749633789062, 'max_x': 550.5919799804688, 'max_y': 839.013916015625}	50 MB 75 MB 100 MB 125 MB PCSI_0210 Panc−AdenoCA Cancer type 8:33791127−43503910 Position With other complex events Type 15 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 3; SV types t2tINV: 4; TRA: 6 194 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 30 CN segments 0.7568568 FDR fragment joints 0 FDR chr. breakp. enrich.
154	1	Upper_Left	PCSI_0230	18:29885709−75219927	5, 13	20	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	PCSI_0230 Panc−AdenoCA Cancer type 18:29885709−75219927 Position With other complex events Type 8 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 4; SV types t2tINV: 2; TRA: 2 235 SVs in sample 5, 13 Oscillating CN (2 and 3 states) 20 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
154	2	Upper_Right	PCSI_0233	8:32367518−100716200	6, 15	19	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	PCSI_0233 Panc−AdenoCA Cancer type 8:32367518−100716200 Position With other complex events Type 6 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 9 71 SVs in sample 6, 15 Oscillating CN (2 and 3 states) 19 CN segments 0.6471662 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
154	3	Lower_Left	PCSI_0240	21:23137397−41798616	6, 10	18	{'min_x': 40.539798736572266, 'min_y': 693.2749633789062, 'max_x': 235.4998016357422, 'max_y': 839.013916015625}	20 MB 25 MB 30 MB 35 MB 40 MB PCSI_0240 Panc−AdenoCA Cancer type 21:23137397−41798616 Position With other complex events Type 8 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 9 65 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 18 CN segments 0.930656 FDR fragment joints 0 FDR chr. breakp. enrich.
154	4	Lower_Right	PCSI_0261	2:143484174−151012579	4, 8	10	{'min_x': 308.17999267578125, 'min_y': 693.2749633789062, 'max_x': 520.8118286132812, 'max_y': 839.013916015625}	0 MB 50 MB 100 MB 150 MB 200 MB PCSI_0261 Panc−AdenoCA Cancer type 2:143484174−151012579 Position With other complex events Type 7 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 6 382 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 10 CN segments 0.9000538 FDR fragment joints 0.03 FDR chr. breakp. enrich.
155	1	Upper_Left	PCSI_0261	5:55427909−147893239	4, 13	19	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	PCSI_0261 Panc−AdenoCA Cancer type 5:55427909−147893239 Position With other complex events Type 18 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 6; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 8 382 SVs in sample 4, 13 Oscillating CN (2 and 3 states) 19 CN segments 0.7510435 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
155	2	Upper_Right	PCSI_0261	8:47403900−133181064	4, 11	18	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	PCSI_0261 Panc−AdenoCA Cancer type 8:47403900−133181064 Position With other complex events Type 7 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 4 382 SVs in sample 4, 11 Oscillating CN (2 and 3 states) 18 CN segments 0.8653243 FDR fragment joints 0.66 FDR chr. breakp. enrich. 12:34059230−90708383; Linked to chrs
155	3	Lower_Left	PCSI_0268	1:1109651−22405832	4, 5	34	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 266.0118103027344, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB PCSI_0268 Panc−AdenoCA Cancer type 1:1109651−22405832 Position With other complex events Type 7 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 0; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 7 104 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 34 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
155	4	Lower_Right	PCSI_0279	22:18521810−51136116	6, 8	16	{'min_x': 317.95001220703125, 'min_y': 693.2749633789062, 'max_x': 550.419921875, 'max_y': 839.013916015625}	20 MB 30 MB 40 MB 50 MB PCSI_0279 Panc−AdenoCA Cancer type 22:18521810−51136116 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 57 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 16 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich.
156	1	Upper_Left	PCSI_0281	5:75405316−169709323	4, 5	8	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	PCSI_0281 Panc−AdenoCA Cancer type 5:75405316−169709323 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 4; SV types t2tINV: 2; TRA: 0 85 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 8 CN segments 0.9000538 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
156	2	Upper_Right	PCSI_0281	18:18569763−26413726	4, 6	22	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	PCSI_0281 Panc−AdenoCA Cancer type 18:18569763−26413726 Position With other complex events Type 16 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 8; SV types t2tINV: 5; TRA: 0 85 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 22 CN segments 0.4637733 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
156	3	Lower_Left	PCSI_0284	8:25945162−132424548	4, 7	68	{'min_x': 60.18009948730469, 'min_y': 693.2749633789062, 'max_x': 254.82196044921875, 'max_y': 839.013916015625}	50 MB 75 MB 100 MB 125 MB PCSI_0284 Panc−AdenoCA Cancer type 8:25945162−132424548 Position With other complex events Type 40 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 14; DUP: 8; h2hINV: 10; SV types t2tINV: 8; TRA: 2 238 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 68 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
156	4	Lower_Right	PCSI_0285	17:57949419−61791871	4, 8	50	{'min_x': 318.4100036621094, 'min_y': 693.2749633789062, 'max_x': 559.1299438476562, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB PCSI_0285 Panc−AdenoCA Cancer type 17:57949419−61791871 Position With other complex events Type 63 Interleaved intrachr. SVs 70 Total SVs (intrachr. + transl.) DEL: 21; DUP: 14; h2hINV: 13; SV types t2tINV: 15; TRA: 7 446 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 50 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
157	1	Upper_Left	PCSI_0287	11:31044158−45136475	5, 5	5	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.3340148925781}	PCSI_0287 Panc−AdenoCA Cancer type 11:31044158−45136475 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 152 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.9599662 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
157	2	Upper_Right	PCSI_0290	8:42316395−146260778	4, 9	14	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	PCSI_0290 Panc−AdenoCA Cancer type 8:42316395−146260778 Position With other complex events Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 0; TRA: 2 137 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 14 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 11:55509544−78804415; Linked to chrs
157	3	Lower_Left	PCSI_0290	18:1700778−25341902	5, 10	56	{'min_x': 52.01020050048828, 'min_y': 693.2749633789062, 'max_x': 264.81005859375, 'max_y': 839.013916015625}	5 MB 10 MB 15 MB 20 MB 25 MB PCSI_0290 Panc−AdenoCA Cancer type 18:1700778−25341902 Position With other complex events Type 32 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 9; DUP: 8; h2hINV: 8; SV types t2tINV: 7; TRA: 7 137 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 56 CN segments 0.952954 FDR fragment joints 0 FDR chr. breakp. enrich.
157	4	Lower_Right	PCSI_0300	7:139885932−159081404	6, 13	46	{'min_x': 342.3399963378906, 'min_y': 693.2749633789062, 'max_x': 562.6823120117188, 'max_y': 839.013916015625}	80 MB 100 MB 120 MB 140 MB 160 MB PCSI_0300 Panc−AdenoCA Cancer type 7:139885932−159081404 Position With other complex events Type 35 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 9; DUP: 9; h2hINV: 9; SV types t2tINV: 8; TRA: 1 208 SVs in sample 6, 13 Oscillating CN (2 and 3 states) 46 CN segments 0.9875525 FDR fragment joints 0 FDR chr. breakp. enrich.
158	1	Upper_Left	PCSI_0300	12:24383751−68089214	6, 7	72	{'min_x': 58.51020050048828, 'min_y': 280.6499938964844, 'max_x': 229.22010803222656, 'max_y': 410.3340148925781}	PCSI_0300 Panc−AdenoCA Cancer type 12:24383751−68089214 Position With other complex events Type 76 Interleaved intrachr. SVs 78 Total SVs (intrachr. + transl.) DEL: 17; DUP: 21; h2hINV: 22; SV types t2tINV: 16; TRA: 2 208 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 72 CN segments 0.7027324 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
158	2	Upper_Right	PCSI_0324	8:78094013−140299410	6, 6	6	{'min_x': 344.2300109863281, 'min_y': 280.6499938964844, 'max_x': 522.4959716796875, 'max_y': 410.3340148925781}	PCSI_0324 Panc−AdenoCA Cancer type 8:78094013−140299410 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 0; DUP: 5; h2hINV: 2; SV types t2tINV: 1; TRA: 0 204 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.5435077 FDR fragment joints 0.23 FDR chr. breakp. enrich. Linked to chrs
158	3	Lower_Left	PCSI_0325	3:85734262−174611972	6, 6	85	{'min_x': 58.51020050048828, 'min_y': 693.2749633789062, 'max_x': 229.22010803222656, 'max_y': 839.013916015625}	90 MB 120 MB 150 MB PCSI_0325 Panc−AdenoCA Cancer type 3:85734262−174611972 Position With other complex events Type 56 Interleaved intrachr. SVs 59 Total SVs (intrachr. + transl.) DEL: 15; DUP: 13; h2hINV: 16; SV types t2tINV: 12; TRA: 3 207 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 85 CN segments 0.9589247 FDR fragment joints 0 FDR chr. breakp. enrich.
158	4	Lower_Right	PCSI_0337	9:16003998−24326188	6, 7	20	{'min_x': 307.4599914550781, 'min_y': 693.2749633789062, 'max_x': 549.4198608398438, 'max_y': 839.013916015625}	16 MB 18 MB 20 MB 22 MB 24 MB PCSI_0337 Panc−AdenoCA Cancer type 9:16003998−24326188 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 4; SV types t2tINV: 3; TRA: 0 54 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 20 CN segments 0.9000538 FDR fragment joints 0 FDR chr. breakp. enrich.
159	1	Upper_Left	PCSI_0337	19:11827395−17911949	4, 5	8	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	PCSI_0337 Panc−AdenoCA Cancer type 19:11827395−17911949 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 0 54 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 8 CN segments 0.9599662 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
159	2	Upper_Right	PCSI_0340	2:3167627−206554663	5, 7	38	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	PCSI_0340 Panc−AdenoCA Cancer type 2:3167627−206554663 Position With other complex events Type 14 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 6; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 8 237 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 38 CN segments 0.5435077 FDR fragment joints 0.06 FDR chr. breakp. enrich. Linked to chrs
159	3	Lower_Left	PCSI_0345	19:21513068−58739452	6, 8	17	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB PCSI_0345 Panc−AdenoCA Cancer type 19:21513068−58739452 Position With other complex events Type 11 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 5; SV types t2tINV: 4; TRA: 13 92 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 17 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
159	4	Lower_Right	PCSI_0347	1:73507136−231782377	6, 9	26	{'min_x': 340.4700012207031, 'min_y': 693.2749633789062, 'max_x': 562.3920288085938, 'max_y': 839.013916015625}	100 MB 150 MB 200 MB 250 MB PCSI_0347 Panc−AdenoCA Cancer type 1:73507136−231782377 Position With other complex events Type 12 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 1; SV types t2tINV: 2; TRA: 7 63 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 26 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
160	1	Upper_Left	PCSI_0352	6:40037807−56846580	6, 12	29	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	PCSI_0352 Panc−AdenoCA Cancer type 6:40037807−56846580 Position With other complex events Type 6 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 1; SV types t2tINV: 3; TRA: 8 72 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 29 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 14:20953269−101623828; Linked to chrs
160	2	Upper_Right	PCSI_0353	6:31811163−53484589	5, 17	17	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	PCSI_0353 Panc−AdenoCA Cancer type 6:31811163−53484589 Position With other complex events Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 6; SV types t2tINV: 6; TRA: 0 105 SVs in sample 5, 17 Oscillating CN (2 and 3 states) 17 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
160	3	Lower_Left	PCSI_0353	14:20259866−102375473	5, 9	58	{'min_x': 61.849998474121094, 'min_y': 693.2749633789062, 'max_x': 264.23211669921875, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB PCSI_0353 Panc−AdenoCA Cancer type 14:20259866−102375473 Position With other complex events Type 38 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 8; DUP: 9; h2hINV: 12; SV types t2tINV: 9; TRA: 2 105 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 58 CN segments 0.9109641 FDR fragment joints 0 FDR chr. breakp. enrich.
160	4	Lower_Right	PCSI_0356	12:31165322−84134078	5, 9	22	{'min_x': 346.04998779296875, 'min_y': 693.2749633789062, 'max_x': 540.4602661132812, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 70 MB 80 MB PCSI_0356 Panc−AdenoCA Cancer type 12:31165322−84134078 Position With other complex events Type 10 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 1; DUP: 4; h2hINV: 2; SV types t2tINV: 3; TRA: 2 228 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 22 CN segments 0.6776251 FDR fragment joints 0.07 FDR chr. breakp. enrich.
161	1	Upper_Left	PCSI_0356	18:1947225−25427315	6, 6	26	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	PCSI_0356 Panc−AdenoCA Cancer type 18:1947225−25427315 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 4; SV types t2tINV: 2; TRA: 0 228 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 26 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
161	2	Upper_Right	PCSI_0392	6:8838119−69082829	5, 6	57	{'min_x': 351.3500061035156, 'min_y': 280.6499938964844, 'max_x': 515.3779296875, 'max_y': 410.3340148925781}	PCSI_0392 Panc−AdenoCA Cancer type 6:8838119−69082829 Position With other complex events Type 34 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 5; DUP: 9; h2hINV: 13; SV types t2tINV: 7; TRA: 2 160 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 57 CN segments 0.641841 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
161	3	Lower_Left	PCSI_0392	8:95993359−135574872	6, 17	37	{'min_x': 61.849998474121094, 'min_y': 693.2749633789062, 'max_x': 225.87779235839844, 'max_y': 839.013916015625}	50 MB 100 MB PCSI_0392 Panc−AdenoCA Cancer type 8:95993359−135574872 Position With other complex events Type 27 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 5; DUP: 11; h2hINV: 5; SV types t2tINV: 6; TRA: 1 160 SVs in sample 6, 17 Oscillating CN (2 and 3 states) 37 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
161	4	Lower_Right	PCSI_0392	18:20260488−25314382	4, 7	15	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 551.7301025390625, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB PCSI_0392 Panc−AdenoCA Cancer type 18:20260488−25314382 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 5; SV types t2tINV: 4; TRA: 0 160 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 15 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
162	1	Upper_Left	PCSI_0450	19:34867315−47884220	4, 6	37	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	PCSI_0450 Panc−AdenoCA Cancer type 19:34867315−47884220 Position With other complex events Type 20 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 8; DUP: 2; h2hINV: 7; SV types t2tINV: 3; TRA: 5 80 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 37 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
162	2	Upper_Right	PCSI_0450	X:9534069−137725602	6, 6	6	{'min_x': 344.2300109863281, 'min_y': 280.6499938964844, 'max_x': 522.4959716796875, 'max_y': 410.3340148925781}	PCSI_0450 Panc−AdenoCA Cancer type X:9534069−137725602 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 0 80 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.6776251 FDR fragment joints 0.55 FDR chr. breakp. enrich. Linked to chrs
162	3	Lower_Left	PCSI_0453	17:26321720−77389422	6, 25	25	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 266.840087890625, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 70 MB 80 MB PCSI_0453 Panc−AdenoCA Cancer type 17:26321720−77389422 Position With other complex events Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 2 102 SVs in sample 6, 25 Oscillating CN (2 and 3 states) 25 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
162	4	Lower_Right	PCSI_0456	18:52279996−66883860	6, 11	21	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 533.0704956054688, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB PCSI_0456 Panc−AdenoCA Cancer type 18:52279996−66883860 Position With other complex events Type 12 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 3; TRA: 3 99 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 21 CN segments 0.8462769 FDR fragment joints 0 FDR chr. breakp. enrich.
163	1	Upper_Left	PCSI_0468	9:5835505−36865594	5, 12	12	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	PCSI_0468 Panc−AdenoCA Cancer type 9:5835505−36865594 Position With other complex events Type 8 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 11 105 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
163	2	Upper_Right	PCSI_0472	3:13788797−189021715	5, 9	20	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	PCSI_0472 Panc−AdenoCA Cancer type 3:13788797−189021715 Position With other complex events Type 12 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 4; SV types t2tINV: 2; TRA: 6 238 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 20 CN segments 0.8653243 FDR fragment joints 0.01 FDR chr. breakp. enrich. 10:28947349−34511967; Linked to chrs
163	3	Lower_Left	PCSI_0528	17:63528018−67790466	4, 7	14	{'min_x': 57.06019973754883, 'min_y': 693.2749633789062, 'max_x': 227.31985473632812, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB PCSI_0528 Panc−AdenoCA Cancer type 17:63528018−67790466 Position With other complex events Type 24 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 9; DUP: 5; h2hINV: 5; SV types t2tINV: 5; TRA: 0 76 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 14 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
163	4	Lower_Right	PCSI_0531	18:9032446−50330464	6, 8	17	{'min_x': 312.8900146484375, 'min_y': 693.2749633789062, 'max_x': 556.6103515625, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB PCSI_0531 Panc−AdenoCA Cancer type 18:9032446−50330464 Position With other complex events Type 8 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 3 96 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 17 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
164	1	Upper_Left	PCSI_0572	1:107128798−114787742	5, 5	5	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	PCSI_0572 Panc−AdenoCA Cancer type 1:107128798−114787742 Position With other complex events Type 6 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 0; SV types t2tINV: 1; TRA: 4 86 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 2:21945480−110876000; Linked to chrs
164	2	Upper_Right	ITNET-0134	8:80326174−145581514	4, 4	4	{'min_x': 344.2300109863281, 'min_y': 280.6499938964844, 'max_x': 522.4959716796875, 'max_y': 410.3340148925781}	ITNET−0134 Panc−Endocrine Cancer type 8:80326174−145581514 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 4 55 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 4 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
164	3	Lower_Left	ITNET-1047	9:29933578−36500038	4, 7	18	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	50 MB 100 MB ITNET−1047 Panc−Endocrine Cancer type 9:29933578−36500038 Position With other complex events Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 245 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 18 CN segments 0.9723381 FDR fragment joints 0 FDR chr. breakp. enrich.
164	4	Lower_Right	ITNET-1047	11:48710192−61425002	6, 10	10	{'min_x': 331.6300048828125, 'min_y': 693.2749633789062, 'max_x': 554.6800537109375, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB 70 MB ITNET−1047 Panc−Endocrine Cancer type 11:48710192−61425002 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 1 245 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich.
165	1	Upper_Left	EOPC-022	2:25811734−39390809	4, 4	4	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.42401123046875}	EOPC−022 Prost−AdenoCA Cancer type 2:25811734−39390809 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 5; TRA: 15 46 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 4 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 1:100218185−116714121; Linked to chrs
165	2	Upper_Right	EOPC-030	12:9146108−106049040	5, 12	12	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	EOPC−030 Prost−AdenoCA Cancer type 12:9146108−106049040 Position With other complex events Type 7 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 0; TRA: 14 116 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.7568568 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
165	3	Lower_Left	EOPC-030	13:22615390−105145326	6, 11	11	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 256.52197265625, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB EOPC−030 Prost−AdenoCA Cancer type 13:22615390−105145326 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 5; DUP: 1; h2hINV: 3; SV types t2tINV: 3; TRA: 0 116 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
165	4	Lower_Right	EOPC-041	2:20591505−103430435	5, 9	25	{'min_x': 346.2200012207031, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB EOPC−041 Prost−AdenoCA Cancer type 2:20591505−103430435 Position With other complex events Type 16 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 4; SV types t2tINV: 4; TRA: 20 131 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 25 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
166	1	Upper_Left	EOPC-041	8:14804569−76501181	4, 9	33	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	EOPC−041 Prost−AdenoCA Cancer type 8:14804569−76501181 Position With other complex events Type 14 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 3; SV types t2tINV: 4; TRA: 1 131 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 33 CN segments 0.925252 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
166	2	Upper_Right	EOPC-041	19:42614927−44488345	6, 9	15	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	EOPC−041 Prost−AdenoCA Cancer type 19:42614927−44488345 Position With other complex events Type 8 Interleaved intrachr. SVs 30 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 22 131 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 15 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich. 2:20591505−103430434; Linked to chrs
166	3	Lower_Left	EOPC-049	10:129911442−133833453	4, 4	4	{'min_x': 54.730098724365234, 'min_y': 693.2749633789062, 'max_x': 232.99598693847656, 'max_y': 839.013916015625}	131 MB 132 MB 133 MB EOPC−049 Prost−AdenoCA Cancer type 10:129911442−133833453 Position Canonical without polyploidization Type 8 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 11 50 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 4 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
166	4	Lower_Right	CPCG0047	21:39834144−44199722	5, 5	5	{'min_x': 316.25, 'min_y': 693.2749633789062, 'max_x': 547.9000244140625, 'max_y': 839.013916015625}	40 MB 41 MB 42 MB 43 MB 44 MB CPCG0047 Prost−AdenoCA Cancer type 21:39834144−44199722 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 0 74 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
167	1	Upper_Left	CPCG0094	1:8589683−155821955	5, 8	10	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	CPCG0094 Prost−AdenoCA Cancer type 1:8589683−155821955 Position With other complex events Type 15 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 2; SV types t2tINV: 4; TRA: 18 75 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 10 CN segments 0.8378534 FDR fragment joints 0 FDR chr. breakp. enrich. 2:13930709−194034057; Linked to chrs
167	2	Upper_Right	CPCG0099	7:48017345−154624761	6, 21	46	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CPCG0099 Prost−AdenoCA Cancer type 7:48017345−154624761 Position With other complex events Type 20 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 5; DUP: 8; h2hINV: 4; SV types t2tINV: 3; TRA: 0 116 SVs in sample 6, 21 Oscillating CN (2 and 3 states) 46 CN segments 0.662962 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
167	3	Lower_Left	CPCG0123	4:40113263−89954086	5, 5	5	{'min_x': 54.730098724365234, 'min_y': 693.2749633789062, 'max_x': 269.1697998046875, 'max_y': 839.013916015625}	50 MB 60 MB 70 MB 80 MB 90 MB CPCG0123 Prost−AdenoCA Cancer type 4:40113263−89954086 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 2; SV types t2tINV: 1; TRA: 9 144 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.9875525 FDR fragment joints 0 FDR chr. breakp. enrich.
167	4	Lower_Right	CPCG0124	8:5872316−42557666	4, 7	14	{'min_x': 333.44000244140625, 'min_y': 693.2749633789062, 'max_x': 542.3704833984375, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB CPCG0124 Prost−AdenoCA Cancer type 8:5872316−42557666 Position With other complex events Type 15 Interleaved intrachr. SVs 46 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 3; SV types t2tINV: 4; TRA: 31 121 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 14 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
168	1	Upper_Left	CPCG0166	10:89626569−95441303	5, 5	5	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.3340148925781}	CPCG0166 Prost−AdenoCA Cancer type 10:89626569−95441303 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 1; TRA: 0 126 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.6776251 FDR fragment joints 0.63 FDR chr. breakp. enrich. Linked to chrs
168	2	Upper_Right	CPCG0189	11:78278095−82964421	5, 5	5	{'min_x': 344.2300109863281, 'min_y': 280.6499938964844, 'max_x': 522.4959716796875, 'max_y': 410.3340148925781}	CPCG0189 Prost−AdenoCA Cancer type 11:78278095−82964421 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 2 92 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
168	3	Lower_Left	CPCG0191	10:6994207−108361744	4, 9	14	{'min_x': 58.96989822387695, 'min_y': 693.2749633789062, 'max_x': 251.87196350097656, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB CPCG0191 Prost−AdenoCA Cancer type 10:6994207−108361744 Position With other complex events Type 23 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 7; SV types t2tINV: 8; TRA: 2 121 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 14 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
168	4	Lower_Right	CPCG0196	2:71553010−204756130	5, 5	5	{'min_x': 322.1099853515625, 'min_y': 693.2749633789062, 'max_x': 552.1719360351562, 'max_y': 839.013916015625}	80 MB 120 MB 160 MB 200 MB CPCG0196 Prost−AdenoCA Cancer type 2:71553010−204756130 Position Canonical without polyploidization Type 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 4; SV types t2tINV: 4; TRA: 0 116 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.8462769 FDR fragment joints 0.1 FDR chr. breakp. enrich.
169	1	Upper_Left	CPCG0206	11:45858528−97193270	4, 7	12	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CPCG0206 Prost−AdenoCA Cancer type 11:45858528−97193270 Position With other complex events Type 6 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 3 173 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 12 CN segments 0.9723381 FDR fragment joints 0.26 FDR chr. breakp. enrich. Linked to chrs
169	2	Upper_Right	CPCG0236	20:30850339−33795463	5, 5	10	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CPCG0236 Prost−AdenoCA Cancer type 20:30850339−33795463 Position With other complex events Type 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 7; DUP: 4; h2hINV: 2; SV types t2tINV: 2; TRA: 0 237 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 10 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
169	3	Lower_Left	CPCG0242	9:82867617−108956321	4, 4	23	{'min_x': 58.830101013183594, 'min_y': 693.2749633789062, 'max_x': 246.24192810058594, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB CPCG0242 Prost−AdenoCA Cancer type 9:82867617−108956321 Position With other complex events Type 15 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 6; SV types t2tINV: 4; TRA: 2 217 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 23 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
169	4	Lower_Right	CPCG0249	12:40224539−88916203	6, 6	11	{'min_x': 348.80999755859375, 'min_y': 693.2749633789062, 'max_x': 562.152099609375, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB CPCG0249 Prost−AdenoCA Cancer type 12:40224539−88916203 Position With other complex events Type 12 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 1; SV types t2tINV: 1; TRA: 8 458 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 11 CN segments 0.8572806 FDR fragment joints 0.1 FDR chr. breakp. enrich.
170	1	Upper_Left	CPCG0251	3:9531696−111833851	5, 6	6	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.3340148925781}	CPCG0251 Prost−AdenoCA Cancer type 3:9531696−111833851 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 3; SV types t2tINV: 4; TRA: 10 67 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9625775 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
170	2	Upper_Right	CPCG0263	3:51760828−135855244	5, 7	17	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CPCG0263 Prost−AdenoCA Cancer type 3:51760828−135855244 Position With other complex events Type 21 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 6; SV types t2tINV: 4; TRA: 0 67 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 17 CN segments 0.9462199 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
170	3	Lower_Left	CPCG0268	6:66095219−128649048	5, 5	5	{'min_x': 54.730098724365234, 'min_y': 693.2749633789062, 'max_x': 239.0019989013672, 'max_y': 839.013916015625}	80 MB 90 MB 100 MB 110 MB 120 MB CPCG0268 Prost−AdenoCA Cancer type 6:66095219−128649048 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 2; SV types t2tINV: 3; TRA: 1 135 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.6776251 FDR fragment joints 0.02 FDR chr. breakp. enrich.
170	4	Lower_Right	CPCG0342	2:61542346−65123885	6, 6	6	{'min_x': 336.9700012207031, 'min_y': 693.2749633789062, 'max_x': 550.480224609375, 'max_y': 839.013916015625}	62 MB 63 MB 64 MB 65 MB CPCG0342 Prost−AdenoCA Cancer type 2:61542346−65123885 Position Canonical without polyploidization Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 0 72 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9625775 FDR fragment joints 0.01 FDR chr. breakp. enrich.
171	1	Upper_Left	CPCG0357	1:234433222−235613195	4, 8	13	{'min_x': 60.18009948730469, 'min_y': 280.6499938964844, 'max_x': 227.5441131591797, 'max_y': 410.42401123046875}	CPCG0357 Prost−AdenoCA Cancer type 1:234433222−235613195 Position With other complex events Type 33 Interleaved intrachr. SVs 71 Total SVs (intrachr. + transl.) DEL: 11; DUP: 11; h2hINV: 7; SV types t2tINV: 4; TRA: 38 162 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 13 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 11:33186637−34681925; Linked to chrs
171	2	Upper_Right	CPCG0357	11:33186637−34681926	4, 5	7	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CPCG0357 Prost−AdenoCA Cancer type 11:33186637−34681926 Position With other complex events Type 15 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 5; SV types t2tINV: 3; TRA: 29 162 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 7 CN segments 0.6372084 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
171	3	Lower_Left	CPCG0379	17:45491837−70847983	6, 9	9	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 264.64007568359375, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 70 MB 80 MB CPCG0379 Prost−AdenoCA Cancer type 17:45491837−70847983 Position After polyploidization Type 13 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 7 107 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich.
171	4	Lower_Right	0091_CRUK_PC_0091	18:8673012−67370977	5, 7	8	{'min_x': 312.6700134277344, 'min_y': 693.2749633789062, 'max_x': 528.2501220703125, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB 60 MB 0091_CRUK_PC_0091 Prost−AdenoCA Cancer type 18:8673012−67370977 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 5; DUP: 1; h2hINV: 3; SV types t2tINV: 2; TRA: 2 308 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 8 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
172	1	Upper_Left	A21-0096_CRUK_PC_0096	X:32559602−90575521	5, 7	24	{'min_x': 61.36989974975586, 'min_y': 280.6499938964844, 'max_x': 226.35601806640625, 'max_y': 410.3340148925781}	A21−0096_CRUK_PC_0096 Prost−AdenoCA Cancer type X:32559602−90575521 Position With other complex events Type 7 Interleaved intrachr. SVs 16 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 1; SV types t2tINV: 0; TRA: 9 496 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 24 CN segments 0.9501265 FDR fragment joints 0.55 FDR chr. breakp. enrich. Linked to chrs
172	2	Upper_Right	A22-0016_CRUK_PC_0016	4:25070963−26242242	6, 13	13	{'min_x': 321.5199890136719, 'min_y': 276.3299865722656, 'max_x': 545.2039794921875, 'max_y': 410.3340148925781}	A22−0016_CRUK_PC_0016 Prost−AdenoCA Cancer type 4:25070963−26242242 Position With other complex events Type 6 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 19 156 SVs in sample 6, 13 Oscillating CN (2 and 3 states) 13 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. 2:210205164−210324505;5:54361714−175053850 Linked to chrs
172	3	Lower_Left	A22-0016_CRUK_PC_0016	6:12626345−160987932	5, 7	24	{'min_x': 61.36989974975586, 'min_y': 693.2749633789062, 'max_x': 269.38214111328125, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 160 MB A22−0016_CRUK_PC_0016 Prost−AdenoCA Cancer type 6:12626345−160987932 Position With other complex events Type 11 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 15 156 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 24 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
172	4	Lower_Right	A29-0017_CRUK_PC_0017	8:55705727−120347671	4, 5	17	{'min_x': 350.8699951171875, 'min_y': 693.2749633789062, 'max_x': 515.8560180664062, 'max_y': 839.013916015625}	50 MB 100 MB A29−0017_CRUK_PC_0017 Prost−AdenoCA Cancer type 8:55705727−120347671 Position With other complex events Type 10 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 23 322 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 17 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
173	1	Upper_Left	A29-0017_CRUK_PC_0017	17:7580636−45324930	4, 5	8	{'min_x': 61.36989974975586, 'min_y': 280.6499938964844, 'max_x': 226.35601806640625, 'max_y': 410.3340148925781}	A29−0017_CRUK_PC_0017 Prost−AdenoCA Cancer type 17:7580636−45324930 Position With other complex events Type 6 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 0; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 8 322 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 8 CN segments 0.615458 FDR fragment joints 0.13 FDR chr. breakp. enrich. Linked to chrs
173	2	Upper_Right	A32-0019_CRUK_PC_0019	2:171308068−191866282	5, 7	14	{'min_x': 350.8699951171875, 'min_y': 280.6499938964844, 'max_x': 515.8560180664062, 'max_y': 410.42401123046875}	A32−0019_CRUK_PC_0019 Prost−AdenoCA Cancer type 2:171308068−191866282 Position With other complex events Type 6 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 6 192 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 14 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 3:32985863−156750376; Linked to chrs
173	3	Lower_Left	A32-0019_CRUK_PC_0019	3:32985863−156750377	5, 12	12	{'min_x': 61.36989974975586, 'min_y': 693.2749633789062, 'max_x': 226.35601806640625, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB A32−0019_CRUK_PC_0019 Prost−AdenoCA Cancer type 3:32985863−156750377 Position With other complex events Type 10 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 4; SV types t2tINV: 3; TRA: 2 192 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.615458 FDR fragment joints 0.03 FDR chr. breakp. enrich.
173	4	Lower_Right	A34-0022_CRUK_PC_0022	13:75922651−79259286	6, 6	6	{'min_x': 344.2300109863281, 'min_y': 693.2749633789062, 'max_x': 526.1102294921875, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB A34−0022_CRUK_PC_0022 Prost−AdenoCA Cancer type 13:75922651−79259286 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 0 461 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9284301 FDR fragment joints 0.17 FDR chr. breakp. enrich.
174	1	Upper_Left	c039014f-821c-43d6-9d3c-914f9c8d98fa	6:57910476−98537020	5, 9	9	{'min_x': 40.86989974975586, 'min_y': 280.6499938964844, 'max_x': 246.8539581298828, 'max_y': 410.3340148925781}	c039014f−821c−43d6−9d3c−914f9c8d98fa Prost−AdenoCA Cancer type 6:57910476−98537020 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 3; SV types t2tINV: 5; TRA: 0 222 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.615458 FDR fragment joints 0.93 FDR chr. breakp. enrich. Linked to chrs
174	2	Upper_Right	c039014f-821c-43d6-9d3c-914f9c8d98fa	11:29320290−106781287	6, 9	20	{'min_x': 330.3699951171875, 'min_y': 280.6499938964844, 'max_x': 536.3538818359375, 'max_y': 410.3340148925781}	c039014f−821c−43d6−9d3c−914f9c8d98fa Prost−AdenoCA Cancer type 11:29320290−106781287 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 0 222 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 20 CN segments 0.7735152 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
174	3	Lower_Left	f6381367-142c-45d0-92b3-c1727d1813ce	10:59938517−98135181	5, 5	5	{'min_x': 39.539798736572266, 'min_y': 693.2749633789062, 'max_x': 248.18994140625, 'max_y': 839.013916015625}	70 MB 80 MB 90 MB f6381367−142c−45d0−92b3−c1727d1813ce Prost−AdenoCA Cancer type 10:59938517−98135181 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 1 133 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 1 FDR fragment joints 0.03 FDR chr. breakp. enrich.
174	4	Lower_Right	MELA-0001	8:54422125−99862970	4, 7	57	{'min_x': 323.19000244140625, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 834.6940307617188}	75 MB 100 MB 125 MB MELA−0001 Skin−Melanoma Cancer type 8:54422125−99862970 Position With other complex events Type 14 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 2; SV types t2tINV: 2; TRA: 31 460 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 57 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
175	1	Upper_Left	MELA-0002	22:17741148−36618400	6, 8	13	{'min_x': 35.360198974609375, 'min_y': 276.3299865722656, 'max_x': 252.3719482421875, 'max_y': 410.3340148925781}	MELA−0002 Skin−Melanoma Cancer type 22:17741148−36618400 Position With other complex events Type 6 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 8 748 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 13 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 2:11161529−144813239;7:1508469−101805271 Linked to chrs
175	2	Upper_Right	MELA-0003	1:15885881−58152236	6, 6	160	{'min_x': 324.8599853515625, 'min_y': 276.3299865722656, 'max_x': 541.8719482421875, 'max_y': 410.3340148925781}	MELA−0003 Skin−Melanoma Cancer type 1:15885881−58152236 Position With other complex events Type 71 Interleaved intrachr. SVs 308 Total SVs (intrachr. + transl.) DEL: 20; DUP: 20; h2hINV: 15; SV types t2tINV: 16; TRA: 237 1187 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 160 CN segments 0.5558459 FDR fragment joints 0 FDR chr. breakp. enrich. 12:43076099−128657836;5:1296136−45874995 Linked to chrs
175	3	Lower_Left	MELA-0005	6:8393693−111434013	6, 7	53	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	30 MB 60 MB 90 MB MELA−0005 Skin−Melanoma Cancer type 6:8393693−111434013 Position With other complex events Type 11 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 2; SV types t2tINV: 2; TRA: 24 220 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 53 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
175	4	Lower_Right	MELA-0005	11:78619623−104782805	4, 5	60	{'min_x': 320.7900085449219, 'min_y': 693.2749633789062, 'max_x': 529.8823852539062, 'max_y': 834.6940307617188}	50 MB 60 MB 70 MB 80 MB 90 MB 100 MB MELA−0005 Skin−Melanoma Cancer type 11:78619623−104782805 Position With other complex events Type 22 Interleaved intrachr. SVs 34 Total SVs (intrachr. + transl.) DEL: 4; DUP: 6; h2hINV: 6; SV types t2tINV: 6; TRA: 12 220 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 60 CN segments 0.9332614 FDR fragment joints 0 FDR chr. breakp. enrich.
176	1	Upper_Left	MELA-0007	22:24125398−51210651	6, 9	150	{'min_x': 58.51020050048828, 'min_y': 280.6499938964844, 'max_x': 229.22010803222656, 'max_y': 410.3340148925781}	MELA−0007 Skin−Melanoma Cancer type 22:24125398−51210651 Position With other complex events Type 67 Interleaved intrachr. SVs 171 Total SVs (intrachr. + transl.) DEL: 19; DUP: 17; h2hINV: 18; SV types t2tINV: 13; TRA: 104 377 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 150 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
176	2	Upper_Right	MELA-0008	11:77104049−134650672	5, 10	15	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	MELA−0008 Skin−Melanoma Cancer type 11:77104049−134650672 Position With other complex events Type 8 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 0; SV types t2tINV: 1; TRA: 6 142 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 15 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 22:41378272−41557630; Linked to chrs
176	3	Lower_Left	MELA-0009	3:19250926−195326589	5, 12	53	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB MELA−0009 Skin−Melanoma Cancer type 3:19250926−195326589 Position With other complex events Type 23 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 5; SV types t2tINV: 5; TRA: 10 351 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 53 CN segments 0.7286575 FDR fragment joints 0 FDR chr. breakp. enrich.
176	4	Lower_Right	MELA-0009	11:41485920−112489309	5, 8	69	{'min_x': 348.010009765625, 'min_y': 693.2749633789062, 'max_x': 519.822021484375, 'max_y': 839.013916015625}	60 MB 80 MB 100 MB MELA−0009 Skin−Melanoma Cancer type 11:41485920−112489309 Position With other complex events Type 40 Interleaved intrachr. SVs 94 Total SVs (intrachr. + transl.) DEL: 10; DUP: 11; h2hINV: 10; SV types t2tINV: 9; TRA: 54 351 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 69 CN segments 0.7392975 FDR fragment joints 0 FDR chr. breakp. enrich.
177	1	Upper_Left	MELA-0012	9:4860008−31734961	6, 21	34	{'min_x': 61.849998474121094, 'min_y': 280.6499938964844, 'max_x': 225.87779235839844, 'max_y': 410.42401123046875}	MELA−0012 Skin−Melanoma Cancer type 9:4860008−31734961 Position With other complex events Type 27 Interleaved intrachr. SVs 32 Total SVs (intrachr. + transl.) DEL: 11; DUP: 5; h2hINV: 5; SV types t2tINV: 6; TRA: 5 508 SVs in sample 6, 21 Oscillating CN (2 and 3 states) 34 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 7:32236661−117391258; Linked to chrs
177	2	Upper_Right	MELA-0012	10:34937946−111551297	5, 11	21	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	MELA−0012 Skin−Melanoma Cancer type 10:34937946−111551297 Position With other complex events Type 8 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 3 508 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 21 CN segments 0.615458 FDR fragment joints 0.53 FDR chr. breakp. enrich. Linked to chrs
177	3	Lower_Left	MELA-0012	11:60665556−76908360	5, 9	96	{'min_x': 32.019901275634766, 'min_y': 693.2749633789062, 'max_x': 244.0499725341797, 'max_y': 830.3740844726562}	40 MB 60 MB 80 MB MELA−0012 Skin−Melanoma Cancer type 11:60665556−76908360 Position With other complex events Type 47 Interleaved intrachr. SVs 80 Total SVs (intrachr. + transl.) DEL: 12; DUP: 10; h2hINV: 14; SV types t2tINV: 11; TRA: 33 508 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 96 CN segments 0.9783158 FDR fragment joints 0 FDR chr. breakp. enrich.
177	4	Lower_Right	MELA-0015	19:29765034−58719123	4, 5	31	{'min_x': 336.5299987792969, 'min_y': 693.2749633789062, 'max_x': 522.3600463867188, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB MELA−0015 Skin−Melanoma Cancer type 19:29765034−58719123 Position With other complex events Type 15 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 4; SV types t2tINV: 5; TRA: 2 201 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 31 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
178	1	Upper_Left	MELA-0043	20:924675−9380462	4, 7	22	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	MELA−0043 Skin−Melanoma Cancer type 20:924675−9380462 Position With other complex events Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 1; SV types t2tINV: 3; TRA: 1 106 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 22 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
178	2	Upper_Right	MELA-0048	5:1054293−127185143	6, 7	161	{'min_x': 326.5299987792969, 'min_y': 276.3299865722656, 'max_x': 540.1959838867188, 'max_y': 410.3340148925781}	MELA−0048 Skin−Melanoma Cancer type 5:1054293−127185143 Position With other complex events Type 32 Interleaved intrachr. SVs 163 Total SVs (intrachr. + transl.) DEL: 11; DUP: 6; h2hINV: 7; SV types t2tINV: 8; TRA: 131 444 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 161 CN segments 0.6942198 FDR fragment joints 0 FDR chr. breakp. enrich. 2:35447197−238700316;7:858862−151538982 Linked to chrs
178	3	Lower_Left	MELA-0050	11:51487991−83958719	6, 6	52	{'min_x': 61.849998474121094, 'min_y': 693.2749633789062, 'max_x': 240.8300018310547, 'max_y': 839.013916015625}	60 MB 70 MB 80 MB MELA−0050 Skin−Melanoma Cancer type 11:51487991−83958719 Position With other complex events Type 26 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 11; DUP: 9; h2hINV: 4; SV types t2tINV: 2; TRA: 2 94 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 52 CN segments 0.332153 FDR fragment joints 0 FDR chr. breakp. enrich.
178	4	Lower_Right	MELA-0060	11:2569509−63788627	5, 11	31	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB MELA−0060 Skin−Melanoma Cancer type 11:2569509−63788627 Position With other complex events Type 20 Interleaved intrachr. SVs 22 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 5; SV types t2tINV: 6; TRA: 2 213 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 31 CN segments 0.9419607 FDR fragment joints 0 FDR chr. breakp. enrich.
179	1	Upper_Left	MELA-0064	5:75710−38913517	5, 8	105	{'min_x': 58.51020050048828, 'min_y': 280.6499938964844, 'max_x': 229.22010803222656, 'max_y': 410.3340148925781}	MELA−0064 Skin−Melanoma Cancer type 5:75710−38913517 Position With other complex events Type 79 Interleaved intrachr. SVs 104 Total SVs (intrachr. + transl.) DEL: 22; DUP: 14; h2hINV: 21; SV types t2tINV: 22; TRA: 25 380 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 105 CN segments 0.7995907 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
179	2	Upper_Right	MELA-0064	7:67546621−151505707	4, 7	29	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	MELA−0064 Skin−Melanoma Cancer type 7:67546621−151505707 Position With other complex events Type 29 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 5; DUP: 8; h2hINV: 4; SV types t2tINV: 12; TRA: 20 380 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 29 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
179	3	Lower_Left	MELA-0064	11:51188282−94965346	4, 7	94	{'min_x': 42.03010177612305, 'min_y': 693.2749633789062, 'max_x': 260.3119201660156, 'max_y': 834.6940307617188}	60 MB 70 MB 80 MB 90 MB 100 MB MELA−0064 Skin−Melanoma Cancer type 11:51188282−94965346 Position With other complex events Type 90 Interleaved intrachr. SVs 178 Total SVs (intrachr. + transl.) DEL: 25; DUP: 23; h2hINV: 23; SV types t2tINV: 19; TRA: 88 380 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 94 CN segments 0.7789125 FDR fragment joints 0 FDR chr. breakp. enrich.
179	4	Lower_Right	MELA-0066	1:160797429−216909159	5, 11	17	{'min_x': 303.4200134277344, 'min_y': 693.2749633789062, 'max_x': 540.182373046875, 'max_y': 839.013916015625}	160 MB 180 MB 200 MB 220 MB 240 MB MELA−0066 Skin−Melanoma Cancer type 1:160797429−216909159 Position With other complex events Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 4; SV types t2tINV: 2; TRA: 2 355 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 17 CN segments 0.615458 FDR fragment joints 0.03 FDR chr. breakp. enrich.
180	1	Upper_Left	MELA-0069	2:13198317−216809264	5, 8	51	{'min_x': 38.70000076293945, 'min_y': 276.3299865722656, 'max_x': 249.0299530029297, 'max_y': 410.3340148925781}	MELA−0069 Skin−Melanoma Cancer type 2:13198317−216809264 Position With other complex events Type 11 Interleaved intrachr. SVs 26 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 4; SV types t2tINV: 2; TRA: 15 401 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 51 CN segments 0.7510435 FDR fragment joints 0.27 FDR chr. breakp. enrich. 6:3865883−64390629;9:1637851−118991851 Linked to chrs
180	2	Upper_Right	MELA-0069	6:3865883−64390630	6, 7	106	{'min_x': 323.19000244140625, 'min_y': 276.3299865722656, 'max_x': 543.5379638671875, 'max_y': 410.3340148925781}	MELA−0069 Skin−Melanoma Cancer type 6:3865883−64390630 Position With other complex events Type 49 Interleaved intrachr. SVs 129 Total SVs (intrachr. + transl.) DEL: 11; DUP: 9; h2hINV: 15; SV types t2tINV: 14; TRA: 80 401 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 106 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 14:77426835−91651121;2:13198317−216809263 Linked to chrs
180	3	Lower_Left	MELA-0069	11:66817953−80753867	4, 7	122	{'min_x': 38.70000076293945, 'min_y': 693.2749633789062, 'max_x': 265.7601318359375, 'max_y': 834.6940307617188}	20 MB 40 MB 60 MB 80 MB MELA−0069 Skin−Melanoma Cancer type 11:66817953−80753867 Position With other complex events Type 64 Interleaved intrachr. SVs 134 Total SVs (intrachr. + transl.) DEL: 20; DUP: 14; h2hINV: 16; SV types t2tINV: 14; TRA: 70 401 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 122 CN segments 0.8690452 FDR fragment joints 0 FDR chr. breakp. enrich.
180	4	Lower_Right	MELA-0070	3:107828103−110133076	5, 7	13	{'min_x': 325.4700012207031, 'min_y': 693.2749633789062, 'max_x': 544.6522216796875, 'max_y': 839.013916015625}	100 MB 120 MB 140 MB 160 MB MELA−0070 Skin−Melanoma Cancer type 3:107828103−110133076 Position With other complex events Type 20 Interleaved intrachr. SVs 65 Total SVs (intrachr. + transl.) DEL: 5; DUP: 7; h2hINV: 3; SV types t2tINV: 5; TRA: 45 450 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 13 CN segments 0.7333688 FDR fragment joints 0 FDR chr. breakp. enrich.
181	1	Upper_Left	MELA-0070	11:69251922−83096232	4, 7	92	{'min_x': 32.019901275634766, 'min_y': 272.0099792480469, 'max_x': 255.70394897460938, 'max_y': 410.4242248535156}	MELA−0070 Skin−Melanoma Cancer type 11:69251922−83096232 Position With other complex events Type 33 Interleaved intrachr. SVs 107 Total SVs (intrachr. + transl.) DEL: 10; DUP: 7; h2hINV: 9; SV types t2tINV: 7; TRA: 74 450 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 92 CN segments 0.7559325 FDR fragment joints 0 FDR chr. breakp. enrich. 13:26276510−102632900;16:69653875−83050345 5:703450−42018197;9:447092−9513408 Linked to chrs
181	2	Upper_Right	MELA-0160	5:376141−17139643	5, 10	13	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	MELA−0160 Skin−Melanoma Cancer type 5:376141−17139643 Position With other complex events Type 18 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 5; SV types t2tINV: 4; TRA: 1 96 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 13 CN segments 0.9348624 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
181	3	Lower_Left	MELA-0167	7:29323351−150218313	6, 10	47	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 270.491943359375, 'max_y': 839.013916015625}	60 MB 90 MB 120 MB 150 MB MELA−0167 Skin−Melanoma Cancer type 7:29323351−150218313 Position With other complex events Type 20 Interleaved intrachr. SVs 64 Total SVs (intrachr. + transl.) DEL: 1; DUP: 9; h2hINV: 6; SV types t2tINV: 4; TRA: 44 339 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 47 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
181	4	Lower_Right	MELA-0167	9:18954759−39157408	4, 8	8	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB MELA−0167 Skin−Melanoma Cancer type 9:18954759−39157408 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 0 339 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.9284301 FDR fragment joints 0.37 FDR chr. breakp. enrich.
182	1	Upper_Left	MELA-0168	6:67475142−169821533	6, 6	6	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	MELA−0168 Skin−Melanoma Cancer type 6:67475142−169821533 Position Before polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 57 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9284301 FDR fragment joints 0.08 FDR chr. breakp. enrich. Linked to chrs
182	2	Upper_Right	MELA-0168	22:17962914−29759005	6, 11	15	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	MELA−0168 Skin−Melanoma Cancer type 22:17962914−29759005 Position With other complex events Type 10 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 1; SV types t2tINV: 3; TRA: 4 57 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 15 CN segments 0.8988396 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
182	3	Lower_Left	MELA-0173	15:49713725−96355825	6, 8	31	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 262.5719299316406, 'max_y': 839.013916015625}	60 MB 70 MB 80 MB 90 MB 100 MB MELA−0173 Skin−Melanoma Cancer type 15:49713725−96355825 Position With other complex events Type 18 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 5; SV types t2tINV: 5; TRA: 3 90 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 31 CN segments 0.7568568 FDR fragment joints 0 FDR chr. breakp. enrich.
182	4	Lower_Right	MELA-0187	6:64985024−128497164	6, 14	24	{'min_x': 338.05999755859375, 'min_y': 693.2749633789062, 'max_x': 550.8418579101562, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB 125 MB MELA−0187 Skin−Melanoma Cancer type 6:64985024−128497164 Position With other complex events Type 12 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 4; TRA: 8 313 SVs in sample 6, 14 Oscillating CN (2 and 3 states) 24 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich.
183	1	Upper_Left	MELA-0187	11:54893769−126272083	6, 12	179	{'min_x': 58.51020050048828, 'min_y': 280.6499938964844, 'max_x': 229.22010803222656, 'max_y': 410.3340148925781}	MELA−0187 Skin−Melanoma Cancer type 11:54893769−126272083 Position With other complex events Type 198 Interleaved intrachr. SVs 218 Total SVs (intrachr. + transl.) DEL: 51; DUP: 52; h2hINV: 50; SV types t2tINV: 45; TRA: 20 313 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 179 CN segments 0.930656 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
183	2	Upper_Right	MELA-0192	X:62938682−74484110	5, 5	11	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	MELA−0192 Skin−Melanoma Cancer type X:62938682−74484110 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 2; SV types t2tINV: 5; TRA: 0 55 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 11 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
183	3	Lower_Left	MELA-0193	12:30161467−133173511	5, 6	31	{'min_x': 37.03010177612305, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 834.6940307617188}	50 MB 100 MB MELA−0193 Skin−Melanoma Cancer type 12:30161467−133173511 Position With other complex events Type 11 Interleaved intrachr. SVs 28 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 4; TRA: 17 264 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 31 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
183	4	Lower_Right	MELA-0196	2:38033476−88438303	6, 12	84	{'min_x': 324.1499938964844, 'min_y': 693.2749633789062, 'max_x': 538.1521606445312, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB MELA−0196 Skin−Melanoma Cancer type 2:38033476−88438303 Position With other complex events Type 59 Interleaved intrachr. SVs 68 Total SVs (intrachr. + transl.) DEL: 15; DUP: 17; h2hINV: 11; SV types t2tINV: 16; TRA: 9 101 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 84 CN segments 0.905477 FDR fragment joints 0 FDR chr. breakp. enrich.
184	1	Upper_Left	MELA-0202	7:6051022−155559216	5, 9	44	{'min_x': 58.51020050048828, 'min_y': 280.6499938964844, 'max_x': 229.22010803222656, 'max_y': 410.3340148925781}	MELA−0202 Skin−Melanoma Cancer type 7:6051022−155559216 Position With other complex events Type 42 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 10; DUP: 12; h2hINV: 11; SV types t2tINV: 9; TRA: 0 103 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 44 CN segments 0.9550868 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
184	2	Upper_Right	MELA-0205	9:11612380−31055136	5, 8	28	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	MELA−0205 Skin−Melanoma Cancer type 9:11612380−31055136 Position With other complex events Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 3; SV types t2tINV: 4; TRA: 0 33 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 28 CN segments 0.9794281 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
184	3	Lower_Left	MELA-0213	22:19600873−50879547	5, 6	10	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 262.4698791503906, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB MELA−0213 Skin−Melanoma Cancer type 22:19600873−50879547 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 0; SV types t2tINV: 3; TRA: 0 34 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 10 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
184	4	Lower_Right	MELA-0223	20:264096−23474579	4, 4	24	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 523.9197998046875, 'max_y': 839.013916015625}	5 MB 10 MB 15 MB 20 MB MELA−0223 Skin−Melanoma Cancer type 20:264096−23474579 Position With other complex events Type 10 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 3; SV types t2tINV: 1; TRA: 4 104 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 24 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
185	1	Upper_Left	MELA-0226	11:2979632−83289483	6, 11	11	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	MELA−0226 Skin−Melanoma Cancer type 11:2979632−83289483 Position With other complex events Type 13 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 4; SV types t2tINV: 4; TRA: 0 152 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
185	2	Upper_Right	MELA-0226	14:76917881−90636670	5, 8	8	{'min_x': 344.2300109863281, 'min_y': 280.6499938964844, 'max_x': 522.4959716796875, 'max_y': 410.42401123046875}	MELA−0226 Skin−Melanoma Cancer type 14:76917881−90636670 Position Canonical without polyploidization Type 11 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 1; SV types t2tINV: 3; TRA: 2 152 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 7:123055563−158071676; Linked to chrs
185	3	Lower_Left	MELA-0231	4:58934408−183626934	5, 10	47	{'min_x': 32.019901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 830.3740844726562}	50 MB 100 MB 150 MB MELA−0231 Skin−Melanoma Cancer type 4:58934408−183626934 Position With other complex events Type 10 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 4; SV types t2tINV: 2; TRA: 28 1234 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 47 CN segments 0.615458 FDR fragment joints 0.03 FDR chr. breakp. enrich.
185	4	Lower_Right	MELA-0231	7:712296−54531288	5, 26	37	{'min_x': 308.3500061035156, 'min_y': 693.2749633789062, 'max_x': 555.6522216796875, 'max_y': 830.3740844726562}	0 MB 50 MB 100 MB 150 MB MELA−0231 Skin−Melanoma Cancer type 7:712296−54531288 Position With other complex events Type 23 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 8; DUP: 5; h2hINV: 6; SV types t2tINV: 4; TRA: 15 1234 SVs in sample 5, 26 Oscillating CN (2 and 3 states) 37 CN segments 0.7282798 FDR fragment joints 0 FDR chr. breakp. enrich.
186	1	Upper_Left	MELA-0231	8:9543398−106192556	6, 8	61	{'min_x': 35.360198974609375, 'min_y': 272.0099792480469, 'max_x': 252.3719482421875, 'max_y': 410.4242248535156}	MELA−0231 Skin−Melanoma Cancer type 8:9543398−106192556 Position With other complex events Type 7 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 2; DUP: 6; h2hINV: 4; SV types t2tINV: 2; TRA: 40 1234 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 61 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 12:4111597−34617369;15:27228030−90601941 18:58999177−77021614;2:5310579−242675571 Linked to chrs
186	2	Upper_Right	MELA-0231	14:27456610−34055768	5, 5	16	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	MELA−0231 Skin−Melanoma Cancer type 14:27456610−34055768 Position With other complex events Type 17 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 5; DUP: 9; h2hINV: 1; SV types t2tINV: 2; TRA: 16 1234 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 16 CN segments 0.6735663 FDR fragment joints 0 FDR chr. breakp. enrich. 2:5310579−242675571; Linked to chrs
186	3	Lower_Left	MELA-0231	16:76956420−89223828	5, 9	18	{'min_x': 30.019899368286133, 'min_y': 693.2749633789062, 'max_x': 236.66989135742188, 'max_y': 834.6940307617188}	40 MB 60 MB 80 MB MELA−0231 Skin−Melanoma Cancer type 16:76956420−89223828 Position With other complex events Type 9 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 0; SV types t2tINV: 3; TRA: 9 1234 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 18 CN segments 0.6776251 FDR fragment joints 1 FDR chr. breakp. enrich.
186	4	Lower_Right	MELA-0231	18:58999177−77021615	6, 10	39	{'min_x': 353.0199890136719, 'min_y': 693.2749633789062, 'max_x': 513.7119140625, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB MELA−0231 Skin−Melanoma Cancer type 18:58999177−77021615 Position With other complex events Type 10 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 4; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 25 1234 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 39 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
187	1	Upper_Left	MELA-0256	X:119143192−141952863	4, 10	10	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	MELA−0256 Skin−Melanoma Cancer type X:119143192−141952863 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 0; TRA: 0 92 SVs in sample 4, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.615458 FDR fragment joints 0.34 FDR chr. breakp. enrich. Linked to chrs
187	2	Upper_Right	1404791b-86bf-4dfd-85b4-c8ff356f109c	7:306183−65693059	6, 10	89	{'min_x': 323.19000244140625, 'min_y': 272.0099792480469, 'max_x': 543.5379638671875, 'max_y': 410.4242248535156}	1404791b−86bf−4dfd−85b4−c8ff356f109c Skin−Melanoma Cancer type 7:306183−65693059 Position With other complex events Type 31 Interleaved intrachr. SVs 98 Total SVs (intrachr. + transl.) DEL: 7; DUP: 7; h2hINV: 7; SV types t2tINV: 10; TRA: 67 573 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 89 CN segments 0.8988396 FDR fragment joints 0 FDR chr. breakp. enrich. 11:33008500−79611121;19:32205724−58908288 22:29353674−50585361;6:503244−53879503 Linked to chrs
187	3	Lower_Left	1404791b-86bf-4dfd-85b4-c8ff356f109c	22:29353674−50585362	5, 8	73	{'min_x': 35.360198974609375, 'min_y': 693.2749633789062, 'max_x': 264.68011474609375, 'max_y': 830.3740844726562}	30 MB 40 MB 50 MB 1404791b−86bf−4dfd−85b4−c8ff356f109c Skin−Melanoma Cancer type 22:29353674−50585362 Position With other complex events Type 45 Interleaved intrachr. SVs 127 Total SVs (intrachr. + transl.) DEL: 12; DUP: 15; h2hINV: 10; SV types t2tINV: 8; TRA: 82 573 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 73 CN segments 0.9625775 FDR fragment joints 0 FDR chr. breakp. enrich.
187	4	Lower_Right	238111f9-a08b-49b4-9035-cc43026330e7	10:881509−38175147	6, 11	30	{'min_x': 329.20001220703125, 'min_y': 693.2749633789062, 'max_x': 537.5299072265625, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB 238111f9−a08b−49b4−9035−cc43026330e7 Skin−Melanoma Cancer type 10:881509−38175147 Position With other complex events Type 11 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 5; DUP: 3; h2hINV: 1; SV types t2tINV: 2; TRA: 0 87 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 30 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
188	1	Upper_Left	296f44f9-3ecb-4b40-ae51-c3a06e3fbe00	6:4799433−14498344	4, 8	57	{'min_x': 40.86989974975586, 'min_y': 280.6499938964844, 'max_x': 246.8539581298828, 'max_y': 410.3340148925781}	296f44f9−3ecb−4b40−ae51−c3a06e3fbe00 Skin−Melanoma Cancer type 6:4799433−14498344 Position With other complex events Type 79 Interleaved intrachr. SVs 83 Total SVs (intrachr. + transl.) DEL: 22; DUP: 22; h2hINV: 17; SV types t2tINV: 18; TRA: 4 170 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 57 CN segments 0.7735152 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
188	2	Upper_Right	296f44f9-3ecb-4b40-ae51-c3a06e3fbe00	12:68553802−74066796	5, 5	24	{'min_x': 330.3699951171875, 'min_y': 280.6499938964844, 'max_x': 536.3538818359375, 'max_y': 410.3340148925781}	296f44f9−3ecb−4b40−ae51−c3a06e3fbe00 Skin−Melanoma Cancer type 12:68553802−74066796 Position With other complex events Type 10 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 4; SV types t2tINV: 3; TRA: 1 170 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 24 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
188	3	Lower_Left	3fea3f02-2db3-44e0-984e-c61130d92c9b	7:90201391−158391119	4, 11	45	{'min_x': 39.76020050048828, 'min_y': 693.2749633789062, 'max_x': 247.6617889404297, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 3fea3f02−2db3−44e0−984e−c61130d92c9b Skin−Melanoma Cancer type 7:90201391−158391119 Position With other complex events Type 21 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 2; DUP: 9; h2hINV: 5; SV types t2tINV: 5; TRA: 0 262 SVs in sample 4, 11 Oscillating CN (2 and 3 states) 45 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
188	4	Lower_Right	3fea3f02-2db3-44e0-984e-c61130d92c9b	20:31479759−60071503	6, 16	18	{'min_x': 329.57000732421875, 'min_y': 693.2749633789062, 'max_x': 557.8801879882812, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 3fea3f02−2db3−44e0−984e−c61130d92c9b Skin−Melanoma Cancer type 20:31479759−60071503 Position With other complex events Type 10 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 3 262 SVs in sample 6, 16 Oscillating CN (2 and 3 states) 18 CN segments 0.7995907 FDR fragment joints 0 FDR chr. breakp. enrich.
189	1	Upper_Left	5f6df69c-4ebf-4811-8b28-ad393dfbe1a3	3:81208042−140376909	6, 6	6	{'min_x': 41.04999923706055, 'min_y': 280.6499938964844, 'max_x': 246.67596435546875, 'max_y': 410.3340148925781}	5f6df69c−4ebf−4811−8b28−ad393dfbe1a3 Skin−Melanoma Cancer type 3:81208042−140376909 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 0 160 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 6 CN segments 0.9284301 FDR fragment joints 0.03 FDR chr. breakp. enrich. Linked to chrs
189	2	Upper_Right	76cc1d42-acec-46b3-9663-5e4de2550353	11:49654668−56498706	5, 7	7	{'min_x': 328.3699951171875, 'min_y': 280.6499938964844, 'max_x': 538.35791015625, 'max_y': 410.3340148925781}	76cc1d42−acec−46b3−9663−5e4de2550353 Skin−Melanoma Cancer type 11:49654668−56498706 Position Before polyploidization Type 6 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 4 245 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.8572806 FDR fragment joints 0.01 FDR chr. breakp. enrich. Linked to chrs
189	3	Lower_Left	7b92fcd4-f9be-4b97-94a2-b2e8348aeaba	1:57268038−116153671	6, 18	46	{'min_x': 39.710201263427734, 'min_y': 693.2749633789062, 'max_x': 248.02195739746094, 'max_y': 839.013916015625}	60 MB 80 MB 100 MB 7b92fcd4−f9be−4b97−94a2−b2e8348aeaba Skin−Melanoma Cancer type 1:57268038−116153671 Position With other complex events Type 21 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 6; DUP: 6; h2hINV: 5; SV types t2tINV: 4; TRA: 17 137 SVs in sample 6, 18 Oscillating CN (2 and 3 states) 46 CN segments 0.9460923 FDR fragment joints 0 FDR chr. breakp. enrich.
189	4	Lower_Right	7ce09a09-074e-4f38-bed7-98ab34347fbe	3:120763840−170508368	5, 5	19	{'min_x': 325.30999755859375, 'min_y': 693.2749633789062, 'max_x': 543.26220703125, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 160 MB 7ce09a09−074e−4f38−bed7−98ab34347fbe Skin−Melanoma Cancer type 3:120763840−170508368 Position With other complex events Type 8 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 1; SV types t2tINV: 3; TRA: 4 201 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 19 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
190	1	Upper_Left	8c54fcfd-999f-43c5-b31f-26d006f5fff3	8:27003357−144300868	6, 11	41	{'min_x': 44.21989822387695, 'min_y': 280.6499938964844, 'max_x': 243.50396728515625, 'max_y': 410.3340148925781}	8c54fcfd−999f−43c5−b31f−26d006f5fff3 Skin−Melanoma Cancer type 8:27003357−144300868 Position With other complex events Type 70 Interleaved intrachr. SVs 84 Total SVs (intrachr. + transl.) DEL: 23; DUP: 15; h2hINV: 18; SV types t2tINV: 14; TRA: 14 351 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 41 CN segments 0.626975 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
190	2	Upper_Right	b85b14d7-3b5a-4800-af12-622ec03b9fe5	8:50126618−55588669	4, 5	23	{'min_x': 329.4100036621094, 'min_y': 280.6499938964844, 'max_x': 537.322021484375, 'max_y': 410.42401123046875}	b85b14d7−3b5a−4800−af12−622ec03b9fe5 Skin−Melanoma Cancer type 8:50126618−55588669 Position With other complex events Type 8 Interleaved intrachr. SVs 82 Total SVs (intrachr. + transl.) DEL: 1; DUP: 1; h2hINV: 5; SV types t2tINV: 1; TRA: 74 633 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 23 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 11:68369991−101011601; Linked to chrs
190	3	Lower_Left	b85b14d7-3b5a-4800-af12-622ec03b9fe5	11:68369991−101011602	6, 6	63	{'min_x': 39.91019821166992, 'min_y': 693.2749633789062, 'max_x': 267.1321716308594, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB b85b14d7−3b5a−4800−af12−622ec03b9fe5 Skin−Melanoma Cancer type 11:68369991−101011602 Position With other complex events Type 67 Interleaved intrachr. SVs 198 Total SVs (intrachr. + transl.) DEL: 15; DUP: 18; h2hINV: 20; SV types t2tINV: 14; TRA: 131 633 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 63 CN segments 0.7549835 FDR fragment joints 0 FDR chr. breakp. enrich.
190	4	Lower_Right	b85b14d7-3b5a-4800-af12-622ec03b9fe5	15:47687942−55499374	4, 5	28	{'min_x': 305.7300109863281, 'min_y': 693.2749633789062, 'max_x': 537.322021484375, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB 80 MB b85b14d7−3b5a−4800−af12−622ec03b9fe5 Skin−Melanoma Cancer type 15:47687942−55499374 Position With other complex events Type 8 Interleaved intrachr. SVs 70 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 3; TRA: 62 633 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 28 CN segments 0.9483317 FDR fragment joints 0 FDR chr. breakp. enrich.
191	1	Upper_Left	d8eac750-9daf-4465-b672-9e31fd369057	7:92899327−128870216	4, 9	12	{'min_x': 40.039798736572266, 'min_y': 280.6499938964844, 'max_x': 247.69195556640625, 'max_y': 410.3340148925781}	d8eac750−9daf−4465−b672−9e31fd369057 Skin−Melanoma Cancer type 7:92899327−128870216 Position With other complex events Type 7 Interleaved intrachr. SVs 7 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 0 266 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 12 CN segments 0.6776251 FDR fragment joints 0.03 FDR chr. breakp. enrich. Linked to chrs
191	2	Upper_Right	12bfd446-2ee5-4664-a492-c023d134f60f	10:11662562−50056640	5, 5	12	{'min_x': 330.3699951171875, 'min_y': 280.6499938964844, 'max_x': 536.3538818359375, 'max_y': 410.42401123046875}	12bfd446−2ee5−4664−a492−c023d134f60f SoftTissue−Leiomyo Cancer type 10:11662562−50056640 Position With other complex events Type 9 Interleaved intrachr. SVs 21 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 4; SV types t2tINV: 5; TRA: 3 247 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 12 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 9:434615−126676282; Linked to chrs
191	3	Lower_Left	12bfd446-2ee5-4664-a492-c023d134f60f	11:39261849−50164804	4, 4	4	{'min_x': 40.86989974975586, 'min_y': 693.2749633789062, 'max_x': 268.110107421875, 'max_y': 839.013916015625}	10 MB 20 MB 30 MB 40 MB 50 MB 12bfd446−2ee5−4664−a492−c023d134f60f SoftTissue−Leiomyo Cancer type 11:39261849−50164804 Position Canonical without polyploidization Type 14 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 6; DUP: 2; h2hINV: 2; SV types t2tINV: 4; TRA: 0 247 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 4 CN segments 0.615458 FDR fragment joints 0.26 FDR chr. breakp. enrich.
191	4	Lower_Right	7f9031da-124a-4a38-83e6-878a50e58c24	3:94022172−188180159	5, 9	9	{'min_x': 326.20001220703125, 'min_y': 693.2749633789062, 'max_x': 537.3599243164062, 'max_y': 834.6940307617188}	50 MB 100 MB 150 MB 7f9031da−124a−4a38−83e6−878a50e58c24 SoftTissue−Leiomyo Cancer type 3:94022172−188180159 Position With other complex events Type 25 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 9; DUP: 7; h2hINV: 4; SV types t2tINV: 5; TRA: 4 229 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 9 CN segments 0.8824283 FDR fragment joints 0 FDR chr. breakp. enrich.
192	1	Upper_Left	9c9b53e5-cdbe-4510-a839-4a3b5039681b	18:25133083−67867958	6, 8	32	{'min_x': 38.539798736572266, 'min_y': 280.6499938964844, 'max_x': 249.18795776367188, 'max_y': 410.3340148925781}	9c9b53e5−cdbe−4510−a839−4a3b5039681b SoftTissue−Leiomyo Cancer type 18:25133083−67867958 Position With other complex events Type 9 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 2; SV types t2tINV: 4; TRA: 4 240 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 32 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
192	2	Upper_Right	c20682a1-f340-430d-99f9-077fe093ed19	3:138369667−192817448	5, 7	34	{'min_x': 330.57000732421875, 'min_y': 280.6499938964844, 'max_x': 536.1538696289062, 'max_y': 410.42401123046875}	c20682a1−f340−430d−99f9−077fe093ed19 SoftTissue−Leiomyo Cancer type 3:138369667−192817448 Position With other complex events Type 15 Interleaved intrachr. SVs 25 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 6; SV types t2tINV: 5; TRA: 10 215 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 34 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 6:18987971−150829167; Linked to chrs
192	3	Lower_Left	2905cbd1-719b-46d9-b8af-8fe4927bc473	2:103504725−236615450	6, 12	82	{'min_x': 30.360200881958008, 'min_y': 693.2749633789062, 'max_x': 257.36993408203125, 'max_y': 831.1439819335938}	50 MB 100 MB 150 MB 200 MB 2905cbd1−719b−46d9−b8af−8fe4927bc473 SoftTissue−Liposarc Cancer type 2:103504725−236615450 Position With other complex events Type 15 Interleaved intrachr. SVs 155 Total SVs (intrachr. + transl.) DEL: 2; DUP: 7; h2hINV: 5; SV types t2tINV: 1; TRA: 140 1958 SVs in sample 6, 12 Oscillating CN (2 and 3 states) 82 CN segments 0.9804396 FDR fragment joints 0.23 FDR chr. breakp. enrich. 1:145389851−238867162;11:12674170−130091311
192	4	Lower_Right	2905cbd1-719b-46d9-b8af-8fe4927bc473	5:893523−179304807	5, 15	189	{'min_x': 309.3900146484375, 'min_y': 693.2749633789062, 'max_x': 545.2039794921875, 'max_y': 835.4639282226562}	0 MB 50 MB 100 MB 150 MB 2905cbd1−719b−46d9−b8af−8fe4927bc473 SoftTissue−Liposarc Cancer type 5:893523−179304807 Position With other complex events Type 19 Interleaved intrachr. SVs 274 Total SVs (intrachr. + transl.) DEL: 5; DUP: 5; h2hINV: 4; SV types t2tINV: 5; TRA: 255 1958 SVs in sample 5, 15 Oscillating CN (2 and 3 states) 189 CN segments 0.9034513 FDR fragment joints 0 FDR chr. breakp. enrich. 1:145389851−238867162;12:8404400−101121300 17:50057932−77131856;19:10607945−56113175
193	1	Upper_Left	2905cbd1-719b-46d9-b8af-8fe4927bc473	6:47184887−51731046	4, 5	42	{'min_x': 30.360200881958008, 'min_y': 267.6899719238281, 'max_x': 257.36993408203125, 'max_y': 410.3340148925781}	2905cbd1−719b−46d9−b8af−8fe4927bc473 SoftTissue−Liposarc Cancer type 6:47184887−51731046 Position With other complex events Type 11 Interleaved intrachr. SVs 60 Total SVs (intrachr. + transl.) DEL: 6; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 49 1958 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 42 CN segments 0.7993446 FDR fragment joints 0 FDR chr. breakp. enrich. 1:145389851−238867162;11:12674170−130091311 12:8404400−101121300;17:50057932−77131856 Linked to chrs
193	2	Upper_Right	2905cbd1-719b-46d9-b8af-8fe4927bc473	7:159034−86160841	5, 8	250	{'min_x': 319.8599853515625, 'min_y': 263.3699645996094, 'max_x': 546.8699951171875, 'max_y': 410.424072265625}	2905cbd1−719b−46d9−b8af−8fe4927bc473 SoftTissue−Liposarc Cancer type 7:159034−86160841 Position With other complex events Type 22 Interleaved intrachr. SVs 251 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 5; SV types t2tINV: 8; TRA: 229 1958 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 250 CN segments 0.8883474 FDR fragment joints 0 FDR chr. breakp. enrich. 1:145389851−238867162;11:12674170−130091311 12:8404400−101121300;17:50057932−77131856 19:10607945−56113175;2:103504725−236615449 Linked to chrs
193	3	Lower_Left	2905cbd1-719b-46d9-b8af-8fe4927bc473	19:10607945−56113176	5, 7	73	{'min_x': 32.019901275634766, 'min_y': 693.2749633789062, 'max_x': 254.03794860839844, 'max_y': 831.1439819335938}	20 MB 30 MB 40 MB 50 MB 2905cbd1−719b−46d9−b8af−8fe4927bc473 SoftTissue−Liposarc Cancer type 19:10607945−56113176 Position With other complex events Type 8 Interleaved intrachr. SVs 140 Total SVs (intrachr. + transl.) DEL: 3; DUP: 0; h2hINV: 3; SV types t2tINV: 2; TRA: 132 1958 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 73 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. 1:145389851−238867162;10:9380961−36837630
193	4	Lower_Right	2905cbd1-719b-46d9-b8af-8fe4927bc473	X:1766391−152187954	5, 8	145	{'min_x': 321.5199890136719, 'min_y': 693.2749633789062, 'max_x': 557.05224609375, 'max_y': 835.4639282226562}	50 MB 100 MB 150 MB 2905cbd1−719b−46d9−b8af−8fe4927bc473 SoftTissue−Liposarc Cancer type X:1766391−152187954 Position With other complex events Type 32 Interleaved intrachr. SVs 230 Total SVs (intrachr. + transl.) DEL: 6; DUP: 6; h2hINV: 11; SV types t2tINV: 9; TRA: 198 1958 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 145 CN segments 0.9728377 FDR fragment joints 0 FDR chr. breakp. enrich. 1:145389851−238867162;10:9380961−36837630 11:12674170−130091311;12:8404400−101121300
194	1	Upper_Left	2cacd9d0-8414-4f17-8259-c9d838597f39	4:7659968−47714738	5, 7	164	{'min_x': 32.019901275634766, 'min_y': 276.3299865722656, 'max_x': 255.70394897460938, 'max_y': 410.3340148925781}	2cacd9d0−8414−4f17−8259−c9d838597f39 SoftTissue−Liposarc Cancer type 4:7659968−47714738 Position With other complex events Type 34 Interleaved intrachr. SVs 199 Total SVs (intrachr. + transl.) DEL: 8; DUP: 7; h2hINV: 9; SV types t2tINV: 10; TRA: 165 531 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 164 CN segments 0.8548712 FDR fragment joints 0 FDR chr. breakp. enrich. 1:180979548−248890603;12:17335568−78414574 Linked to chrs
194	2	Upper_Right	3505f91d-bc66-4732-84b6-18c5b32ca6b8	13:20111633−31209010	6, 9	35	{'min_x': 321.5199890136719, 'min_y': 276.3299865722656, 'max_x': 545.2039794921875, 'max_y': 410.3340148925781}	3505f91d−bc66−4732−84b6−18c5b32ca6b8 SoftTissue−Liposarc Cancer type 13:20111633−31209010 Position With other complex events Type 14 Interleaved intrachr. SVs 65 Total SVs (intrachr. + transl.) DEL: 3; DUP: 6; h2hINV: 3; SV types t2tINV: 2; TRA: 51 1246 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 35 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 12:4488859−131646236;5:111534825−180595775 Linked to chrs
194	3	Lower_Left	3608bfbb-2a92-4ec2-a330-bf4790a8b65c	1:145028117−172009311	5, 8	67	{'min_x': 39.88010025024414, 'min_y': 693.2749633789062, 'max_x': 247.85195922851562, 'max_y': 839.013916015625}	120 MB 160 MB 200 MB 3608bfbb−2a92−4ec2−a330−bf4790a8b65c SoftTissue−Liposarc Cancer type 1:145028117−172009311 Position With other complex events Type 22 Interleaved intrachr. SVs 127 Total SVs (intrachr. + transl.) DEL: 7; DUP: 6; h2hINV: 5; SV types t2tINV: 4; TRA: 105 448 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 67 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
194	4	Lower_Right	3608bfbb-2a92-4ec2-a330-bf4790a8b65c	7:65666837−150670275	5, 11	39	{'min_x': 319.239990234375, 'min_y': 693.2749633789062, 'max_x': 558.5921630859375, 'max_y': 839.013916015625}	70 MB 90 MB 110 MB 130 MB 150 MB 3608bfbb−2a92−4ec2−a330−bf4790a8b65c SoftTissue−Liposarc Cancer type 7:65666837−150670275 Position With other complex events Type 14 Interleaved intrachr. SVs 38 Total SVs (intrachr. + transl.) DEL: 6; DUP: 5; h2hINV: 2; SV types t2tINV: 1; TRA: 24 448 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 39 CN segments 0.4101979 FDR fragment joints 0 FDR chr. breakp. enrich.
195	1	Upper_Left	3608bfbb-2a92-4ec2-a330-bf4790a8b65c	X:16247627−46643679	5, 5	85	{'min_x': 32.019901275634766, 'min_y': 276.3299865722656, 'max_x': 255.70394897460938, 'max_y': 410.3340148925781}	3608bfbb−2a92−4ec2−a330−bf4790a8b65c SoftTissue−Liposarc Cancer type X:16247627−46643679 Position With other complex events Type 20 Interleaved intrachr. SVs 108 Total SVs (intrachr. + transl.) DEL: 10; DUP: 6; h2hINV: 1; SV types t2tINV: 3; TRA: 88 448 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 85 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich. 1:145028117−172009310;7:65666837−150670274 Linked to chrs
195	2	Upper_Right	39f68467-3d37-4b19-aa43-ed7b120c619d	3:4159559−20777597	5, 7	61	{'min_x': 328.7099914550781, 'min_y': 280.6499938964844, 'max_x': 538.0198974609375, 'max_y': 410.42401123046875}	39f68467−3d37−4b19−aa43−ed7b120c619d SoftTissue−Liposarc Cancer type 3:4159559−20777597 Position With other complex events Type 14 Interleaved intrachr. SVs 107 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 5; SV types t2tINV: 2; TRA: 93 1635 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 61 CN segments 0.615458 FDR fragment joints 0.03 FDR chr. breakp. enrich. 22:23956086−48888565; Linked to chrs
195	3	Lower_Left	39f68467-3d37-4b19-aa43-ed7b120c619d	4:127090720−151907883	6, 15	60	{'min_x': 39.210201263427734, 'min_y': 693.2749633789062, 'max_x': 267.1418151855469, 'max_y': 839.013916015625}	140 MB 150 MB 160 MB 170 MB 180 MB 39f68467−3d37−4b19−aa43−ed7b120c619d SoftTissue−Liposarc Cancer type 4:127090720−151907883 Position With other complex events Type 30 Interleaved intrachr. SVs 49 Total SVs (intrachr. + transl.) DEL: 4; DUP: 8; h2hINV: 11; SV types t2tINV: 7; TRA: 19 1635 SVs in sample 6, 15 Oscillating CN (2 and 3 states) 60 CN segments 0.9284301 FDR fragment joints 0.12 FDR chr. breakp. enrich.
195	4	Lower_Right	39f68467-3d37-4b19-aa43-ed7b120c619d	5:492905−14929135	4, 6	43	{'min_x': 308.7200012207031, 'min_y': 693.2749633789062, 'max_x': 557.8222045898438, 'max_y': 834.6940307617188}	0 MB 40 MB 80 MB 120 MB 160 MB 39f68467−3d37−4b19−aa43−ed7b120c619d SoftTissue−Liposarc Cancer type 5:492905−14929135 Position With other complex events Type 16 Interleaved intrachr. SVs 100 Total SVs (intrachr. + transl.) DEL: 9; DUP: 4; h2hINV: 3; SV types t2tINV: 0; TRA: 84 1635 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 43 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
196	1	Upper_Left	39f68467-3d37-4b19-aa43-ed7b120c619d	6:29105248−126918492	4, 11	64	{'min_x': 37.03010177612305, 'min_y': 276.3299865722656, 'max_x': 250.69595336914062, 'max_y': 410.3340148925781}	39f68467−3d37−4b19−aa43−ed7b120c619d SoftTissue−Liposarc Cancer type 6:29105248−126918492 Position With other complex events Type 12 Interleaved intrachr. SVs 206 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 194 1635 SVs in sample 4, 11 Oscillating CN (2 and 3 states) 64 CN segments 0.8474427 FDR fragment joints 0 FDR chr. breakp. enrich. 20:33082736−57423557;3:4159559−20777596 Linked to chrs
196	2	Upper_Right	39f68467-3d37-4b19-aa43-ed7b120c619d	20:33082736−57423558	6, 8	48	{'min_x': 324.8599853515625, 'min_y': 276.3299865722656, 'max_x': 541.8719482421875, 'max_y': 410.3340148925781}	39f68467−3d37−4b19−aa43−ed7b120c619d SoftTissue−Liposarc Cancer type 20:33082736−57423558 Position With other complex events Type 8 Interleaved intrachr. SVs 73 Total SVs (intrachr. + transl.) DEL: 4; DUP: 0; h2hINV: 3; SV types t2tINV: 1; TRA: 65 1635 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 48 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. 3:4159559−20777596;4:127090720−151907882 Linked to chrs
196	3	Lower_Left	6b189eff-b919-49d6-8775-dbf32c9ccbba	1:52359894−60254337	4, 4	33	{'min_x': 38.70000076293945, 'min_y': 693.2749633789062, 'max_x': 247.5139617919922, 'max_y': 834.6940307617188}	60 MB 70 MB 80 MB 90 MB 6b189eff−b919−49d6−8775−dbf32c9ccbba SoftTissue−Liposarc Cancer type 1:52359894−60254337 Position With other complex events Type 7 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 47 890 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 33 CN segments 1 FDR fragment joints 0.7 FDR chr. breakp. enrich.
196	4	Lower_Right	6b189eff-b919-49d6-8775-dbf32c9ccbba	14:95901595−105399403	5, 6	34	{'min_x': 309.8699951171875, 'min_y': 693.2749633789062, 'max_x': 537.013916015625, 'max_y': 839.013916015625}	96 MB 98 MB 100 MB 102 MB 104 MB 6b189eff−b919−49d6−8775−dbf32c9ccbba SoftTissue−Liposarc Cancer type 14:95901595−105399403 Position With other complex events Type 10 Interleaved intrachr. SVs 79 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 1; SV types t2tINV: 4; TRA: 69 890 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 34 CN segments 0.7590432 FDR fragment joints 0 FDR chr. breakp. enrich.
197	1	Upper_Left	6b189eff-b919-49d6-8775-dbf32c9ccbba	15:22563932−54759738	4, 10	26	{'min_x': 40.210201263427734, 'min_y': 280.6499938964844, 'max_x': 247.5139617919922, 'max_y': 410.3340148925781}	6b189eff−b919−49d6−8775−dbf32c9ccbba SoftTissue−Liposarc Cancer type 15:22563932−54759738 Position With other complex events Type 23 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 6; SV types t2tINV: 8; TRA: 0 890 SVs in sample 4, 10 Oscillating CN (2 and 3 states) 26 CN segments 0.7861024 FDR fragment joints 1 FDR chr. breakp. enrich. Linked to chrs
197	2	Upper_Right	73d2e8ef-4e10-416a-845b-f48374e48ecb	17:38121352−80696808	6, 11	51	{'min_x': 323.19000244140625, 'min_y': 272.0099792480469, 'max_x': 543.5379638671875, 'max_y': 410.4242248535156}	73d2e8ef−4e10−416a−845b−f48374e48ecb SoftTissue−Liposarc Cancer type 17:38121352−80696808 Position With other complex events Type 7 Interleaved intrachr. SVs 71 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 2; TRA: 64 1088 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 51 CN segments 0.930656 FDR fragment joints 0 FDR chr. breakp. enrich. 12:57518989−72095051;22:32381273−48585046 3:3279482−196670439;5:703397−41841708 Linked to chrs
197	3	Lower_Left	8f3f6f7c-4b50-467e-a6e8-d836735913f6	1:1201892−21330306	5, 7	9	{'min_x': 41.710201263427734, 'min_y': 693.2749633789062, 'max_x': 246.01596069335938, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 8f3f6f7c−4b50−467e−a6e8−d836735913f6 SoftTissue−Liposarc Cancer type 1:1201892−21330306 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 1; SV types t2tINV: 2; TRA: 0 782 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 9 CN segments 0.9284301 FDR fragment joints 0 FDR chr. breakp. enrich.
197	4	Lower_Right	8f3f6f7c-4b50-467e-a6e8-d836735913f6	3:190977465−197689209	4, 7	23	{'min_x': 331.2099914550781, 'min_y': 693.2749633789062, 'max_x': 535.515869140625, 'max_y': 839.013916015625}	170 MB 180 MB 190 MB 8f3f6f7c−4b50−467e−a6e8−d836735913f6 SoftTissue−Liposarc Cancer type 3:190977465−197689209 Position With other complex events Type 17 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 4; DUP: 8; h2hINV: 2; SV types t2tINV: 3; TRA: 0 782 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 23 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich.
198	1	Upper_Left	8f3f6f7c-4b50-467e-a6e8-d836735913f6	17:5483205−17481065	4, 7	11	{'min_x': 41.710201263427734, 'min_y': 280.6499938964844, 'max_x': 246.01596069335938, 'max_y': 410.3340148925781}	8f3f6f7c−4b50−467e−a6e8−d836735913f6 SoftTissue−Liposarc Cancer type 17:5483205−17481065 Position With other complex events Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 0 782 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 11 CN segments 0.9284301 FDR fragment joints 0.22 FDR chr. breakp. enrich. Linked to chrs
198	2	Upper_Right	8f3f6f7c-4b50-467e-a6e8-d836735913f6	18:43622824−72635271	5, 8	8	{'min_x': 331.2099914550781, 'min_y': 280.6499938964844, 'max_x': 535.515869140625, 'max_y': 410.3340148925781}	8f3f6f7c−4b50−467e−a6e8−d836735913f6 SoftTissue−Liposarc Cancer type 18:43622824−72635271 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 2; SV types t2tINV: 3; TRA: 0 782 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
198	3	Lower_Left	9517413b-b5b8-4130-8ba1-d86d44abe2ec	5:274679−32089188	5, 5	50	{'min_x': 38.210201263427734, 'min_y': 693.2749633789062, 'max_x': 268.6021423339844, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB 9517413b−b5b8−4130−8ba1−d86d44abe2ec SoftTissue−Liposarc Cancer type 5:274679−32089188 Position With other complex events Type 19 Interleaved intrachr. SVs 73 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 7; SV types t2tINV: 5; TRA: 54 498 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 50 CN segments 0.982453 FDR fragment joints 0 FDR chr. breakp. enrich.
198	4	Lower_Right	9517413b-b5b8-4130-8ba1-d86d44abe2ec	18:20983183−30290774	4, 6	30	{'min_x': 327.7099914550781, 'min_y': 693.2749633789062, 'max_x': 552.710205078125, 'max_y': 839.013916015625}	21 MB 24 MB 27 MB 30 MB 9517413b−b5b8−4130−8ba1−d86d44abe2ec SoftTissue−Liposarc Cancer type 18:20983183−30290774 Position With other complex events Type 9 Interleaved intrachr. SVs 55 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 2; TRA: 46 498 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 30 CN segments 0.7257048 FDR fragment joints 0 FDR chr. breakp. enrich.
199	1	Upper_Left	b5f27002-4277-418d-90b0-cc5a2742692e	3:16208743−73683673	6, 11	13	{'min_x': 39.539798736572266, 'min_y': 280.6499938964844, 'max_x': 248.18994140625, 'max_y': 410.42401123046875}	b5f27002−4277−418d−90b0−cc5a2742692e SoftTissue−Liposarc Cancer type 3:16208743−73683673 Position With other complex events Type 16 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 2; DUP: 4; h2hINV: 6; SV types t2tINV: 4; TRA: 8 895 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 13 CN segments 0.8653243 FDR fragment joints 0.22 FDR chr. breakp. enrich. 9:1073973−27003043; Linked to chrs
199	2	Upper_Right	b5f27002-4277-418d-90b0-cc5a2742692e	13:65093605−113188518	5, 6	41	{'min_x': 321.5199890136719, 'min_y': 267.6899719238281, 'max_x': 545.2039794921875, 'max_y': 410.3340148925781}	b5f27002−4277−418d−90b0−cc5a2742692e SoftTissue−Liposarc Cancer type 13:65093605−113188518 Position With other complex events Type 7 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 0; SV types t2tINV: 1; TRA: 47 895 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 41 CN segments 1 FDR fragment joints 0 FDR chr. breakp. enrich. 1:175909202−201271526;15:77063545−87618665 3:16208743−73683672;6:121478880−150364307 Linked to chrs
199	3	Lower_Left	cd73a55f-03c1-4da0-9fa7-1ae4a263664e	15:22370209−52646685	4, 10	21	{'min_x': 40.36989974975586, 'min_y': 693.2749633789062, 'max_x': 247.36195373535156, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB cd73a55f−03c1−4da0−9fa7−1ae4a263664e SoftTissue−Liposarc Cancer type 15:22370209−52646685 Position With other complex events Type 12 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 5; h2hINV: 3; SV types t2tINV: 1; TRA: 1 595 SVs in sample 4, 10 Oscillating CN (2 and 3 states) 21 CN segments 0.6776251 FDR fragment joints 0.5 FDR chr. breakp. enrich.
199	4	Lower_Right	e7a72f7e-77b1-4d95-8f37-39a6cffc35dc	19:29150130−38233328	4, 7	35	{'min_x': 331.0400085449219, 'min_y': 693.2749633789062, 'max_x': 535.6859130859375, 'max_y': 839.013916015625}	20 MB 30 MB e7a72f7e−77b1−4d95−8f37−39a6cffc35dc SoftTissue−Liposarc Cancer type 19:29150130−38233328 Position With other complex events Type 6 Interleaved intrachr. SVs 79 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 0; SV types t2tINV: 3; TRA: 73 696 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 35 CN segments 0.930656 FDR fragment joints 0 FDR chr. breakp. enrich.
200	1	Upper_Left	e7a72f7e-77b1-4d95-8f37-39a6cffc35dc	22:16915315−49000417	4, 5	35	{'min_x': 40.360198974609375, 'min_y': 276.3299865722656, 'max_x': 247.36395263671875, 'max_y': 410.3340148925781}	e7a72f7e−77b1−4d95−8f37−39a6cffc35dc SoftTissue−Liposarc Cancer type 22:16915315−49000417 Position With other complex events Type 6 Interleaved intrachr. SVs 44 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 38 696 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 35 CN segments 0.8874881 FDR fragment joints 0 FDR chr. breakp. enrich. 11:993833−37433475;5:1295334−20553338 Linked to chrs
200	2	Upper_Right	CGP_donor_GC00002	17:38202359−40046302	5, 6	54	{'min_x': 349.67999267578125, 'min_y': 280.6499938964844, 'max_x': 517.0442504882812, 'max_y': 410.3340148925781}	CGP_donor_GC00002 Stomach−AdenoCA Cancer type 17:38202359−40046302 Position With other complex events Type 42 Interleaved intrachr. SVs 57 Total SVs (intrachr. + transl.) DEL: 13; DUP: 11; h2hINV: 6; SV types t2tINV: 12; TRA: 15 442 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 54 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
200	3	Lower_Left	CGP_donor_GC00002	19:7239458−34549451	6, 6	42	{'min_x': 60.18009948730469, 'min_y': 693.2749633789062, 'max_x': 246.59986877441406, 'max_y': 839.013916015625}	20 MB 30 MB 40 MB 50 MB CGP_donor_GC00002 Stomach−AdenoCA Cancer type 19:7239458−34549451 Position With other complex events Type 38 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 11; DUP: 7; h2hINV: 11; SV types t2tINV: 9; TRA: 4 442 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 42 CN segments 0.9550868 FDR fragment joints 0 FDR chr. breakp. enrich.
200	4	Lower_Right	CGP_donor_GC00008	5:35107612−41952066	5, 9	48	{'min_x': 319.0299987792969, 'min_y': 693.2749633789062, 'max_x': 524.632080078125, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 100 MB 120 MB CGP_donor_GC00008 Stomach−AdenoCA Cancer type 5:35107612−41952066 Position With other complex events Type 43 Interleaved intrachr. SVs 46 Total SVs (intrachr. + transl.) DEL: 9; DUP: 13; h2hINV: 10; SV types t2tINV: 11; TRA: 3 307 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 48 CN segments 0.7964069 FDR fragment joints 0 FDR chr. breakp. enrich.
201	1	Upper_Left	CGP_donor_GC00008	19:13824051−29025405	5, 12	12	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_GC00008 Stomach−AdenoCA Cancer type 19:13824051−29025405 Position With other complex events Type 19 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 1; DUP: 5; h2hINV: 7; SV types t2tINV: 6; TRA: 1 307 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 12 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
201	2	Upper_Right	CGP_donor_GC00013	2:223705573−228623701	4, 6	52	{'min_x': 349.67999267578125, 'min_y': 280.6499938964844, 'max_x': 517.0442504882812, 'max_y': 410.3340148925781}	CGP_donor_GC00013 Stomach−AdenoCA Cancer type 2:223705573−228623701 Position With other complex events Type 40 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 11; DUP: 12; h2hINV: 7; SV types t2tINV: 10; TRA: 0 95 SVs in sample 4, 6 Oscillating CN (2 and 3 states) 52 CN segments 0.8135044 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
201	3	Lower_Left	CGP_donor_GC00018	11:104455729−127800985	5, 10	16	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 244.93214416503906, 'max_y': 839.013916015625}	80 MB 100 MB 120 MB CGP_donor_GC00018 Stomach−AdenoCA Cancer type 11:104455729−127800985 Position With other complex events Type 8 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 1; TRA: 6 85 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 16 CN segments 0.8066159 FDR fragment joints 0 FDR chr. breakp. enrich.
201	4	Lower_Right	CGP_donor_GC00019	17:34964923−73655919	4, 7	22	{'min_x': 337.510009765625, 'min_y': 693.2749633789062, 'max_x': 536.6600952148438, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 70 MB CGP_donor_GC00019 Stomach−AdenoCA Cancer type 17:34964923−73655919 Position With other complex events Type 13 Interleaved intrachr. SVs 18 Total SVs (intrachr. + transl.) DEL: 3; DUP: 4; h2hINV: 2; SV types t2tINV: 4; TRA: 5 101 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 22 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
202	1	Upper_Left	CGP_donor_GC00020	8:99969120−137759332	4, 7	41	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.42401123046875}	CGP_donor_GC00020 Stomach−AdenoCA Cancer type 8:99969120−137759332 Position With other complex events Type 6 Interleaved intrachr. SVs 23 Total SVs (intrachr. + transl.) DEL: 1; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 17 403 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 41 CN segments 0.7861024 FDR fragment joints 0 FDR chr. breakp. enrich. 1:22345572−221724578; Linked to chrs
202	2	Upper_Right	CGP_donor_GC00020	11:69004148−111983118	4, 5	40	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_GC00020 Stomach−AdenoCA Cancer type 11:69004148−111983118 Position With other complex events Type 11 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 3; SV types t2tINV: 4; TRA: 13 403 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 40 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
202	3	Lower_Left	CGP_donor_GC00033	3:98369145−186328430	5, 14	28	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB CGP_donor_GC00033 Stomach−AdenoCA Cancer type 3:98369145−186328430 Position With other complex events Type 10 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 1; DUP: 6; h2hINV: 1; SV types t2tINV: 2; TRA: 3 925 SVs in sample 5, 14 Oscillating CN (2 and 3 states) 28 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
202	4	Lower_Right	CGP_donor_GC00037	12:20006408−108461993	5, 8	13	{'min_x': 343.17999267578125, 'min_y': 693.2749633789062, 'max_x': 540.6322631835938, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB CGP_donor_GC00037 Stomach−AdenoCA Cancer type 12:20006408−108461993 Position With other complex events Type 7 Interleaved intrachr. SVs 17 Total SVs (intrachr. + transl.) DEL: 1; DUP: 0; h2hINV: 3; SV types t2tINV: 3; TRA: 10 58 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 13 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
203	1	Upper_Left	CGP_donor_GC00046	10:62613110−77504895	5, 11	11	{'min_x': 63.519901275634766, 'min_y': 280.6499938964844, 'max_x': 224.2118377685547, 'max_y': 410.3340148925781}	CGP_donor_GC00046 Stomach−AdenoCA Cancer type 10:62613110−77504895 Position With other complex events Type 10 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 0; DUP: 4; h2hINV: 3; SV types t2tINV: 3; TRA: 0 76 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 11 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
203	2	Upper_Right	CGP_donor_GC00047	5:6115950−152429287	6, 10	19	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.42401123046875}	CGP_donor_GC00047 Stomach−AdenoCA Cancer type 5:6115950−152429287 Position With other complex events Type 10 Interleaved intrachr. SVs 29 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 2; SV types t2tINV: 3; TRA: 19 187 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 19 CN segments 0.7359483 FDR fragment joints 0 FDR chr. breakp. enrich. 1:26335498−206855060; Linked to chrs
203	3	Lower_Left	CGP_donor_GC00047	8:65287254−138950505	4, 9	24	{'min_x': 35.360198974609375, 'min_y': 693.2749633789062, 'max_x': 224.2118377685547, 'max_y': 834.6940307617188}	50 MB 100 MB CGP_donor_GC00047 Stomach−AdenoCA Cancer type 8:65287254−138950505 Position With other complex events Type 7 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 3; TRA: 29 187 SVs in sample 4, 9 Oscillating CN (2 and 3 states) 24 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
203	4	Lower_Right	CGP_donor_GC00052	7:42989699−154627590	6, 6	62	{'min_x': 321.5199890136719, 'min_y': 693.2749633789062, 'max_x': 543.8921508789062, 'max_y': 839.013916015625}	50 MB 75 MB 100 MB 125 MB 150 MB CGP_donor_GC00052 Stomach−AdenoCA Cancer type 7:42989699−154627590 Position With other complex events Type 48 Interleaved intrachr. SVs 54 Total SVs (intrachr. + transl.) DEL: 5; DUP: 12; h2hINV: 16; SV types t2tINV: 15; TRA: 6 309 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 62 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
204	1	Upper_Left	CGP_donor_GC00052	21:15959382−46300731	5, 7	7	{'min_x': 54.730098724365234, 'min_y': 280.6499938964844, 'max_x': 232.99598693847656, 'max_y': 410.3340148925781}	CGP_donor_GC00052 Stomach−AdenoCA Cancer type 21:15959382−46300731 Position Canonical without polyploidization Type 7 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 0; SV types t2tINV: 2; TRA: 4 309 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 7 CN segments 0.7425546 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
204	2	Upper_Right	CGP_donor_GC00053	13:39597021−104940825	5, 10	23	{'min_x': 353.0199890136719, 'min_y': 280.6499938964844, 'max_x': 513.7119140625, 'max_y': 410.3340148925781}	CGP_donor_GC00053 Stomach−AdenoCA Cancer type 13:39597021−104940825 Position With other complex events Type 11 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 5; DUP: 4; h2hINV: 0; SV types t2tINV: 2; TRA: 1 317 SVs in sample 5, 10 Oscillating CN (2 and 3 states) 23 CN segments 0.5435077 FDR fragment joints 0.2 FDR chr. breakp. enrich. Linked to chrs
204	3	Lower_Left	CGP_donor_GC00053	18:1608546−71962999	6, 10	66	{'min_x': 63.519901275634766, 'min_y': 693.2749633789062, 'max_x': 229.71986389160156, 'max_y': 839.013916015625}	20 MB 40 MB 60 MB CGP_donor_GC00053 Stomach−AdenoCA Cancer type 18:1608546−71962999 Position With other complex events Type 33 Interleaved intrachr. SVs 36 Total SVs (intrachr. + transl.) DEL: 9; DUP: 9; h2hINV: 6; SV types t2tINV: 9; TRA: 3 317 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 66 CN segments 0.9875525 FDR fragment joints 0 FDR chr. breakp. enrich.
204	4	Lower_Right	0aecac64-5982-4d76-8f31-958f6a00951d	12:24064615−98708265	4, 4	66	{'min_x': 329.8699951171875, 'min_y': 693.2749633789062, 'max_x': 550.8222045898438, 'max_y': 839.013916015625}	25 MB 50 MB 75 MB 100 MB 0aecac64−5982−4d76−8f31−958f6a00951d Stomach−AdenoCA Cancer type 12:24064615−98708265 Position With other complex events Type 48 Interleaved intrachr. SVs 56 Total SVs (intrachr. + transl.) DEL: 10; DUP: 16; h2hINV: 10; SV types t2tINV: 12; TRA: 8 332 SVs in sample 4, 4 Oscillating CN (2 and 3 states) 66 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
205	1	Upper_Left	0b4e8d73-459d-4930-9d1a-abb8d53e1844	2:101189993−207792558	5, 7	19	{'min_x': 38.210201263427734, 'min_y': 280.6499938964844, 'max_x': 249.51795959472656, 'max_y': 410.3340148925781}	0b4e8d73−459d−4930−9d1a−abb8d53e1844 Stomach−AdenoCA Cancer type 2:101189993−207792558 Position With other complex events Type 9 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 2; SV types t2tINV: 2; TRA: 0 208 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 19 CN segments 0.9723381 FDR fragment joints 0.83 FDR chr. breakp. enrich. Linked to chrs
205	2	Upper_Right	1ca3c5e0-32b0-4467-8ec0-ca212e35d2b3	6:30271712−157786893	5, 12	48	{'min_x': 321.5199890136719, 'min_y': 276.3299865722656, 'max_x': 545.2039794921875, 'max_y': 410.3340148925781}	1ca3c5e0−32b0−4467−8ec0−ca212e35d2b3 Stomach−AdenoCA Cancer type 6:30271712−157786893 Position With other complex events Type 11 Interleaved intrachr. SVs 33 Total SVs (intrachr. + transl.) DEL: 4; DUP: 1; h2hINV: 1; SV types t2tINV: 5; TRA: 22 313 SVs in sample 5, 12 Oscillating CN (2 and 3 states) 48 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich. 11:17850371−130169014;13:27261037−79173978 Linked to chrs
205	3	Lower_Left	283776cd-32e8-4a79-bed1-1411c9d3a9e0	9:1273053−106799638	4, 8	63	{'min_x': 38.70000076293945, 'min_y': 693.2749633789062, 'max_x': 249.0279541015625, 'max_y': 839.013916015625}	50 MB 100 MB 283776cd−32e8−4a79−bed1−1411c9d3a9e0 Stomach−AdenoCA Cancer type 9:1273053−106799638 Position With other complex events Type 35 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 10; DUP: 8; h2hINV: 7; SV types t2tINV: 10; TRA: 0 99 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 63 CN segments 0.9176394 FDR fragment joints 0 FDR chr. breakp. enrich.
205	4	Lower_Right	2d291fa3-f0fd-4bc1-91a6-783863714190	2:744061−80962231	5, 9	52	{'min_x': 308.6499938964844, 'min_y': 693.2749633789062, 'max_x': 537.1322021484375, 'max_y': 834.6940307617188}	0 MB 50 MB 100 MB 150 MB 200 MB 2d291fa3−f0fd−4bc1−91a6−783863714190 Stomach−AdenoCA Cancer type 2:744061−80962231 Position With other complex events Type 20 Interleaved intrachr. SVs 57 Total SVs (intrachr. + transl.) DEL: 5; DUP: 7; h2hINV: 2; SV types t2tINV: 6; TRA: 37 408 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 52 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
206	1	Upper_Left	2d291fa3-f0fd-4bc1-91a6-783863714190	12:7030656−104650534	6, 8	243	{'min_x': 38.70000076293945, 'min_y': 276.3299865722656, 'max_x': 249.0299530029297, 'max_y': 410.3340148925781}	2d291fa3−f0fd−4bc1−91a6−783863714190 Stomach−AdenoCA Cancer type 12:7030656−104650534 Position With other complex events Type 103 Interleaved intrachr. SVs 169 Total SVs (intrachr. + transl.) DEL: 27; DUP: 25; h2hINV: 24; SV types t2tINV: 27; TRA: 66 408 SVs in sample 6, 8 Oscillating CN (2 and 3 states) 243 CN segments 0.8572806 FDR fragment joints 0 FDR chr. breakp. enrich. 10:83825888−84983844;2:744061−80962230 Linked to chrs
206	2	Upper_Right	337819d2-5281-4b41-9583-a476924bc837	6:20138021−151484461	4, 8	28	{'min_x': 321.5199890136719, 'min_y': 276.3299865722656, 'max_x': 545.2039794921875, 'max_y': 410.3340148925781}	337819d2−5281−4b41−9583−a476924bc837 Stomach−AdenoCA Cancer type 6:20138021−151484461 Position With other complex events Type 7 Interleaved intrachr. SVs 14 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 7 210 SVs in sample 4, 8 Oscillating CN (2 and 3 states) 28 CN segments 0.8988396 FDR fragment joints 0 FDR chr. breakp. enrich. 14:56203717−106008232;2:63345548−242350180 Linked to chrs
206	3	Lower_Left	337819d2-5281-4b41-9583-a476924bc837	16:24987472−67049646	5, 9	11	{'min_x': 38.86989974975586, 'min_y': 693.2749633789062, 'max_x': 248.8579559326172, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 337819d2−5281−4b41−9583−a476924bc837 Stomach−AdenoCA Cancer type 16:24987472−67049646 Position With other complex events Type 8 Interleaved intrachr. SVs 9 Total SVs (intrachr. + transl.) DEL: 3; DUP: 1; h2hINV: 2; SV types t2tINV: 2; TRA: 1 210 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 11 CN segments 0.854603 FDR fragment joints 0.01 FDR chr. breakp. enrich.
206	4	Lower_Right	53086e20-a727-40d6-b42d-8030109b5130	6:28215328−141062702	5, 6	20	{'min_x': 328.20001220703125, 'min_y': 693.2749633789062, 'max_x': 556.3722534179688, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 160 MB 53086e20−a727−40d6−b42d−8030109b5130 Stomach−AdenoCA Cancer type 6:28215328−141062702 Position With other complex events Type 7 Interleaved intrachr. SVs 24 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 2; SV types t2tINV: 1; TRA: 17 246 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 20 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
207	1	Upper_Left	53086e20-a727-40d6-b42d-8030109b5130	17:3107404−39977217	4, 10	24	{'min_x': 38.70000076293945, 'min_y': 280.6499938964844, 'max_x': 249.0279541015625, 'max_y': 410.42401123046875}	53086e20−a727−40d6−b42d−8030109b5130 Stomach−AdenoCA Cancer type 17:3107404−39977217 Position With other complex events Type 32 Interleaved intrachr. SVs 43 Total SVs (intrachr. + transl.) DEL: 6; DUP: 8; h2hINV: 6; SV types t2tINV: 12; TRA: 11 246 SVs in sample 4, 10 Oscillating CN (2 and 3 states) 24 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. 6:28215328−141062701; Linked to chrs
207	2	Upper_Right	647dc54f-a51b-40ea-9d97-c93598c2af71	18:1875598−19427543	6, 15	20	{'min_x': 329.7099914550781, 'min_y': 280.6499938964844, 'max_x': 537.0219116210938, 'max_y': 410.3340148925781}	647dc54f−a51b−40ea−9d97−c93598c2af71 Stomach−AdenoCA Cancer type 18:1875598−19427543 Position With other complex events Type 12 Interleaved intrachr. SVs 12 Total SVs (intrachr. + transl.) DEL: 2; DUP: 5; h2hINV: 2; SV types t2tINV: 3; TRA: 0 294 SVs in sample 6, 15 Oscillating CN (2 and 3 states) 20 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
207	3	Lower_Left	8b5746f9-dbee-40bd-9141-1081960cf286	1:17246972−229690987	6, 11	48	{'min_x': 39.88010025024414, 'min_y': 693.2749633789062, 'max_x': 247.85195922851562, 'max_y': 839.013916015625}	50 MB 100 MB 150 MB 200 MB 8b5746f9−dbee−40bd−9141−1081960cf286 Stomach−AdenoCA Cancer type 1:17246972−229690987 Position With other complex events Type 10 Interleaved intrachr. SVs 27 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 3; SV types t2tINV: 3; TRA: 17 363 SVs in sample 6, 11 Oscillating CN (2 and 3 states) 48 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
207	4	Lower_Right	8b5746f9-dbee-40bd-9141-1081960cf286	13:58047889−91889039	5, 7	57	{'min_x': 329.3800048828125, 'min_y': 693.2749633789062, 'max_x': 537.3518676757812, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB 8b5746f9−dbee−40bd−9141−1081960cf286 Stomach−AdenoCA Cancer type 13:58047889−91889039 Position With other complex events Type 30 Interleaved intrachr. SVs 42 Total SVs (intrachr. + transl.) DEL: 8; DUP: 9; h2hINV: 4; SV types t2tINV: 9; TRA: 12 363 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 57 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
208	1	Upper_Left	8b5746f9-dbee-40bd-9141-1081960cf286	16:693417−62053802	5, 8	8	{'min_x': 39.88010025024414, 'min_y': 280.6499938964844, 'max_x': 247.85195922851562, 'max_y': 410.3340148925781}	8b5746f9−dbee−40bd−9141−1081960cf286 Stomach−AdenoCA Cancer type 16:693417−62053802 Position Canonical without polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 2; DUP: 1; h2hINV: 1; SV types t2tINV: 2; TRA: 0 363 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.9284301 FDR fragment joints 0.02 FDR chr. breakp. enrich. Linked to chrs
208	2	Upper_Right	8b5746f9-dbee-40bd-9141-1081960cf286	19:3088176−57557538	6, 9	90	{'min_x': 329.3800048828125, 'min_y': 280.6499938964844, 'max_x': 537.3518676757812, 'max_y': 410.42401123046875}	8b5746f9−dbee−40bd−9141−1081960cf286 Stomach−AdenoCA Cancer type 19:3088176−57557538 Position With other complex events Type 58 Interleaved intrachr. SVs 63 Total SVs (intrachr. + transl.) DEL: 14; DUP: 17; h2hINV: 12; SV types t2tINV: 15; TRA: 5 363 SVs in sample 6, 9 Oscillating CN (2 and 3 states) 90 CN segments 0.9087805 FDR fragment joints 0 FDR chr. breakp. enrich. 17:1358751−56764163; Linked to chrs
208	3	Lower_Left	c991697f-77f9-412a-9bd1-0e47f7387cb2	8:18453850−78826170	5, 8	79	{'min_x': 40.86989974975586, 'min_y': 693.2749633789062, 'max_x': 246.8539581298828, 'max_y': 839.013916015625}	40 MB 60 MB 80 MB c991697f−77f9−412a−9bd1−0e47f7387cb2 Stomach−AdenoCA Cancer type 8:18453850−78826170 Position With other complex events Type 43 Interleaved intrachr. SVs 51 Total SVs (intrachr. + transl.) DEL: 11; DUP: 13; h2hINV: 10; SV types t2tINV: 9; TRA: 8 187 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 79 CN segments 0.8653243 FDR fragment joints 0 FDR chr. breakp. enrich.
208	4	Lower_Right	c991697f-77f9-412a-9bd1-0e47f7387cb2	17:25815792−62916421	5, 9	70	{'min_x': 330.3699951171875, 'min_y': 693.2749633789062, 'max_x': 540.3201904296875, 'max_y': 839.013916015625}	30 MB 40 MB 50 MB 60 MB c991697f−77f9−412a−9bd1−0e47f7387cb2 Stomach−AdenoCA Cancer type 17:25815792−62916421 Position With other complex events Type 35 Interleaved intrachr. SVs 40 Total SVs (intrachr. + transl.) DEL: 4; DUP: 7; h2hINV: 16; SV types t2tINV: 8; TRA: 5 187 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 70 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich.
209	1	Upper_Left	cb622cd6-776d-4681-8a67-4addd61c66b8	5:94993806−173860097	4, 5	94	{'min_x': 37.03010177612305, 'min_y': 276.3299865722656, 'max_x': 250.69595336914062, 'max_y': 410.3340148925781}	cb622cd6−776d−4681−8a67−4addd61c66b8 Stomach−AdenoCA Cancer type 5:94993806−173860097 Position With other complex events Type 29 Interleaved intrachr. SVs 98 Total SVs (intrachr. + transl.) DEL: 6; DUP: 7; h2hINV: 11; SV types t2tINV: 5; TRA: 69 1322 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 94 CN segments 0.5435077 FDR fragment joints 0 FDR chr. breakp. enrich. 17:2599904−79841998;3:12028186−62799588 Linked to chrs
209	2	Upper_Right	cb622cd6-776d-4681-8a67-4addd61c66b8	6:64442061−96377194	5, 8	8	{'min_x': 327.7699890136719, 'min_y': 280.6499938964844, 'max_x': 538.9576416015625, 'max_y': 410.3340148925781}	cb622cd6−776d−4681−8a67−4addd61c66b8 Stomach−AdenoCA Cancer type 6:64442061−96377194 Position Before polyploidization Type 6 Interleaved intrachr. SVs 6 Total SVs (intrachr. + transl.) DEL: 1; DUP: 3; h2hINV: 1; SV types t2tINV: 1; TRA: 0 1322 SVs in sample 5, 8 Oscillating CN (2 and 3 states) 8 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
209	3	Lower_Left	cb622cd6-776d-4681-8a67-4addd61c66b8	7:75111917−159113377	6, 6	71	{'min_x': 38.269901275634766, 'min_y': 693.2749633789062, 'max_x': 272.2021789550781, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 160 MB cb622cd6−776d−4681−8a67−4addd61c66b8 Stomach−AdenoCA Cancer type 7:75111917−159113377 Position With other complex events Type 14 Interleaved intrachr. SVs 84 Total SVs (intrachr. + transl.) DEL: 5; DUP: 2; h2hINV: 4; SV types t2tINV: 3; TRA: 70 1322 SVs in sample 6, 6 Oscillating CN (2 and 3 states) 71 CN segments 0.8773673 FDR fragment joints 0 FDR chr. breakp. enrich.
209	4	Lower_Right	cb622cd6-776d-4681-8a67-4addd61c66b8	19:16006717−23829529	4, 7	44	{'min_x': 326.5299987792969, 'min_y': 693.2749633789062, 'max_x': 538.9576416015625, 'max_y': 834.6940307617188}	10 MB 20 MB 30 MB 40 MB 50 MB cb622cd6−776d−4681−8a67−4addd61c66b8 Stomach−AdenoCA Cancer type 19:16006717−23829529 Position With other complex events Type 11 Interleaved intrachr. SVs 99 Total SVs (intrachr. + transl.) DEL: 5; DUP: 1; h2hINV: 2; SV types t2tINV: 3; TRA: 88 1322 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 44 CN segments 0.9717738 FDR fragment joints 0 FDR chr. breakp. enrich.
210	1	Upper_Left	e2aaabd9-f4ba-4763-a28a-c14d46a4bc5d	6:1632693−2284818	5, 7	11	{'min_x': 39.039798736572266, 'min_y': 280.6499938964844, 'max_x': 248.68995666503906, 'max_y': 410.3340148925781}	e2aaabd9−f4ba−4763−a28a−c14d46a4bc5d Stomach−AdenoCA Cancer type 6:1632693−2284818 Position With other complex events Type 8 Interleaved intrachr. SVs 8 Total SVs (intrachr. + transl.) DEL: 6; DUP: 0; h2hINV: 1; SV types t2tINV: 1; TRA: 0 565 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 11 CN segments 0.2796253 FDR fragment joints 0.72 FDR chr. breakp. enrich. Linked to chrs
210	2	Upper_Right	e37cae9e-0656-4b89-b326-739a5cc859e0	3:374952−134097822	4, 7	42	{'min_x': 324.8599853515625, 'min_y': 276.3299865722656, 'max_x': 541.8719482421875, 'max_y': 410.3340148925781}	e37cae9e−0656−4b89−b326−739a5cc859e0 Stomach−AdenoCA Cancer type 3:374952−134097822 Position With other complex events Type 17 Interleaved intrachr. SVs 39 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 4; SV types t2tINV: 4; TRA: 22 303 SVs in sample 4, 7 Oscillating CN (2 and 3 states) 42 CN segments 0.615458 FDR fragment joints 0 FDR chr. breakp. enrich. 12:38025321−70035231;7:5548287−146623411 Linked to chrs
210	3	Lower_Left	2b76cc9c-c379-43e4-9c3f-56197a3353be	19:46536637−46823329	5, 5	5	{'min_x': 39.70000076293945, 'min_y': 693.2749633789062, 'max_x': 260.14019775390625, 'max_y': 839.013916015625}	20 MB 30 MB 40 MB 50 MB 2b76cc9c−c379−43e4−9c3f−56197a3353be Uterus−AdenoCA Cancer type 19:46536637−46823329 Position After polyploidization Type 9 Interleaved intrachr. SVs 10 Total SVs (intrachr. + transl.) DEL: 2; DUP: 2; h2hINV: 4; SV types t2tINV: 1; TRA: 1 345 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 5 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
210	4	Lower_Right	2b865f8c-539f-4cb2-8f08-41709e9511e5	5:55406655−175308957	5, 7	13	{'min_x': 330.5400085449219, 'min_y': 693.2749633789062, 'max_x': 558.5418701171875, 'max_y': 839.013916015625}	75 MB 100 MB 125 MB 150 MB 175 MB 2b865f8c−539f−4cb2−8f08−41709e9511e5 Uterus−AdenoCA Cancer type 5:55406655−175308957 Position With other complex events Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 4; DUP: 3; h2hINV: 2; SV types t2tINV: 0; TRA: 2 221 SVs in sample 5, 7 Oscillating CN (2 and 3 states) 13 CN segments 0.7425546 FDR fragment joints 0.51 FDR chr. breakp. enrich.
211	1	Upper_Left	5ffa2ec6-2d94-4b09-8fb9-3591cf38fa4f	7:33023335−53917686	5, 5	24	{'min_x': 42.88010025024414, 'min_y': 280.6499938964844, 'max_x': 244.84996032714844, 'max_y': 410.3340148925781}	5ffa2ec6−2d94−4b09−8fb9−3591cf38fa4f Uterus−AdenoCA Cancer type 7:33023335−53917686 Position With other complex events Type 13 Interleaved intrachr. SVs 20 Total SVs (intrachr. + transl.) DEL: 3; DUP: 3; h2hINV: 2; SV types t2tINV: 5; TRA: 7 137 SVs in sample 5, 5 Oscillating CN (2 and 3 states) 24 CN segments 0.9109641 FDR fragment joints 0 FDR chr. breakp. enrich. Linked to chrs
211	2	Upper_Right	748e38b1-2ead-4a0a-8881-d640617b856b	1:54723498−244586486	5, 6	54	{'min_x': 328.0400085449219, 'min_y': 280.6499938964844, 'max_x': 538.6879272460938, 'max_y': 410.3340148925781}	748e38b1−2ead−4a0a−8881−d640617b856b Uterus−AdenoCA Cancer type 1:54723498−244586486 Position With other complex events Type 11 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 2; DUP: 3; h2hINV: 3; SV types t2tINV: 3; TRA: 8 409 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 54 CN segments 0.615458 FDR fragment joints 0.07 FDR chr. breakp. enrich. Linked to chrs
211	3	Lower_Left	748e38b1-2ead-4a0a-8881-d640617b856b	6:101518828−135926443	4, 5	41	{'min_x': 38.539798736572266, 'min_y': 693.2749633789062, 'max_x': 262.1617736816406, 'max_y': 839.013916015625}	40 MB 80 MB 120 MB 160 MB 748e38b1−2ead−4a0a−8881−d640617b856b Uterus−AdenoCA Cancer type 6:101518828−135926443 Position With other complex events Type 29 Interleaved intrachr. SVs 35 Total SVs (intrachr. + transl.) DEL: 5; DUP: 8; h2hINV: 8; SV types t2tINV: 8; TRA: 6 409 SVs in sample 4, 5 Oscillating CN (2 and 3 states) 41 CN segments 0.9425269 FDR fragment joints 0 FDR chr. breakp. enrich.
211	4	Lower_Right	748e38b1-2ead-4a0a-8881-d640617b856b	8:126280423−138629562	5, 11	16	{'min_x': 307.75, 'min_y': 693.2749633789062, 'max_x': 538.6879272460938, 'max_y': 839.013916015625}	0 MB 50 MB 100 MB 748e38b1−2ead−4a0a−8881−d640617b856b Uterus−AdenoCA Cancer type 8:126280423−138629562 Position With other complex events Type 17 Interleaved intrachr. SVs 19 Total SVs (intrachr. + transl.) DEL: 4; DUP: 5; h2hINV: 3; SV types t2tINV: 5; TRA: 2 409 SVs in sample 5, 11 Oscillating CN (2 and 3 states) 16 CN segments 0.9958447 FDR fragment joints 0 FDR chr. breakp. enrich.
212	1	Upper_Left	af37d8f0-fea0-47f6-be0a-2fb55a5da5c4	1:16306658−167711700	5, 6	15	{'min_x': 42.080101013183594, 'min_y': 280.6499938964844, 'max_x': 245.64794921875, 'max_y': 410.3340148925781}	af37d8f0−fea0−47f6−be0a−2fb55a5da5c4 Uterus−AdenoCA Cancer type 1:16306658−167711700 Position With other complex events Type 15 Interleaved intrachr. SVs 15 Total SVs (intrachr. + transl.) DEL: 4; DUP: 4; h2hINV: 4; SV types t2tINV: 3; TRA: 0 315 SVs in sample 5, 6 Oscillating CN (2 and 3 states) 15 CN segments 0.9905774 FDR fragment joints 0.54 FDR chr. breakp. enrich. Linked to chrs
212	2	Upper_Right	b60f22ac-a659-4f33-b01d-820e86a9a5c9	19:12718468−44715346	6, 10	10	{'min_x': 329.7099914550781, 'min_y': 280.6499938964844, 'max_x': 537.0219116210938, 'max_y': 410.3340148925781}	b60f22ac−a659−4f33−b01d−820e86a9a5c9 Uterus−AdenoCA Cancer type 19:12718468−44715346 Position Canonical without polyploidization Type 9 Interleaved intrachr. SVs 11 Total SVs (intrachr. + transl.) DEL: 2; DUP: 0; h2hINV: 4; SV types t2tINV: 3; TRA: 2 353 SVs in sample 6, 10 Oscillating CN (2 and 3 states) 10 CN segments 0.7425546 FDR fragment joints 0.02 FDR chr. breakp. enrich. Linked to chrs
212	3	Lower_Left	bad34c92-1e64-4187-a0b4-061105fd13ba	17:36816085−74685847	5, 9	38	{'min_x': 36.31990051269531, 'min_y': 693.2749633789062, 'max_x': 248.51995849609375, 'max_y': 839.013916015625}	40 MB 50 MB 60 MB 70 MB bad34c92−1e64−4187−a0b4−061105fd13ba Uterus−AdenoCA Cancer type 17:36816085−74685847 Position With other complex events Type 7 Interleaved intrachr. SVs 13 Total SVs (intrachr. + transl.) DEL: 3; DUP: 2; h2hINV: 1; SV types t2tINV: 1; TRA: 6 315 SVs in sample 5, 9 Oscillating CN (2 and 3 states) 38 CN segments 0.6776251 FDR fragment joints 0 FDR chr. breakp. enrich.
212	4	Lower_Right	c88e3901-f3ee-436a-ba80-143c8eab7d69	8:51305779−141554762	6, 7	78	{'min_x': 309.8699951171875, 'min_y': 693.2749633789062, 'max_x': 551.1421508789062, 'max_y': 834.6940307617188}	40 MB 60 MB 80 MB 100 MB 120 MB 140 MB c88e3901−f3ee−436a−ba80−143c8eab7d69 Uterus−AdenoCA Cancer type 8:51305779−141554762 Position With other complex events Type 31 Interleaved intrachr. SVs 45 Total SVs (intrachr. + transl.) DEL: 6; DUP: 8; h2hINV: 8; SV types t2tINV: 9; TRA: 14 382 SVs in sample 6, 7 Oscillating CN (2 and 3 states) 78 CN segments 0.9161301 FDR fragment joints 0 FDR chr. breakp. enrich.
